Download Complete Issue (12300kb) - Academic Journals
Download Complete Issue (12300kb) - Academic Journals
Download Complete Issue (12300kb) - Academic Journals
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
African Journal of<br />
Microbiology Research<br />
Volume 5 Number 16 18 August, 2011<br />
ISSN 1996-0808
About AJMR<br />
The African Journal of Microbiology Research is published monthly (one volume per year) by <strong>Academic</strong><br />
<strong>Journals</strong>.<br />
The African Journal of Microbiology Research (ISSN 1996-0808, IMPACT FACTOR 0.533) is an open access<br />
journal that provides rapid publication (weekly) of articles in all areas of Microbiology such as: Environmental<br />
Microbiology, Clinical Microbiology, Immunology, Viriology, Bacteriology, Phycology, Mycology and<br />
Parasitology, Protozoology, Microbial Ecology, Probiotics and Prebiotics, Molecular Microbiology,<br />
Biotechnology, Food Microbiology, Industrial Microbiology, Cell Physiology, Environmental Biotechnology,<br />
Genetics, Enzymology, Molecular and Cellular Biology, Plant Pathology, Entomology, Biomedical Sciences,<br />
Botany and Plant Sciences, Soil and Environmental Sciences, Zoology, Endocrinology, Toxicology. The Journal<br />
welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence.<br />
Papers will be published shortly after acceptance. All articles are peer-reviewed.<br />
Submission of Manuscript<br />
Submit manuscripts as e-mail attachment to the Editorial Office at: ajmr@acadjournals.org. A manuscript<br />
number will be mailed to the corresponding author shortly after submission.<br />
The African Journal of Microbiology Research will only accept manuscripts submitted as e-mail attachments.<br />
Please read the Instructions for Authors before submitting your manuscript. The manuscript files should be<br />
given the last name of the first author.
Editors<br />
Prof. Dr. Stefan Schmidt<br />
Applied and Environmental Microbiology<br />
School of Biochemistry, Genetics and Microbiology<br />
University of KwaZulu-Natal<br />
Private Bag X01<br />
Scottsville, Pietermaritzburg 3209<br />
South Africa.<br />
E-mail: ajmr.acadjourn@gmail.com<br />
Prof. Veronica Chima Nwosu (nee Dike)<br />
Department of Microbiology and Immunology<br />
Kunming Medical University<br />
Kunming 650031,<br />
China.<br />
Dr. Jianfeng Wu<br />
Dept. of Environmental Health Sciences,<br />
School of Public Health,<br />
University of Michigan<br />
USA<br />
Dr. Ahmet Yilmaz Coban<br />
OMU Medical School,<br />
Department of Medical Microbiology,<br />
Samsun,<br />
Turkey.
Editorial Board<br />
Dr. Kwang Young Song<br />
Department of Biological Engineering,<br />
School of Biological and Chemical Engineering,<br />
Yanbian Universityof Science and Technology,<br />
Yanji,<br />
China.<br />
Dr. Kamel Belhamel<br />
Faculty of Technology,<br />
University of Bejaia<br />
Algeria.<br />
Dr. Sladjana Jevremovic<br />
Institute for Biological Research<br />
Sinisa Stankovic,<br />
Belgrade,<br />
Serbia.<br />
Dr. Tamer Edirne<br />
Dept. of Family Medicine, Univ. of Pamukkale<br />
Turkey.<br />
Dr. R. Balaji Raja M.Tech (Ph.D)<br />
Assistant Professor,<br />
Department of Biotechnology,<br />
School of Bioengineering,<br />
SRM University,<br />
Chennai.<br />
India<br />
Dr. Mohd Fuat ABD Razak<br />
Institute for Medical Research<br />
Malaysia.<br />
Dr. Minglei Wang<br />
University of Illinois at Urbana-Champaign<br />
USA.<br />
Dr. Davide Pacifico<br />
Istituto di Virologia Vegetale – CNR<br />
Italy.<br />
Prof. Branislava Kocic<br />
Specaialist of Microbiology and Parasitology<br />
University of Nis, School of Medicine Institute<br />
for Public Health Nis, Bul. Z. Djindjica 50, 18000 Nis<br />
Serbia.<br />
Dr. Ntobeko A. B. Ntusi<br />
Cardiac Clinic, Department of Medicine,<br />
University of Cape Town and<br />
Department of Cardiovascular Medicine,<br />
University of Oxford<br />
South Africa and<br />
United Kingdom.<br />
Prof. N. S. Alzoreky<br />
Food Science & Nutrition Department,<br />
College of Agricultural Sciences & Food,<br />
King Faisal University,<br />
Saudi Arabia.<br />
Dr. Sivakumar Swaminathan<br />
Department of Agronomy,<br />
College of Agriculture and Life Sciences,<br />
Iowa State University,<br />
Ames, Iowa 50011<br />
USA.<br />
Dr. Alfredo J. Anceno.<br />
School of Environment, Resources and Development (SERD),<br />
Asian Institute of Technology,<br />
Thailand.<br />
Dr. Okonko, Iheanyi Omezuruike<br />
Department of Virology,<br />
Faculty of Basic Medical Sciences,<br />
College of Medicine,<br />
University of Ibadan,<br />
University College Hospital,<br />
Ibadan,<br />
Nigeria.<br />
Dr. S. Meena Kumari<br />
Department of Biosciences<br />
Faculty of Science<br />
University of Mauritius<br />
Reduit<br />
Mauritius.<br />
Luki Subehi<br />
Parasitology & Mycology Dept,<br />
Baghaeei Lab.,<br />
Shams Abadi St.<br />
Isfahan<br />
Iran.
Electronic submission of manuscripts is strongly<br />
encouraged, provided that the text, tables, and figures are<br />
included in a single Microsoft Word file (preferably in Arial<br />
font).<br />
The cover letter should include the corresponding author's<br />
full address and telephone/fax numbers and should be in<br />
an e-mail message sent to the Editor, with the file, whose<br />
name should begin with the first author's surname, as an<br />
attachment.<br />
Article Types<br />
Three types of manuscripts may be submitted:<br />
Regular articles: These should describe new and carefully<br />
confirmed findings, and experimental procedures should<br />
be given in sufficient detail for others to verify the work.<br />
The length of a full paper should be the minimum required<br />
to describe and interpret the work clearly.<br />
Short Communications: A Short Communication is suitable<br />
for recording the results of complete small investigations<br />
or giving details of new models or hypotheses, innovative<br />
methods, techniques or apparatus. The style of main<br />
sections need not conform to that of full-length papers.<br />
Short communications are 2 to 4 printed pages (about 6 to<br />
12 manuscript pages) in length.<br />
Reviews: Submissions of reviews and perspectives covering<br />
topics of current interest are welcome and encouraged.<br />
Reviews should be concise and no longer than 4-6 printed<br />
pages (about 12 to 18 manuscript pages). Reviews are also<br />
peer-reviewed.<br />
Review Process<br />
Instructions for Author<br />
All manuscripts are reviewed by an editor and members of<br />
the Editorial Board or qualified outside reviewers. Authors<br />
cannot nominate reviewers. Only reviewers randomly<br />
selected from our database with specialization in the<br />
subject area will be contacted to evaluate the manuscripts.<br />
The process will be blind review.<br />
Decisions will be made as rapidly as possible, and the<br />
journal strives to return reviewers’ comments to authors as<br />
fast as possible. The editorial board will re-review<br />
manuscripts that are accepted pending revision. It is the<br />
goal of the AJMR to publish manuscripts within weeks<br />
after submission.<br />
Regular articles<br />
All portions of the manuscript must be typed doublespaced<br />
and all pages numbered starting from the title<br />
page.<br />
The Title should be a brief phrase describing the<br />
contents of the paper. The Title Page should include the<br />
authors' full names and affiliations, the name of the<br />
corresponding author along with phone, fax and E-mail<br />
information. Present addresses of authors should<br />
appear as a footnote.<br />
The Abstract should be informative and completely selfexplanatory,<br />
briefly present the topic, state the scope of<br />
the experiments, indicate significant data, and point out<br />
major findings and conclusions. The Abstract should be<br />
100 to 200 words in length.. <strong>Complete</strong> sentences, active<br />
verbs, and the third person should be used, and the<br />
abstract should be written in the past tense. Standard<br />
nomenclature should be used and abbreviations should<br />
be avoided. No literature should be cited.<br />
Following the abstract, about 3 to 10 key words that will<br />
provide indexing references should be listed.<br />
A list of non-standard Abbreviations should be added.<br />
In general, non-standard abbreviations should be used<br />
only when the full term is very long and used often.<br />
Each abbreviation should be spelled out and introduced<br />
in parentheses the first time it is used in the text. Only<br />
recommended SI units should be used. Authors should<br />
use the solidus presentation (mg/ml). Standard<br />
abbreviations (such as ATP and DNA) need not be<br />
defined.<br />
The Introduction should provide a clear statement of<br />
the problem, the relevant literature on the subject, and<br />
the proposed approach or solution. It should be<br />
understandable to colleagues from a broad range of<br />
scientific disciplines.<br />
Materials and methods should be complete enough<br />
to allow experiments to be reproduced. However, only<br />
truly new procedures should be described in detail;<br />
previously published procedures should be cited, and<br />
important modifications of published procedures should<br />
be mentioned briefly. Capitalize trade names and<br />
include the manufacturer's name and address.<br />
Subheadings should be used. Methods in general use<br />
need not be described in detail.
Results should be presented with clarity and precision.<br />
The results should be written in the past tense when<br />
describing findings in the authors' experiments.<br />
Previously published findings should be written in the<br />
present tense. Results should be explained, but largely<br />
without referring to the literature. Discussion,<br />
speculation and detailed interpretation of data should<br />
not be included in the Results but should be put into the<br />
Discussion section.<br />
The Discussion should interpret the findings in view of<br />
the results obtained in this and in past studies on this<br />
topic. State the conclusions in a few sentences at the end<br />
of the paper. The Results and Discussion sections can<br />
include subheadings, and when appropriate, both<br />
sections can be combined.<br />
The Acknowledgments of people, grants, funds, etc<br />
should be brief.<br />
Tables should be kept to a minimum and be designed to<br />
be as simple as possible. Tables are to be typed doublespaced<br />
throughout, including headings and footnotes.<br />
Each table should be on a separate page, numbered<br />
consecutively in Arabic numerals and supplied with a<br />
heading and a legend. Tables should be self-explanatory<br />
without reference to the text. The details of the methods<br />
used in the experiments should preferably be described<br />
in the legend instead of in the text. The same data should<br />
not be presented in both table and graph form or<br />
repeated in the text.<br />
Figure legends should be typed in numerical order on a<br />
separate sheet. Graphics should be prepared using<br />
applications capable of generating high resolution GIF,<br />
TIFF, JPEG or Powerpoint before pasting in the Microsoft<br />
Word manuscript file. Tables should be prepared in<br />
Microsoft Word. Use Arabic numerals to designate<br />
figures and upper case letters for their parts (Figure 1).<br />
Begin each legend with a title and include sufficient<br />
description so that the figure is understandable without<br />
reading the text of the manuscript. Information given in<br />
legends should not be repeated in the text.<br />
References: In the text, a reference identified by means<br />
of an author‘s name should be followed by the date of<br />
the reference in parentheses. When there are more than<br />
two authors, only the first author‘s name should be<br />
mentioned, followed by ’et al‘. In the event that an<br />
author cited has had two or more works published during<br />
the same year, the reference, both in the text and in the<br />
reference list, should be identified by a lower case letter<br />
like ’a‘ and ’b‘ after the date to distinguish the works.<br />
Examples:<br />
Abayomi (2000), Agindotan et al. (2003), (Kelebeni,<br />
1983), (Usman and Smith, 1992), (Chege, 1998;<br />
1987a,b; Tijani, 1993,1995), (Kumasi et al., 2001)<br />
References should be listed at the end of the paper in<br />
alphabetical order. Articles in preparation or articles<br />
submitted for publication, unpublished observations,<br />
personal communications, etc. should not be included<br />
in the reference list but should only be mentioned in<br />
the article text (e.g., A. Kingori, University of Nairobi,<br />
Kenya, personal communication). Journal names are<br />
abbreviated according to Chemical Abstracts. Authors<br />
are fully responsible for the accuracy of the references.<br />
Examples:<br />
Chikere CB, Omoni VT and Chikere BO (2008).<br />
Distribution of potential nosocomial pathogens in a<br />
hospital environment. Afr. J. Biotechnol. 7: 3535-3539.<br />
Moran GJ, Amii RN, Abrahamian FM, Talan DA (2005).<br />
Methicillinresistant Staphylococcus aureus in<br />
community-acquired skin infections. Emerg. Infect. Dis.<br />
11: 928-930.<br />
Pitout JDD, Church DL, Gregson DB, Chow BL,<br />
McCracken M, Mulvey M, Laupland KB (2007).<br />
Molecular epidemiology of CTXM-producing<br />
Escherichia coli in the Calgary Health Region:<br />
emergence of CTX-M-15-producing isolates.<br />
Antimicrob. Agents Chemother. 51: 1281-1286.<br />
Pelczar JR, Harley JP, Klein DA (1993). Microbiology:<br />
Concepts and Applications. McGraw-Hill Inc., New York,<br />
pp. 591-603.<br />
Short Communications<br />
Short Communications are limited to a maximum of<br />
two figures and one table. They should present a<br />
complete study that is more limited in scope than is<br />
found in full-length papers. The items of manuscript<br />
preparation listed above apply to Short<br />
Communications with the following differences: (1)<br />
Abstracts are limited to 100 words; (2) instead of a<br />
separate Materials and Methods section, experimental<br />
procedures may be incorporated into Figure Legends<br />
and Table footnotes; (3) Results and Discussion should<br />
be combined into a single section.<br />
Proofs and Reprints: Electronic proofs will be sent (email<br />
attachment) to the corresponding author as a PDF<br />
file. Page proofs are considered to be the final version<br />
of the manuscript. With the exception of typographical<br />
or minor clerical errors, no changes will be made in the<br />
manuscript at the proof stage.
Fees and Charges: Authors are required to pay a $550 handling fee. Publication of an article in the African Journal of<br />
Microbiology Research is not contingent upon the author's ability to pay the charges. Neither is acceptance to pay the<br />
handling fee a guarantee that the paper will be accepted for publication. Authors may still request (in advance) that<br />
the editorial office waive some of the handling fee under special circumstances.<br />
Copyright: © 2012, <strong>Academic</strong> <strong>Journals</strong>.<br />
All rights Reserved. In accessing this journal, you agree that you will access the contents for your own personal use<br />
but not for any commercial use. Any use and or copies of this Journal in whole or in part must include the customary<br />
bibliographic citation, including author attribution, date and article title.<br />
Submission of a manuscript implies: that the work described has not been published before (except in the form of an<br />
abstract or as part of a published lecture, or thesis) that it is not under consideration for publication elsewhere; that if<br />
and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the<br />
publisher.<br />
Disclaimer of Warranties<br />
In no event shall <strong>Academic</strong> <strong>Journals</strong> be liable for any special, incidental, indirect, or consequential damages of any<br />
kind arising out of or in connection with the use of the articles or other material derived from the AJMR whether or<br />
not advised of the possibility of damage, and on any theory of liability.<br />
This publication is provided "as is" without warranty of any kind, either expressed or implied, including, but not<br />
limited to, the implied warranties of merchantability, fitness for a particular purpose, or non-infringement.<br />
Descriptions of, or references to, products or publications does not imply endorsement of that product or publication.<br />
While every effort is made by <strong>Academic</strong> <strong>Journals</strong> to see that no inaccurate or misleading data, opinion or statements<br />
appear in this publication, they wish to make it clear that the data and opinions appearing in the articles and<br />
advertisements herein are the responsibility of the contributor or advertiser concerned. <strong>Academic</strong> <strong>Journals</strong> makes no<br />
warranty of any kind, either express or implied, regarding the quality, accuracy, availability, or validity of the data or<br />
information in this publication or of any other publication to which it may be linked.
International African Journal Journal of Medicine of Microbiology and Medical Research Sciences<br />
Table of Contents: Volume 5 Number 16 18 August, 2011<br />
nces<br />
Research Articles<br />
ARTICLES<br />
Isolation and characterization of a psychrophilic bacterium producing cold<br />
active lactose hydrolyzing enzyme from soil of Mt. Himalaya in Nepal 2198<br />
E. S. Nam, Y. H. Kim, K. H. Shon, and J. K. Ahn<br />
Nigerian phages: The first bacteriophages from Tropical Africa 2207<br />
Adeniran S. Koko, Hans W. Ackermann, Monisola A. Taiwo<br />
and Sunday A. Omilabu<br />
Evaluation of real-time PCR for Mycobacterium ulcerans in endemic region<br />
in Côte d’Ivoire 2211<br />
Elise Solange Ngazoa-Kakou, Euloge Ekaza, Nguetta Aka, David<br />
Coulibaly-N’Golo1, Bakary Coulibaly and Mireille Dosso<br />
Contamination of cattle carcasses by Escherichia coli shiga like toxin with<br />
high antimicrobials resistence 2217<br />
Everlon Cid Rigobelo, Renato Pariz Maluta, Clarissa Araújo Borges,<br />
Lívia Gerbasi Beraldo, Manoel Victor Franco, Lemos Sirlei<br />
Aparecida Maestá and Fernando Antonio de Ávila<br />
Determination of insecticidal toxicity of three species of entomopathogenic<br />
spore-forming bacterial isolates against Tenebrio molitor L. (Coleoptera:<br />
Tenebrionidae) 2222<br />
N. Du Rand and M. D. Laing<br />
What changed in necrotizing fasciitis in twenty-five years? 2229<br />
Baris Yildiz, Derya Karakoc, Erhan Hamaloglu, Arif Ozdemir<br />
and Ahmet Ozenc
Table of Contents: Volume 5 Number 16 18 August, 2011<br />
Table of Content: Volume 6 Number 23 21 June, 2012<br />
nces<br />
ARTICLES<br />
ARTICLES<br />
Aspects of bacterial colonization in newborn babies 2234<br />
Fariba Heshmati, Seyeed Amir Yazdanparast , Seyeed Akbar Moosavi ,<br />
Influence of ciprofloxacin on glioma cell line GL26: A new application for<br />
Hussein Dargahi, and Farnaz Tabibzadeh<br />
an old antibiotic<br />
Abdolreza Esmaeilzadeh, Massoumeh Ebtekar, Alireza Biglari and<br />
Zuhair Mohammad Hassan 4891<br />
Evaluation of anticarcinogenicity effect of Artemia urmiana by Salmonella<br />
typhimurium TA 100 strain 2241<br />
Masumeh Abbasi, Saman Mahdavi and Sedigheh Mehrabian<br />
Identification of microbial diversity in caecal content of broiler chicken<br />
S. Nathiya, G. Dhinakar Raj, A. Rajasekar, D. Vijayalakshmi and T. Devasena 4897<br />
mRNA expression of iron metabolism relation genes in macrophages by<br />
infection with Salmonella typhimurium 2245<br />
Microbial quality of some non-sterile pharmaceutical products sourced<br />
Pan Xin<br />
from some retail pharmacies in Lagos, Nigeria<br />
Adeola Anifowoshe R., Opara Morrison I. and Adeleye Isaac A. 4903<br />
Expanding drug resistance through integron acquisition in Salmonella spp.<br />
isolates obtained in Iran 2249<br />
Molecular detection of adhesins genes and biofilm formation in methicillin<br />
Bahareh Rajaei, Seyed Davar Siadat, Mohamad Reza Razavi,<br />
resistant Staphylococcus aureus<br />
Mohammad Reza Aghasadeghi, Nahid Sepehri Rad, Farzad Badmasti,<br />
Karima BEKIR, Omayma HADDAD, Mohammed GRISSA, Kamel CHAIEB,<br />
Somieh Khanjani Jafroodi, Taraneh Rajaei, Arfa Moshiri, Saifuddin Javadian<br />
Amina BAKHROUF and Salem IBRAHIM ELGARSSDI 4908<br />
The synthesis and role of hydroxyectoine in halophilic bacterium<br />
Amylase production by moderately halophilic Bacillus cereus in solid<br />
Halomonas ventosae DL7 2254<br />
state fermentation<br />
Daochen Zhu, Chenxiang Wang, Shoko Hosoi-Tanabe,<br />
P. Vijayabaskar, D. Jayalakshmi and T. Shankar 4918<br />
Weimin Zhang and Shinichi Nagata<br />
Networking clusters and sequence characteristics of clustered regularly<br />
Virulence and characteristics of a new nucleopolyhedrovirus strain of<br />
interspaced short palindromic repeats (CRISPR) direct repeats and their<br />
Dendrolimus kikuchii (Lepidoptera: Lasiocampidae) 2261<br />
evolutionary comparison with cas1 genes in lactic acid bacteria<br />
Miao Miao Yang, Meng Lou Li, Yu Zhu Wang, Liang Jian Qu, Ke Yue Huai,<br />
Kaibo Deng, Fei Liu, Chuntao Gu and Guicheng Huo 4927<br />
Xue Wen Nie, Lu Qin Qiao, Jin Ying Ding and Yong An Zhang<br />
Characterization of Staphylococcus spp strains isolated from hospital,<br />
Antibacterial screening of the root, stem and leaf extracts of Terminalia albida sc.<br />
community and environmental in Puebla city, Mexico 2266<br />
elliot on selected pathogenic bacteria<br />
Ana Marta de los Ángeles Lobo-Sánchez, Patricia Lozano-Zaraín,<br />
S. M. Ayodele, G. Alpheus and O. M. Iruaga 1457<br />
Ygnacio Martínez-Laguna, Zita Gutiérrez-Cázarez, Antonio Rivera-Tapia,<br />
Carmen Torres and Rosa del Carmen Rocha-Gracia
Table of Contents: Volume 5 Number 16 18 August, 2011<br />
nces<br />
ARTICLES<br />
Interaction of severe acute respiratory syndrome (SARS) nucleocapsid<br />
protein with macrophage migration inhibitory factor protein (MIF) 2273<br />
Yang Lin, Baohua Wang, Yijun Liu, Zhigang Yu, Manhua Cui and Haichun Ma<br />
Isolation and characterization of high caffeine-tolerant bacterium strains<br />
from the soil of tea garden 2278<br />
Fang-Yuan Fan, Yan Xu, Yue-Rong Liang, Xin-Qiang Zheng,<br />
Devajit Borthakur and Jian-Liang Lu<br />
Biopreservative potential of marine Lactobacillus spp 2282<br />
K. Indira, S. Jayalakshmi, A. Gopalakrishnan and M. Srinivasan<br />
Ephedra alata as biologically-based strategy inhibit aflatoxigenic<br />
seedborne mold 2297<br />
Al-Qarawi, A. A., Abd_Allah, E. F. and Hashem Abeer<br />
Primary resistance rates of Mycobacterium tuberculosis complex strains<br />
isolated from new tuberculosis cases: A 6-year observation 2304<br />
Servet Kayhan, Alper Akgüneş, Hikmet Tereci and Ümit Tutar<br />
Cytokine genes expression in mice hepatocytes during malaria infection 2311<br />
Saad Alkahtani, AL-Farraj S. A., Saud A. Alarifi, AL-Eissa Mohammed saad<br />
and Al-Dahmash B
Table of Contents: Volume 5 Number 16 18 August, 2011<br />
nces<br />
ARTICLES<br />
Phylogenetic analysis of the nematicidal actinobacteria from agricultural<br />
soil of China 2316<br />
Xu Chuan Kun, Lou Xiao Jun, Xi Jia Qin, Gu Lei, Duan Chang Qun, Mo Ming He,<br />
Zhang Ke Qin, Yang Fa Xiang and Fang Dun Huang<br />
A new recommended disinfectant for dental instruments 2325<br />
Jamileh bigom Taheri, Mahin Bakhshi, Sedigheh Bakhtiari, Bahare Nazemi,<br />
Fateme Fallah, Sahand Rezaie, Hamed Mortazavi and Somayyeh Azimi<br />
The functional roles of the residue tyrosine at position 26 in staphylococcal<br />
enterotoxin C2 2329<br />
Hongbo Wang, Junyi Zhou, Mingkai Xu, Huiwen Zhang and Chenggang Zhang<br />
Prevalence study of cytomegalovirus (CMV) infection among foreign<br />
manpower in Jeddah Saudi Arabia 2338<br />
N. A. Redwan, M. M. M. Ahmed and M. S. H. AL Awfi<br />
Antibacterial and cytotoxic activity of Eremurus persicus<br />
(Jaub and Spach) Boiss 2349<br />
Mojdeh Hakemi Vala, Jinous Asgarpanah, Mohammad Hossein Hedayati,<br />
Jeilan Shirali and Fatemeh Bagheri Bejestani<br />
Optimization of ultrasound-assisted extraction conditions using orthogonal<br />
matrix design to enhance the antimicrobial activity of extracts from<br />
Cichorium intybus root 2353<br />
Quanzhen Wang, Haitao Liu, Jinhong Du, Jian Cui, Guo Chen and Yuyan Liu
Table of Contents: Volume 5 Number 16 18 August, 2011<br />
nces<br />
ARTICLES<br />
Optimization of the production of exopolysaccharides by Bacillus thuringiensis<br />
27 in sand biological soil crusts and its bioflocculant activity 2359<br />
Z. R. Wang, J. P. Sheng, X. L. Tian, T. T. Wu, W. Z. Liu and L. Shen<br />
A simple and efficient method that uses low concentration fetal bovine<br />
serum to culture and purify Schwann cells 2367<br />
Han Feng, Qu Wei, Jiang Huajun, Fu Chongyang, Lu Ming, Zhang Weiguo and<br />
Lv Decheng<br />
First report on Enterobacter sakazakii from Sudanese patients 2374<br />
Humodi A. Saeed and Rania M. Musallam<br />
In search of enteroviruses in water media in Marrakech 2380<br />
Amina Hssaine, Jawhar Gharbi, Rafik Harrath, Rajae Harrak,<br />
Abderrahman Chait, Mahjoub Aouni and Jamal Hafid<br />
Laboratory analysis of a fatal meningococcal case due to serogroup B<br />
Neisseria meningitidis belonging to ST- 4821 complex 2385<br />
Zengguo Wang, Tiejun Hou, Zhijun Chen, Jinsong Li, Shouzhi Wu,<br />
Xiaoguang Wei, Yahui Sun and Quanli Du<br />
Genotyping of Hepatitis C virus (HCV) in infected patients from Saudi Arabia 2388<br />
Mohammed Ali M. Marie
African Journal of Microbiology Research Vol. 5(16), pp. 2198-2206, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR10.609<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Isolation and characterization of a psychrophilic<br />
bacterium producing cold active lactose hydrolyzing<br />
enzyme from soil of Mt. Himalaya in Nepal<br />
E. S. Nam 1 , Y. H. Kim 2 , K. H. Shon 2 , and J. K. Ahn 2 *<br />
1 Department of Chemical and Biomolecular Engineering, Sogang University, Seoul 121-742, Republic of Korea.<br />
2 Department of Agricultural Sciences, Korea National Open University, Seoul 110-791, Republic of Korea.<br />
Accepted 18 February, 2011<br />
Psychrophilic bacteria, which grew on lactose as a carbon source, were isolated from soil of Island<br />
Peak area at Mt. Himalaya in Nepal, and identified. 148 bacterial isolates were isolated via X-gal<br />
hydrolysis on plate. Among these, three isolates, referred to as KNOUC 401, 402 and 403, displayed<br />
good cold-adapted growth and activity for hydrolysis of o-nitrophenyl- -D-galactopyranoside (ONPG)<br />
and lactose in cell free extracts. Strain KNOUC403 showing negative activity in -hemolysis was<br />
selected and identified. The strain was gram-positive bacilli, non-motile, catalase-positive and aerobic.<br />
Optimum growth was done at 20°C and pH 6.5~6.8. Anteiso-C15:0 (68.14%) was predominant in the fatty<br />
acid composition of cell. The physiological and biochemical properties, cellular fatty acid composition<br />
and sequence of 16S rDNA, suggest that strain KNOUC403 indicate a taxonomic affiliation to<br />
Arthrobacter psychrolactophilus. The optimal conditions for ONPG hydrolysis of cell free extracts from<br />
the strain were 15°C and pH 6.0, and the enzyme was stable at 4°C for 42 h. Zymogram assay of cell free<br />
extract from the strain in nondenaturing polyacrylamide gel showed a distinct band of X-gal hydrolysis.<br />
Key words: Psychrophilic bacteria, Arthrobacter psychrolactophilus, cold-active lactose hydrolyzing enzyme,<br />
Mt. Himalaya.<br />
INTRODUCTION<br />
Recently a wide diversity of cold adapted microorganisms<br />
have been found in various cold environments<br />
(Groudieva et al., 2004), and their enzymes attracted<br />
interests because of their biotechnological potential<br />
offering economical and ecological advantages such as<br />
energy saving, function in cold environment, minimizing<br />
undesirable chemical reactions that occur at high<br />
temperature, and inactivating easily by heating when<br />
required (Russell, 1988; Margesin and Schinner, 1999;<br />
Margesin et al., 2002; Cavicchioli et al., 2002). Owing to<br />
the fact that cold completely penetrates microorganisms,<br />
all components including enzymes of psychrophiles living<br />
in cold environment must be suitably adapted. Therefore<br />
psychrophiles can produce cold adapted enzymes which<br />
*Corresponding author. E-mail: ajk@knou.ac.kr. Tel: +82-2<br />
3668-4630. Fax: +82-2-3668-4187.<br />
are highly flexible in structure enabling increased<br />
complementarity between the active site and substrate at<br />
a low energy cost resulting in high catalytic activity at low<br />
temperature and labile at elevated temperature<br />
(Cavicchioli et al., 2002). A variety of useful cold active<br />
enzymes have been found in psychrophiles (Feller et al.,<br />
1997; Marshall, 1997; Gerday et al., 2000; Groudieva et<br />
al., 2004).<br />
Cold active enzymes are attractive in food industry, e.g.<br />
processing of fruit juices and milk, as there is an<br />
increasing industrial trend to treat foodstuffs under low<br />
temperature conditions in order to avoid changes in taste<br />
and nutritional value, and to save energy (Margesin and<br />
Schinner, 1994; Russel, 1998). Cold active enzyme<br />
hydrolyzing lactose to glucose and galactose at<br />
refrigerating temperature is an important food-industrial<br />
enzyme, because it can be used to produce lactose<br />
hydrolyzed milk for the lactose intolerant people, and can<br />
also be used to convert lactose in whey, a by-product of
cheese industry, to more readily fermentable glucose and<br />
galactose. Until now, some psychrophilic bacteria<br />
producing -galactosidase have been reported, but none<br />
of them have been hitherto used practically in the food<br />
industry, meaning that more study is required to find<br />
better microbial source. The aim of this study was to<br />
isolate a psychrophilic bacterium, from Mt. Himalaya of<br />
Nepal, producing the cold-active lactose hydrolyzing<br />
enzyme practically useful in food industry.<br />
MATERIALS AND METHODS<br />
Isolation and cultivation condition of microorganisms<br />
A soil sample was collected from each of the 39 regions of Island<br />
Peak area (27°55'N, 86°56'E) of 4,500 to 6,000 m height in Mt.<br />
Himalaya of Nepal by using sterilized awls, sterilized spoons and<br />
sterilized Falcon tubes. To cultivate the psychrophilic bacteria, 5 g<br />
of soil samples were added to 45 ml of Brain heart infusion (BHI;<br />
Difco Laboratories, Detroit, Mich) broth containing 1% (w/v) lactose,<br />
and incubated at 4°C aerobically by shaking (200 rpm) for 30 days.<br />
1 ml of cells grown in this enrichment were spread onto BHI agar<br />
containing 1% (w/v) lactose and 0.01% (w/v) 5-bromo-4-chloro-3indolyl-<br />
-D-galactopyranoside (X-gal; Duchefa Biochemei, Holland).<br />
After incubation at 4°C for 15 days, blue colonies were selected,<br />
then cultivated in brain heart infusion broth or agar for identification<br />
and determining properties of lactose hydrolyzing enzyme.<br />
Morphological, biochemical and physiological properties<br />
Isolates showing good growth and good X-gal hydrolysis on BHI<br />
agar, and high activity for hydrolysis of ONPG and lactose were<br />
investigated for Gram staining, morphological, biochemical, and<br />
physiological properties. Cell was grown in BHI broth to determine<br />
growth conditions of various temperatures (5 to 40°C) and pH (4.0<br />
to 8.0). pH of media was adjusted with HCl or NaOH. Acid<br />
production from carbohydrate and utilization of sole carbon sources<br />
were determined using API 20E and API 50CH test strips (Bio-<br />
Merieux Inc., France). For the test of hemolysis, a colony was<br />
streaked on sheep blood agar (KOMED. Co. Ltd). After incubation<br />
at 15°C for 3 days, -hemolytic activity was detected by lysis and<br />
complete digestion of red blood cell contents surrounding colony. All<br />
biochemical and physiological tests were done at 15°C for 3 days<br />
Composition of cellular fatty acid<br />
The cell biomass for cellular fatty acid composition analysis was<br />
collected from BHI agar plates after incubation at 15°C for 3 days.<br />
Cells were harvested, and the cellular fatty acids were saponified,<br />
methylated and extracted, following the instructions in the manual<br />
for Sherlock Microbial Identification System (MIDI, USA). The fatty<br />
acids were analyzed by gas chromatography (Hewlett Packard<br />
6890, USA) and identified using the microbial identification software<br />
package (Sasser, 1990).<br />
16S rDNA sequence determination and phylogenetic analysis<br />
Isolation of genomic DNA, PCR amplification of the 16S rDNA gene<br />
and sequencing of the purified PCR product were carried out as<br />
described by Rainey et al. (1996). Universal primers of fD1 (5’gagtttgatcctggctcag-3’)<br />
and rD1 (5’-agaaaggaggtgatccagcc-3’) were<br />
used for PCR. PCR product was purified by ethanol precipitation,<br />
Nam et al. 2199<br />
and sequenced with a model 377 Genetic Analyzer (Perkin-Elmer<br />
Co.). The 16S rDNA sequence obtained in this study was aligned<br />
against the previously determined sequences of the genus of<br />
Arthrobacter available from the Ribosomal Database Project<br />
(Maidak et al., 1996). The phylogenetic tree for the data set was<br />
inferred using the neighbor-joining method (Saitou and Nei, 1987).<br />
The PHYLIP package (Felsentein, 1993) was used for constructing<br />
the tree.<br />
Assay of lactose hydrolyzing enzyme activity<br />
Microorganism was cultivated at 4°C aerobically by shaking (200<br />
rpm) for 7 days to the late of log phase, and harvested by<br />
centrifugation at 8,000 X g for 10 min at 4°C, suspended in sodium<br />
phosphate buffer (0.01 M, pH 6.8), washed 2 times by the same<br />
buffer, suspended in the same buffer, and sonificated at 4°C. Cell<br />
debris was eliminated by centrifugation at 12,000 g and 4°C for 20<br />
min. The cell free extracts were used for assay of lactose<br />
hydrolyzing enzyme. Lactose hydrolyzing enzyme activity was<br />
determined by measuring the rate of hydrolysis of o-nitrophenyl β-<br />
D-galactopyranoside (ONPG) or lactose as substrate. The<br />
procedure of Miller (1972) for hydrolysis of ONPG was used. An<br />
aliquot of cell free extracts (0.5 ml) was added to 2.5 ml of ONPG<br />
(0.04 M) dissolved in sodium phosphate buffer (0.01 M, pH 6.8) and<br />
incubated at 4°C for 2 h. The reaction was stopped by addition of 3<br />
ml of 0.5 M Na2CO3 dissolved in H2O and the absorbance at 420<br />
nm was measured.<br />
One unit of enzyme activity for hydrolysis of ONPG was defined<br />
as the activity hydrolyzing 1 mol of ONPG per min by cell free<br />
extract from 1 ml of culture that was concentrated to 8 of A600. The<br />
hydrolysis of lactose was assayed by measuring the release of<br />
glucose from lactose. The reaction mixture consisted of 1.6 ml of<br />
skim milk (lactose conc., 4.7%) and 0.4 ml of cell free extracts. The<br />
mixture was incubated at 4°C for 5 days followed by heating in<br />
boiling water for 2 min. After centrifugation, glucose concentration in<br />
the supernatant was determined by the colorimetric method with a<br />
commercial Glucose C-II test kit (Wako Chemical Co., Japan) at<br />
505 nm. One unit of enzyme activity for hydrolysis of lactose is the<br />
activity of hydrolyzing 1 mol of lactose per day by cell free extracts<br />
from 1 ml of culture that was concentrated to 8 of A600 . Zymogram<br />
assay for the cell free extracts of a selected strain was performed.<br />
After native-PAGE of cell free extracts on 10% (w/v) polyacrylamide<br />
gel (Laemmli, 1970), the gel was stained with 0.25 mM X-gal<br />
(Trimbur et al., 1994) at 4°C for 2 h. Hydrolysis of X-Gal was<br />
confirmed by blue band within the polyacrylamide gel.<br />
Effect of temperature and pH on lactose hydrolyzing enzyme<br />
The effect of temperature on the activity of cell free extracts for<br />
ONPG hydrolysis was analyzed by measuring the enzyme activity<br />
at various temperatures (5 to 40°C) in sodium phosphate buffer<br />
(0.01 M, pH 6.8). Effect of pH on enzyme activity was evaluated at<br />
pH ranging from 4.3 to 7.8 at 4°C was used for the pH from 4.3 to<br />
6.0, and Na-phosphates buffer (0.01 M) was used for the pH from<br />
6.0 to 7.8. Stability of enzyme was investigated by residual activity<br />
during incubation of cell free extracts in sodium phosphate buffer<br />
(0.01 M, pH 6.8) for 42 h at 4 and 37°C.<br />
RESULTS<br />
Isolation of strain producing cold active lactose<br />
hydrolyzing enzyme<br />
Psychrophilic bacteria, which grow and hydrolyze lactose
2200 Afr. J. Microbiol. Res.<br />
Table 1. Physiological and biochemical properties of isolated strains.<br />
Characteristics<br />
Strains<br />
KNOUC401 KNOUC402 KNOUC403<br />
Gram staining - + +<br />
Shape Rod Rod Rod<br />
Motility - + -<br />
Spore formation - + -<br />
Optimum temp for growth 20°C 20°C 20°C<br />
Optimum pH for growth 6.8 6.5-6.8 6.5-6.8<br />
Growth at 4°C + + +<br />
Growth at 37°C + + -<br />
Catalase + + +<br />
Oxidase + + -<br />
ONPG hydrolysis + + +<br />
PNPG hydrolysis + + +<br />
Nitrate reduction - - -<br />
Gas production + - -<br />
H2S formation - - -<br />
Citrate utilization + - -<br />
Growth on MacConkey agar + - -<br />
Utilization of<br />
D-glucose + + +<br />
D-mannitol - - -<br />
D-maltose + + -<br />
D-rhamnose + + -<br />
D-mannose - - -<br />
D-galactose - - -<br />
D-lactose + + +<br />
D-fructose - - -<br />
D-adonitol - + -<br />
D-raffinose + + -<br />
D-sorbitol + + -<br />
Sucrose + - -<br />
Xylitol + + -<br />
Ducitol + + +<br />
Gelatin - - -<br />
Sorbose - - +<br />
Glycerol + + -<br />
Erythrol - - -<br />
Genus Aeromonas Bacillus Arthrobacter<br />
+, Positive reaction; -, Negative reaction.<br />
at low temperature, were isolated from the soil of Island<br />
Peak area at Mt. Himalaya in Nepal. 148 bacterial<br />
isolates were isolated via X-gal hydrolysis after soil<br />
samples were fortified in BHI broth, spread and incubated<br />
on BHI agar at 4°C. Among these, three isolates, referred<br />
to as KNOUC 401, KNOUC402 and KNOUC403, showed<br />
good growth at low temperature (4°C), formed distinct<br />
blue colony on BHI plate containing X-Gal, and their cell<br />
free extracts showed practically useful activity for<br />
hydrolysis of ONPG and lactose.<br />
Identification of strain KNOUC403<br />
The strains of KNOUC401, KNOUC402 and KNOUC403<br />
were characterized for their physiological and<br />
biochemical properties to get information on their<br />
suitability for use in the food industry. KNOUC401,<br />
KNOUC402 and KNOUC403 were presumably identified<br />
as Aeromonas, Bacillus and Athrobacter respectively by<br />
phenotypic features as in Table 1. Isolate KNOUC 403<br />
was negative for β-hemolysis on sheep blood agar, but
Table 2. Properties of preliminarily selected strains.<br />
Area (M) Strain No.<br />
Hydrolysis of<br />
ONPG (Unit 1) ) Lactose (Unit 2) )<br />
Nam et al. 2201<br />
Identification Hemolysis<br />
4700 KNOUC401 3.3394 11.54 Aeromonas +<br />
4950 KNOUC402 0.1467 1.04 Bacillus +<br />
5550 KNOUC403 0.23319 2.76 Arthrobacter -<br />
1)<br />
One unit of enzyme activity is defined as the activity hydrolyzing 1 mol of ONPG per min by cell free extract from 1 ml of culture whose<br />
A600 is 8.<br />
2)<br />
One unit of enzyme activity is the one hydrolyzing 1 mol of lactose per day at 4°C by cell free extracts from 1 ml of culture whose A600<br />
is 8.<br />
Table 3. Composition of major cellular fatty acids of<br />
strain KNOUC403.<br />
Fatty acid Contents (%)<br />
14:0 iso 5.73<br />
15:0 iso 3.14<br />
15:0 anteiso 68.14<br />
16:0 iso 8.08<br />
17:0 iso 4.21<br />
KNOUC401 and 402 were positive (Table 2). Therefore,<br />
we selected strain KNOUC403 for further study. For<br />
further identification of strain KNOUC403, the strain was<br />
tested for its cellular fatty acid composition and the<br />
sequence of 16S rDNA. The cellular fatty acids of<br />
KNOUC403 were composed of anteiso-C15:0 (68.14%),<br />
iso-C16:0 (8.08%), iso-C14:0 (5.73%), anteiso-C17:0 (4.21%),<br />
iso-C15:0 (3.14%), with additional fatty acids comprising<br />
less than 1% (Table 3).<br />
The sequence of 16S rDNA (GeneBank accession No.<br />
HQ610444) of strain KNOUC403 determined as 1,492 bp<br />
is shown in Figure 1, and the phylogenetic tree<br />
constructed by the neighbor-joining method (Felsenstein,<br />
1993) is shown in Figure 2. Comparing 16S rDNA<br />
sequence of strain KNOUC403 with the sequences in<br />
Ribosomal Data base Project (Maidak et al, 1996) and<br />
NCBI, demonstrated that strain KNOUC401 should be<br />
classified as an Arthrobacter sp., and its closest relative<br />
was Arthrobacter psychrolactophilus (98 to 100%).<br />
Therefore, strain KNOUC403 was identified as A.<br />
psychrolactophilus, and the strain was named as A.<br />
psychrolactophilus KNOUC403.<br />
Properties of lactose hydrolyzing enzyme<br />
Cell free extracts of strain KNOUC403 was tested for the<br />
properties of lactose hydrolyzing enzyme related to pH<br />
and temperature to confirm the possibility as a source of<br />
cold active lactose hydrolyzing enzyme. The optimal<br />
temperature for hydrolysis of ONPG was 15°C (Figure<br />
3a). The enzyme exhibited ca. 87% of maximal activity at<br />
4°C, and the enzyme activity decreased to less than 80%<br />
of maximal activity with a further increase in temperature<br />
to 40°C. The optimal pH was pH 6.0, it exhibited activities<br />
higher than 80% of optimum activity at broad pH from 4.3<br />
to 7.8 (Figure 3b), meaning that this strain produces cold<br />
active lactose hydrolyzing enzyme useful at wide range of<br />
pH. To determine the stability at 4 and 37°C, the cell free<br />
extracts in Na-phosphate buffer (0.01 M, pH 6.8) was<br />
incubated at those temperatures for 42 h and residual<br />
activity were tested during incubation. It was stable at<br />
4°C but lost its all activity at 37°C in 42 h (Figure 4). To<br />
confirm the existence of lactose hydrolyzing enzyme in<br />
crude cell free extracts of strain KNOUC403, zymogram<br />
assay for X-gal hydrolysis was performed. There was a<br />
distinct band of X-gal hydrolysis (Figure 5). In native<br />
electrophoresis, the enzyme moved to the spot of around<br />
130 kDa.<br />
DISCUSSION<br />
Cold-adapted lactose hydrolyzing enzymes of high<br />
activity at low temperature would be useful for hydrolysis<br />
of lactose in refrigerated milk; enabling it to be consumed<br />
by lactose-intolerant individuals, and for converting whey<br />
to a sweetener by hydrolyzing lactose to sweeter sugars<br />
of glucose and galactose. Psychrophilic bacteria living in<br />
cold environments, such as glacier silts, place of high<br />
altitude in Himalaya, Arctic soils and Antarctic environments,<br />
are potentially useful sources of cold-adapted<br />
enzymes. Among strains isolated from soil of perpetual<br />
snow area at Island peak region of Mt. Himalaya in<br />
Nepal, we selected the strain KNOUC403 showing the<br />
good growth and lactose hydrolyzing activity at 4°C, and<br />
no activity of β-hemolysis. The growth physiology of this<br />
strain, growing at 4~30°C with optimum growth<br />
temperature of 20~30°C and not growing over 37°C, is<br />
well fitted to define this strain as a psychrophile (Kocur et<br />
al., 1991). The strain KNOUC403 has phenotypic<br />
characters of Gram positive, rod, nonsporing, nonmotile ,<br />
and catalase negative, that are fitting to the genus<br />
Arthrobacter (Holt et al., 1994), as in Table 1. The
2202 Afr. J. Microbiol. Res.<br />
GATGAACGCTGGCGGCGTGCTTAACACATGCAAGTCGAACGATGAACCCCGCTTG<br />
CGGGGGGATTAGTGGCGAACGGGTGAGTAACACGTGAGTAACCTGCCCTTAACTC<br />
TGGGATAAGCCTTGGAAACGAGGTCTAATACTGGATATTGACTTTGCCTCGCATGG<br />
GGTTTGGTTGAAAGATTTATTGGTTTTGGATGGACTCGCGGCCTATCAGCTTGTTG<br />
GTGAGGTAATGGCTCACCAAGGCGACGACGGGTAGCCGGCCTGAGAGGGTGACC<br />
GGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGG<br />
AATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACG<br />
GCCTTCGGGTTGTAAACCTCTTTCAGTAGGGAACAAGGCCAGCATTTTTGTTGGTT<br />
GAGGGTACTTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAAT<br />
ACGTAGGGCGCAAGCGTTATCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGT<br />
TTGTCGCGTCTGCCGTGAAAGTCCGGGGCTCAACCCCGGATCTGCGGTGGGTAC<br />
GGGCAGACTAGAGTGATGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATG<br />
CGCAGATATCAGGAGGAACACCGATGGCGAAGGCAGGTCTCTGGGCATTAACTGA<br />
CGCTGAGGAGCGAAAGCATGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCAT<br />
GCCGTAAACGTTGGGCACTAGGTGTGGGGGACATTCCACGTTTTCCGCGCCGTAG<br />
CTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAG<br />
GAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGCGGATTAATTCGATGCAAC<br />
GCGAAGAACCTTACCAAGGCTTGACATGAACTGGAAATACCTGGAAACAGGTGCC<br />
CCGCTTGCGGTCGGTTTACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAG<br />
ATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTCGTTCTATGTTGCCAGCACGTA<br />
ATGGTGGGGACTCATAGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGAGGACG<br />
ACGTCAAATCATCATGCCCCTTATGTCTTGGGCTTCACGCATGCTACAATGGCCGG<br />
TACAATGGGTTGCGATACTGTGAGGTGGAGCTAATCCCAAAAAGCCGGTCTCAGTT<br />
CGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGA<br />
TCAGCAACGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCAAGT<br />
CACGAAAGTTGGTAACACCCGAAGCCGGTGGCCTAACCCCCTTGTGGGGAGGGA<br />
GCTGTCGAAGGTGGGACTGGCGATTGGGACTAAGTCGTAACAAGGTAGCCGTACC<br />
GGAAGGTGC<br />
Figure 1. 16S rDNA sequence of strain KNOUC403 (1,492 bp).<br />
cellular fatty acid composition profile of KNOUC403 with<br />
anteiso-C15:0 as a predominant fatty acid is typical for a<br />
member of genus Arthrobacter (Lee et al., 2003; Storms<br />
et al., 2003; Kotouckova et al., 2004; Margesin et al.,<br />
2004). Heyrman et al. (2005) reported that predominant<br />
fatty acid of the genus Arthrobacter was anteiso-C15:0 and<br />
iso-C15:0. The predominant fatty acids of A.<br />
psychrolactophilus (sp. nov.) was also anteiso-C15:0 that<br />
comprised 73% of total fatty acids (Loveland-Curtze et<br />
al., 1999). Therefore “Loveland-Curtze et al. (1999) it has<br />
been reported that several Arthrobacter strains produced<br />
cold-active -galactosidase (Coker et al., 2003;<br />
Nakagawa et al., 2003). Arthrobacter sp. 20B -<br />
galactosidase was optimally active at pH 6.0 to 8.0 and
Nam et al. 2203<br />
Figure 2. Phylogenetic tree based on 16S rDNA sequence showing the position of strain KNOUC403 as the type strain of Arthrobacter<br />
species and the representative of some other related taxa. Scale bar represents 0.01 substitutions per nucleotide.<br />
Relative Relative activity(%) activity (%)<br />
100<br />
90<br />
80<br />
70<br />
60<br />
0 10 20 30 40<br />
Temperature Temp.<br />
A
2204 Afr. J. Microbiol. Res.<br />
Relative actitvity(%)<br />
100<br />
90<br />
80<br />
70<br />
60<br />
Na-acetate buffer (0.01M)<br />
4 5 6 7 8<br />
pH<br />
B<br />
Na-phosphate buffer (0.01 M)<br />
Figure 3. Effects of temperature (A) and pH (B) on the activity of lactose hydrolyzing enzyme in cell free<br />
extracts of Arthrobacter psychrolactophilus KNOUC403 for the hydrolysis of ONPG. *Effect of temperature on<br />
enzyme activity was analyzed in Na-phosphate buffer (0.01 M, pH 6.8). *Values are means of triplicates ± S.D.<br />
*Effect of pH on enzyme activity was evaluated at 4°C in Na-acetate buffer (0.01 M, pH 4.3 to 6.3) and Naphosphate<br />
buffer (0.01 M, pH 5.8 to 7.8), *values are means of triplicates ± S.D.<br />
Residual activity(%)<br />
120<br />
100<br />
80<br />
60<br />
40<br />
20<br />
0<br />
0 6 12 18 24 30 36 42 48<br />
Hours<br />
Figure 4. Stability of lactose hydrolyzing enzyme in cell free extracts of Arthrobacter<br />
psychrolactophilus KNOUC403 at 4°C ( ) and 37°C ( ) in Na-phosphate buffer (0.01 M, pH<br />
6.8). *Values are means of triplicates ±S.D.<br />
25°C (Bialkowska et al., 2009).<br />
A -galactosidase of Arthrobacter sp. obtained from<br />
Antarctic dry valley soil was cold optimal at 18°C, showed<br />
50% activity of optimum activity at 0°C, and was an<br />
unstable one, inactivated within 10 min at 37°C (Coker et<br />
al., 2003). Arthrobacter reported by Nakagawa et al.<br />
(2006) produced cold active -galactosidase with<br />
optimum temperature of 10°C and optimum pH of 8.0.<br />
However, two -galactosidases of Pseudoalteromonas<br />
sp., a psychrophile, were not cold active enzymes whose<br />
optimum temperature were 26°C (Fernandes et al., 2002)<br />
and 45°C (Hoyoux et al., 2001) showing that all
KDa Ma 1 2<br />
X-gal hydrolyzing enzyme<br />
Figure 5. Native polyacylamide electrophoresis and zymogram of cell free extracts of<br />
strain Arthrobacter psychrolactophilus KNOUC 403. The protein was analyzed on a<br />
10% polyacrylamide gel. Ma: Kaleidoscope polypeptide standards marker. 1: The gel<br />
was stained with Coomassie Brilliant Blue R-250. 2: The gel was soaked in 0.1 M Xgal<br />
solution (in Z-buffer) at 4°C for 2 h.<br />
psychrophiles do not always produce cold active enzyme.<br />
The other -galactosidases of Athrobacter sp. B7<br />
(Trimbur et al., 1994) and Arthrobacter sp. C2-2<br />
(Karasova-Lipovova et al., 2003) were characterized also<br />
by high optimum temperature of 40°C. The lactose<br />
hydrolyzing enzyme in cell free extracts of strain<br />
KNOUC403 shows high activity at 4°C and in wide range<br />
of pH 4.3 to 7.8, is stable at 4°C, and has a moderate but<br />
valuable stability at 37°C, meaning that this strain has<br />
high possibility of producing cold active lactose<br />
hydrolyzing enzyme that is useful for hydrolysis of lactose<br />
in foods of wide range of pH at refrigerating temperature.<br />
Judging from these findings of physiological and<br />
enzymatic properties, A. psychrolactophilus KNOUC403<br />
is a psychrophile of useful source, for a cold active<br />
lactose hydrolyzing enzyme that would have advantages<br />
for application in the food industry.<br />
ACKNOWLEDGEMENTS<br />
This research was performed by the support of the Korea<br />
Institute of Planning and Evaluation for Technology of<br />
Food, Agriculture and Fishery. We thank the College of<br />
Agriculture and Life Science Alpine Association, Seoul<br />
National University for sampling soils at the area of Island<br />
Peak in Himalaya.<br />
REFERENCES<br />
Bialkowska A, Cieslinski H, Nowakowska KM, Kur J, Turkiexicz M<br />
(2009). A new -galactosidase with a low temperature optimum<br />
Nam et al. 2205<br />
isolated from the Antarctic Arthrobacter sp. 20B: gene cloning,<br />
purification and characterization. Arch. Microbiol., 191: 825-835.<br />
Cavicchioli R, Siddiqui KS, Andrews D, Sowers KR (2002). Lowtemperature<br />
extremophiles and their applications. Curr. Opin.<br />
Biotechnol., 13: 253-261.<br />
Coker J, Peter P, Loveland J, Brenchley JE (2003). Biochemical<br />
characterization of a -galactosidase with a low temperature optimum<br />
obtained from an Antarctic Arthrobacter isolates. J. Bacteriol., 185:<br />
5473-5482.<br />
Feller G, Zekhnini Z, Lamotte-Brasseur J, Gerday C (1997). Enzymes<br />
from cold-adapted microorganisms. The class C -lactamase from<br />
the Antarctic psychrophile Psychrobacter immobilis A5. Eur. J.<br />
Biochem., 244: 186-191.<br />
Felsenstein J (1993). PHYLIP: Phylogenetic Inference Package, version<br />
3.5. Department of Genetics, University of Washington, Seattle, WA,<br />
USA.<br />
Fernandes S, Geueke B, Delgado O (2002). -galactosidase from a<br />
cold-adapted bacterium; purification, characterization and application<br />
for lactose hydrolysis. Appl. Microbiol. Biotechnol., 58: 313-321.<br />
Gerday C, Aittaleb M, Bentahir M, Chessa JP, Claverie P, Collins T,<br />
D’Amico SM, Dumont J, Garsoux G, Georlette D, Hoyoux A,<br />
Lonhienne T, Meuwiw MA, Feller G (2000). Cold-adapted enzymes:<br />
from fundamentals to biotechnology. Trends Biotechnol., 18: 103-107.<br />
Groudieva T, Kambourova C, Yusef C, Royter C, Grote C, Trinks C,<br />
Antranikian C (2004). Diversity and cold-active hydrolytic enzymes of<br />
culturable bacteria associated with Arctic sea ice, Spitzbergen.<br />
Extremophiles, 8(6): 475-488.<br />
Heyrman J, Verbeeren J, Schumann P, Swings J, De Vos P (2005). Six<br />
novel Arthrobacter species isolated from deteriorated mural paintings.<br />
In. J. Syst. Evol. Microbiol., 55: 1457-1464.<br />
Holt JG, Krieg NR, Sneath PH, Staley JT, Williams ST (1994). Bergey’s<br />
manual of determinative bacteriology. 9 th Ed. Williams & Wilkins,<br />
Baltimore.<br />
Hoyoux A, Jennes I, Dubiose P, Genicot S, Dubaik F, Francoi JM<br />
(2001). Cold-adapted -galactosidase from the Antarctic psychrophile<br />
Pseudoalteromonas haloplanktis. Appl. Environ. Microbiol., 67: 1529-<br />
1535.<br />
Karasova-Lipovova P, Strnad H, Spiwok VMS, Kralova B, Russell NJ<br />
(2003). The cloning, purification and characterization of a cold-active
2206 Afr. J. Microbiol. Res.<br />
-galactosidase from the psychrotolerant Antarctic bacterium<br />
Arthrobacter sp. C2-2. Enzyme Microb. Technol., 33: 836-844.<br />
Kocur M, Kloos WE, Schleifer KH (1991). The genus Micrococcus. In:<br />
Balows A., Truper H.G., Dworkin M., Harder W., Scheifer K.H.(Eds.)<br />
The prokaryotes, Springer, Berlin Heidelberg New York, 2: 1300-<br />
1311.<br />
Kotouckova L, Schumann P, Durnova E, Sproer C, Sedlacek I, Neca J,<br />
Zdrahal Nemec M (2004). Arthrobacter nitroguajacolicus sp. nov., a<br />
novel 4-nitroguaiacol-degrading Actinobacterium. Int. J. Syst. Evol.<br />
Microbiol., 54: 773-777.<br />
Laemmli UK (1970). Cleavage of structural proteins during the<br />
assembly of the head of bacteriophage T4. Nature., 227: 680-685.<br />
Lee JS, Lee KC, Pyun YR, Bae KS (2003). Arthrobacter koreensis sp.<br />
nov., a novel alkalitolerant bacterium from soil. Int. J. Syst. Evol.<br />
Microbiol., 53: 1277-1280.<br />
Loveland-Curtze J, Sheridan PP, Gutshall KR, Brenchle JE (1999).<br />
Biochemical and phylogenetic analyses of psychrophilic isolated<br />
belong to the Arthrobacter subgroup and description of Arthrobacter<br />
psychrolactophilus sp. nov. Arch. Microbiol., 171: 355-363.<br />
Maidak BL, Olsen GJ, Larson N, Overbeck R, MaCoughey MJ, Woese<br />
CR (1996). The Ribosomal Database Project (RDP). Nucleic Acids<br />
Res., 24: 82-85.<br />
Margesin R, Schinner F (1994). Properties of cold-adapted<br />
microorganisms and their potential role in biotechnology. J.<br />
Biotechnol., 33: 1-14.<br />
Margesin R, Schinner F (1999). Biotechnological applications of coldadapted<br />
organisms. Berlin; Springer, pp. 1-16<br />
Margesin R, Feller G, Gerday C, Russel NJ (2002). Cold-adapted<br />
microorganisms; adaptation strategies and biotechnological potential.<br />
In The Encyclopedia of Environmental Microbiology, Edited by G.<br />
Bitton. New York: Wiley, 2: 871-885.<br />
Margesin R, Schumann P, Sproer C, Counot AM (2004). Arthrobacter<br />
psychrophenolicus sp. nov., isolated from an alpine ice cave. Int. J.<br />
Syst. Evol., 54: 2067-2072.<br />
Marshall CJ (1997). Cold-adapted enzymes. Trends Biotechnol., 15:<br />
359-364.<br />
Miller JH (1972). Experients in molecular genetics. Cold Spring Harbor<br />
Laboratory, Cold Spring Harber, N.Y.<br />
Nakagawa T, Fujimoto Y, Uchino M (2003). Isolation and<br />
characterization of psychrophiles producing cold-active -<br />
galactosidase. Lett. Appl. Microbiol., 37: 154-157.<br />
Nakagawa T, Fujimoto Y, Ikehata R, Miyaji T, Tomizuka N (2006).<br />
Purification and molecular characterization of cold-active -<br />
galactosidase from Arthrobacter psychrolactophilus strains F2. Appl.<br />
Microbiol. Biotechnol., 72: 720-725.<br />
Rainey FA, Ward-Rainey N, Kroppenstedt RM, Stackebrandt E (1996).<br />
The genus Nocardiopsis represents a phylogenetically coherent<br />
taxon and a distinct actinomycete lineage: proposal of<br />
Nocardiopsacease fam. nov. Int. Syst. Bacteriol., 46: 1088-1092.<br />
Russell NJ (1998). Molecular adaptations in psychrophilic bacteria:<br />
potential for biotechnological applications. Adv. Biochem. Engin.<br />
Biotechnol., 61: 1-21.<br />
Saitou N, Nei M (1987). The neighbor-joining method: a new method for<br />
reconstruction phylogenetic trees. Mol. Biol. Evol., 4: 406-424.<br />
Sasser M (1990). Identification of bacteria by gas chromatography of<br />
cellular fatty acids. MIDI Technical. Note Newark. DE: MIDI Inc., USA,<br />
p. 101.<br />
Storms V, Devries LA, Coopman R, Schumann P, Vyncke F, Gillis M<br />
(2003). Arthrobacter gandavensis sp. nov. for strains of veterinary<br />
origin. Int. J. Syst. Evol. Microbiol., 53: 1881-1884.<br />
Trimbur DE, Gutshall KR, Prema P, Brenchley JE (1994).<br />
Characterization of a psychrophilic Arthrobacter gene and its coldactive<br />
-galactosidase. Appl. Environ. Microbiol., 60: 4554-4552.
African Journal of Microbiology Research Vol. 5(16), pp. 2207-2210, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR10.647<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Nigerian phages: The first bacteriophages from<br />
Tropical Africa<br />
Adeniran S. Koko 1,3 , Hans W. Ackermann 2 *, Monisola A. Taiwo 1 and Sunday A. Omilabu 1<br />
1 Department of Botany and Microbiology, University of Lagos, Lagos, Nigeria.<br />
2 Félix d'Hérelle Reference Center for Bacterial Viruses, Department of Microbiology, Faculty of Medicine,<br />
Laval University, Québec, QC, G1K 7P4, Canada.<br />
3 Quest Diagnostics West Hills, CA 91304, CA, USA.<br />
Accepted 28 March, 2011<br />
Fifteen morphological bacteriophage types were observed in enrichment cultures of sewage, surface<br />
water and human feces collected in Lagos, Nigeria. All phages were tailed and belonged to the<br />
Myoviridae, Siphoviridae or Podoviridae families. Most phages could be assigned to well-known<br />
morphotypes. Ten of them corresponded to phages of enterobacteria or pseudomonads. Four<br />
morphotypes (φKZ, T4 and χ, Jersey) prevailed in most samples. Most others occurred in traces only.<br />
Key words: Bacteriophages, ecology, identification, morphotypes.<br />
INTRODUCTION<br />
Phage ecology has essentially been investigated in North<br />
America, Europe and the oceans. Research into phage<br />
ecology in other parts of the world is almost nonexistent.<br />
As a result the phage flora of vast geographic areas,<br />
namely most of South America, Africa, Australia, China,<br />
India, all of Middle America, the Middle East and Siberia<br />
remains essentially unknown. The only reports on phages<br />
from African environments are limited to tailed phages in<br />
the subsoil of the Moroccan and Tunisian Sahara (Prigent<br />
et al., 2005) and the Namibian desert (Prestel et al.,<br />
2008), RNA phages in sewage in South Africa (Grabow<br />
et al., 1993; Schaper et al., 2002), and unknown phages<br />
of nonidentified bacteria in Senegal (Bettarel et al., 2006).<br />
The Saharan phages were observed by electron<br />
microscopy, but not propagated or identified. The<br />
Namibian phages were observed by electron microscopy<br />
in bulk cultures, but they were not isolated and only one<br />
of the morphotypes present was identified. In addition,<br />
there are isolated reports of specific phages in various<br />
parts of the world, for example Vibrio phages from shrimp<br />
fisheries in Thailand (Pasharawipas et al., 2005), Bacillus<br />
*Corresponding author. E-mail: ackermann@mcb.ulaval.ca. Tel:<br />
+418 656-2131; 2558. Fax +418 656-7555.<br />
phages from deep sea wells in China (Liu et al., 2006),<br />
phages of particular actinomycetes in Australia (Kurtböke<br />
et al., 1993a, 1993b), and Thermus phages in Kamchatka<br />
hot springs (Yu et al., 2006).<br />
This situation is deeply insatisfactory from an ecological<br />
viewpoint. We intended to identify and diagnose our<br />
phages as precisely as possible. This is the first<br />
investigation of the bacteriophage flora in tropical Africa.<br />
MATERIALS AND METHODS<br />
We collected samples of sewage and surface water at the<br />
University of Lagos and in the Iddo area of the Lagos Lagoon, a<br />
natural lagoon of brackish water connected to the Atlantic Ocean<br />
through creeks. Nineteen water samples and one of human feces<br />
were enriched in Lagos, often three to four times in parallel, with<br />
common bacteria isolated from human wound and skin infections in<br />
Lagos hospitals (Bacillus spp., Escherichia coli, Klebsiella<br />
pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus<br />
and Xanthomonas sp.). Enrichment cultures were filtered, but single<br />
plaque purification was not attempted. Samples were examined in<br />
Canada by one of us (H.-W.A.). Approximately 75 enrichment<br />
cultures of 1 ml each were received. Although all vials were intact<br />
and none had leaked during transportation, all were heavily<br />
contaminated by viable enterobacteria and pseudomonads. This<br />
contamination had clearly occurred in Nigeria before shipment.<br />
Samples were too small for filtration and were clarified by simple<br />
decantation during storage for 1 month. Supernatants were<br />
centrifuged at 25,000 g using a Beckman J2-21 centrifuge and a
2208 Afr. J. Microbiol. Res.<br />
Table 1. Bacteriophage observations by sample.<br />
Sample Bacteriophage morphotype<br />
A41 φKZ Lu11 T4 χ χ (chi) Jersey N4 T7 Others<br />
1 * + + + + φ29, 44AJHD<br />
2 ++ + (+) * +<br />
3 +++ (+) *<br />
4 ++ * * *<br />
5 * ++ * * *<br />
6 + ++ *<br />
7 * ** * M1, S1<br />
8 ++ * ** * +<br />
9 * ++ + + ++ *<br />
10 ** + + ++<br />
11 * + * ++<br />
12 ** * ++ * * M1, S1<br />
13 * + * *<br />
14 + + * * ++ 121<br />
15 + * + +++<br />
Iddo (+) * + * φ29<br />
OPP1 * * * *<br />
Berger (+) +<br />
Unilag (+) * (+) S2<br />
Feces * + * * (+) * T5, φ29<br />
+++, ++, +, (+), *: Variable quantities of phages; +++, many; *, traces. M1, S1, S2: Novel morphotypes of Myoviridae (M) and Siphoviridae (S) families.<br />
Table 2. Main dimensions of bacteriophage phage morphtypes.<br />
Family Type Head, nm Tail, nm<br />
YerA41 130 235 x 20<br />
φKZ 121 190 x 21<br />
Myoviridae<br />
Lu11<br />
121<br />
121<br />
116<br />
190 x 21<br />
115 x 17<br />
M1 133 156 x 17<br />
T4 111 x 78 113 x 16<br />
Siphoviridae<br />
Podoviridae<br />
χ (chi) 63 227 x 10<br />
Jersey 68 160 x 8<br />
T5 78 183 x 8<br />
S1 99 664 x 8<br />
S2 90 237 x 8<br />
N4 70 10<br />
T7 60 17 x 8<br />
φ29 54 x 42 36 x 12<br />
44JHD 45 35 x 12<br />
JA-18.1 fixed-angle rotor and were washed twice with 0.1 M<br />
ammonium acetate (pH 7.0). Sediments were deposited on copper<br />
grids with carbon-coated Formvar films, stained with 2% potassium<br />
phosphotungstate (pH 7.0) and examined in a Philips EM 300<br />
electron microscope. Magnification was calibrated by means of T4<br />
phage tails (length 114 nm).<br />
RESULTS AND DISCUSSION<br />
Fifteen morphological bacteriophage types, listed roughly<br />
by family and size in Tables 1 and 2, were observed. All<br />
were tailed and had contractile, long and noncontractile<br />
or short tails. They were thus identified as members of<br />
the Myoviridae, Siphoviridae or Podoviridae families,<br />
respectively. Twelve morphotypes (shortly "types")<br />
corresponded to well-known phages described in earlier<br />
reviews or books to which the reader is referred<br />
(Ackerrmann and DuBow, 1987; Ackermann, 1987). Part<br />
of the corresponding phage groups (φKZ, T4, T7, N4, φ29<br />
and AJHD) relate to phage genera or subfamilies defined<br />
by the International Committee on Taxonomy of Viruses<br />
or ICTV (Hendrix and Casjens, 2005; Lavigne et al.,<br />
2008; 2009). Ten types corresponded to known<br />
enterobacterial and Pseudomonas bacteriophage species<br />
and only two corresponded to species of Bacillus or<br />
Staphylococcus phages (podovirus types φ29 and<br />
44AHJD, respectively). Most preparations were mixtures<br />
of 4 to 5, even 7 phage morphotypes (Table 1),<br />
suggesting that none of the bacteria used for enrichment<br />
had been pure. Most phage morphotypes could be<br />
related to well-known viruses with specific hosts. Four<br />
morphotypes were almost ubiquitous, namely : φKZ, T4,<br />
Jersey and χ (chi). Others occurred in traces only and<br />
were detected by intense scrutinizing only. This is not an
indication of their frequency or rarity in nature. No exact<br />
quantitation is possible here because the apparent<br />
frequency of phages in enrichment cultures depends on<br />
many variables (phage inoculum, host sensitivity, vitality<br />
of phages and nutrients), all of which may lead to<br />
overcrowding of some phages by others.<br />
Part of this may have occurred during transportation<br />
since, as noted earlier, no sample was sterile on arrival in<br />
Canada. Finally, the very procedure of negative staining<br />
often leads to uneven distribution of particles and<br />
gathering of different particles in different places of<br />
electron microscopical grids. Three particle types (M1,<br />
S1, S2; myovirus 1, siphovirus 1 and 2) could not be<br />
attributed to known bacteriophages and may represent<br />
novel species. Type S1 is particularly interesting. Types<br />
M1 and S2 are morphologically unremarkable and not<br />
illustrated for lack of space.<br />
Myoviridae<br />
Morphotype A41 corresponds to a giant phage of this<br />
name, observed in Yersinia enterocolitica in Canada<br />
(Stevenson and Airdrie, 1984). It has so far not been<br />
found elsewhere. Types φKZ and Lu11 correspond to<br />
giant Pseudomonas phages distinguished by the<br />
presence of long, curly tail fibers in the latter (Figure 2).<br />
Phages of type φKZ were previously isolated in Denmark,<br />
Germany, Georgia, Russia and the U.S.A. Type Lu11 is<br />
known from the Philippines only (Krylov et al., 2007). The<br />
relative frequency of the φKZ and Lu11 types is not<br />
surprising as representatives of these types multiply<br />
extremely well and may conceivably overcrowd other<br />
phages in mixed cultures. Enterobacterial phages of type<br />
121 were first observed in Romania (Nacesco et al.,<br />
1969) and later in Canada by one of us (Ackermann and<br />
Nguyen, 1983). Type 121 is characterized by a large<br />
head and a relatively short tail. Type T4, easily<br />
recognized by its elongated head and a tail with six long<br />
tail fibers, seems to be truly ubiquitous and has been<br />
reported in many countries (Ackermann and Krisch,<br />
1997) (Figures 1 to 4).<br />
Type M1 does not, to our knowledge, correspond to<br />
any myovirus known. As types A41, φKZ, Lu11 and 121,<br />
It has an unusually large head.<br />
Siphoviridae<br />
Phages of the χ (chi) type are characterized by a<br />
relatively small head and a thick tail equipped with a<br />
single long, wavy tail fiber. The original phage χ is<br />
specific to mobile bacteria of E. coli, Salmonella and<br />
Serratia (Meynell, 1961). The tail fiber is difficult to see<br />
and apparently easily removed by centrifugation. Despite<br />
their relatively thick tails, χ and its relatives are<br />
Koko et al. 2209<br />
Figure 1-4. Myoviridae, morphotypes A41,<br />
T4, φKZ, and LU11, respectively.<br />
Phosphotungstate, final magnification x<br />
297,000; bars represent 100 nm.<br />
siphoviruses. Type Jersey has a conspicuous base plate<br />
with six spikes. It was first found in Salmonella paratyphi<br />
B and seems to be restricted to Salmonella bacteria.<br />
However, the orginal phage Jersey has a tail of 116 nm in<br />
length only (Ackermann and Berthiaume, 1969) while the<br />
Jersey-like particles here have tails of much longer length<br />
(Figures 5 to 6). It may be speculated that they are tail<br />
length variants of the normal phage Jersey, phage Jersey<br />
in nature. Type T5 is indistinguishable from coliphage T5.<br />
Type S1 is morphologically unremarkable, but apparently<br />
has not been encountered elsewhere and may be novel.<br />
Type S2 is very interesting as it displays a single, rigid,<br />
thick, spiral tail fiber of approximately 200 nm in length.<br />
The spirals have a periodicity of 47 nm. Prestel et al.<br />
(2008) observed similar particles in the sand of the<br />
Namibian desert.<br />
Podoviridae<br />
The N4 morphotype shows bundles of short tail fibers<br />
laying at the sides of the tail. Phages of this type seem to<br />
be very frequent in enterobacteria. Some of them<br />
arespecific to capsulated bacteria, for example, Klebsiella<br />
and Vi antigen-containing Salmonella bacteria. However,<br />
the rather uncharacteristic morphology of these phages<br />
suggests that "type N4" is heterogeneous and comprises<br />
several genomically unrelated phages. The T7 type is<br />
very frequent in Gram-negative bacteria, especially<br />
enterics, pseudomonads and vibrios. It seems to be<br />
ubiquitous and to have a world-wide distribution. So far,
2210 Afr. J. Microbiol. Res.<br />
Figures 5-10: 5-6, Siphoviridae; 7-10, Podoviridae. 5,<br />
morphotypes χ (chi, left) and Jersey (right). 6, type Sx with<br />
long spiral tail fiber and an adventitious particle of type φKZ.<br />
7-10, Podoviridae. Types T7, N4, 44AJHD, and φ29,<br />
respectively. Phosphotungstate. Final magnification x<br />
148,500 in Figure. 6 and x 297,000 in all others; bars<br />
represent 100 nm.<br />
all sequenced T7-like phages have shown genomic<br />
relationships (Lavigne et al., 2008). The types<br />
represented by Bacillus phage φ29 and Staphylococcus<br />
phage 44AJHD occur in traces only. They differ in head<br />
shape (prolate in φ29 and isometric in 44AJHD), but<br />
share genomic relationships (Lavigne et al., 2008) and a<br />
particular tail structure with a collar and collar<br />
appendages. The phages represent two different genera<br />
of the same phage subfamily, the Nanovirinae (Lavigne<br />
et al., 2008). Type φ29 is ubiquitous and occurs not only<br />
in bacilli, but also in Kurthia and Streptococcus bacteria.<br />
Phages of types A41, φKZ, Lu11, 121, T4, χ, Jersey, T7,<br />
φ29 and 44AJHD are known to be virulent. This indicates<br />
that most phages here reported derive from lytic phage<br />
infections in the environment. At least eight types (φKZ,<br />
121, T4, χ, Jersey, N4, T7 and φ29) seem to have a<br />
global distribution (Figures 7 to 10). This is consistent<br />
with metagenomic studies reporting the occurrence of T4<br />
and T7 genes in the Arctic Ocean, the Gulf of Mexico and<br />
the Sargasso Sea (Angly et al., 2006) but remains to be<br />
ascertained by further ecological studies, especially in<br />
Third-World countries. It should be interesting to study<br />
the geographical distribution of phages and to investigate<br />
whether all phages of similar habitats occur world-wide or<br />
are limited to certain regions.<br />
Electron microscopy for its rapidity and wealth of<br />
information it generates appears as the technique of<br />
choice for these investigations. We believe that we are<br />
just at the threshold of phage ecology and we have<br />
experienced that each ecological investigation of phage<br />
habitats in any country is likely to yield new and<br />
interesting phages.<br />
REFERENCES<br />
Ackermann HW, Berthiaume L (1969). Ultrastructure des phages de lysotypie<br />
des Escherichia coli 0127:B8. Can. J. Microbiol., 15: 859-862.<br />
Ackermann HW, DuBow MS (1987). Viruses of Prokaryotes. Vol II.<br />
Natural Groups of Bacteriophages. CRC Press, Boca Raton, FL, pp.<br />
72-121.<br />
Ackermann HW, DuBow MS, Gershman M, Karska-Wysocki B,<br />
Kasatiya SS, Loessner MJ, Mamet-Bratley MD, Regué M (1997).<br />
Taxonomic changes in tailed phages of enterobacteria. Arch. Virol.<br />
142:1381-1390.<br />
Ackermann HW, Krisch H (1997). A catalogue of T4-type<br />
bacteriophages. Arch. Virol. 142:2329-2345.<br />
Ackermann HW, Nguyen TM (1983). Sewage coliphages investigated<br />
by electron microscopy. Appl. Environ. Microbiol. 45:1049-1059.<br />
Angly FE, Felts B, Breitbart M, Salamon P, Edwards RA, Carlson C,<br />
Chan AM, Haynes M, Kelley S, Liu H, Mahaffy JM, Mueller JE, Nulton<br />
J, Olson R, Parsons R, Rayhawk S, Suttle CA, Rohwer F (2006). The<br />
marine viromes of four oceanic regions. PloS Biol. 4:2121-2131 (e368).<br />
Bettarel Y, Bouvy M, Dumont C, Sime-Ngando T (2006). Virusbacterium<br />
interactions in water and sediment of West African inland<br />
water system. Appl. Environ. Microbiol. 72:5274-5282.<br />
Grabow W, Holtzhausen C, de Villiers C (1993). Research on<br />
bacteriophages as indicators of water quality. WRC Report No.<br />
321/1/93, Water Research Commission, Pretoria, South Africa.<br />
Hendrix RW, Casjens SR (2005). Caudovirales. In: Fauquet et al. (eds)<br />
Virus Taxonomy: VIIIth Report of the International Committee on<br />
Taxonomy of Viruses, Elsevier <strong>Academic</strong> Press. pp. 35-42.<br />
Kurtböke DI, Murphy NE, Sivasithamparam K (1993a). Use of<br />
bacteriophage for the selective isolation of thermophilic actinomycetes<br />
from composted eucalyptus bark. Can. J. Microbiol. 39:46-51.<br />
Kurtböke DI, Wilson CR, Sivasithamparam K (1993b). Occurrence of<br />
Actinomadura phage in organic mulches used for avocado<br />
plantations in Western Australia. Can. J. Microbiol. 39:389-394.<br />
Krylov VN, Dela Cruz DM, Hertveldt K, Ackermann HW (2007). "φKZlike<br />
viruses" - a proposed new genus of myovirus bacteriophages.<br />
Arch. Virol. 152:1955-1959.<br />
Lavigne R, Seto D, Mahadevan P, Ackermann HW, Kropinski AM<br />
(2008). Unifying classical and molecular taxonomic classification.<br />
Analysis of the Podoviridae using BLASTP-based tools. Res.<br />
Microbiol. 159:406-414.<br />
Lavigne R, Darius P, Summer EJ, Seto D, Mahadevan P, Nilsson<br />
AS, Ackermann HW, Kropinski AM (2009). Classification of<br />
Myoviridae bacteriophages using protein sequence similarity. BCM<br />
Microbiol. 9:224.<br />
Liu B, Wu SJ, Song Q, Zhang XB, Xie LH (2006) Two novel<br />
bacteriophages of thermophilic bacteria isolated from deep-sea<br />
hydrothermal fields. Curr. Microbiol. 53:163-166.<br />
Meynell EW (1961). A phage, χ, which attacks motile bacteria. J. Gen.<br />
Microbiol. 25:253-290.<br />
Nacesco N, Constantinesco SP, Petrovici A (1969). Aspects électronooptiques<br />
du phage convertisseur Proteus vulgaris 121. Arch. Roum.<br />
Pathol. Exp. Microbiol. 28:838-848.<br />
Pasharawipas T, Thaikua S, Sriurairatana S, Ruangpan L,<br />
Direkbusarakum S, Manopvisetcharean J, Flegel TW (2005). Partial<br />
characterization of a novel bacteriophage of Vibrio harveyi isolated<br />
from shrimp culture ponds in Thailand. Virus Res. 114:63-69.<br />
Prestel E, Salamitou S, Dubow MS (2008). An examination of the bacteriophages<br />
and bacteria of the Namib desert. J. Microbiol. 46:364-372.<br />
Prigent M, Leroy M, Confalonieri F, Dutertre M, DuBow MS (2005). A<br />
diversity of bacteriophage forms and genomes can be isolated from<br />
the surface sands of the Sahara Desert. Extremophiles 9:289-296.<br />
Schaper M, Jofre J, Uys M, Grabow WOK (2002). Distribution of<br />
genotypes of F-specific RNA bacteriophages in human and nonhuman<br />
sources of faecal pollution in South Africa and Spain. J. Appl.<br />
Microbiol. 92:657-667.<br />
Stevenson RMW, Airdrie DW (1984) Isolation of Yersinia ruckeri<br />
bacteriophages. Appl. Environ. Microbiol. 47:1201-1205.<br />
Yu MX, Slater MR, Ackermann HW (2006). Isolation and characterization<br />
of Thermus bacteriophages. Arch. Virol. 151:663-679.
African Journal of Microbiology Research Vol. 5(16), pp. 2211-2216, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR10.767<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Evaluation of real-time PCR for Mycobacterium<br />
ulcerans in endemic region in Côte d’Ivoire<br />
Elise Solange Ngazoa-Kakou 1,3 *, Euloge Ekaza 1 , Nguetta Aka 2 , David Coulibaly-N’Golo 1 ,<br />
Bakary Coulibaly 2 and Mireille Dosso 1,2<br />
1 Plateforme de Biologie Moléculaire, Institut Pasteur Cote d’Ivoire, BP 490 Abidjan, Cote d’Ivoire.<br />
2 Unité des Mycobactéries Tuberculeuses et Atypiques, Institut Pasteur Cote d’Ivoire, BP 490 Abidjan, Cote d’Ivoire.<br />
3 Institut des Nutraceutiques et des Aliments Fonctionnels, Université Laval, Qc, G1K 7P4, Canada.<br />
Accepted 19 May, 2011<br />
Buruli ulcer (BU) is caused by a mycobacterium called Mycobacterium ulcerans. The events of BU are<br />
the skin lesions. The lack of early diagnosis and treatment cause severe disability. Today the<br />
emergence to BU in Africa and particularly in Côte d’Ivoire needs faster diagnosis to control and to<br />
prevent the infection by M. ulcerans. The surveillance of BU is difficult, because the transmission of M.<br />
ulcerans occurs in rural regions where the transport of fresh collected sample is long, and the detection<br />
with culture technique needs several months. This study has allowed the application of polymerase<br />
chain reaction (PCR) technique in real time with two targets for molecular diagnosis of BU in Côte<br />
d'Ivoire. 63 samples (clinical, environmental, local strains and reference strains) were analyzed in realtime<br />
PCR by comparing the target of the Insertion Sequence (IS) 2404 and the sequence Ketoreductase-<br />
B (KR-B), located respectively on the chromosome and on the virulence plasmid. 49 samples (76%)<br />
were positive in real-time for both targets. The sensitivity of the PCR shows a detection limit of 0.25<br />
genome copy for both targets. The capacity, speed and sensitivity of real-time PCR assays improve the<br />
diagnosis and contribute to strengthening the eradication of BU in Côte d’Ivoire.<br />
Key words: Buruli ulcer, Mycobacterium ulcerans, real-time, insertion sequence, ketoreductase, Côte d’Ivoire.<br />
INTRODUCTION<br />
Mycobacterium ulcerans is the third mycobacteria<br />
infection after tuberculosis and Leprosy and it causes<br />
Buruli ulcer (BU), a severe skin disease that has<br />
irreversible consequences in rural populations<br />
(MacCallum et al., 1993). The WHO was esteemed that<br />
33 countries was endemic or semi-endemic for the Buruli<br />
ulcer (Asiedu et al., 2000; Janssens et al., 2005). The<br />
eradication of Buruli ulcer is difficult because, the lack of<br />
early diagnostic in rural endemic regions, and the<br />
unknown of the disease in medical national structures<br />
system. In the rural westlands and marshes of West<br />
Africa, children are most affected (Asiedu et al., 2000;<br />
WHO, 2008). The polymerase chain reaction (PCR) was<br />
become the gold method to confirm clinical and<br />
environmental samples (Ross et al., 1997a, b; Portaels et<br />
*Corresponding author. E-mail: ngazoa_solange@yahoo.fr.<br />
al., 2001; Marsollier et al., 2004; Portaels et al., 2008).<br />
The most using targets were the insertion sequence<br />
IS2404 or IS26406 and the Ketoreductase B (KR-B),<br />
these are respectively located on the chromosome and<br />
on the virulence plasmid pMUM001 (van Werf et al.,<br />
2003). The cytotoxic mycolactone of M. ulcerans is produced<br />
from of three large multienzymes complexes called<br />
polypeptide synthases that are encoded by the genes<br />
mlsA1, mlsA2, and mlsB located on the plasmid (Stinear<br />
et al. 2004; 2005). The detection of M. ulcerans in clinical<br />
and in environmental samples was improved for the both<br />
most targets IS2404 and KR such aquatic insects, snails<br />
or in plants (Ross et al. 1994; Stinear et al. 2000;<br />
Eddyani et al. 2004; Philipps et al., 2005). In West Africa,<br />
the endemic region of BU is located in Côte d’Ivoire that<br />
has more 2000 confirmatory cases yearly (WHO, 2010).<br />
Molecular detection was the best method to confirm new<br />
human cases because of the low-growth of M. ulcerans in<br />
vitro (Portaels et al., 2001). Recently, de Vandelannoote
2212 Afr. J. Microbiol. Res.<br />
et al. (2010) have detected M. ulcerans using real-time<br />
PCR in small animals and in water sample in a BUendemic<br />
region. However, the sensitivity, the specificity<br />
and the capacity of real-time PCR are the major step<br />
forward to detect M. ulcerans. The application of real-time<br />
PCR in the Institute Pasteur contributes to increase the<br />
capacities of the national surveillance to eradicate the<br />
BU, by elucidating of the ecology and the transmission in<br />
the environment. The main aim of this study is to<br />
evaluate the performance of real time PCR as molecular<br />
diagnosis method, by using two targets IS2404 and KR-B<br />
to identify M. ulcerans in several types’ samples in Buruli<br />
ulcer-endemic region in Côte d’Ivoire.<br />
MATERIALS AND METHODS<br />
Mycobacterial strains<br />
Local strains were gathered from patients with Buruli ulcerative form<br />
in Cote d’Ivoire endemic regions. Those strains were isolated and<br />
maintained within Abidjan Pasteur Institute Mycobacterial<br />
Laboratory. Fresh swab clinical specimens were spilt for DNA<br />
extraction and culture technique. Environmental samples were<br />
collected in 2009 from different endemic regions of BU and were<br />
inclusive with strains isolated from water insects Reference strains<br />
were provided from the Institute of Tropical Medicine, Antwerp,<br />
Belgium (ITM) and from Centre Pasteur of Yaoundé, Cameroon<br />
(Table 1).<br />
DNA extraction<br />
Clinical specimen<br />
DNA from clinical samples was extracted using Phenol extraction<br />
method as previously described (Ekaza et al., 2004; Coulibaly et<br />
al., 2010).<br />
Bacterial strains<br />
DNA from bacterial strains was extracted by a phenol/chloroform<br />
method. Briefly five to ten colonies were harvested from<br />
Löwenstein-Jensen slants and suspended in 250 µl of lysis buffer.<br />
After overnight incubation at 37°C, phenol chloroform extraction<br />
was applied. The DNA was washed in ethanol and the pellet was<br />
dried and eluted in 50 µl of sterile water.<br />
Environmental samples<br />
Aquatic insects were placed in sterile box and add to liquid<br />
nitrogen, the matrix was crushed and 2 ml of 50 mM NaOH were<br />
added. 1 ml of sample was added to 150 µl of 0.1 M Tris and<br />
heated 20 min, 95°C. The extraction protocol of Mo Bio kit was<br />
applied following the instructions of the manufacturer. The pellet<br />
was eluted in sterile water and stored at -20°C.<br />
Real-time TaqMan PCR assays<br />
Real-time PCR was performed using PCR Reagents Kit (Promega,<br />
Madison, WI, USA) and the 7300 real-time PCR (Applied<br />
Biosystems, Forster City, USA). The reaction took place in a final<br />
volume of 25 µl and contained 5 µl of DNA, 0.3 µM of each primer,<br />
namely IS2404R and IS2404F (Rondoni et al., 2003) or KR-B-F and<br />
KR-B-F (Fyfe et al., 2007), and 0.25 µM of labelled IS2404 probe or<br />
KR-B probe, 20 µl PCR-Mix containing 25 mM MgCl2, Rox Dye<br />
Pure (Invitrogen, Cergy Pontoise, France), 10 mM dNTPs, 5X<br />
Buffer, 0.2 µl Go-Taq Flexi DNA Polymerase (Promega, Madison,<br />
WI, USA).<br />
PCR consisted of 35 cycles of melting at 95°C for 5 s, annealing<br />
and extension at 60°C for 1 min. A DNA segment of 58 and 65 bp<br />
for IS2404 and KR respectively in length was thus amplified.<br />
Fluorescence of FAM liberated from the probe by TaqMan was<br />
measured to determine the amplification threshold cycle (Ct), which<br />
was the first cycle at which fluorescent emission was 10-fold higher<br />
than the standard deviation of the mean baseline emission.<br />
Negative controls were performed with 5 µl of sterile water. A serial<br />
10-fold dilution of 2x10 7 CFU/µl extracted DNA was used to<br />
establish the standard curve. Each sample was duplicated and<br />
tested in real time assays.<br />
Sensitivity test of real-time PCR assays<br />
To determine the detection limit of both assays, serial dilutions of<br />
extracted DNA from 2.5 x10 4 CFU/µl from 2MU II strain<br />
(unpublished) and 5 µl were tested duplicate in real-time assays.<br />
RESULTS<br />
Sensitivity of the real-time PCR of M. ulcerans<br />
The serial dilution of DNA solution containing 2.5x10 4<br />
CFU/µl of M. ulcerans (2MUII) shows the detection by<br />
dilution (10 -6 ) with the target IS2404 by Ct 39. 27 and with<br />
the Ketoreductase-B by Ct 35.29 (Table 2) The detection<br />
limit of both assays was corresponding of 0.25 genome<br />
copies from M. ulcerans. The IS2404 is more sensitive<br />
with similar detection limit than the assay using<br />
Ketoreductase-B gen.<br />
Evaluation of real-time PCR for Insertion sequence<br />
IS2404 and Ketoreductase-B by different samples of<br />
M. ulcerans<br />
From 63 samples tested in real-time assays, 47 samples<br />
(74%) were positive by IS2404 and 40 samples (77%) by<br />
KR. Both assays show identical performance by the<br />
detection of local strains and clinical samples (Table 3).<br />
References strains show similar results by both real-time<br />
assays. No environmental sample was detected in both<br />
assays. 31 clinical samples (96%) were detected in both<br />
assays and confirm the sensitivity of real-time assays. 14<br />
samples (26%) were detected negative for both detection<br />
targets and 3 samples (5%) were negative by IS 2404<br />
real-time or by KR-B real-time assay.<br />
DISCUSSION<br />
Buruli ulcer was endemic in Côte d’Ivoire. The infection
Table 1. Types samples of M. ulcerans tested in this study.<br />
Samples Source or strain References<br />
ITM 9540 References strain Stieger et al., 2006<br />
ITM 980912 References strain Stieger et al., 2006<br />
ITM 842 References strain Stieger et al., 2006<br />
ITM 7922 References strain Stieger et al., 2006<br />
ITM 940662 References strain Stieger et al., 2006<br />
ITM 990006 References strain Stieger et al. unpublished<br />
ITM 94821 References strain Stieger et al. unpublished<br />
ITM 5150 References strain Stieger et al. 2006<br />
ITM 970483 References strain Stieger et al. 2006<br />
ITM 051459 References strain Stieger et al. 2006<br />
CIV-B043 Local laboratory strain This study<br />
CIV-B058 Local laboratory strain This study<br />
CIV-01-0104 Local laboratory strain This study<br />
CIV-01-098 Local laboratory strain This study<br />
CIV-01-0119 Local laboratory strain This study<br />
CIV-01-044 Local laboratory strain This study<br />
CIV-06-046 Local laboratory strain This study<br />
CIV-06-0120 Local laboratory strain This study<br />
CIV-01-054a Local laboratory strain This study<br />
CIV-009 Local laboratory strain This study<br />
CIV-090 Local laboratory strain This study<br />
CIV-091 Local laboratory strain This study<br />
CIV-028 Local laboratory strain This study<br />
CIV-077 Local laboratory strain This study<br />
CIV-01-093 Local laboratory strain This study<br />
CIV-01-043 Local laboratory strain This study<br />
01-021b Local laboratory strain This study<br />
U064 Local laboratory strain This study<br />
U044 Local laboratory strain This study<br />
02-43 Local laboratory strain This study<br />
B12 Local laboratory strain This study<br />
06-108 Local laboratory strain This study<br />
06-117 Local laboratory strain This study<br />
01-078 Local laboratory strain This study<br />
B043 Local laboratory strain This study<br />
02-003 Local laboratory strain This study<br />
06-120 Local laboratory strain This study<br />
01-104 Local laboratory strain This study<br />
01-109 Local laboratory strain This study<br />
08U-045 Local laboratory strain This study<br />
U059 Local laboratory strain This study<br />
01-098 Local laboratory strain This study<br />
UB09-960 Clinical sample This study<br />
UB09-973 Clinical sample This study<br />
UB09-988 Clinical sample This study<br />
UB09-989 Clinical sample This study<br />
UB09-995 Clinical sample This study<br />
UB09-997 Clinical sample This study<br />
UB09-1009 Clinical sample This study<br />
UB09-1025 Clinical sample This study<br />
UB09-1027 Clinical sample This study<br />
Ngazoa-Kakou et al. 2213
2214 Afr. J. Microbiol. Res.<br />
Table 1 Contd.<br />
UB09-1039 Clinical sample This study<br />
UB09-1042 Clinical sample This study<br />
UB09-1043 Clinical sample This study<br />
UBE1 Environmental sample This study<br />
UBE2 Environmental sample This study<br />
UBES1 Environmental sample This study<br />
UBES2 Environmental sample This study<br />
UBES3 Environmental sample This study<br />
UBSE4 Environmental sample This study<br />
UBSE5 Environmental sample This study<br />
UBSE6 Environmental sample This study<br />
UBSE7 Environmental sample This study<br />
Table 2. Sensitivity of the both real-time TaqMan assays.<br />
Dilution of DNA CFU/µl IS2404 Ct KR-B Ct<br />
2.5.10 4 20.88 ±1.8 19.6 ±1.2<br />
2.5.10 3 24.85 ±1.7 22.03 ±0.7<br />
2.5.10 2 28.35 ±1.4 25.3 ±1.1<br />
2.5.10 1 31.82 ±1.3 28.46 ±1.4<br />
2.5.10 0 35.45 ±1.7 30.18 ±1.3<br />
0.25 39.27 ±1.8 35.29±1.2<br />
Table 3. Detection of different samples for M. ulcerans in real-time assays.<br />
Sample type<br />
IS2404<br />
KR-B<br />
Positive Negative Positive Negative<br />
Clinical 8 4 8 4<br />
Environmental 0 9 0 9<br />
Local strains 30 2 31 1<br />
References strains 9 1 10 0<br />
Total 47 16 49 14<br />
% 74 26 77 23<br />
can be eradicated if the national surveillance becomes<br />
effective in all regions. Early diagnostic is the only step to<br />
prevent ulceration that has irreversible consequences for<br />
the patients. The number of cases of M. ulcerans in Côte<br />
d’Ivoire continues to rise, with more 2000 new human<br />
cases reported in 2009 compared with 1440 cases in<br />
2008 and 1 case in 1978 (WHO, 2010). With increasing<br />
numbers of clinical specimens for diagnosis as well as<br />
the need to determine the mode of transmission and the<br />
natural reservoir of the mycobacteria, rapid, sensitive,<br />
and specific molecular tests are needed. Fyfe et al.<br />
(2007) have developed two multiplex, real-time TaqMan<br />
PCR assays for the detection of M. ulcerans DNA in<br />
clinical and environmental samples. Recently, de<br />
Vandelannoote et al. (2010) have detected M. ulcerans in<br />
small animals in Ghana. To ameliorate the capacity of<br />
molecular diagnostic, we apply the real-time PCR with<br />
two targets in monoplex reaction to detect M. ulcerans in<br />
clinical and environmental samples. The IS2404 is the<br />
most target for M. ulcerans PCR used in several labours<br />
(Stinear et al., 1999). The Ketoreductase B domain is<br />
present in 15 copies within the mycolactone synthase<br />
gen and the real-time assay has shown gut sensitivity in<br />
previous assay (Rondoni et al., 2003). Real-time PCR is<br />
more 10-10.000 sensitive than classic PCR, however the<br />
PCR is recommended by WHO as the confirmatory test<br />
for clinical diagnosis of M. ulcerans infection.<br />
The application in this study of real-time assays to
detect clinical samples of Buruli ulcer was chosen in<br />
rapidity and the capacity for the most endemic area of M.<br />
ulcerans in West Africa. Our results confirm the sensitivity<br />
of both assays and the detection limit was 0. 25 genome<br />
copies. However, 96% of clinical samples have been<br />
confirmed the infection of M. ulcerans in this study. This<br />
detection limit was consistent of the results of Rondoni et<br />
al. (2003) with the detection of 0.2 genome copy in realtime<br />
of IS2404. Fyfe et al. (2007) have demonstrated that<br />
IS2404 or KR real-time PCR assays are able to detect all<br />
geographic strains of the world including African strains.<br />
The combination of both assays has facilitated to detect<br />
simultaneous mycolactone producing strains by the target<br />
KR-B and non-mycolactone producing strains by the<br />
target IS2404.<br />
The application of several types of samples confirms<br />
the specificity of both real-time assays. Because of the<br />
long storage of references ITM strains DNA, several<br />
strains missed by real-time assays. No environmental<br />
sample shows the presence of DNA of M. ulcerans in<br />
both assays. The presence of inhibitors in environmental<br />
samples was investigated because of the correlation of<br />
the high incidence of BU in Côte d’Ivoire. Our results<br />
show gut performance of real-time assay for both targets<br />
to detect mycolactone producing strain and non<br />
producing strains. We will investigate in future studies to<br />
detect M. ulcerans in environmental samples.<br />
In view of the high number of the samples received in<br />
the case of the confirmation of the cases of Buruli ulcer in<br />
Côte d’Ivoire and the search for the environmental<br />
reservoir of M. ulcerans. This technology is going to allow<br />
the avoidance of not only the long manipulations, but also<br />
the contaminations after PCR, and also to increase the<br />
sensibility and the specificity of the detection. However,<br />
the application of real-time PCR for M. ulcerans in<br />
Institute Pasteur will permit us to elucidate the ecology<br />
and the transmission of BU in Côte d’Ivoire.<br />
ACKNOWLEDGEMENTS<br />
The authors thank the Centre Pasteur of Yaoundé,<br />
Cameroon for the grateful gift of DNA of the strain MU2II.<br />
We thank the Institute for Tropical Medicine of Antwerp,<br />
Belgium for the references DNA using in this study. We<br />
thank the national surveillance program of Buruli ulcer<br />
and the World Health Organization. We thank Dr S.<br />
Bouzid for critical support of all parts in this work. This<br />
work was supported by a grant of Institut Pasteur de Côte<br />
d’Ivoire and Réseau International des Instituts Pasteur<br />
(RIIP).<br />
REFERENCES<br />
Asiedu K, Scherpbier R, Raviglione M (2000). Buruli Ulcer,<br />
Mycobacterium ulcerans infection. World Health Organization,<br />
Geneva, Switzerland, WHO.<br />
Coulibaly B, Coulibaly-N’Golo MDG, Ekaza E, Aka N, N’Guessan KR,<br />
Ngazoa-Kakou et al. 2215<br />
Baudryard A, Assandé JM, Trébissou N, Guédé-Guina F, Dosso M<br />
(2010). Implementation of in vitro culture of Mycobacterium ulcerans<br />
from clinical samples versus detection of acid fast bacilli and bacterial<br />
genome in Abidjan, Cote d’Ivoire. Bull. Soc. Path. Exo., 103(12): 2-7.<br />
PMID: 20084485.<br />
Eddyani M, Ofori-Adjei D, Teugels G, De Weirdt D, Boakye D, Meyers<br />
W, Portaels F (2004). Potential role for fish in transmission of<br />
Mycobacterium ulcerans disease (Buruli Ulcer): an environmental<br />
study. Appl. Environ. Microbiol., 70(9): 5679-5681. PMID: 15345458.<br />
Ekaza E, Kacou-N'douba A, Oniangue NC, Ehuie P, N'Guessan KR, Aka<br />
N, Bouzid SA, Faye-Kette H, Dosso M (2004). Contribution of genic<br />
amplification in the detection of M. ulcerans in exudates and in<br />
cutaneous biopsies in Cote d’Ivoire. Bull. Soc. Path. Exo., 97(2): 95-<br />
96.<br />
Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, Azuolas J,<br />
Stinear TP (2007). Development and application of two multiplex realtime<br />
PCR assays for the detection of Mycobacterium ulcerans in<br />
clinical and environmental samples. Appl. Environ. Microbiol., 73(15):<br />
4733-4740. PMID: 17526786.<br />
Janssens PG, Pattyn SR, Meyers WM, Portaels F (2005). Buruli Ulcer:<br />
Anhistorical overview with updating to 2005. Bull. Seances Acad. R.<br />
Sci. Outre Mer., 51: 165–199.<br />
MacCallum P, Tolhurst J, Buckle G, Sissons H (1993). A new<br />
mycobacterial infection in man. J. Pathol. Bacteriol., 60: 93–122.<br />
PMID: 18935206.<br />
Marsollier L, Stinear T, Aubry J, Saint Andre´ JP, Robert R, Legras P,<br />
Manceau AL, Audrain C, Bourdon S, Kouakou H, Carbonnelle B<br />
(2004). Aquatic plants stimulate the growth of and biofilm formation<br />
by Mycobacterium ulcerans in axenic culture and harbor these<br />
bacteria in the environment. Appl. Environ. Microbiol., 70(2): 1097–<br />
1103. PMID: 14766593.<br />
Phillips R, Horsfield C, Kuijper S, Lartey A, Tetteh I, Etuaful S,<br />
Nyamekye B, Awuah P, Nyarko KM, Osei-Sarpong F, Lucas S, Kolk<br />
AH, Wansbrough-Jones M (2005). Sensitivity of PCR targeting the<br />
IS2404 insertion sequence of Mycobacterium ulcerans in an assay<br />
using punch biopsy specimens for diagnosis of Buruli Ulcer. J. Clin.<br />
Microbiol., 43(8): 3650–3656. PMID: 16081892.<br />
Portaels F, Johnson P, Meyers WM (ed.) (2001). Buruli Ulcer; diagnosis<br />
of Mycobacterium ulcerans disease; a manual for health care<br />
providers. World Health Organization, Geneva, Switzerland.<br />
Portaels F, Meyers WM, Ablordey A, Castro AG, Chemlal K, de Rijk P,<br />
Elsen P, Fissette K, Fraga AG, Lee R, Mahrous E, Small PL, Stragier<br />
P, Torrado E, Van Aerde A, Silva MT, Pedrosa J (2008). First<br />
cultivation and characterization of Mycobacterium ulcerans from the<br />
environment. PLoS. Negl. Trop. Dis., 2(3):e178.<br />
Rondini S, Mensah-Quainoo E, Troll H, Bodmer T, Pluschke G (2003).<br />
Development and application of real-time PCR assay for<br />
quantification of Mycobacterium ulcerans DNA. J. Clin. Microbiol.,<br />
41(9): 4231–4237. PMID: 12958250.<br />
Ross B, Johnson P, Oppedisano F, Marino L, Sievers A, Stinear T,<br />
Hayman J, Veitch M, Robins-Browne R (1997). Detection of<br />
Mycobacterium ulcerans in environmental samples during an<br />
outbreak of ulcerative disease. Appl. Environ. Microbiol., 63(10):<br />
4135–4138. PMID: 9327583.<br />
Ross B, Marino L, Oppedisano F, Edwards R, Robins-Browne R,<br />
Johnson P (1997). Development of a PCR assay for rapid diagnosis<br />
of Mycobacterium ulcerans infection. J. Clin. Microbiol., 35(7): 1696–<br />
1700. PMID: 9196176.<br />
Stinear TP, Davis JK, Marino L, Robin-Browne RM, Oppedisano F,<br />
Sievers A, Johnson PDR (1999). Identification and characterization of<br />
IS2404 and IS2606: two distinct repeated sequences for detection of<br />
Mycobacterium ulcerans by PCR. J. Clin. Microbiol., 37(4): 1018–<br />
1023. PMID: 10074520.<br />
Stinear T, Davies JK, Jenkin GA, Portaels F, Ross BC, Oppedisano F,<br />
Purcell M, Hayman JA, Johnson PD (2000). A simple PCR method<br />
for rapid genotype analysis of Mycobacterium ulcerans. J. Clin.<br />
Microbiol., 38(4): 1482–1487. PMID: 10747130.<br />
Stinear TP, Mve-Obiang A, Small PL, Frigui W, Pryor MJ, Brosch R,<br />
Jenkin GA, Johnson PD, Davies JK, Lee RE, Adusumilli S, Garnier T,<br />
Haydock SF, Leadlay PF, Cole ST (2004). Giant plasmid-encoded<br />
polyketide synthases produce the macrolide toxin of Mycobacterium<br />
ulcerans. Proc. Natl. Acad. Sci., 101(5): 1345-1349.PMID: 14736915.
2216 Afr. J. Microbiol. Res.<br />
Stragier P, Ablordey A, Bayonne LM, Lugor YL, Sindani IS, Suykerbuyk<br />
P, Wabinga H, Meyers WM, Portaels F (2006). Heterogeneity among<br />
Mycobacterium ulcerans Isolates from Africa. Emerging Infectious<br />
Diseases, 12(5): 844-847. PMID: 16704851.<br />
van der Werf T, Stinear T, Stienstra Y, van der Graaf W, Small P<br />
(2003). Mycolactones and Mycobacterium ulcerans disease. Lancet,<br />
362(9389): 1062–1064. PMID: 14522538.<br />
de Vandelannoote K, Durnez L, Amissah D, Gryseels S, Dodoo A,<br />
Yeboah S, Addo P, Eddyani M, Leirs H, Ablordey A, Portaels F<br />
(2010). Application of real-time PCR in Ghana, a Buruli Ulcerendemic<br />
country, confirms the presence of Mycobacterium ulcerans<br />
in the environment. FEMS. Microbiol. Lett., 304(2): 191-194. PMID:<br />
20146745.<br />
World Health Organization (2008). Buruli Ulcer: progress report, 2004–<br />
2008. Wkly. Epidemiol. Rec., 83(17): 145–156. PMID: 18437758.<br />
World Health Organization (2010). Annual Meeting of Buruli Ulcer, 22-<br />
24 march Geneva, Switzerland
African Journal of Microbiology Research Vol. 5(16), pp. 2217-2221, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR10.782<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Contamination of cattle carcasses by Escherichia coli<br />
shiga like toxin with high antimicrobials resistence<br />
Everlon Cid Rigobelo 1 *, Renato Pariz Maluta 2 , Clarissa Araújo Borges 2 ,<br />
Lívia Gerbasi Beraldo 2 , Manoel Victor Franco 3 , Lemos Sirlei Aparecida Maestá 1 and<br />
Fernando Antonio de Ávila 4<br />
1 Campus Experimental de Dracena- Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Brazil.<br />
2 Programa de Pós-Graduação em Microbiologia Agropecuária Universidade Estadual Paulista Júlio de Mesquita Filho<br />
(UNESP) Jaboticabal Brazil.<br />
3 Faculdade de Ciências Agrárias e Veterinárias de Jaboticabal. Departamento de Biologia Aplicada a Agropecuária,<br />
Brazil.<br />
4 Faculdade de Ciências Agrárias e Veterinárias de Jaboticabal, Departamento de Patologia Veterinária, Brazil.<br />
Accepted 15 March, 2011<br />
During processing of cattle carcasses, contamination may occurs with the transfer of microbiota of<br />
animals feaces to carcasses. This contamination many times may be by Escherichia coli carriers of<br />
virulence factor as stx and eae genes being classified as Shiga like toxin. Shiga toxin-producing<br />
Escherichia coli (STEC) is recognized wordwide as human pathogen. A survey was performed to<br />
determine the sensibility profile to several antimicrobial drugs of STEC in carcasses obtained from an<br />
abattoir in Brazil between March 2008 and August at 2009. A total of 120 STEC were isolated. All<br />
isolates were confirmed as being E. coli by their biochemical analysis and submitted to polymerase<br />
chain reaction (PCR) for detection of stx, eae and ehly genes. No strains was isolated being carriers of<br />
ehly gene. The number of isolates carriers of eae gene were 48/120. The most frequent resistance was<br />
seen against cephalothin (84.0%), streptomycin (45.0%), nalidixic acid (42.0%) and tetracycline (20.0%).<br />
Multidrug resistance (MDR) to three or more antimicrobial agents was observed in 46 (38.3%) E. coli<br />
isolates. The findings of STEC and MRD show that cattle carcasses may be a reservoir of pathogenic<br />
bacterial for the consumer public.<br />
Key words: Multi-drug resistance, Escherichia coli, shiga toxin-producing Escherichia coli (STEC).<br />
INTRODUCTION<br />
Pathogenic Escherichia coli are classified at different<br />
groups of strains that cause a common disease using<br />
common and remarkable assortments of virulence factors<br />
(Kaper et al., 2004). One such pathotype, the STEC is<br />
the causative agent of severe clinical syndromes in<br />
humans such as haemolytic uremic syndrome (HUS) and<br />
haemorrhagic colitis. However the transmission of STEC<br />
*Corresponding author. E-mail: everlon@dracena.unesp.br. Tel:<br />
+ 55 (18) 3821- 8200.<br />
Abbreviations: STEC, Shiga toxin-producing Escherichia coli;<br />
PCR, polymerase chain reaction; MDR, multidrug resistance;<br />
HUS, haemolytic uremic syndrome; PR, Paraná.<br />
occurs by waterborne, from person to person and also<br />
may be transmitted by food borne (Nataro and Kaper,<br />
1998). E. coli is regarded as an indicator of fecal<br />
contamination when isolated from carcass processing.<br />
Levels of E. coli associated with cattle carcasses can<br />
increase or decrease during processing according to<br />
factors such as the levels of fecal contamination of live<br />
cattle, efficiency of evisceration and hygienic practices in<br />
the abattoir (Bell, 1997).<br />
Cattle, considered primary reservoirs of both O157 and<br />
non-O157 STEC bacteria (Bettelheim, 2000), frequently<br />
carry STEC without showing any pathological symptoms<br />
(Blanco et al., 1997). The full list of bacterial virulence<br />
determinants necessary for STEC's pathological effects is<br />
not known. Two types of Shiga like toxin, stx1 and stx2<br />
(encoded by stx1 and stx2 genes), are associated with
2218 Afr. J. Microbiol. Res.<br />
human disease. These toxins vary in their amino-acid<br />
sequence (Kaper et al., 1998) antigenicity, and in their<br />
activation and receptor specificity (Schmitt et al., 1999).<br />
E. coli acquire stx genes, and the subsequent ability to<br />
produce toxins, following infection with temperate<br />
bacteriophages (James et al., 2001). The ability of E. coli<br />
to adhere to intestinal epithe-lium is crucial in the<br />
colonization of the intestine, and therefore the<br />
progression of disease in humans.<br />
The protein intimin, encoded by the eae gene, enables<br />
intimate attachment of E. coli to intestinal cells<br />
(Donnenberg et al., 1992), causing characteristic<br />
attaching/effacing lesions (Paton et al., 1998). This<br />
attachment also enables Shiga toxins to be injected into<br />
the epithelial cytoplasm through a type III secretion<br />
system (Kaper, 2004). Other virulence factors such as<br />
intimin (eae) and hemolysin (hly A) are thought to<br />
enhance pathogenicity, but are not required for strains to<br />
produce severe disease, including HUS (Bonnet et al.,<br />
1998; Acheson, 2000). Antimicrobial therapy is an<br />
important tool for infection treatment, resistance to<br />
antimicrobials is a cause of great concern in veterinary<br />
medicine (Monro and Polk, 2000). Indeed, a close<br />
association between the use of antimicrobial agents for<br />
the treatment of infections in animals and the observed<br />
levels of resistance exists (Chaslus-Dancia, 2001). The<br />
use of antibiotics in animal agriculture has been a<br />
controversial issue due to the potential transfer of<br />
antibiotic resistance from animals to humans. This could<br />
have several public health implications that may cause<br />
treatment failure, including death and illness prolongation,<br />
as well as increase in the associated costs (Kelly et<br />
al., 2004).<br />
The direct impact of resistance evolved from the use of<br />
antimicrobials in treatment of animal infection, is not<br />
clear. Since the antimicrobials routinely used for the treatment<br />
of infections in humans are also used in animals for<br />
both therapy and prevention or as growth promotion<br />
factors, it is not easy to describe the relative contributions<br />
of animal derived resistant strains to human E. coli<br />
disease (Maynard et al., 2004). Outbreaks have been<br />
associated with consumption of STEC contaminated and<br />
undercooked hamburgers, subsequent to both animal<br />
and foods (Erickson and Doyle, 2007). This probably<br />
occurs because during the processing of the carcass,<br />
fecal contamination or transfer of bacteria from the<br />
animal's hide to the carcass can facilitate transmission of<br />
pathogenic E. coli to food supplies (Bell, 1997; Barkocy-<br />
Gallagher et al., 2001). Some studies found a high<br />
prevalence of STEC in feces of healthy cattle, in Brazil,<br />
(Irino et al., 2005), Rio de Janeiro (Cerqueira et al.,<br />
1999), Rio Grande do Sul (Moreira et al., 2003; Timm et<br />
al., 2007) and also in Paraná (PR), (Farah et al., 2007;<br />
Pigatto et al., 2008) and a prevalence of 1 to 2% of STEC<br />
in cases of diarrhea in humans was reported by Vaz et<br />
al. (2004), De Toni et al. (2009). The objective of this<br />
study was to determine the virulence profiles and the<br />
antimicrobial drug resistance of E. coli isolates from beef<br />
carcasses at an abattoir in Brazil.<br />
MATERIALS AND METHODS<br />
Carcass samples<br />
Six hundred carcass samples were collected an abattoir in São<br />
Paulo State, in southwestern Brazil, between March 2008 and<br />
August 2009. Samples studied were from carcasses cattle raised at<br />
pastures. Sampling of 150 feedlot cattle was done on four different<br />
occasions, two in the rain season and two in the dry season. Each<br />
sample was obtained using a Specie- Sponge (3M- Brazil)<br />
moistened with 25 ml of Brilliant Green (BBL/Becton Dickins on) in<br />
a stomacher bag. Sponges were wrung out as much as possible<br />
within the bag and used to swab each area. Each carcass was<br />
followed along the processing and sampled at three different stages<br />
always at the same site of the rump, near the anus over an area of<br />
10 × 30 cm, delineated by a sterile metal template, from the same<br />
half of each carcass. All samples were taken to the laboratory in an<br />
ice-cooled bag and kept for 12 h at room temperature.<br />
Bacterial isolates<br />
One hundred microliters of each sample was streaked on<br />
MacConkey agar plates (Oxoid Limited) and incubated at 37°C for<br />
24 h. Colonies showing E. coli characteristics were submitted to<br />
Gram staining and identified by standard biochemical tests; oxidase<br />
negative, indole positive, Simon's citrate negative, urease negative<br />
and hydrogen sulfide negative (Koneman et al., 1997). The isolates<br />
were serotyped for O157 using Latex Agglutination test kit (Oxoid,<br />
Basingstoke, UK). Negative strains were considered non-O157<br />
strains.<br />
PCR screening of samples<br />
Bacterial strains, grown overnight in nutrient broth (Sigma Chemical<br />
Company) at 37°C, were pelleted by centrifugation at 12, 000 g for<br />
1 min , resuspended in 200 µl of sterile distilled water and lyzed by<br />
boiling for 10 min. Lysate was centrifuged as described above and<br />
150 µl of the supernatants were used as DNA for the PCR (Wani et<br />
al., 2003). A total of 120 E. coli isolates were subjected to PCR. stx<br />
1, stx 2 and eae genes were detected using the primers and PCR<br />
conditions described by China et al. (1998) .<br />
Expression of E-Hly<br />
Expression of enterohemolysin was determined based on the<br />
method described by Beutin et al. (1989). Plates were incubated at<br />
37°C for 24 h and observed for hemolysis after 3 h (for expression<br />
of a -hemolysin) and 24 h (for E- Hly), respectively. The reference<br />
strains used in this assay were E. coli U4- 41 (positive control for a -<br />
hemolysin), E. coli 32511 (STEC O157: H7) (positive control for E-<br />
Hly), and E. coli K12 (negative control).<br />
Susceptibility testing<br />
In vitro susceptibility testing was performed by a standardized disk<br />
diffusion method (CLSI 2008). Staphylococcus aureus ATCC 29213<br />
and E. coli ATCC 25922 served as quality control strains. Four<br />
antimicrobial agents were selected for the tests: cephalothin,<br />
streptomycin, nalidixic acid and tetracycline. The antimicrobials<br />
used in this study were the same used by farmers in animal<br />
produce.
Table 1. Distribution of the Escherichia coli isolates at two different<br />
seasons collected between March 2008 and August 2009.<br />
Carcass<br />
Collection Season Stx genes eae<br />
1º Rainy 35/150 23/150<br />
2º Rainy 47/150 12/150<br />
3º Dry 17/150 5/150<br />
4º<br />
Total<br />
Dry 21/150<br />
120 Stx+<br />
8/150<br />
48 eae+<br />
Figure 1. Photograph of a 1.5% agarose gel stained with ethidium<br />
bromide. Columns: 1 = 100 bp DNA ladder; 2 = positive control; 3 =<br />
negative control; 4 = strain positive for eae; 4, 6 and 8 = strain<br />
negative for all studied genes; 7 = strain positive for stx1 and stx2.<br />
RESULTS<br />
All isolates, confirmed as being E. coli by their<br />
biochemical analysis, were submitted to PCR for the<br />
detection of sequences of virulence genes. From each<br />
MacConkey agar plate a loopful from a confluent<br />
bacterial growth was collected and analyzed. A total six<br />
hundred E. coli strains isolates the cattle carcasses were<br />
separate 120 isolates that carrying stx1, stx2 and eae<br />
genes. These isolates just 45 were carriers of eae gene<br />
(Table1 and Figure 1). All isolates were collected of<br />
preevisceration stage. There were not isolating of strains<br />
of pre-evisceration stages and neither of post-processing<br />
stage (data not show). The isolates number containing<br />
both stx and eae gene during rainy season were high<br />
than dry season (Table1) and also the isolates number<br />
that carried the eae genes were high than the number of<br />
isolates that carried eae genes. In no isolates was<br />
verified the expression of enterohemolisyn. All isolates<br />
Rigobelo et al. 2219<br />
were tested for this hemolytic toxin and also no isolated<br />
were isolates was serotyped as O157. E. coli strains<br />
were tested against ten antimicrobial agents. The<br />
resistance pattern observed was: cephalothin (84.0%),<br />
streptomycin (45.0%) and nalidixic acid (42.0%) and<br />
tetracycline (20.0%) (Figure 1), 24% of the isolates were<br />
resistant to all the antibiotics tested. Multidrug resistance<br />
was seen in 38.4% of the isolates and resistance to 2 or<br />
3 antibiotics was common (Figure 2 and 3).<br />
DISCUSSION<br />
Among 600 strains analyzed only three were<br />
enterohemolysin positive. These results were similar to<br />
Rigobelo et al. (2008) that analyzed 216 samples from<br />
bovine carcasses and all of the isolates were negative for<br />
ehly gene. During raining season were found a high<br />
prevalence of STEC than dry season; probably the<br />
presence of water increased the spread of bacteria<br />
STEC. Some authors as Rogerie et al. (2001) reported<br />
lower post processing of nonO157 STEC prevalence<br />
(1.9%) on carcasses sampled during the summer in<br />
plants in France. Similarly, the non-O157 STEC<br />
prevalence on carcasses processed in Hong Kong was<br />
reported to be 1.7% (Leung et al., 2001), however, Arthur<br />
et al. (2002) reported higher level (54.0%) of contamination<br />
with nonO157 STEC in carcasses processed in<br />
the United States. Major sources of pathogens in<br />
processing of carcasses have been the hide and hair<br />
(Barkocy-Gallagher et al., 2001). It is not clear what<br />
proportion of non-O157 STEC bacteria detected in cattle<br />
feces or on beef carcasses is able to cause disease in<br />
humans. Gyles et al. (1998) defend the idea that all<br />
STEC bacteria could be pathogenic under adequate<br />
circumstances. In the present study, the detected level of<br />
STEC strains (20%) did not match those reported by<br />
others (Rogerie et al., 2001; Leung et al., 2001; Mora et<br />
al., 2005). To the best of our knowledge, we could not<br />
find data from Brazil for comparison. Only Rigobelo et al.<br />
(2006) report of STEC (1.25%) and Rigobelo et al. (2008)<br />
report (1, 4%) of STEC. These differences were probably<br />
because of low hygienic conditions of abattoir where we<br />
collected the samples.<br />
Some authors have reported the detection of STEC<br />
strains in fecal samples of dairy cattle (Irino et al., 2005),<br />
from diarrheic (Leomil et al., 2003) and from mastitic<br />
cattle (Lira et al., 2004) but none from abattoir samples.<br />
In all of them, the stx 2 gene has been predominantly<br />
found, and the non-O 157 STEC strains detected. Only a<br />
small number of O157 strains have been detected among<br />
bovine fecal samples 0.6% as reported by Irino et al.<br />
(2005), they did not express the stx gene. Interestingly,<br />
the O157: H 7 strains isolated in São Paulo State from<br />
human infections, were all stx -producers (Vaz et al.,<br />
2004 ), predominantly presenting the stx 1 gene. For<br />
more than four decades it has been a common practice<br />
on farms to use antimicrobial agents for disease
2220 Afr. J. Microbiol. Res.<br />
Figure 2. Antimicrobial resistance pattern of Escherichia coli isolate. CFL-cephalothin;<br />
STR - streptomycin – NAL-nalidixic acid; TET-tetracycline.<br />
Figure 3. Distribution of multidrug resistance to four antimicrobial drugs among<br />
Escherichia coli strains (n=120).<br />
prevention and growth promotion of animals. Widespread<br />
use of antimicrobial agents, select for resistance<br />
enhancement and may have promoted the increasing<br />
frequency of STEC strain's multidrug resistance in<br />
bovines. This could result in STEC population increases<br />
and perhaps greater shedding which could lead to higher<br />
contamination of animal food products with STEC (Zhao<br />
et al., 2001).<br />
Khan et al. (2002) reported resistance to one or more<br />
antibiotics in 49.2% of STEC strains in India, with some<br />
strains exhibiting multidrug resistance. Antimicrobial<br />
resistant bacteria from animals may colonize human<br />
population via the food chain; it is possible that resistant<br />
bacteria may be readily transferred to humans from<br />
animals used as food sources (Van den Bogaard and<br />
Stobberingh, 2000). During processing at an abattoir in<br />
Brazil we report a high level (20%) of occurrence of<br />
STEC strains on beef carcasses and also high
antimicrobial resistance suggesting poor hygienic<br />
conditions of slaughter of animals.<br />
ACKNOWLEDGEMENT<br />
FAPESP Fundação de Amparo Pesquisa do Estado de<br />
São Paulo financial support.<br />
REFERENCES<br />
Acheson DW (2000). How does Escherichia coli O157:H7 testing in<br />
meat compare with what we are seeing clinically? J. Food Protect.,<br />
63: 819–821.<br />
Arthur TM, Barkocy-Gallagher GA, Rivera-Betancourt M, Koohmaraie M<br />
(2002). Prevalence and characterization of non O157 Shiga toxin<br />
producing Escherichia coli on carcasses in commercial beef cattle<br />
processing plants. Appl. Environ. Microbiol., 68: 4847–4852.<br />
Barkocy-Gallagher GA, Arthur GA, Siragusa GR, Keen JE, Elder RO,<br />
Laegreid WW, Koohmaraie M (2001). Genotype analyses of<br />
Escherichia coli O157: H7 and O157 nonmotile isolates recovered<br />
from beef cattle and carcasses at processing plants in the<br />
Midwestern states of the United States. Appl. Environ. Microbiol., 67:<br />
3810– 3818.<br />
Bell RG (1997). Distribution and sources of microbial contamination of<br />
beef carcasses. J. Appl. Microbiol., 82: 292–300.<br />
Bettelheim KA (2000). Role of non - O15 7 VTEC. J. Appl. Microbiol.,<br />
88: 385–505.<br />
Beutin L, Geier D, Zimmermann S, Aleksic S, Gillespie HA, Whittam TS<br />
(1989). Epidemiological relatedness and clonal types of natural<br />
populations of Escherichia coli strains producing Shiga toxins in<br />
separate populations of cattle and sheep. Appl. Environ. Microbiol.,<br />
63: 2175–2180.<br />
Blanco J, Blanco M, Blanco JE (1993). Enterotoxigenic, verotoxigenic<br />
and necrotoxigenic Escherichia coli isolated from cattle in Spain. Am.<br />
J. Vet. Res., 54: 1446– 1451.<br />
Blanco M, Blanco JE, Blanco J, Mora A, Prado C, Alonso MP, Mourino<br />
M, Madrid C, Balsalobre C, Juarez A (1997). Distribuition and<br />
characterization of faecal verotoxin producing Escherichia coli<br />
(VTEC) isolated from healthy cattle. Vet. Microbiol., 54: 309–319.<br />
Bonnet R, Souweine B, Gauthier G, Rich C, Livrelli V, Sirot J, Joly B,<br />
Forestier C (1998). Non-O157:H7 Stx2 producing Escherichia coli<br />
strains associated with sporadic cases of hemolytic uremic syndrome<br />
in adults. J. Clin. Microbiol., 36: 1777– 1780.<br />
Cerqueira AMF, Guth BEC, Joaquim RM, Andrade JRC (1999). High<br />
occurrence of Shiga toxin-producing Escherichia coli (STEC) in<br />
healthy cattle in Rio de Janeiro state, Brazil. Vet. Microbiol., 70: 111-<br />
121.<br />
China B, Pirson V, Mainil J (1998). Prevalence and molecular typing of<br />
attaching and effacing Escherichia coli among calf population in<br />
Belgium. Vet. Microbiol., 63: 249 –259.<br />
De Toni F, Souza EM, Pedrosa FO, Klassen K, Irino K, Rigo LU,<br />
Steffens MBR, Fialho OB, Farah SMSS, Fadel-Picheth CMT (2009).<br />
A prospective study on Shiga toxin-producing Escherichia coli in<br />
children with diarrhoea in Paraná state, Brazil. Lett. Appl. Microbiol.,<br />
48: 645-647.<br />
Donnenberg MS, Kaper JB (1992). Enteropathogenic Escherichia coli.<br />
Infect. Immun., 60: 3953– 3961.<br />
Erickson MC, Doyle MP (2007). Food as a vehicle for transmission of<br />
Shiga toxin-producing Escherichia coli. J. Food Prot., 70: 2426-2449.<br />
Farah SMSS, Souza EM, Pedrosa FO, Irino K, Silva LR, Rigo LU,<br />
Steffens MBR, Pigatto CP, Fadel-Picheth, CMT (2007). Phenotypic<br />
and genotypic traits of Shiga toxin-producing Escherichia coli strains<br />
isolated from beef cattle from Paraná state, Southern Brazil. Lett.<br />
Appl. Microbiol., 44: 607-612.<br />
Gyles C, Johnson R, Gao, A, Ziebell K, Pierard D, Aleksic S, Boerlis, P<br />
(1998). Association of enterohemorrhagic Escherichia coli hemolysin<br />
with serotypes of Shiga toxin producing E. coli of humans and bovine<br />
origins. Appl. Environm. Microbiol., 64: 4134 –4141.<br />
Irino K, Kato MAMF, Vaz TMI, Ramos, II, Souza MAC, Cruz AS, Gomes<br />
Rigobelo et al. 2221<br />
TAT, Vieira, MAM, Guth BEC (2005). Serotypes and virulence markers<br />
of Shiga toxin-producing Escherichia coli (STEC) isolated from dairy<br />
cattle in São Paulo State, Brazil. Vet. Microbiol., 105: 29 –36.<br />
James CE (2001). Lytic and lysogenic infection of diverse Escherichia<br />
coli and Shigella strains with a verocytotoxigenic bacteriophage.<br />
Appl. Environ. Microbiol., 67: 4335–4337.<br />
Kaper JB, Nataro JP (2004). Mobley LT. Pathogenic Escherichia coli.<br />
Nat. Rev. Microbiol., 2: 123– 140.<br />
Kaper JB, O’brian AD (1998). Escherichia coli O157:H7 and other Shiga<br />
Toxin-producing E. coli Strains. Washington DC: ASM Press.<br />
Khan A, Das SC, Ramamurthy T, Sikdar A, Khanam J, Yamasaki S,<br />
Takeda Y, Nair, GB (2002). Antibiotic resistance, virulence gene, and<br />
molecular profiles of Shiga toxin producing Escherichia coli isolates<br />
from diverse source in Calcutta India. J. Clin, Microbiol., 40: 2009–<br />
2015.<br />
Koneman EW, Allen SD, Schrekenberger PC, Janda WM, Winn WC<br />
(1997). Color Atlas and Textbook Microbiology, 5 ed. Lippincott<br />
Company, Philadelphia.<br />
Leomil L, Aidar-Ugrinovich L, Guth BEC, Irino K, Vettorato MP, Onuma<br />
DL, De Castro AFP (2003). Frequency of Shiga toxin-producing<br />
Escherichia coli (STEC) isolates among diarrheic and non-diarrheic<br />
calves in Brazil. Vet. Microbiol., 97: 103– 109.<br />
Leung PHM, Yam WC, Ng WW, Peiris JS (2001). The prevalence and<br />
characterization of verotoxin-producing Escherichia coli isolated from<br />
cattle and pigs in an abattoir in Hong Kong. Epidemiol. Infect., 126:<br />
173–179.<br />
Lira WM, Macedo C, Marin JM (2004). The incidence of Shiga<br />
toxinproducing Escherichia coli in cattle with mastitis in Brazil. J.<br />
Appl. Microbiol., 97: 861–866.<br />
Maynard C, Bekal S, Sanschagrin F, Levesque RC, Brousseau R,<br />
Masson L, Lariviere S, Harel J (2004). Heterogeneity among<br />
virulence and antimicrobial resistance gene profiles of extraintestinal<br />
Escherichia coli isolates of animal and human origin. J. Clin.<br />
Microbiol., 42: 5444–5452.<br />
Mora A, Blanco JE, Blanco M, Alonso MP, Dhabi G, Echeita A,<br />
Gonzalez EA, Bernardez MI, Blanco J (2005). Antimicrobial<br />
resistance of Shiga toxin (verotoxin)-producing Escherichia coli<br />
O157:H7 and non-O157 strains isolated from humans, cattle, sheep<br />
and food in Spain. Res. Microbiol., 156: 793-806.<br />
Moreira CN, Pereira MA, Brod CS, Rodrigues DP, Carvalhal JB, Aleixo<br />
JAG (2003). Shiga toxin-producing Escherichia coli (STEC) isolated<br />
from healthy dairy cattle in Southern Brazil. Vet. Microbiol., 93: 179-<br />
183.<br />
Nataro JP, Kaper JB (1998). Diarrheagenic Escherichia coli. Clin.<br />
Microbiol. Rev., 11: 142–201.<br />
Paton JC, Paton AW (1998). Pathogenesis and diagnosis of Shiga-<br />
toxin producing Escherichia coli infections. Clin. Microbiol. Rev., 11:<br />
450–479.<br />
Pigatto CP, Schocken-Iturrino RP, Souza EM, Pedrosa FO, Comarella<br />
L, Irino K, Kato MAMF, Farah SMSS, Warth JF, Fadel-Picheth CMT<br />
(2008). Virulence properties and antimicrobial susceptibility of Shiga<br />
toxin-producing Escherichia coli strains isolated from healthy cattle<br />
from Paraná state, Brazil. Can. J. Microbiol., 54: 588-593.<br />
Rigobelo EC, Santo E, Marin JM (2008). Beef carcass contamination by<br />
Shiga toxin-producing Escherichia coli strains in an abattoir in Brazil:<br />
Characterization and Resistance to antimicrobial drugs. Foodborne<br />
and diseases., 5: 6.<br />
Rigobelo EC, Stella AE, Ávila FA, Macedo C, Marin JM (2006).<br />
Characterization of Escherichia coli isolated from carcasses of beef<br />
cattle during their processing at an abattoir in Brazil. Inter. J. Food<br />
Microbiol., 110: 194-198.<br />
Schmitt CK, Meysick KC, O’Brien AD (1999). Bacterial toxins: friends or<br />
foes? Emerging Infect. Dis., 5: 224–234.<br />
Timm CD, Irino K, Gomes TAT, Vieira MM, Guth BEC, Vaz TMI, Moreira<br />
CN, Aleixo JAG (2007). Virulence markers and serotypes of Shiga<br />
toxin-producing Escherichia coli, isolated from cattle in Rio Grande<br />
do Sul, Brazil. Lett. Appl. Microbiol., 44: 419-425.<br />
Vaz TMI, Irino K, Kato MAMF, Dias AMG, Gomes TAT, Medeiros MIC,<br />
Rocha MMM, Guth BEC (2004). Virulence properties and<br />
characteristics of Shiga toxin-producing Escherichia coli in São<br />
Paulo, Brazil, from 1976 through 1999. J. Clin. Microbiol., 42: 903-<br />
905.
African Journal of Microbiology Research Vol. 5(16), pp. 2222-2228, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.069<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Determination of insecticidal toxicity of three species of<br />
entomopathogenic spore-forming bacterial isolates<br />
against Tenebrio molitor L. (Coleoptera: Tenebrionidae)<br />
N. Du Rand and M. D. Laing<br />
Department of Plant Pathology, University of KwaZulu-Natal, Private Bag X01, Scottsville 3209, Pietermaritzburg,<br />
Republic of South Africa.<br />
Accepted 30 July, 2011<br />
Bioassays were conducted using larvae of mealworms, Tenebrio molitor, to determine lethal<br />
concentration for five entomopathogenic strains of spore-forming bacteria. Lethal concentration was<br />
determined by feeding T. molitor larvae cabbage discs dipped in whole cell cultures of these five strains<br />
of bacteria. The strains of bacteria were isolates of Bacillus cereus, Bacillus thuringiensis and<br />
Brevibacillus laterosporus. An isolate of B. cereus required the highest concentration of viable spores<br />
(8.531 x 10 7 spores ml -1 ) to achieve its LC50, whereas an isolate of B. laterosporus required the lowest<br />
concentration of viable spores (3.388 x 10 6 spores ml -1 ) to achieve LC50.<br />
Key words: Mealworms, spore-forming bacteria, bioassays.<br />
INTRODUCTION<br />
The first isolates of B. thuringiensis Berliner subspecies<br />
effective against coleopterans were isolated from a<br />
mealworm larva, Tenebrio molitor L. (Coleoptera:<br />
Tenebrionidae). This subspecies was subsequently<br />
named B. thuringiensis subsp. tenebrionis (Kriege et al.,<br />
1983). Another coleopteran specific strain was later<br />
isolated, B. thuringiensis subsp. san diego (Herrnstadt et<br />
al., 1986). These subsp. of B. thuringiensis are effective<br />
against one of the USA’s most important potato pests,<br />
the Colorado potato beetle, Leptinotarsa decemlineata<br />
Say (Coleoptera: Chrysomelidae) (Nault and Kennedy,<br />
1999). Colorado potato beetle has since been reported to<br />
have developed resistance to the Cry3A toxin (Whaldon<br />
et al., 1993). The development of resistance to pesticides<br />
is not uncommon in insects repeatedly subjected to a<br />
single pesticide, especially when only one toxin is<br />
involved (Ferré and Van Rie, 1992; Tabashnik, 1994).<br />
Various other coleopteran specific B. thuringiensis<br />
strains have been isolated and are effective against<br />
*Corresponding author. E-mail: 962082021@ukzn.ac.za.<br />
scarabaeid beetles such as Anomala cuprea Hope<br />
(Coleoptera: Dynastidae), A. rufocuprea Motschulsky<br />
(Coleoptera: Dynastidae) and Popillia japonica Newman<br />
(Coleoptera: Scarabaeidae) (Ohba et al., 1992).<br />
Bioassays on coleopterans are usually conducted on<br />
the Colorado potato beetle because these beetles are of<br />
economic importance and are a major pest in Asia,<br />
Europe and North America (Hare, 1990). These beetles<br />
are also the standard beetles used in bioassays to<br />
determine the International Units (IU) of toxicity (Navon,<br />
2000). However, it is absent from South Africa, and<br />
therefore T. molitor was used as the test organism<br />
because it is readily available in South Africa and easy to<br />
rear (Hinze, 2000).<br />
The aim of this research was to determine and<br />
compare the level of toxicity of five endospore-forming,<br />
entomopathogenic bacterial isolates, namely NDR1,<br />
NDR2, NDR3, NDR5 and NDR11.<br />
MATERIALS AND METHODS<br />
Samples<br />
Bacterial isolates were obtained from diseased insects such as T.<br />
molitor, Coleoptera adults and larvae of Schizonycha spp.
collected in sugarcane areas in KwaZulu-Natal (KZN), and debris<br />
from insect-rich environments such as compost, grain dust from<br />
grain storage bins and T. molitor cultures.<br />
Sample collection<br />
Mushroom compost was sampled from a mushroom farm (Karkloof,<br />
KwaZulu-Natal), compost from an urban garden (Hillcrest, KwaZulu-<br />
Natal) and grain dust was sampled from a chicken grain storage<br />
facility (Pietermaritzburg, KwaZulu-Natal). Diseased T. molitor<br />
larvae were collected from the insect rearing facility (University of<br />
KwaZulu-Natal). Adult beetles were collected from light traps in<br />
sugarcane areas in the KwaZulu-Natal midlands by employees of<br />
the South African Sugar Research Institute (SASRI, Mt. Edgcombe,<br />
KZN). White grubs were collected from sugarcane areas by staff<br />
members of SASRI and were delivered in plastic containers filled<br />
with soil. Diseased grubs were removed from these containers and<br />
placed into sterile Petri dishes. All samples were stored in a<br />
refrigerator kept at 4°C.<br />
Isolation of endospore-forming bacteria<br />
Isolation of Bacillus spp. was conducted using a similar<br />
pasteurization method to that described by Ohba and Aizawa<br />
(1978). Suspensions were shaken vigorously for 30 s at full speed<br />
on a vortex shaker. Mixed suspensions were then left to stand for<br />
1 h at room temperature. Suspensions were then vortexed a<br />
second time at full speed for 30 s and then subjected to a<br />
pasteurization process in a preheated water bath for 10 min at<br />
80°C. After pasteurization 0.1 ml aliquots of the suspensions were<br />
plated out onto nutrient agar (Biolab, Biolab Diagnostics, 259<br />
Davidson Road, Wadeville, Johannesburg) (Thiery and Frachon,<br />
1997).<br />
Plates were incubated for 24 h at 30°C in an incubator and<br />
examined for colonies with typical B. cereus morphology (fast<br />
growing, rhizoid, irregular, raised, smooth, and opaque white) or<br />
‘colonies with an ‘ice crystal’ appearance wider than 2 mm<br />
(Damgaard et al., 1997; Prescott et al., 1999; Selvakumar et al.,<br />
2007). Various other white colored bacterial colonies larger than<br />
2 mm in diameter were selected for microscopic evaluation. The<br />
number of colonies isolated from each isolate was estimated and<br />
counted using a colony counter. Selected colonies were then<br />
purified by sub-culturing onto nutrient agar plates and incubated for<br />
3 days at 30°C in an incubator. Colonies were stored on nutrient<br />
agar slants. Not all colonies from each sample that fitted the<br />
description above were selected due to the large number of<br />
colonies formed.<br />
Selected isolates were subjected to Gram staining as well as<br />
Coomassie Blue staining [Coomassie Blue stain 0.133% (w/v) and<br />
methanol 50% (v/v)] for 1 min. Slides were then rinsed gently for<br />
30 s with distilled water and blotted dry with tissue paper (Ammons<br />
et al., 2002). Isolates were screened for the presence of crystal<br />
proteins using light microscopy with a 100 x oil immersion objective<br />
lens (Bernhard et al., 1997; Young et al., 1998). Crystal proteins<br />
stained as dark blue structures (Ammons et al., 2002). Isolates<br />
were screened for size of cells, spore morphology and the presence<br />
of crystal proteins. Isolates without crystal proteins, but with cells<br />
broader than 0.9 µm, were also selected. This was done in order to<br />
include B. cereus, which does not produce crystal proteins. Rodshaped<br />
bacterial cells containing oval spores were selected<br />
because they fit the description of B. cereus, B. thuringiensis and B.<br />
laterosporus cells. Selected cultures were purified by sub-culturing<br />
and were assigned numbers NDR1-NDR14.<br />
Multiple dose bioassay<br />
A pure culture of T. molitor was obtained from a pet shop in<br />
Rand and Laing 2223<br />
Pietermaritzburg, KZN, SA. The culture was reared on a diet of<br />
commercial chicken meal (Meadow Feeds, P.O. Box 426,<br />
Pietermaritzburg, SA) (Hinze, 2000). Bran was not used because<br />
this contains phytic acid that affects the absorption of calcium which<br />
is and essential mineral for a healthy T. molitor culture (Hinze,<br />
2000). T. molitor larvae were reared in 350 mm x 250 mm square<br />
plastic containers containing chicken meal to a depth of 70 mm. For<br />
moisture, potatoes skins, cabbage leaves and carrot peels were<br />
added once a week (Hinze, 2000). Carrots are an essential additive<br />
because most of the micronutrients required by T. molitor larvae are<br />
present in carrots (Hinze, 2000). Adults and pupae were removed<br />
carefully with forceps from the cultures on a regular basis and<br />
placed into in 350 mm x 250 mm square plastic containers<br />
containing chicken meal to a depth of 70 mm. After 14 mo of<br />
rearing, a population of T. molitor larvae was available that was<br />
large enough for the planned bioassays. It was not possible to<br />
determine the instars’ stages because meal worms have between<br />
10 and 14 instars, and several instars occur with larvae in the same<br />
size range (25 mm in length) (Anonymous, 2008a). Therefore,<br />
larvae sized between 18-20 mm were used in the bioassays.<br />
Test organism preparation<br />
T. molitor larvae were carefully removed from the media by gently<br />
sifting the chicken meal through a sieve. This procedure separated<br />
the T. molitor larvae and the chicken meal effectively. The T. molitor<br />
larvae, sized between 18-20 mm, were placed in a division of a<br />
plastic ice tray, for counting purposes, prior to being inoculated with<br />
the bacterial isolates (NDR1, NDR2, NDR3, NDR5 and NDR11).<br />
Isolates NDR1, NDR3 and NDR11 were isolates of B. thuringiensis.<br />
NDR2 was an isolate of B. laterosporus, formerly Bacillus<br />
laterosporus (De Oliviera et al., 2004). NDR5 was an isolate of<br />
B. cereus.<br />
Inoculum preparation<br />
Bacterial isolates NDR1, NDR2, NDR3, NDR5 and NDR11 were<br />
used to inoculate 150 ml of sterile tryptone soy broth (TSB) (Biolab,<br />
Biolab Diagnostics, 259 Davidson Road, Wadeville, Johannesburg)<br />
and incubated in a shaker water bath at 250 rpm for 5 d at 30°C<br />
(Meadows et al., 1992). A viable spore count was conducted using<br />
a standard viable spore technique (Wheelis and Segel, 1979). The<br />
concentration of the viable spores was measured in colony forming<br />
units (CFUs). The final whole culture (FWC), which consisted of<br />
spores and crystal proteins, was used for inoculation. For NDR5<br />
only spores are present because this isolate does not produce<br />
crystal proteins.<br />
Inoculation<br />
Discs with an 18 mm diameter were cut out of the inner leaves of<br />
freshly purchased cabbage using a pre-sterilized test tube cap. The<br />
FWC of NDR1, NDR2, NDR3, NDR5 and NDR11 were diluted with<br />
sterile distilled water to make up concentrations ranges of 20, 40,<br />
60, 80 and 100%. Cabbage discs were dipped into the whole cell<br />
bacterial suspensions and fed to the T. molitor larvae in Petri<br />
dishes. The trials were conducted in sterile Petri dishes. Control<br />
discs were dipped into sterile distilled water. Twenty larvae per<br />
dose in replicates of five were used for each bioassay for NDR1,<br />
NDR2, NDR3 and NDR11. A total of 28 larvae per dose in<br />
replicates of five were used for NDR5. Dead larvae turned black<br />
and liquefied internally. Koch’s postulate was used to determine if<br />
the isolates were responsible for the insect deaths (Prescott et al.,<br />
1999). The amount of cabbage disc consumption (mm) was a<br />
general observation and was not recorded because larval mortality
2224 Afr. J. Microbiol. Res.<br />
Table 1. (LSTATS) PROBAN analysis of three replicate bioassays of five spore-forming bacteria tested against Tenebrio<br />
molitor, with regression parameters displaying the efficacy of these assays.<br />
Isolate No of larvae affected LC50 a 95% Fl b Slope X 2 (df-13)<br />
NDR1 n<br />
Assay 1 68 7.495 7.414 - 7.548 5.45 1.42<br />
Assay 2 55 7.391 7.256 - 7.497 2.54 3.47<br />
Assay 3 61 7.332 7.176 - 7.436 2.59 3.13<br />
Mean 61 7.406 7.282 - 7.494 3.53 -<br />
NDR2 n<br />
Assay 1 63 6.572 6.488 - 6.630 4.65 2.47<br />
Assay 2 68 6.507 6.358 - 6.603 3.02 0.36<br />
Assay 3 65 6.512 6.388 - 6.600 3.26 2.36<br />
Mean 65 6.530 6.411 - 6.611 3.64 -<br />
NDR3 n<br />
Assay 1 49 7.219 7.092 - 7.344 2.35 2.65<br />
Assay 2 46 7.281 7.170 - 7.403 2.56 1.32<br />
Assay 3 53 7.207 7.084 - 7.312 2.63 5.27<br />
Mean 49 7.236 7.115 - 7.353 2.51 -<br />
NDR5 n<br />
Assay 1 51 7.904 7.786 - 8.070 1.95 4.56<br />
Assay 2 49 7.927 7.809 - 8.101 1.97 2.04<br />
Assay 3 56 7.963 7.832 - 8.142 1.71 3.66<br />
Mean 52 7.931 7.809 - 8.104 1.88 -<br />
NDR11 n<br />
Assay 1 57 7.095 6.953 - 7.199 2.57 2.62<br />
Assay 2 48 7.178 7.087 - 7.266 3.35 2.48<br />
Assay 3 50 7.146 7.037 - 7.248 2.79 0.63<br />
Mean 52 7.140 7.026 - 7.237 2.90 -<br />
a Lethal concentration (LC50); b 95% fiducial limits were log transformed concentrations of bacterial spores per ml; n 20 larvae per<br />
dose in replicates of five (total of 100 larvae per bioassay).<br />
was the objective of this study. Results were recorded after 5 days.<br />
Statistical analyses<br />
The statistical computer programs (LSTATS) P/PROBAN Version<br />
2.1 (1992), as programmed by Van Ark (1983), and SPSS Version<br />
11.5, were used to calculate the regression parameters that<br />
included the determination of lethal concentration (LC50) and their<br />
fiducial limits. Each sample reflected three estimates of LC50 and<br />
fiducial limits. These were compared using a standard one-way<br />
ANOVA. A similar format to that of Hatting (2002) was used to<br />
depict the results obtained (Table 1). The LC50 values were<br />
converted back to concentrations of viable spores to determine the<br />
50% mortality dose.<br />
RESULTS<br />
Mortality of T. molitor larvae in the control Petri dishes<br />
was zero, and the cabbage discs were completely<br />
consumed after 5 days. The complete consumption of the<br />
cabbage discs indicates that no toxic effects were<br />
present in the control. Cabbage discs that were<br />
inoculated with different doses of the various bacterial<br />
isolates were consumed according to dose. An overall<br />
trend observed was that the more concentrated the<br />
inocula of spore-forming bacteria applied to the cabbage<br />
disc, the less the cabbage disc was consumed. Low<br />
bacterial dilutions resulted in levels of cabbage disc<br />
consumption similar to that of the controls but with a low<br />
level of T. molitor mortality. No further larval deaths were<br />
found to occur after 5 days.<br />
The minimum LC50 was 6.530 for NDR2 at a<br />
concentration equal to 3.388 x 10 6 spores ml -1 . The<br />
maximum LC50 was 7.931 (NDR5) at a concentration of<br />
8.531 x 10 7 spores ml -1 (Table 1). NDR5 could thus be<br />
considered the most effective isolate. A comparative<br />
bioassay with B. thuringiensis subsp. tenebrionis was not<br />
conducted because this strain is not a registered biocontrol
Rand and Laing 2225<br />
Table 2. (LSTATS) PROBAN hypothesis test used to determine the homogeneity between the five independent bioassays<br />
using NDR1, NDR2, NDR3, NDR5 and NDR11.<br />
Hypothesis Slopes equal Slopes and intercepts equal<br />
Isolate X 2 Df P X 2 df P<br />
NDR1 0.341 2 0.842 5.404 2 0.065<br />
NDR2 1.445 2 0.49 2.007 2 0.368<br />
NDR3 0.73 2 0.699 0.121 2 0.932<br />
NDR5 0.256 2 0.876 0.317 2 0.851<br />
NDR11 0.846 2 0.661 0.793 2 0.678<br />
Table 3. Results of a parallelism test between the three assays of the five bacterial isolates to determine homogeneity.<br />
Isolate No. of larvae affected Slope ± SE LC50 a 95% Fl X 2 (df-13) G b<br />
NDR1 184 2.82 ± 0.37 7.386 7.314 - 7.443 15.781 0.068<br />
NDR2 196 3.39 ± 0.40 6.530 6.468 - 6.580 7.271 0.055<br />
NDR3 148 2.50 ± 0.34 7.235 7.172 - 7.297 10.132 0.071<br />
NDR5 156 1.85 ± 0.22 7.933 7.861 - 8.021 11.091 0.053<br />
NDR11 155 2.87 ± 0.35 7.140 7.082 - 7.194 8.031 0.058<br />
a The data of the three bioassays were pooled to obtain a more accurate estimation of the LC50 and fiducial limits. b The Fiducial limits<br />
calculated by Fieller’s theorem as a measurement of variation.<br />
agent in SA and is not readily available. B. thuringiensis<br />
subsp. azawai and B. thuringiensis subsp. kurstaki are<br />
the only two subsp. of B. thuringiensis registered in SA<br />
for use as a bio-pesticide (Anonymous, 2008b).<br />
Numbers of larvae used in the assays were either 20<br />
for NDR1, NDR2, NDR3, NDR5 and NDR11 (per single<br />
dose). These were the largest numbers possible at the<br />
time, in this project, due to limited insect rearing facilities,<br />
financial resources and time constraints.<br />
One–way ANOVA was used to determine whether the<br />
slopes and intercepts of the three bioassays of each of<br />
the isolates were comparable. Deviations of the slopes<br />
and intercepts from the Probit lines were homogenous.<br />
These lines were therefore comparable (Tables 2 and 3,<br />
Figure 1).<br />
DISCUSSION<br />
Statistical results<br />
The chi-squared values obtained for each of the<br />
bioassays suggested that the deviations of the observed<br />
mortalities are within the range of accepted parameters<br />
for the calculated Probit line (Table 1) (Van Ark, 1983).<br />
Therefore, it may be concluded that the calculated Probit<br />
line is an acceptable representation of insect response to<br />
B. thuringiensis isolates. Parallelism tests showed that no<br />
significant differences could be detected between the five<br />
bioassays for each of the isolates. This allowed for the<br />
comparison of slopes and intercepts (Table 3). The<br />
slopes of the independent bioassays showed no<br />
significant differences and were found to be homogenous<br />
hence the lines were comparable (Table 2) (Van Ark,<br />
1983). The deviations from the observed mortalities were<br />
within the expected limitations of deviation thus rendering<br />
the Probit line acceptable (Table 2 and Figure 1) (Van<br />
Ark, 1983). Values obtained indicated that the lines for<br />
each of the five bioassays for each isolate were parallel<br />
and hence a similar response was observed for each of<br />
the isolates (Table 2 and Figure 1). The LC50 spore<br />
concentrations for each of the isolates were: NDR1 =<br />
2.432 x 10 7 , NDR2 = 3.388 x 10 6 , NDR3 = 1.718 x 10 7 ,<br />
NDR5 = 8.579 x 10 7 and NDR11 = 1.380 x 10 7 .<br />
G is used as a measure of variation in the calculation of<br />
fiducial limits and is derived from Fieller’s Theorem (Van<br />
Ark, 1983). According to Finney (1971), in a good<br />
bioassay, the value of G will lie between 0.2 and 0.05.<br />
Van Ark (1983) suggested using G values of 0.25 and<br />
0.025. G values above 0.025 indicate that the variation of<br />
mortality is high. Values above 0.25 indicate that the<br />
experimental design is not appropriate and requires<br />
amendment. The fiducial limits cannot be calculated for<br />
assays where the G value is equal to one (Van Ark,<br />
1983). The G values for all five isolates fell within the<br />
parameters set by Van Ark as well as by Finney.<br />
However, the experimental precision was not ideal<br />
because the G values were larger than 0.025, indicating<br />
that the variation in mortalities was large. However, the<br />
values were still acceptable because they did not exceed<br />
0.25 (Table 3).<br />
These results could be improved by conducting six or
2226 Afr. J. Microbiol. Res.<br />
Empirical probit mortality<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
0<br />
Series1<br />
Series2<br />
Series3<br />
Series4<br />
Series5<br />
y = 2.8157x - 15.798<br />
y = 2.5895x - 13.764<br />
y = 1.8497x - 9.6744<br />
y = 3.3919x - 17.15<br />
y = 2.8998x - 15.682<br />
0 1 2 3 4 5 6 7 8 9<br />
Log dose<br />
Figure 1. Separate Probit lines of the pooled data for each of the five isolates. 1. Series 1 = NDR1; Series 2 = NDR2;<br />
Series 3 = NDR3; Series 4 = NDR5 and Series 5 = NDR11.<br />
more bioassays per isolate. This would result in a better it<br />
of line and hence a lower G value (Van Ark, 1983). The<br />
number of insects required in a bioassay for reliable<br />
results depends on the experimental procedures, as well<br />
as the species of insect (Van Ark, 1983).<br />
Toxicity comparison of isolates<br />
The isolate with the best LC50 was NDR2, with a log<br />
value of 6.530 (3.388 x 10 6 spores ml -1 ) (Table 3). This<br />
isolate was identified previously as an isolate of<br />
B. laterosporus. Assays conducted with isolates of<br />
B. laterosporus did not exhibit any toxicity towards<br />
T. molitor. However, toxicity was evident against<br />
mosquitoes (Culex quinquefasciatus and Aedes aegypti)<br />
and a species of snail Biomphalaria glabrata (Favret and<br />
Yousten, 1985). Assays conducted by Rivers et al. (1991)<br />
on T. molitor with strains of B. laterosporus showed these<br />
strains to have toxicity values similar to those obtained<br />
from strains of B. thuringiensis subsp. tenebrionis.<br />
The isolate with the weakest LC50 was NDR5, with a<br />
log value of 7.933 (8.579 x 10 7 spores ml -1 ). This isolate<br />
was identified previously as an isolate of B. cereus. This<br />
species is not often used in entomopathogenic bioassays<br />
because it is considered an organism associated with<br />
gastrointestinal diseases and is often found as a food<br />
contaminant. However, B. cereus strains with insecticidal<br />
properties against coleopteran larvae have been isolated<br />
from species of white grub (Selvakumar et al. 2007;<br />
Sushil et al., 2008). The insecticidal properties of this<br />
organism lie in its ability to produce vegetative<br />
insecticidal proteins (VIP) (Estruch et al., 1996; Moar et<br />
al., 1994; Yu et al., 1997) which have been found to be<br />
effective against Western Corn Rootworm, Diabrotica<br />
virgifera LeConte (Coleoptera, Chrysomelidae) (Warren,<br />
1997).<br />
All five bacterial isolates (NDR1, NDR2, NDR3, NDR5<br />
and NDR11) displayed toxicity against T. molitor. The<br />
three B. thuringiensis isolates (NDR1, NDR3 and NDR11)<br />
displayed high levels of toxicity to T. molitor but were less<br />
toxic than the B. laterosporus isolate (NDR2) (Table 3).<br />
The dose response of the B. cereus isolate (NDR5) was<br />
found to stand alone from the other two species tested<br />
(Figure 1). This is indicative of substantially greater<br />
toxicity than the other isolates.<br />
Standardization assays often involve the use of purified<br />
or extracted crystal proteins (Cry and Cyt toxins) and do<br />
not include any of the other toxins and synergists (e.g.,<br />
chitinases) produced by these species of bacteria
(Thamthiankul et al., 2001; Lee et al., 2007). B.<br />
thuringiensis and B. cereus are able to synthesize<br />
chitinases (Lee et al., 2007). Other toxins may play an<br />
important role in preventing target insects from becoming<br />
resistant because they would have to evolve resistance<br />
against more than one compound concurrently. In the<br />
bioassays used in this research, the FWC were used in<br />
toxicity determination. Hence, other unknown toxins and<br />
synergistic factors were included. Whole cultures<br />
consisting of spore and crystal suspensions are often<br />
used in bioassays to determine toxicity. The use of FWCs<br />
is applied where whole culture products will be<br />
commercialized, as opposed to pure protein crystals (De<br />
Oliviera, 2004; Lambert et al., 1992). Whole culture<br />
products have to be screened for beta-exotoxins because<br />
current registration of B. thuringiensis products requires<br />
the absence of these toxins (Prieto-Samsonova et al.,<br />
1997). Continuous sub-culturing of B. thuringiensis can<br />
be problematic because it may cause a decline in toxicity<br />
(Sachidanandham and Jayaraman, 2003).<br />
ACKNOWLEDGEMENTS<br />
Authors are thankful to M. Ohba and K. Kagoshima for Hserotyping<br />
of some of the isolates and to the team from<br />
The South African Sugar Research Institute (SASRI) for<br />
the collection and delivery of the white grubs and adult<br />
beetles.<br />
REFERENCES<br />
Ammons D, Rampersad J, Khan A (2002). Usefulness of staining<br />
parasporal bodies when screening for Bacillus thuringiensis. J.<br />
Invertebr. Pathol., 79: 203-204.<br />
Anonymous(2008a). www.wikipedia.org (12/12/08)<br />
Anonymous (2008b). www.pesticideinfo.org (21/12/08)<br />
Bernhard K, Jarrett P, Meadows M, Butt J, Ellis DJ, Roberts GM, Pauli<br />
S, Rodgers P, Burges HD (1997). Natural isolation of Bacillus<br />
thuringiensis: Worldwide distribution, characterization, and activity<br />
against insect pests. J. Invertebr. Pathol., 70: 59-68.<br />
Damgaard PH, Hansen BM, Pedersen RC Eilenberg J (1997). Natural<br />
occurrence of Bacillus thuringiensis on cabbage foliage and in insects<br />
associated with cabbage crops. J. Appl. Microbiol., 82: 253-258.<br />
De Oliviera, EJ, Rabinovitch L, Monnerat RG, Passos LKJ, Zahner V<br />
(2004). Molecular characterization of Brevibacillus laterosporus and<br />
its potential use in biological control. Appl. Environ. Microbiol., 70:<br />
6657-6664.<br />
Estruch JJ, Warren GW, Mullins MA, Nye GJ, Craig JA, Koziel MG<br />
(1996). Vip3A, a novel Bacillus thuringiensis vegetative insecticidal<br />
protein with a wide spectrum of activities against lepidopteran<br />
insects. Proc. Nat. Acad. Sci., 93: 5389-5394.<br />
Favret ME, Yousten AA (1985). Insecticidal activity of Bacillus<br />
laterosporus. J. Invertebr. Pathol., 45: 195-203.<br />
Ferré J, Van Rie, J (1992). Biochemistry and genetics of insect<br />
resistance to Bacillus thuringiensis. Ann. Rev. Entomol., 47: 501-533.<br />
Finney DJ (1971). Statistical Method in Biological Assays. Second<br />
edition. Griffin, London, UK.<br />
Hare JD (1990). Ecology and maintenance of the Colorado potato<br />
beetle. Ann. Rev. Entomol., 35: 81-100.<br />
Hatting JL (2002). Fungal cereal parasitism of cereal aphids in South<br />
Africa. PhD thesis. University of Natal, Pietermaritzburg, South<br />
Africa.<br />
Rand and Laing 2227<br />
Herrnstadt C, Soares GG, Wilcox GR, Edwards DL (1986). A new strain<br />
of Bacillus thuringiensis with activity against Coleopteran insects. Bio-<br />
Technology., 4: 305-308.<br />
Hinze I (2000). A guide to keeping and breeding waxbills in a British bird<br />
room. Part III. Cultivating live food. Avizadium., 12: 14-16.<br />
Kriege A, Huger AM, Langernbruch GA, Schnetter W (1983). Bacillus<br />
thuringiensis var. tenebrionis: A new pathotype effective against<br />
larvae of Coleoptera. J. Appl. Entomol., 96: 500-508.<br />
Lambert B, Höfte H, Annys K, Janssens S, Soetaert P, Peferoen M<br />
(1992). Novel Bacillus thuringiensis insecticidal crystal proteins with a<br />
silent activity against Coleopteran larvae. Appl. Environ. Microbiol.,<br />
58: 2536-2542.<br />
Lee HS, Jang JS, Choi SK, Lee DW, Kim EJ, Jung HC, Pan JG (2007).<br />
Identification and expression of GH-8 family chitosanases from<br />
several Bacillus thuringiensis subspecies. FEMS. Micro. Let.,<br />
277: 133-141.<br />
Meadows MP, Ellis DJ, Butt J, Burges HD (1992). Distribution,<br />
frequency, and diversity of Bacillus thuringiensis in an animal feed<br />
mill. Appl. Environ. Microbiol., 58: 1344-1350.<br />
Moar, WJ, Trumble JT, Hice RH, Backman PA (1994). Insecticidal<br />
activity of the CryIIA protein from the NRD-12 isolate of Bacillus<br />
thuringiensis subsp. kurstaki expressed in Escherichia coli Migula<br />
and Bacillus thuringiensis and in a leaf colonizing strain of Bacillus<br />
cereus. Appl. Environ. Microbiol., 60: 896-902.<br />
Nault BA, Kennedy GG (1999). Influence of foliar-applied Bacillus<br />
thuringiensis subsp. tenebrionis and early potato harvest on<br />
abundance and overwinter survival of Colorado potato beetles<br />
(Coleoptera: Chrysomelidae) in North Carolina. Hortic. Entomol., 92:<br />
1165-1171.<br />
Navon A (2000). Bioassays of entomopathogenic microbes and<br />
nematodes: In Navon A, Ascher KRS (eds) Bioassays of Bacillus<br />
thuringiensis, Part 1. CABI, New York, USA, pp. 1-24.<br />
Ohba M, Aizawa K (1978). Serological identification of Bacillus<br />
thuringiensis and related bacteria isolated in Japan. J. Invertebr.<br />
Pathol., 32: 303-309.<br />
Ohba, M, Iwahana H, Asano S, Suzuki N, Sato R, Hori H (1992). A<br />
unique isolate of Bacillus thuringiensis serovar japonensis with a high<br />
larvicidal activity specific for scarabaeid beetles. Lett. Appl.<br />
Microbiol., 14: 54-57.<br />
Prescott LM, Harley JP, Klien DA (1999). Microbiology. Fourth Edition.<br />
WCB McGraw-Hill, New York.<br />
Prieto-Samsonova DL, Vasquez-Parelan RI, Ayra-Pardo C, Gonzalez-<br />
Cabera J, de la Riva GA (1997). “Bacillus thuringiensis: From<br />
biodiversity to biotechnology.” J. Ind. Microbiol. Biotechnol., 19: 202-<br />
219.<br />
Rivers DB, Vann CN, Zimmack HL, Dean DH (1991). Mosquitocidal<br />
activity of Bacillus laterosporus. J. Invertebr. Pathol., 58: 444-447.<br />
Sachidanandham R, Jayaraman K (2003). Formation of spontaneous<br />
asporogenic variants of Bacillus thuringiensis subsp. galleriae in<br />
continuous cultures. Appl. Microbiol. Biotechnol., 40: 504-507.<br />
Selvakumar G, Mohan M, Sushil SN, Kundu S, Bhatta JC, Gupta HS<br />
(2007). Characteristic and phylogenic analysis of an<br />
entomopathogenic Bacillus cereus strain WGPSB-2 (MTCC 7182)<br />
isolated from white grub, Anomala dimidiate (Coleoptera:<br />
Scarabaeidae). Biocontrol Sci., 17: 525-534.<br />
Sushil NS, Mohan M, Selvakumar G, Bhatt JC, Gupta HS (2008).<br />
Isolation and toxicty evaluation of bacterial entomopathogens against<br />
phytophagous white grubs (Coleoptera: Scarabaeidae) in Indian<br />
Himalayan hills. Int. J. Pest Manage., 54: 301-307.<br />
Tabashnik BE (1994). Evolution of resistance to Bacillus thuringiensis.<br />
Ann. Rev. Entomol., 39: 47-79.<br />
Thamthiankul S, Suan-Ngay S, Tantimavanich S, Panbangred, W<br />
(2001). Chitinase from Bacillus thuringiensis subsp. pakistani. Appl.<br />
Microbiol. Biotechnol., 56: 395-401.<br />
Thiery I, Frachon E (1997). Identification, isolation, culturing and<br />
preservation of entomopathogenic bacteria. In Lacey L (ed) Manual<br />
of Techniques in Insect Pathology. <strong>Academic</strong> Press, London, UK, pp.<br />
55-77.<br />
Van AH (1983). Introduction to Probit analysis with (LSTATS)<br />
P/PROBAN. Science Bulletin, Department of Agriculture, Rep. South<br />
Afr., 399: 1-16.<br />
Whaldon ME, Miller DL, Hollingworth RM, Grafius EJ, Miller JR (1993).
2228 Afr. J. Microbiol. Res.<br />
Selection of Colorado potato beetle (Coleoptera: Chrysomelidae) strain<br />
resistant to Bacillus thuringiensis. J. Econ. Entomol., 86: 226-233.<br />
Warren GW (1997). Vegetative insecticidal proteins: novel proteins for<br />
control of corn pests, p. 109-121. In Carozzi N, Koziel M (ed)<br />
Advances in Insect Control: the Role of Transgenic Plants. Taylor<br />
and Francis, London, UK, pp. 109-121.<br />
Wheelis ML, Segel WP (1979). Introduction to the Microbial World. A<br />
Laboratory Manual. Prentice-Hall, New Jersey.<br />
Young JM, Chilcott CN, Broadwell A, Wigley AJ, Lecadet MM (1998).<br />
Identification of serovars of Bacillus thuringiensis Berliner 1915 in<br />
New Zealand. N. Z. J. Crop Hortic. Sci., 26: 63-68.<br />
Yu CG, Mullins MA, Warren GW, Koziel MG, Estruch JJ (1997). The<br />
Bacillus thuringiensis vegetative insecticidal protein VIP3A lyses<br />
midgut epithelium of susceptible insects. Appl. Environ. Microbiol.,<br />
65: 532-536.
African Journal of Microbiology Research Vol. 5(16), pp. 2229-2233, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.108<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
What changed in necrotizing fasciitis in twenty-five<br />
years?<br />
Baris Yildiz 1 *, Derya Karakoc 2 , Erhan Hamaloglu 2 , Arif Ozdemir 2 and Ahmet Ozenc 2<br />
1 Ankara Numune Teaching and Research Hospital, 6th General Surgery, Ankara, Turkey.<br />
2 Department of General Surgery, Faculty of Medicine, Hacettepe University, Ankara, Turkey.<br />
Accepted 30 June, 2011<br />
Necrotizing fasciitis (NF) is a deadly soft tissue infection characterized by necrosis of subcutaneous<br />
tissues. In this study, our aim was to identify variables affecting patient outcome and mortality in<br />
necrotizing fasciitis and their temporal changes. We reviewed records of 45 patients treated at our<br />
institution between 1979 and 2004. Data about gender, age, etiology, site of involvement, bacteriology,<br />
type of surgery, supportive treatment, accompanying diseases, mortality were collected. Factors<br />
contributing to mortality were sepsis, renal failure, liver failure, multi organ failure, disseminated<br />
intravascular coagulopathy and long term intubation. Mortalities accumulated in first 23 patients. There<br />
was not difference in microbiology, demographics, etiology, site of involvement, debridement technics<br />
between first patients and recent patients of the institution. Mortality in necrotizing fasciitis is mostly<br />
because of sepsis and associated disorders. Adequate control of the microbiological agent and<br />
preventing further contamination of the wound is cardinal part of treatment in NF.<br />
Key words: Necrotizing fasciitis, bacteriology, mortality, sepsis, Fournier’s gangrene.<br />
INTRODUCTION<br />
Necrotizing fasciitis (NF) is deeply located infection of<br />
subcutaneous tissue resulting in progressive destruction.<br />
Its histological patterns are large necrosis of the fascia,<br />
subcutaneous fat and skin with thrombosis of the<br />
microvasculature and sparing of the underlying muscles<br />
and the skin (Wilson, 1952; Giuliano et al., 1977; Misago<br />
et al., 1996).<br />
NF can be divided into two groups depending on the<br />
causative organism. In type I, at least one anaerobic<br />
species is isolated in combination with facultative<br />
anaerobic species and members of Enterobacteriaceae.<br />
In type II, group A streptococci or Staphylococcus aureus<br />
are isolated (Levine and Manders, 2005).<br />
There are a number of predisposing factors to NF such<br />
as diabetes mellitus (DM) (Salcido, 2007) immunocompromised<br />
state, corticosteroid use, intravenous drug<br />
abuse, trauma, malnutrition, burns and atherosclerosis<br />
(Thompson et al., 1993). Early diagnosis and prompt<br />
*Corresponding author. E-mail: baris104@yahoo.com. Tel: +90-<br />
532- 445 46 55. Fax: +90-312- 424 15 20.<br />
Abbreviations: NF, Necrotizing fasciitis; DM, diabetes mellitus.<br />
treatment consisting of surgery and antibiotics are key to<br />
improved patient outcome in NF.<br />
Depending on the depth of invasion, necrotizing soft<br />
tissue infections can cause extensive local tissue<br />
destruction, tissue necrosis, systemic toxicity and even<br />
death. Mortality rates for necrotizing soft tissue infections<br />
range from 6% to as high as 76% despite advances in<br />
management (Brandt et al., 2000; Singh et al., 2002;<br />
Bilton et al., 1998).<br />
In this study, our aim was to identify the temporal<br />
changes in incidence, etiology, bacteriology, management<br />
and outcome in NF at our institution to help define<br />
better strategies in treatment for this challenging<br />
condition.<br />
MATERIALS AND METHODS<br />
After ethics commitee approval was obtained, inpatient records of<br />
patients treated for necrotizing fasciitis between 1979 and 2004 in<br />
our university hospital general surgery department were retrospectively<br />
reviewed. Patients were identified from hospital archives<br />
and data was collected from hospital records and electronic<br />
database. There were 29 men and 16 women whose ages ranged<br />
between 16 and 88 years. We reviewed the charts of the patients
2230 Afr. J. Microbiol. Res.<br />
and recorded sex, age, predisposing factors, duration between the<br />
onset of symptoms and the first surgical debridement, bacteria<br />
isolated, duration of hospital stay, reconstructive proce-dures, and<br />
clinical outcome. Plastic and Reconstructive Surgery at our hospital<br />
was consulted for patients who needed reconstructive procedures<br />
after initial debridement was performed in General Surgery<br />
Department. Broad spectrum antibiotics were given initially and<br />
specific antibiotics were advised after confirmation of the organism<br />
isolated from the wound tissue. Patients with minor skin and softtissue<br />
loss or wound healing with secondary intention were referred<br />
for wound evaluation and wound care. The scrotal advancement<br />
flap, pudendal thigh fasciocutaneous flap, gracilis<br />
muscle/myocutaneous flap, or split-thickness skin graft was used as<br />
the reconstructive procedure to correct the defects arising from<br />
failure of secondary intention or primary closure. The statistical<br />
analysis was carried out with SPSS software (SPSS, Chicago,<br />
Illinois) using Chi-Square test. A P-value < 0.05 was considered<br />
significant.<br />
RESULTS<br />
There were totally 45 patients. The median age of the<br />
patients was 50 (minimum 16, maximum 88). Sixteen<br />
patients (35.6%) were female and 29 (64.4%) were male.<br />
The diagnoses of NF were established based on clinical<br />
symptoms and findings including combinations of fever,<br />
pain, swelling, erythematous change of the involved skin<br />
and purulent discharge.<br />
The most common etiology was perianal abcess (n=17,<br />
37.8%) followed by surgical site infection (n=9, %20) and<br />
others (perineal shaving, decubitus ulcer, strangulating<br />
inguinal hernia, vulvar trauma, intramuscular injection,<br />
pilonidal abcess, colocutaneous fistula, diabetic foot, gun<br />
shot wound, enterocutaneous fistula). It was seen that<br />
majority of cases were actually Fournier’s gangrene. This<br />
was supported by the analysis of the site of involvement<br />
as perianal area, scrotum/vulva with highest frequency<br />
(n=16), followed by combinations of localizations<br />
including scrotum, vulva, gluteus and inguinal region.<br />
Twenty-two percent of patients in our study had comorbidities<br />
while thirteen patients (28.9%) did not have<br />
any accompanying disease. The most common associated<br />
disease was DM (17.8%) followed by malignancies<br />
(8.9%), coronary artery disease (6.7%) and combinations<br />
of DM, hypertension, ulcerative colitis, paraplegia,<br />
chronic obstructive airway disease. During management<br />
46.7% of patients had sepsis and 11.1% had multiorgan<br />
failure.<br />
Polymicrobial bacterial strains were isolated from tissue<br />
and pus cultures. In 9 patients there was not any growth<br />
in bacterial cultures. The rest of isolated bacteria are<br />
listed in Table 1.<br />
Antimicrobial agents, surgery and nutritional support<br />
were the mainstay of treatment for patients with NF.<br />
Antibiotic therapy was started empirically and continued<br />
based on the microbiology of the wounds. In 3 patients<br />
antifungal medication was added to antibiotics. Median<br />
duration of antimicrobial therapy was 17 days (minimum<br />
3 – maximum 55).<br />
Surgery was performed as soon as the diagnosis of NF<br />
was suspected. There was delay in 18 patients between<br />
diagnosis and surgical intervention. Median time of delay<br />
was 1.5 days. Debridement under local anesthesia was<br />
performed only to 4.4% of the patients and 95.6% of the<br />
patients had debridement under general anesthesia. Of<br />
those who had debridement under general anesthesia,<br />
27 (60%) had only one debridement while 9 (20%) had<br />
twice and 4 (8.9%) had three times. Overall, colostomy<br />
was performed to 22.2% of patients and to 90% of the<br />
patients with Fournier’s gangrene.<br />
Twenty-six patients (48.8%) required reconstruction.<br />
Primary closure was performed in 15 (57.6%) patients<br />
whereas 4 (15.3%) patients had split-thickness skin<br />
grafting and 3 (11.3%) had flap reconstruction.<br />
Nutritional support was given to 17 patients. Of these,<br />
six patients received total parenteral nutrition whereas 8<br />
had enteral nutrition.<br />
The longest hospital stay was 92 days while the<br />
shortest stay was 9 days (median: 35.5). The overall<br />
mortality was 22.2% (n=10). Twenty-five percent of<br />
women and 20% of men died. Comparison of survivors<br />
and non-survivors are given in Table 2. Statistically<br />
significant factors contributing to mortality were sepsis<br />
(p=0.001), multiorgan failure (p
Table 1. Combinations of bacteriologic strains isolated from tissues in chronological order starting from 1979 to 2004.<br />
Case Year Microorrganisms<br />
Yildiz et al. 2231<br />
1 1979 Enterobacteriaceae spp.<br />
2 1979 Escherichia coli, Clostridium tetani<br />
3 1980 Coagulase positive Staphylococcus aureus (SCP)<br />
4 1983 No growth<br />
5 1983 Escherichia coli, Proteus, SCP, Diphtheroids<br />
6 1985 Escherichia coli, Diphtheroids<br />
7 1986 Escherichia coli, SCP, Pseudomonas aeruginosa<br />
8 1988 SCP, Acinetobacter<br />
9 1991 Klebsiella pneumonia, Pseudomonas aeruginosa<br />
10 1993 Streptococcus pneumonia, SCP<br />
11 1993 No growth<br />
12 1994 No growth<br />
13 1994 Pseudomonas aeruginosa<br />
14 1994 No growth<br />
15 1995 Enterobacteriaceae species<br />
16 1995 No growth<br />
17 1995 Proteus vulgaris<br />
18 1996 Klebsiella oxytoca, Escherichia coli<br />
19 1996 Escherichia coli, Streptococcus viridens<br />
20 1997 Escherichia coli<br />
21 1997 Enterococcus faecalis, Pseudomonas aeruginosa, Klebsiella Oxytoca<br />
22 1997 Escherichia coli, Streptococcus viridens<br />
23 1997 Escherichia coli, Klebsiella pneumonia, Coagulase positive Staphylococcus aureus<br />
24 1998 Escherichia coli, Staphylococcus aureus<br />
25 1998 Morganella morgagni, Pseudomonas aeruginosa<br />
26 1998 Enterobacteriaceae spp.<br />
27 1998 No growth<br />
28 1998 Streptococcus pneumonia, SCP<br />
29 1998 Staphylococcus aureus<br />
30 1998 Escherichia coli, Klebsiella pneumonia<br />
31 1998 No growth<br />
32 1999 Staphylococcus aureus, Serratia marcescens<br />
33 2000 Escherichia coli, Klebsiella pneumonia, Staphylococcus aureus<br />
34 2001 Escherichia coli, Streptococcus agalactiae<br />
35 2001 Escherichia coli, Pseudomonas aeruginosa<br />
36 2002 No growth<br />
37 2002 Acinetobacter, Staphylococcus epidermidis<br />
38 2003 Acinetobacter, Escherichia coli<br />
39 2003 Staphylococcus epidermidis<br />
40 2003 Morganella morgagni<br />
41 2003 Methicillin resistant Staphylococcus aureus, Escherichia coli, Acinetobacter<br />
42 2003 No growth<br />
43 2003 Escherichia coli, Staphylococcus aureus<br />
44 2003 Streptococcus agalactiae<br />
45 2004 Escherichia coli, Enterococcus faecalis, Proteus mirabilis<br />
debrided area (Villanueva-Sáenz et al., 2002). Colostomy<br />
rate of survivors and non-survivors was similar in our<br />
study while there was an increase in tendency to perform<br />
colostomy in the second half of the study group.<br />
The defects after surgical debridement in NF can be<br />
managed with primary closure, grafting or flap<br />
reconstruction (Baharestani, 2008). Our center had a<br />
propensity towards primary closure whenever possible
2232 Afr. J. Microbiol. Res.<br />
Table 2. Comparison of survivors and non-survivors.<br />
Variable Non survivors Survivors<br />
Age (years) 59.7±16.9 45.6±12.6<br />
Gender 6 Males, 4 Females 23 Males, 12 Females<br />
Etiology Predominantly SSI with peritonitis Predominantly perianal abcess<br />
Duration of symptoms (days) 8±4.24 7.71±4.36<br />
Delay in surgery (days) 2.66±2.05 1.66±1.54<br />
Co-morbidity present 60% 60.7%<br />
Site of involvement Predominantly ABW Predominantly perianal area<br />
Number of debridements 1.4±0.51 1.34±0.787<br />
Colostomy 20% 22.9%<br />
Intubation 60% 8.6%<br />
Duration of Intubation (days) 3.66±3.2 0.087±0.288<br />
Red packed cell transfusion (Units) 4.5±1 1.7±2.2<br />
Antibiotic therapy (days) 14.8±10.56 23.18±14.1<br />
TPN administration 20% 20%<br />
Enteral nutrition 10% 20%<br />
Leukocyte count at admission ( /uL ) 21650±12834 16537±6943<br />
Neutropenia 1 patient 1 patient<br />
Renal failure 70% 34.3%<br />
Liver failure 50% 11.4%<br />
Sepsis 100% 31.4%<br />
SSI:Surgical site infection; ABW:Anterior abdominal wall; TPN: Total parenteral nutrition.<br />
Table 3. Characteristics of first 23 and last 22 cases.<br />
Variable First 23 patients (1979-1996) Last 22 patients (1997-2004)<br />
Age (years) 49.56±16.5 47.90±12.95<br />
Gender 65.2% Male 63.6% Male<br />
Etiology Predominantly SSI with peritonitis and perianal abcess Predominantly perianal abcess<br />
Site of involvement Predominantly perianal area Predominantly perianal area<br />
Number of debridements 1.42±0.676 1.28±0.78<br />
Colostomy 15% 33.3%<br />
Mortality 28.6% None<br />
SSI: Surgical site infection.<br />
and all reconstructions were done between 1997 and<br />
2004.<br />
Empirical antibiotic prophylaxis should be started in NF<br />
until the responsible pathogen is identified in cultures. In<br />
our study, when compared with respect to years, recent<br />
regimens started to contain piperacillin-tazobactam,<br />
teikoplanin and imipenem. Of note, 3 patients with sepsis<br />
in the second half of study received fluconazole along<br />
with antibiotics.<br />
Published mortality rates due to NF vary widely. Brandt<br />
et al. (2000) and Lille et al. (1996) from USA reported<br />
24% (Brandt et al., 2000) and 25% (Lille et al., 1996)<br />
respectively while Rietveld et al (1995) from New Zealand<br />
reported 43% (Rietveld et al., 1995). We found<br />
approximately the same result (22.2%) as those reported<br />
from USA.<br />
In our study, factors predicting mortality were mainly<br />
the end results of sepsis and multi-organ failure. In contrary<br />
to what we found, a study from Canada cited that<br />
the contributing factors for mortality were advanced age,<br />
immunocompromised state and presence of<br />
streptococcal toxic shock syndrome (Golger et al., 2007).<br />
In this study, we tried to reflect our 25 years of<br />
experience in NF between 1979 and 2004. Due to<br />
change in institutional policy our department stopped<br />
admitting and following NF patients after 2004.<br />
The first thing in analysis of cases was better mortality<br />
rate in more recent cases when compared to the earlier<br />
days of the institution. In this regard, when we look at the<br />
variables it seems that microbiology, demographics,
etiology, site of involvement, debridement technics are<br />
similar but frequency of colostomy procedure, type of<br />
antibiotics, utilization of antifungals seem to accumulate<br />
in the second chronological half of the series. The main<br />
outcome of our study is the fact that adequate control of<br />
the microbiological agent and preventing further contamination<br />
of the wound is the cardinal part of the treatment in<br />
NF and particularly in Fournier’s gangrene.<br />
REFERENCES<br />
Anaya DA, Dellinger EP (2007). Necrotizing soft-tissue infection:<br />
diagnosis and management. Clin. Infect. Dis., 44(5): 705-710.<br />
Baharestani MM (2008). Negative pressure wound therapy in the<br />
adjunctive management of necrotizing fascitis: Examining clinical<br />
outcomes. Ostomy Wound Manage., 54(4): 44-50.<br />
Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald J<br />
(1998). Aggressive surgical management of necrotizing fasciitis<br />
serves to decrease mortality: A retrospective study. Am. Surg., 64(5):<br />
397–401.<br />
Brandt MM, Corpron CA, Wahl WL (2000). Necrotizing soft tissue<br />
infections: A surgical disease. Am. Surg., 66(10): 967–997.<br />
Brandt MM, Corpron CA, Wahl WL (2000). Necrotizing soft tissue<br />
infections: A surgical disease. Am. Surg., 66(10): 967-970.<br />
Elliott DC, Kufera JA, Myers RA (1996). Necrotizing soft tissue<br />
infections. Risk factors for mortality and strategies for management.<br />
Ann. Surg., 224(5): 672-683.<br />
Fulda GJ, Khan SU, Zabel DD (2003). Special issues in plastic and<br />
reconstructive surgery. Crit. Care Clin., 19(1): 91-108.<br />
Yildiz et al. 2233<br />
Giuliano A, Lewis F, Hadley K, Blaisdell FW (1977). Bacteriology of<br />
necrotizing fasciitis. Am. J. Surg., 134(1): 52–57.<br />
Golger A, Ching S, Goldsmith CH, Pennie RA, Bain JR (2007). Mortality<br />
in patients with necrotizing fasciitis. Plast. Reconstr. Surg., 119(6):<br />
1803-1807.<br />
Levine EG, Manders SM (2005). Life-threatening necrotizing fasciitis.<br />
Clin. Dermatol., 23(2): 144-147.<br />
Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ (1996). Necrotizing<br />
soft tissue infections: obstacles in diagnosis. J. Am. Coll. Surg.,<br />
182(1): 7-11.<br />
Misago N, Narisawa Y, Ryu S, Gotoh Y, Tanaka T, Yokoyama M,<br />
Kohda H (1996). Necrotizing fasciitis due to group A streptococci: A<br />
clinicopathological study of six patients. J. Dermatol., 23(12): 876–<br />
882.<br />
Rietveld JA, Pilmore HL, Jones PG, Theis JC, Bowie DA, Dempster AG<br />
(1995). Necrotising fasciitis: A single centre's experience. N Z Med.<br />
J., 108(995): 72-74.<br />
Salcido RS (2007). Necrotizing fasciitis: Reviewing the causes and<br />
treatment strategies. Adv. Skin Wound Care., 20(5): 288-293.<br />
Singh G, Sinha SK, Adhikary S, Babu KS, Ray P, Khanna SK (2002).<br />
Necrotizing Infections of soft tissues: A clinical profile. Eur. J. Surg.,<br />
168: 366–371.<br />
Thompson CD, Brekken AL, Kutteh WH (1993). Necrotizing fasciitis: A<br />
review of management guidelines in a large obstetrics and<br />
gynecology teaching hospital. Infect. Dis. Obstet. Gynecol., 1(1): 16-<br />
22.<br />
Villanueva-Sáenz E, Martínez Hernández-Magro P, Valdés Ovalle M,<br />
Montes Vega J, Alvarez-Tostado FJF (2002). Experience in<br />
management of Fournier's gangrene. Tech. Coloproctol., 6(1): 5-10.<br />
Wilson B (1952). Necrotizing fasciitis. Am. Surg., 18: 416–431.
African Journal of Microbiology Research Vol. 5(16) pp. 2234-2240, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Aspects of bacterial colonization in newborn babies<br />
Fariba Heshmati*, Seyeed Amir Yazdanparast , Seyeed Akbar Moosavi , Hussein Dargahi,<br />
and Farnaz Tabibzadeh<br />
Department of Microbiology, Tehran University of Medical Sciences (Hemmat Campus), Tehran, Iran.<br />
Accepted 23 June, 2011<br />
The study of colonization of microbial flora in neonate is very important and finding the causative agent<br />
may lead to explore these infections in neonate. In this research the colonization in neonate was<br />
measured at the beginning and a few hours after birth. Sampling was performed in operating room,<br />
rooming in and nursery section. Some of the neonates deliver by rapture of membrane in normal way<br />
and the other deliver by caesarean section. All the samples which are collected were from these sites:<br />
1) Forehead 2) Oral cavity 3) External ear 4) Auxiliary region 5) Umbilical region 6) Perennial region.<br />
Also we had some sampling from health care personnel who are worked in operating room or nursery<br />
section. At the time of sampling we used sterile gloves, mask and always sterile sets. Sampling was<br />
done by use of sterile swabs which were weltering by sterile phosphate buffer or sterile normal saline<br />
.Then this sterile swab scrubbed on the special surface of the body of neonate and directly transferred<br />
to BA plate, Mac agar plate, EMB agar plate and Sc agar plate and then streaked on these plates. The<br />
regions which were sampled ,numbered by 1 to 6 then in other hours once more the sampling were took<br />
place from the same site, therefore we began from number 7 to 12 and according to this method for<br />
example sampling from neonate A was showed by A1 to A12. The prevalent microorganisms in oral cavity<br />
were as follow: 63.5% GPC, 18.5% GPB and 11% GNC. Staphylococcus epidermidis was the major<br />
microorganism found in neonate forehead. No bacteria growth was found in 50% of samples through<br />
caesarean section. Staphylococcus and Diphtheroied constitute the highest colonization of neonate<br />
skin's microorganisms and their growth rates were low at the onset of the birth, but increased after 12<br />
hours. Colonization of gram-negative bacteria in infant hours after birth considered to be an important<br />
issue that was studied in this research. Hence hand washing of health-care personnel’s can reduce<br />
such bacteria in infant. There was a significant decrease in (GNB) number due to hand washing, hence<br />
application of disinfectant solution in hand washing play an important role in controlling<br />
microorganisms in care unites.<br />
Key words: Colonization, GPC (Gram- positive cocci), GPB (Gram-positive bacilli), GNC (Gram- negative<br />
cocci), GNB (Gram- negative bacilli), Microorganism.<br />
INTRODUCTION<br />
Microbial colonization of newborn infant begins<br />
immediately after birth. Infants’ skin is colonized by flora<br />
derived from the body of the mother and other human<br />
contacts and from various inanimate objects. Initial<br />
colonization is fortunately, depending on the first suitable<br />
organism to arrive at a particular site as well as factors<br />
such as the type of delivery, the amount of vernix<br />
*Corresponding author. E-mail:<br />
heshmati_99_1999@yahoo.com<br />
caseosa persent at birth, the type of nourishment<br />
received (breast milk or formula) and the degree of<br />
exposure in the hospital environment (Guenthner et al.,<br />
1987). Moreover exclusively formula-fed infants were<br />
more often colonized with E.coli, C.difficle, Bacteroides<br />
and Lactobacillus, when compared with breast-fed<br />
infants. Other factors like hospitalization and prematurity<br />
were also associated with higher prevalence of C. difficil<br />
(Guenthner et al., 1987; Penders et al., 2006). However,<br />
in most cases, after a few days the representation of<br />
microbial species with in the neonatal flora was<br />
remarkably similar to the adult pattern of colonization.
Interest in the bacterial colonization of the newborn was<br />
developed in mid 1940s when epidemic of<br />
Staphylococcal pyoderma began to appear in substantial<br />
number in the developed countries (Falle and Schleifer,<br />
1981; Pezzati et al., 2002; McConnell et al., 2004).<br />
Staphylococcal disease continues to be a serious<br />
problem in some nurseries, but gram-negative bacilli are<br />
currently the major encountered pathogens in hospital<br />
acquired infection (Pass et al., 1980). Infant born through<br />
caesarean section had lower number of Bifidobacteria<br />
and Bacteroides, but more often colonized with C.difficle,<br />
when compared with those borne vaginally (Penders et<br />
al., 2006). Occasionally infections are transmitted by a<br />
member of the nursery staff who harbors pathogenic<br />
bacteria on the hands or by contamination of vaginal,<br />
rectal bacteria. However, the hand transmission is more<br />
common in infant to infant (Goldmann et al., 1978). The<br />
number of nosocomial gram-negative infections has<br />
increased dramatically in the past decade but pathogenic<br />
E.coli, Klebsiella, Enterobacter and Pseudomonas<br />
organisms have been responsible for majority of the<br />
gram-negative infections 8 . Gram-negative bacilli (GNB)<br />
cause more than 50% of hospital acquired infections.<br />
These organisms are not thought to be part of the<br />
resident flora of the skin perhaps because of factors<br />
such as desiccation inhibition by skin lipids or<br />
interference by normal cutaneous bacterial flora<br />
(Guenthner et al., 1987). Most studies have assumed that<br />
GNB are part of the transient flora only and easily<br />
removed by hygienic hand washing with soap (McGarrity<br />
and Coriell, 1973). GNB remaining after removal of<br />
transient hand flora with soap and water have not been<br />
studied extensively (McGarrity and Coriell, 1973). The<br />
purpose of this study was to determine the prevalence of<br />
GNB as a part of the non transient flora on the hands of<br />
hospital personnel during the period of nosocomial<br />
infections after hand washes and also analyzing the<br />
influence of working a shift in an intensive care unit on<br />
hand carriage of GNB by nurses, the contribution of a<br />
broad range of external influences and mode of delivery<br />
on neonate's skin micro biotic composition in early<br />
infancy.<br />
MATERIALS AND METHODS<br />
Subjects (infants)<br />
Twenty- two newborn infants born at Amin hospital part of Esfahan<br />
University were included in this study. This research was conducted<br />
in 2 stages. The colonization was measured in the beginning and a<br />
few hours after birth. In the pilot study, 12 infants born by vaginal or<br />
cesarean delivery were studied. In final work, 10 infants (2 infants<br />
were premature) at operating room, rooming in and nursery section<br />
were studied.<br />
Sampling and culture of the skin micro flora<br />
In pilot study and final work, 96 and 80 samples were collected<br />
Figure 1. Sampling on blood agar plate.<br />
Heshmati et al. 2235<br />
respectively from forehead region, oral cavity, perineum, and<br />
external ear, auxiliary and umbilical regions. Samples from the skin<br />
flora were taken 3, 4, 5, 8, 14 and 20 h after vaginal or caesarean<br />
delivery by using cotton-tipped swab weltering in sodium phosphate<br />
buffer that were scrubbed on the surface of the skin and<br />
immediately streaked on to the blood agar, Mac conkey, EMB, and<br />
Sc (sabburo cholramphenicol) plates. Samples were brought to the<br />
laboratory and incubated at 37°C within 24 h after collection (Figure<br />
1). Media were incubated in candle jar at 37°C for 48 h. The<br />
bacterial colonies were analyzed in terms of number and<br />
morphological characteristics and then preserved in BHI and 15%<br />
glycerol for determining their species. Upon discharge from the<br />
newborn nursery at the Amin Hospital for maintaining the<br />
microorganisms, brain heart infusion broth (BHI) and 15% glycerol<br />
was used.<br />
Identification of isolates<br />
Bacteria were stained by Gram stain and also 3% H2O2 solution we<br />
used to detect the catalase enzyme then identified by standard<br />
bacteriological and biochemical methods such as acid production<br />
from carbohydrates, using of MSA (Manitol salt agar medium),<br />
DNAse medium, sensivity to Furazolidon disk(100 µg), Bacitracin<br />
disk(0.04U)for differentiation Micrococcus from Staphylococcus, of<br />
medium, SIM, 10% Nacl nutrient agar, MR-VP, TSI, Simmon citrate<br />
agar, urea agar, Nitrate reduction test. Any bacterial colonies which<br />
resembled -hemolytic streptococci were tested for sensivity to<br />
bacitracin with disks containing 0.04U of bacitracin, if the zone of<br />
inhibition was greater than 15 mm, the streptococci would<br />
presumed to be group A and then precise serological grouping was<br />
carried out. For Fungi (Candida sp) we used Sc medium and germ<br />
tube and by using of Corn meal agar medium for production of<br />
clamidospore (Figure 2).<br />
RESULTS<br />
In the first phase 12 neonates were used to obtain<br />
bacteria flora samples at various time of day. A variety of<br />
microorganisms were isolated from the samples.<br />
However, some samples demonstrated no bacterial<br />
growth. We observed that neonates during the birth<br />
would have colonization with a single bacterial species.<br />
Nevertheless.after a period of time several species of<br />
bacteria would be intermixed together. Several gram<br />
negative bacilli strains isolated at various hours after birth<br />
were characterized (Figures 3, 4, 5, 6 and 7).<br />
Oral cavity was found to be sterile in most of times<br />
especially during birth and consequently colonization of
2236 Afr. J. Microbiol. Res.<br />
Figure 2. Isolate sub cultured.<br />
Figure 3. Frequency of isolated organisms from forehead at the birth time.<br />
Figure 4. Frequency of isolated organisms from forehead after birth time.<br />
Staphylococcus epidermidis<br />
Staphylococcus aureus<br />
Corynebacterium xerosis<br />
Streptococcus spp.<br />
E. coli<br />
Enterobacter agglomerans<br />
Staphylococcus epidermidis<br />
Staphylococcus aureus<br />
Staphylococcus saprophyticus<br />
Micrococcus Luteus<br />
E. coli<br />
Corynebacterium xerosis<br />
Corynebacterium renale
Figure 5. Frequency of isolated organisms from perinea area at the birth time.<br />
Micrococcus luteus<br />
Staphylococcus epidermidis<br />
Staphylococcus aureus<br />
Bacillus spp.<br />
E. coli<br />
Enterobacter agglomerans<br />
Plesiomonas shigelloides<br />
E. coli<br />
Enterobacter agglomerans<br />
Staphylococcus epidermidis<br />
Staphylococcus aureus<br />
Micrococcus roseus<br />
Micrococcus luteus<br />
Micrococcus varians<br />
Fungi<br />
Figure 6. Frequency of isolated organisms from perinea area after birth.<br />
Figure 7. Frequency of isolated organisms from oral cavity 6 h after birth.<br />
Staphylococcus epidermidis<br />
Rhodococcus equi<br />
Moraxella catarrhalis<br />
Aurococcus viridans<br />
Staphylococcus aureus<br />
Micrococcus luteus<br />
Streptococuus beta hemolytic<br />
Bacillus lentus<br />
Heshmati et al. 2237
2238 Afr. J. Microbiol. Res.<br />
Figure 8. Percentage of infant with organisms in various anatomic sites. * KEC (Klebsiella, Enterobacter, or Citrobacter).<br />
bacteria was initiated by ingesting food and other<br />
environmental factors (Figure 7).<br />
Although 8 to 15% of cultures yield -hemolytic<br />
streptococci group B which was detected by CAMP and<br />
Hippurate hydrolysis test, group A streptococci are also<br />
encountered. During a two-day period 16 of 22 neonates<br />
in one nursery had organisms sensitive to bacitracin and<br />
penicillin cultured from their umbilical areas. None of the<br />
infant showed clinical signs or symptoms of disease.<br />
These organisms were presumptively identified as group<br />
A streptococci and the positive cultures were first<br />
interpreted as evidence of group A streptococcal<br />
infection. Several weeks later, organisms from 14 of<br />
these infants were identified as a single strain of -<br />
hemolytic Sterptococcus (Figure 8).<br />
DISCUSSION<br />
Various factors may influence the role of microorganisms<br />
in relationship to colonization such as antibacterial agent<br />
(bacteriocin), bacterial interference and competitive<br />
inhibition. Production of bacteriocin by a bacterial species<br />
can inhibit colonization of other bacterial species. It is<br />
also known that a floral bacteria growth can be<br />
inhibited by another bacterial species through<br />
competitive inhibition. For instance pathogenic<br />
microorganisms like Staphylococcus aurous can<br />
proliferate on the neonatal skin in the absence of skin<br />
normal flora such as coagulase-negative Staphylococci.<br />
External factors can also alter the skin normal flora<br />
population:<br />
1) The climate: augmentation in humidity and<br />
temperature can increase the bacterial growth and hence<br />
modifying their population ratio.<br />
2) Anatomical condition, body site: the distribution of skin<br />
normal flora on the body depends on different anatomical<br />
places. The transient bacteria grow extensively on<br />
exposed body parts such as face, neck and hands.<br />
3) Hospitalization, in this study has revealed that long<br />
term hospitalization can increases the bacterial<br />
colonization in neonates.<br />
4) The disease effect: The presence of systemic<br />
disease can also make the body susceptible to<br />
bacterial growth. In this study has revealed diabetic<br />
neonates born from diabetic mother have greater<br />
potential for bacterial growth than the normal neonates.<br />
5) Disinfectant effect: Base on this study organisms such<br />
as Pseudomonas was the most common, and the E.coli<br />
and Entrobacter were isolated repeatedly from washing<br />
liquid. Nonetheless, it was shown that none of these<br />
disinfectant washing liquid would change the coagulase-<br />
negative staphylococcus population, but using disinfecting
soap increased the Propionobacterium population<br />
extensively.<br />
6) Irradiation: this study show that bacterial growth was<br />
susceptible to U.V light radiation and staphylococci were<br />
the most susceptible one among all the studied<br />
organisms.<br />
One of the controversial points in this study was the<br />
level of colonization for group B Streptococci among the<br />
neonates.<br />
According to the study in the Cooper Green Hospital, the<br />
rate of colonization for sterp B was established during 28<br />
months. They emphasize that strep B was the most<br />
common cause of infection in neonate and twines in<br />
which being considered as high risk group (William et al.,<br />
1999). Nevertheless we found variation in the amount of<br />
these bacteria in forehead and perinea areas (14.2 and<br />
3.5%).Therefore it can be concluded that the main cause<br />
of strep B colonization in neonate was due to exposure of<br />
birth canal.<br />
Base on reported studied (Falle and Schleifer, 1981). at<br />
this study ,bacterial growth were increased in still-birth<br />
,low-weighted birth neonates and also in some twins<br />
and single-born babies ,this increase however was more<br />
profound in twins due to complex delivery involved. We<br />
also have found that there is an increasing rate of<br />
colonization of bacteria in immature and low weight<br />
neonate.<br />
Some studies showed a significant difference exist in<br />
colonization of bacteria on skin of neonates during the<br />
first, fourth and tenth weeks. We have demonstrated that<br />
although the rate of colonization of bacteria after birth is<br />
undetectable but colonization of gram- negative<br />
organisms was more prevalent.<br />
Nobel and Jackman reported that colonization of<br />
staphyloccocus in axillaries area can decrease rate of the<br />
Coryneforms of bacteria (William et al., 1999).<br />
But we have showed different result and that the rate of<br />
colonization of these bacteria was similar both during and<br />
after birth.<br />
We also concluded that the highest rate of colonization<br />
for various species of staphyloccocus was in axillary's<br />
areas .and the highest rate of colonization for Coryneform<br />
bacteria was reported in forehead and auxiliary’s areas.<br />
The S. aureus and S. epidermidis were the most common<br />
organisms in forehead area.<br />
The most common organisms of external ear were<br />
reported to be S. epidermidis; we found the same result<br />
which confirmed pervious studies.<br />
Some of earlier researches and literatures have<br />
reported that anaerobic Sterptococcus species are the<br />
first cause of infection. It seems that specific species<br />
constitute the normal flora of vaginal and oral cavity.<br />
While being born the skin of neonates with cesarean<br />
surgery was found sterile during delivery, but neonates<br />
born through birth canal was found to be colonized with<br />
the normal flora.<br />
Heshmati et al. 2239<br />
Based on other results.the Satphylococcus and<br />
Coryneforms were reported as the most common<br />
organisms.found in neonate skin and E.coli and Proteus<br />
species (10%) were also reported. In this study the same<br />
result has obtained (Sarkany and Gaylarde, 1967).<br />
The S. epidermidis was colonized in upper parts of<br />
body and consisted more than 50% the of<br />
Staphylococcus species. We found the same result too.<br />
The S. 0hominis and S. hemolyticus were found in<br />
auxiliary’s and perinea areas. Other findings indicated<br />
that coagulase negative staphyloccocus was colonized in<br />
perinea area. According to other researches, intestine of<br />
neonates were colonized with high rates of klebsiella, E.<br />
ntrobacter or Citobacter species (William et al., 1999).<br />
We found that the most common organisms in neonate<br />
s, stool were gram- negative bacteria such as E.coli and<br />
Entrobacter species.<br />
We also observed that gram -negative bacilli were<br />
mostly colonized in neonates care units. Therefore, we<br />
disregarded studying bacteria colonization in the first<br />
hours of birth in care units.<br />
Larson reported an inverse relation between the bacteria<br />
colonization and continuous hand washing of personals<br />
and nurses of hospitals.<br />
Moreover, hands can be a transmission bacteria portal<br />
between the neonates. Therefore, it is highly<br />
recommended, to use disinfectants daily and hand<br />
washing should be done in neonates care units and ICU<br />
as well (Pass et al., 1980).<br />
Ethical aspects<br />
Informed consent was obtained from the parents of the<br />
babies.<br />
REFERENCES<br />
Guenthner S.H, Owen Hendley J, Wenzel RP (1987). Gram-Negative<br />
Bacilli as No transient Flora on the Hands of Hospital Personnel. J.<br />
Clin. Microbiol., 25: 488-490.<br />
Penders J, Thijis C, Vink C, Stelma FF, Snijders B, Kummeling I, Brandt<br />
PAvan den, Stobberingh EE (2006). Factors Influencing the<br />
Composition of the Micro biota in Early Infancy. Pediatrics, 118: 511-<br />
521.<br />
Falle A, Schleifer KH (1981). Modified Oxidize and Benzidine Tests for<br />
Separation of Staphylococci from Micrococcci. J. Clin. Microbiol., 13:<br />
1031-1035.<br />
Pezzati M, Biagioli EC, Martelli E, Gambi B, Biagiotti R, Rubaltelli FF<br />
(2002). Umbilical Cord Care The Effect of Eight Different cord-Care<br />
regimens on: Cord Separation Time and Other Outcomes. Biol.<br />
Neonate, 81: 38-44.<br />
McConnell TP, Lee CW, Couillard M, Westbrook Sherrill W (2004).<br />
Trends in Umbilical Cord Care: Scientific Evidence for Practice.<br />
Newborn Infant Nurs. Rev., 4: 211-222.<br />
Pass MA, Khare S, Dillon HC (1980).Twin pregnancies: Incidence of<br />
group B streptococcal colonization and disease. Brief clinical and<br />
laboratory observations. J. Pediatr., 4: 635-637.<br />
Goldmann DA, Leclair J, Macone A (1978). Bacterial colonization of<br />
neonates admitted to an intensive care environment. J. Pediatr.,<br />
93(2): 288-293.
2240 Afr. J. Microbiol. Res.<br />
McGarrity GJ, Coriell LL (1973). Bacterial Contamination of Children’s<br />
Soap Bubbles. Am. J. Dis. Child., 125: 224-227.<br />
William EB, Jeffrey BG, Maurice LD (1999). Risk Factors for Early-onset<br />
Group B Streptococcal Sepsis: Estimation of Odds Ratios by Critical<br />
Literature Review. Pediatrics, 103: e77.<br />
Sarkany I, Gaylarde CC (1967). Skin flora of the newborn. Lancet, 1:<br />
589-590.
African Journal of Microbiology Research Vol. 5(16), pp. 2241-2244, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.234<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Evaluation of anticarcinogenicity effect of Artemia<br />
urmiana by Salmonella typhimurium TA 100 strain<br />
Masumeh Abbasi 1 , Saman Mahdavi 2* and Sedigheh Mehrabian 3<br />
1 Islamic Azad university- Malekan Branch, Iran.<br />
2 Islamic Azad university- Maragheh Branch, Iran.<br />
3 Department of Biology, Faculty of science, Teacher Training University, Tehran, Iran.<br />
Accepted 20 May, 2011<br />
Free radicals are produced during oxidative metabolism in body and they can attack all components of<br />
cells and cause cellular changes and early aging. Antioxidant materials role for balance maintenance in<br />
cells has currently attracted more attention. The aim of this study is investing of antimutation effect of<br />
Artemia, cyst and decapsulated egg extract by Ames test and Salmonella typhimurium TA 100 strain.<br />
These extract prevent reverse mutation caused by carcinogenic materials. In comparison with positive<br />
controls (sodium azid, KMno4, cresol) and negative control (distilled water) antimutagenicity properties<br />
of Artemia was evaluated and confirmed. In addition, the value of astaxanthin in those extracts was<br />
assayed. For quality analysis and separation of astaxanthin, we used thin-layer chromatography (TLC)<br />
chromatography and column chromatography, respectively. Then, the presense of astaxanthin in these<br />
extracts was confirmed by spectrometer IR test. The results showed that antimutagenicity properties of<br />
Artemia urmiana are the same with other salty water Artemia. Antimutagenicity and anticarcinogenicity<br />
properties in decapsulated egg, dried Artemia and cyst are 85, 70 and 100%, respectively.<br />
Key words: Ames test, anticarcinogenicity, antioxidant, Artemia urmiana, Salmonella typhimurium TA 100.<br />
INTRODUCTION<br />
Investigation of anticancer features of Artemia urmiana<br />
by using the Salmonella typhimurium TA100 strain has<br />
been done. However, human has discovered the<br />
presence of Artemia in salty rivers long a time ago. The<br />
first report about Artemia was registered by Schlosser in<br />
1755 A.D. He observed Artemia in the samples of the<br />
water that he has provided from salty rivers in a place<br />
near Lymington. He called it Artemia linneaus by the<br />
scientific name of the crab of salt water and in 1819 a<br />
person whose name was Litch recalled it Artemia salina.<br />
At last Artemia in Urmia sea was called Artemia urmiana<br />
by Clark and Bawn (1976), and by the time being, many<br />
*Corresponding author. E-mail: S.mahdavi@iau-maragheh.ac.ir.<br />
Tel: 009809144150454.<br />
Abbreviations: ISA, International study of Artemia; TLC, thinlayer<br />
chromatography; ROS, reactive oxygen species; FT-IR,<br />
fourier transform infrared.<br />
researches and investigations have being done about<br />
different subjects of Artemia by ISA (International Study<br />
of Artemia) in different countries (Lorenz and Cysewski,<br />
2000). Now a day Artemia (that is the famous shrimp of<br />
salty water) is a good source of protein for human, a food<br />
for marines and is used in drugs (Magbool and Suresh,<br />
2003). Because of it contains Caretonoids such as<br />
Astaxantin, Kantanxantin and Autooxicuein, Artemia is<br />
able to do different biological performances such as<br />
protection against light, removing the injuries caused by<br />
oxygen, immune adjusting in body, and antioxidant activities.<br />
Also reactive oxygen species (ROS) may play a<br />
major role as endogenous initiators of degenerative<br />
processes such as deoxyribonucceic acid (DNA) damage<br />
and mutation that may be related to cancer (Nair and<br />
Risch, 2000) cancer (Nair and Risch, 2000). Test of<br />
carcinogens on rats, is expensive and time consuming.<br />
Recently, bacteria have been using for assessment of the<br />
carcinogenicity of suspected materials which are not only<br />
cost- effective but also give prompt and excellent results.
2242 Afr. J. Microbiol. Res.<br />
Table 1. Survey of genotype results of Salmonella typhimurium TA 100 strain.<br />
Strain rfa mutation UVRB mutation R-Factor<br />
Salmonella typhimurium TA100 + + +<br />
One of the methods of assaying carcinogenic effects via<br />
bacteria is Ames test by use of Salmonella strains which<br />
because of mutation have lost the histidine synthesis<br />
potential and in the medium without histidine will face a<br />
reverse mutation which leads to histidine synthesis. By<br />
measuring the developed colonies in the medium, the<br />
carcinogenicity effect will be identified (Motorelmansk<br />
zeger, 2000). This article discusses different steps of<br />
growth of Artemia that has antioxidant and more<br />
anticancer activities so that in proper step we can use it<br />
as foodstuff and drug for human, poultries and marines.<br />
MATERIALS AND METHODS<br />
Artemia was caught from Urmia Lake and transferred to<br />
the laboratory on summer 2005. The dried Artemia, cyst, and<br />
decapsulated egg gathered and froze at -10°C until utilization.<br />
Salmonella typhimurium TA 100 strain was received directly from<br />
Professor Ames (University of Beverly, CA).<br />
Confirming genotypes of tester strains<br />
The tester strains genotype should be confirmed, so fresh overnight<br />
nutrient broth cultures were used for this purpose. Salmonella<br />
typhimurium strain has deficient in dark repair of mutations (UVrB),<br />
and unable to synthesize a portion of the cell wall (rfa).<br />
rfa mutation<br />
TA 100 strain was tested for crystal violet sensitivity. For this test,<br />
nutrient agar plates were seeded with cultures of the motional strain<br />
and sterile filter paper disc soaked in crystal violet was placed on<br />
the surface of each cultured plate. After 12 h incubation the clear<br />
zone of inhibition (approximately 14 mm) was appeared around the<br />
disc indicating the presence of the rfa mutation which permits large<br />
molecules such as crystal violet to enter and kill the bacteria.<br />
UvrB (UVrB) mutation<br />
The UVrB mutation was confirmed by demonstrating UV sensitivity<br />
in TA100 strain which showed this mutation.<br />
R- factor<br />
The R- factor of TA 100 strain was tested for the presence of the<br />
ampicillin resistance factor. It is a convenient marker that makes it<br />
possible to test for the presence of the R- factor plasmid. The<br />
specific regions of the R-factor plasmid PKM 101 DNA that are<br />
essential for enhancement of UV, chemical mutagens, replication<br />
and ampicillin resistance have been identified.<br />
Astaxanthin exploitation<br />
10 g of each dried Artemia, cyst, and decapsulated egg separately<br />
were placed into glass flasks. Petroleum ether, acetone and water<br />
were added at a ratio of 1.5:7.5:1 to the samples and left under<br />
cover for 2 h. Then the solvents were evaporated in rotary<br />
evaporator until sample dryness. The resulting pigments were<br />
redissolved in an adequate volume of diethyl ether. These solutions<br />
were analyzed by thin-layer chromatography (TLC) analysis and<br />
Fourier transform infrared (FT-IR) spectroscopy. In TLC, mixture<br />
25% acetone in n- hexane was used as developers (Kobayashi<br />
and Katsuraji, 2001). In addition, the values of Astaxantin in<br />
those extracts were assayed. To quality analyze and<br />
separate Astaxantin, we used TLC chromatography and<br />
column chromatography respectively. Then we proved this test IR in<br />
these extracts.<br />
Ames test<br />
In antimutagenicity test, the inhibitions of mutagenic activity of<br />
sodium azide and permanganate potassium by the test samples<br />
were determined. 1 ml of solution of the tested compounds and 0.1<br />
ml of an overnight bacterial culture suspension cultivation for 16 h<br />
at 37°C, approximate cell density (2-5)×10 8 cell/ml and 0.1 ml of<br />
solution of the positive mutagens were carefully mixed with 3 ml<br />
of melted top agar containing 50 µmol/l of histidine- biotin, and<br />
poured onto minimal glucose agar plates. Positive and negative<br />
controls were also included in each assay. Sodium azide and<br />
potassium permanganate were used as diagnostic mutagens<br />
(0.1 ml) in the positive control and plates without mutagens and<br />
test samples were considered as negative control. Their revertants<br />
were counted after incubation of the plates at 37°C for 48 h.<br />
Tester strains were checked routinely to confirm genetic features by<br />
using the procedure described by Maron and Ames (Negi et al.,<br />
2003).<br />
RESULTS<br />
Salmonella typhimurium TA 100 strain has special<br />
mutation in its operon histidine that makes it dependent<br />
to outer histidine source. In relation to mutagenic material<br />
this mutation is reversible, so independent bacteria to<br />
histidine will come out. According to Tables 2, 3 and 4,<br />
the antimutation properties of dry Artemia extract,<br />
decapsulated egg and cyst extract in the Presence of<br />
Positive mutations were confirmed. By using of<br />
Salmonella typhimurium TA 100 strain was shown that<br />
the positive control containing the mutating materials like<br />
azid sodium, Permanganat Potasium and cresol causes<br />
reverted mutation in operon histidine (His+). According to<br />
Tables 2, 3 and 4, in presence of anti-mutagenic material<br />
comparing with control sample, the number of reverted<br />
colonies reduced. Indeed, rate of mutation suppression<br />
was evaluated higher than 40% that was indicating<br />
strong antimutagenicity effect of comparison with three
Table 2. The results of investigation of preventing and moderating of mutagenesis effects of Azide sodium by dried<br />
Artemia, cyst and decapsulated egg by using Salmonella typhimurium TA 100.<br />
Examined material<br />
Number and percent of reverted colonies of bacterium<br />
Salmonella typhimurium TA 100<br />
1 2 3<br />
Positive control (Azid sodium) 1600 - 1500 - 1440 -<br />
Negative control 440 - 512 - 524 -<br />
Dried Artemia extract 600 86% 720 78% 800 69%<br />
Decapsulated egg extract 500 94% 724 78% 632 88%<br />
Cyst extract 480 96% 360 100% 400 100%<br />
Abbasi et al. 2243<br />
Table 3. The results of investigation of preventing and moderating of mutagenesis effects of permangeant potasium by dried<br />
Artemia, cyst and decapsulated egg by using Salmonella typhimurium TA 100.<br />
Examined material<br />
Number and percent of reverted colonies of bacterium<br />
Salmonella typhimurium TA 100<br />
1 2 3<br />
Positive control (Permangeant potasium) 1680 - 1760 - 2000 -<br />
Negative control 440 - 512 - 524 -<br />
Dried Artemia extract 724 77% 884 70% 1016 66%<br />
Decapsulated egg extract 600 87% 724 83% 800 81%<br />
Cyst extract 500 87% 480 100% 360 100%<br />
Table 4. The results of investigation of preventing and moderating of mutagenesis effects of cresol by dried<br />
Artemia, cyst and decapsulated egg by using Salmonella typhimurium TA 100.<br />
Examined material<br />
Number and percent of reverted colonies of bacterium<br />
Salmonella typhimurium TA100<br />
1 2 3<br />
Positive control (cresol) 1560 - 2400 - 2800 -<br />
Negative control 664 - 520 - 480 -<br />
Dried Artemia extract 1000 62% 920 78% 840 84%<br />
Decapsulated egg extract 724 93% 648 92% 734 89%<br />
Cyst extract 480 100% 800 85% 360 100%<br />
promotagen materials (Azid sodium, Permanganat<br />
Potasium and cresol). The result coming out of<br />
chromatography of thin layer TLC has showed that the<br />
progressing of the samples produced from the extract of<br />
dried Artemia, cyst and decapsulated egg on the silica<br />
gel paper leads to the formation of a dark orange band<br />
with Rf=40%. This band from color and RF<br />
measurement point of view looks like astaxantin<br />
reference, and the main created stigma was in result<br />
of the separation of the primary samples. Five weak<br />
spots from dried Artemia and two weak spots from cyst<br />
and one weak stigma from decapsulated egg have been<br />
observed (Figure 1).<br />
At first it was assumed that the light colored bands are<br />
related to the ester from astaxantin or even to the rest<br />
of the combinations in it, but after doing spectrographic<br />
with spectrophotometer and comparing them, it was<br />
observed that these spots are like to the spectrums in<br />
result of the primary bands and the light colored bands<br />
are related to astaxantin extract, because astaxantin<br />
can combine with oxygen in the air and change to other<br />
isomers.<br />
Comparison of spectrums related to the main band<br />
of dried Artemia extract, cyst and decapsulated egg<br />
showed that the depth and intensity of created pigments<br />
are almost the same. It showed that the thickness<br />
of pigment in Artemia egg was the most and in dried<br />
Artemia and cyst were fewer than the expected sample.
2244 Afr. J. Microbiol. Res.<br />
Figure 1. Chromatography of thin layer of dried Artemia<br />
extract (A), Decapsulated egg (B) and cyst (C) on<br />
Chromatographic paper of silica gel.<br />
DISCUSSION<br />
One of the main reasons of death in industrialized<br />
societies is cancer. In the last two decades, different<br />
kinds of mutating, cancer making and chemical materials<br />
in foods have been known (Sarmineto and Ochoa, 2002).<br />
Today scientists believe these genetic damages and<br />
changes caused by succession of mutating DNA or<br />
mutation in genes and other genetic changes in chromosomes<br />
structure have role in cancer. According to Ames<br />
theory 80% of mutating material cause cancer (Gerber et<br />
al., 2002) and most of these mutating and cancer<br />
makings show their damaging effects by producing the<br />
free radicals and active oxygen. Free radicals are related<br />
to various physiological and pathological events such as<br />
inflammation, immunization, aging and etc. It has been<br />
suggested that compounds which possess antioxidant<br />
activity, can inhibit mutation and cancer because they<br />
can scavenge free radicals or induce antioxidant<br />
enzymes (Mikula and Ikova, 2003). Thus, daily use of<br />
antioxidants has an important role in protecting body<br />
against the free radicals, even most of the antioxidants<br />
are known as anticancers (Rosenkraz, 2003). Antioxidant<br />
materials such as carotenoids, astaxantin, fixed vitamin<br />
C, autooxicuien, lipids, fish oil and etc has shown<br />
anticancer features of them. TLC<br />
analysis showed that astaxantin and its isomers seemed<br />
to be the dominant carotenoied in Artemia (Duarte and<br />
Lunec, 2005). Epidemiological studies indicate that there<br />
is a close relationship between diet, life style and human<br />
cancer (Nair and Risch, 2000; Mehrabian and<br />
Shirkhodaei, 2006). The result of this research is in<br />
accordant with other researches. According to Ong<br />
formula, antimutagenicity effect is higher than 40%, so<br />
recent examined materials are high antimutagenicity<br />
ability (Ong et al., 1980). Presence of carotenoid pigments<br />
such as β-caroten, kantaxanthin and astaxanthin<br />
have been found in Artemia structure that most of them<br />
are antioxidant properties (Duarte and Lunec, 2005).<br />
Compounds such as glutation in marine food materials<br />
play major role in elimination and limitation of free<br />
radicals (Trusheva, 2006).<br />
REFERENCES<br />
Clark LS, Bowen ST (1976). The genetics of Artemia saliva V<br />
reproductive isolation. J. Helved., 47(6): 385-390.<br />
Duarte T, Lunec J (2005). When an antioxidant is not an antioxidant? A<br />
review of novel actions and reactions of vitamin C and free radicals.<br />
Free Radic. Res., 39(7): 671-686.<br />
Gerber GB, Leonard A, Hantson PH (2002). Carcinogenicity,<br />
mutagenicity and teratogenicity of manganese compounds. Crit. Rev.<br />
Oncol. Hematol., 42: 25-34.<br />
Kobayashi M, Katsuraji T (2001). In larged and astaxathin<br />
accumulating cyst cells of the green algae hematoccocus<br />
pluvialis. J. Biosci. Bioeng., 92: 565-568.<br />
Lorenz RT, Cysewski GR (2000). Commercial potential for<br />
hematococcus microalgae as a natural source of astaxanthin. Trends<br />
Biotechnol., 18.<br />
Magbool TK, Suresh Kumar S (2003). Microbial quality of shrimp<br />
products of export trade produced from aquaculture shrimp. Int. J.<br />
Food Microbiol., 82: 213-221.<br />
Mehrabian S, Shirkhodaei E (2006). Modulation of mutagenicity of<br />
Various mutagens by Shrimp Flesh and Skin Extracts in Salmonella<br />
Test. Pak. J. Biol. Sci., 9(4): 598-600.<br />
Mikula M, Ikova B (2003). Modulation of mutagenicity of various<br />
mutagens by lignin derivatives. Mut. Res. Genet. Tox., 535: 171-180.<br />
Motorelmansk zeger E (2000). The Ames salmonella<br />
microsomemutagenicity assay. Mutares, 455(1-2): 29-60.<br />
Nair B, Risch H (2000). Cancer epidemical biomarker. J. Genet.,<br />
1: 3-28.<br />
Negi PS, Jayaprakasha GK, Jena BS (2003). Antioxidant and<br />
antimutagenic activities of pomegranate peel extracts. Food Chem.,<br />
80: 393-397.<br />
Ong TM, Wolf CR, Zeiger E (1980). Diferential effects of cytochrome<br />
p45 inducers on promutagen activation capabilities and enzymatic<br />
activities of S9 from rat liver. J. Environ. Pathol. Toxicol., 4: 55-65.<br />
Rosenkraz HS (2003). Synergy between toxicity and genotoxicity<br />
relevance to human cancer risk. Mut. Res., 529: 117-127.<br />
Sarmineto M, Ochoa M (2002). Mutagenicity and antimutagenicity<br />
studies of lipidic extracts from yellow tail fish, lise fish and Cason fish.<br />
Food Chem. Toxicol., 40: 1469-1474.<br />
Trusheva B (2006). Bioactive constituents of Brazilian red proplis.<br />
Evidence-based complementary and Alternative Medicine. Ecam.<br />
Oxford University press, 3(2): 249-254.
African Journal of Microbiology Research Vol. 5(16), pp. 2245-2248, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.549<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
mRNA expression of iron metabolism relation genes in<br />
macrophages by infection with Salmonella typhimurium<br />
Pan Xin<br />
Department of Microbiology, Second Military Medical University, Shanghai 200433, China. E-mail: xinpanpx@163.com.<br />
Tel: 86-21-81870998 or 13524211027. Fax: 86-21-81870998.<br />
Accepted 30 July, 2011<br />
A total number of 13 iron metabolism relation genes expression profiles of RAW264.7 murine<br />
macrophages infected or uninfected with Salmonella typhimurium were tested by real-time polymerase<br />
chain reaction (RT-PCR) to evaluate the metabolism of iron in host-pathogen interplay. The living wildtype<br />
S. typhimurium induces expression of the transferrin receptor (Tfr1) in host cell macrophages,<br />
which results in a sustained increase of the labile iron pool inside the host cell after 1 or 24 h infection.<br />
Gene expression analysis showed that wild-type S. typhimurium drives an active iron acquisition<br />
program with induction of ferrireductase (Steap3), iron membrane transporter Dmt1, and iron regulatory<br />
proteins (Irp1 and Irp2), while not too much iron efflux changing through ferriportin (Fpn1). The spiA -<br />
Salmonella mutant strain used in our studies also caused an increase in Tfr1 at 1 or 24 h, but leading to<br />
decrease in Fpn1 at 24 h as compared with 1 h. The assessment of the labile iron pool after infection<br />
with spiA - Salmonella after 24 h shows an increase. The same of these two phenotypes allowed iron<br />
overload in macrophage and became one of the reasons for Salmonella survival inside the macrophage.<br />
Key words: Macrophage, Salmonella, iron metabolism.<br />
INTRODUCTION<br />
Iron is a critical determinant in host-pathogen interaction.<br />
It is required for full virulence expression by a wide<br />
variety of intracellular bacteria. Deprivation of iron in-vivo<br />
and in-vitro severely reduces the pathogenicity of<br />
Mycobacterium tuberculosis, Coxiella burnettii, Legionella<br />
pneumophila, and S. typhimurium (Braun, 2001). In fact,<br />
attempts to withhold iron by sequestering free iron during<br />
infection is a major defense strategy used by many<br />
species (Bullen et al., 2006). On the other hand, hostcells<br />
require iron for first-line defense mechanisms. Iron<br />
is needed for Haber-Weiss redox chemistry to produce<br />
hydrogen peroxide or hydroxy radicals (Eaton and Qian,<br />
2002). Iron and proteins involved in iron metabolism have<br />
interesting links to the immune system (Hentze et al.,<br />
2004).<br />
How the bacterium tricks the host cell into providing<br />
iron and how the host, at the same time, keeps a delicate<br />
balance between having enough iron for redox reactions<br />
and withholding iron from intracellular bacteria, however,<br />
is not well understood. Here we investigated the<br />
expression profile of macrophage iron homeostasis<br />
following the infection of RAW264.7 murine macrophages<br />
with S. typhimurium.<br />
MATERIALS AND METHODS<br />
Bacterial strains and cell<br />
Wild-type S. typhimurium strain ATCC 14028 (ST) and S.<br />
typhimurium mutant strains spiA::kan (EG5793) (STA) were used.<br />
RAW264.7 murine macrophage-like cell line was obtained from<br />
ATCC.<br />
Primers (synthesized by Bioasia Company)<br />
The primers in Table 1 were used in this study.<br />
Infection assay<br />
Several colonies of Salmonella were collected, washed twice with<br />
cell culture complete medium (DMEM was supplemented with 10%<br />
fetal bovine serum), and resuspended with the same medium.<br />
Multiplicity of infection was adjusted to 50 using a standardized<br />
calibration curve of OD600 / colony-forming units (cfu). Bacteria<br />
were added to RAW264.7 cells in 100×15 mm cell culture dishes.<br />
Infections were initiated by centrifuging the bacteria onto the cell<br />
monolayers at 170×g for 5 min and then incubated for 1h at 37°C<br />
5% CO2. In the second hour, gentamicin was added to a final<br />
concentration o f 100 g/mL, after which, it was lowered to 10
2246 Afr. J. Microbiol. Res.<br />
Table 1. Primers used for real-time quantitative PCR assay.<br />
Gene name Accession number Forward primer (5’ 3’) Reverse Primer (5’ 3’)<br />
Irp1 NM_007386 ACTTTGAAAGCTGCCTTGG CTCCACTTCCAGGAGACAGG<br />
Irp2 NM_022655 TGAAGAAACGGACCTGCTCT GCTCACATCCAACCACCTCT<br />
Tfr1 BC054522 TGCAGAAAAGGTTGCAAATG TGAGCATGTCCAAAGAGTGC<br />
Dmt1 NM_008732 GCCAGCCAGTAAGTTCAAGG GCTGTCCAGGAAGACCTGAG<br />
LcnR BC062878 GCAAGGCTACCCCATACAAA TCTTTGGGCATAGGATGGAG<br />
Lcn2 NM_008491 CTGAATGGGTGGTGAGTGTG TATTCAGCAGAAAGGGGACG<br />
Steap3 BC037435 CTCTCTGTGCAGTCTCGCTG TGCAGAGATGACGTTGAAGG<br />
Hmox1 NM_010442 CCTCACTGGCAGGAAATCAT CCAGAGTGTTCATTCGAGCA<br />
Fpn1 AF226613 TGCCTTAGTTGTCCTTTGGG GTGGAGAGAGAGTGGCCAAG<br />
Hamp1 NM_032541 GAGAGACACCAACTTCCCCA TCAGGATGTGGCTCTAGGCT<br />
Ftl1 NM_010240 AAGATGGGCAACCATCTGAC GCCTCCTAGTCGTGCTTGAG<br />
Ftl2 NM_008049 TGACTTCCTGGAAAGCCACT GCCTCCTAGTCGTGCTTGAG<br />
Fth1 NM_010239 CTCATGAGGAGAGGGAGCAT GTGCACACTCCATTGCATTC<br />
GAPDH NM_008084 CCCACTAACATCAAATGGGG CCTTCCACAATGCCAAAGTT<br />
g/mL. At different time intervals, the RAW264.7 cells were washed<br />
three times with DMEM, and harvested for RNA analysis.<br />
Uninfected cells were used as control.<br />
RNA analysis<br />
Total RNA was isolated 1 h later and DNased using the Microto-<br />
Midi Total RNA Purification System (Invitrogen) according to the<br />
product instructions. RNA concentrations were determined by a<br />
RiboGreen assay (Molecular Probes). The reverse transcription<br />
reactions were carried out with 20 units of MMuLV reverse<br />
transcriptase (Fisher Scientific); 20 units RNase inhibitor (Fisher<br />
Scientific); RT-PCR buffer containing 10 mM Tris-HCl and 50 mM<br />
KCl, 2.5 mM MgCl2, 10 mM dithiothreitol, and 1 mM of each dNTP.<br />
The concentration of each reverse primer was 5 M. 100 ng of total<br />
RNA from each sample was reverse transcribed using reverse<br />
primers. The reverse transcription reactions were incubated for 1<br />
min at 48°C, 5 min at 37°C, 60 min at 42°C, and then 5 min at<br />
95°C.<br />
Real-time RT-PCR was based on the high affinity, doublestranded<br />
DNA binding dye SYBR Green using a Bio-Rad IQ SYBR<br />
Green Supermix according to manufacturer's instructions. A total of<br />
2 L of cDNA was used in the qPCR reactions (1×SYBR green<br />
PCR master mix, 500 nM gene specific forward and reverse<br />
primers). All qPCR reactions started with 2 min at 95°C followed by<br />
40 cycles of 15 s at 94°C and 20 s at 55°C and 30 s at 72°C in an<br />
Applied Biosystems 7900HT Fast Real-Time PCR System, utilizing<br />
SDS 2.1 software. All reactions were run three times. Differences in<br />
mRNA concentrations were quantified by the cycles to fluorescence<br />
–[ Ct experimental gene- Ct housekeeping<br />
midpoint cycle threshold calculation (2<br />
gene]<br />
), using GAPDH as the housekeeping gene.<br />
Statistical analysis<br />
Data were expressed as mean ± SD. An analysis of variance was<br />
performed with Statview 4.0 statistical analysis software, and P <<br />
0.05 was considered statistically significant.<br />
RESULTS<br />
The realtime PCR results are listed in Table 2.<br />
DISCUSSION<br />
We sought to characterize the metabolic changes of<br />
RAW 264.7 macrophage iron homeostasis following the<br />
infection with S. typhimurium. The SPI-2 encoded SpiA<br />
protein is a component of the outer membrane ring of the<br />
type three secretion systems (TTSS) needle complex<br />
(Tobar et al., 2006). A spiA - mutant strain rendered<br />
bacteria unable to translocate effector molecules into<br />
macrophage cytoplasm (Ochman et al., 1996) and<br />
displayed levels of phagosome-lysosome fusion that<br />
were much higher than those displayed by wild-type<br />
Salmonella and similar to those exhibited by heat-killed<br />
Salmonella. So we used STA as non-virulent S.<br />
typhimurium strain to compare with wild-type strain in<br />
studying iron metabolism. Iron is delivered to<br />
macrophages primarily through the transferrin receptor 1<br />
(Tfr1). Tfr1 mRNA levels were significantly increased<br />
following 1 h both of ST and STA infection by 2.20-fold<br />
(F=2036.27, P=0.0001) and 1.72-fold (F=8.64, P=0.0424)<br />
as compared with non-infected RAW264.7 cells.<br />
However, after 24 h of infection, the mRNA level for Tfr1<br />
in ST group decreased 0.7-fold (F=11.94, P=0.0259) as<br />
compared with infected 1 h, but increased 1.88-fold<br />
(F=14.11, P=0.0198) during infection with STA.<br />
We also investigated the expression of other genes that<br />
regulate host cell iron levels by Real time PCR. There are<br />
two main eukaryotic iron-regulatory proteins, Irp1 and<br />
Irp2, which sense changes in the labile iron pool (Galy et<br />
al., 2008). They both act post transcriptionally by<br />
stabilizing their respective target mRNA and by affecting<br />
initiation of translation. When investigating Irp1 mRNA<br />
levels in RAW264.7 phagocytes, we found significant<br />
difference between controls and 1 h of two Salmonella<br />
strains infected cells (2.37-fold for ST, F=27.44,<br />
P=0.0063; 2.51-fold for STA, F=45.85, P=0.0025); when<br />
we compared 1 h with 24 h infected samples, there was
Table 2. mRNA expression of iron metabolism-related genes in RAW264.7 cells after infection with viable Salmonella.<br />
Gene name Uninfected<br />
ST infection sample<br />
STA infection sample<br />
Infection 1 h Infection 24 h Infection 1 h Infection 24 h<br />
Irp1 1 2.37±0.45 2.15±0.68 2.51±0.39 0.68±0.06<br />
Irp2 1 2.77±0.32 3.73±1.01 2.52±0.78 2.76±0.32<br />
Tfr1 1 2.20±0.04 1.83±0.10 1.72±0.43 4.15±0.35<br />
Dmt1 1 12.36±2.24 3.22±0.17 5.36±0.35 12.26±3.41<br />
LcnR 1 3.06±0.41 0.66±0.12 2.23±0.36 0.24±0.05<br />
Lcn2 1 2.07±0.38 17.44±1.41 1.18±0.15 11.63±0.54<br />
Steap3 1 2.86±0.18 1.87±0.43 5.20±0.68 3.78±1.19<br />
Hmox1 1 1.33±0.12 6.81±0.39 2.87±0.31 6.34±0.58<br />
Fpn1 1 1.04±0.12 0.62±0.09 1.42±0.13 0.57±0.12<br />
Hamp1 1 3.88±0.45 11.85±1.73 2.64±0.33 1.42±0.25<br />
Ftl1 1 0.81±0.05 1.17±0.09 1.16±0.04 1.46±0.07<br />
Ftl2 1 0.88±0.03 1.23±0.07 1.18±0.01 1.49±0.04<br />
Fth1 1 0.77±0.07 1.58±0.17 1.34±0.10 1.66±0.13<br />
Xin 2247<br />
Mean values shown were normalized to GAPDH mRNA levels and compared to correlated values found in uninfected macrophages (=1).<br />
no significant difference in ST-infected cells (1.11-fold,<br />
F=0.60, P=0.4831), but Irp1 expression decreased (0.27fold,<br />
F=3996.75, P=0.0001) in 24 h STA -infected cells.<br />
Irp2 mRNA levels was also induced (2.77-fold, F=92.96,<br />
P=0.0006) in 1 h ST-infected cells as compared with noninfected<br />
RAW264.7 cells, and no substantially alter in 24<br />
h ST-infected cells (1.11-fold, F=0.60, P=0.4831) as<br />
compared with 1 h infection. In STA-infected samples,<br />
Irp2 mRNA levels at 1 h increased 2.52-fold (F=11.37,<br />
P=0.0280) as compared with controls, while the mRNA<br />
levels also no substantially alter (0.90-fold, F=0.40,<br />
P=0.5599) after 24 h of infection as compared with 1 h<br />
infection.<br />
After uptake of iron and vesicle acidification, iron is<br />
reduced to its ferrous form by the ferrireductase sixtransmembrane<br />
epithelial antigen of the prostate 3<br />
(Steap3) prior to being transferred across the endosomal<br />
membrane (Ohgami et al., 2005). After 1 h of infection<br />
with wild-type Salmonella, mRNA levels for Steap3 were<br />
increased 2.86-fold (F=313.07, P=0.0001) as compared<br />
with controls. After 24 h infection with ST, Steap3<br />
moderately decreased 0.66-fold (F=10.41, P=0.0321) as<br />
compared with 1 h infection. In STA infection sample,<br />
mRNA levels for Steap3 at 1 h were increased 5.20-fold<br />
(F=115.98, P=0.0004) as compared with controls, but<br />
declined at 24 h infection period (0.67-fold, F=10.85,<br />
P=0.0301) as compared with 1 h infection.<br />
After reduction, ferrous iron is transported into the<br />
cytosol by Divalent metal transporter 1(Dmt1) (Andrews<br />
and Schmidt, 2007). After 1 h of infection with wild-type<br />
Salmonella, mRNA levels for Dmt1 is increased 12.36fold<br />
(F=64.49, P=0.0013) as compared with controls.<br />
After 24 h infection with ST, Dmt1 decreased 0.27-fold<br />
(F=793.44, P=0.0001) as compared with 1 h infection. In<br />
STA infection sample, mRNA levels for Dmt1 at 1 h<br />
(5.36-fold, F=465.08, P=0.0001) were significantly<br />
different from control. This increase continued over a 24<br />
h infection period (2.11-fold, F=14.66, P=0.0186) as<br />
compared with 1 h infection.<br />
The lipocalin system provides the host with another<br />
way of scavenging iron. At the same time, lipocalin2<br />
(Lcn2) can interact with bacterial siderophores to inhibit<br />
bacterial growth and has now been recognized as an<br />
important arm of the innate immune response (Flo et al.,<br />
2004). The secreted gene product Lcn2 is induced 2.07fold<br />
(F=22.88, P=0.0088) when cells are infected with ST<br />
at 1 h as compared with controls. This increase continued<br />
over a 24 h infection period (8.6-fold, F=70.14, P=0.0011)<br />
as compared with 1 h infection. In STA infection sample,<br />
mRNA levels for Lcn2 at 1 h did not alter (1.18-fold,<br />
F=4.00, P=0.1161) as compared with control, but<br />
increased (11.63-fold, F=1183.82, P=0.0001) at 24 h<br />
infection as compared with 1 h infection. Wild type<br />
Salmonella also raised LcnR mRNA levels 3.06-fold<br />
(F=78.44, P=0.0009) at 1 h as compared with control, but<br />
decreased (0.21-fold, F=7956.57, P=0.0001) at 24 h as<br />
compared with 1 h infection. In STA infection sample,<br />
mRNA levels for LcnR at 1 h (2.23-fold, F=19.26,<br />
P=0.0118) were increased as compared with control, but<br />
also decreased (0.07-fold, F=76729.00, P=0.0001) at 24<br />
h infection period as compared with 1 h infection.<br />
Infected host cells can restrict the intracellular iron pool<br />
available for intracellular parasites by transporting iron<br />
out of the cells via ferroportin 1 (Fpn1), a transmembrane<br />
iron efflux protein (Knutson and Wessling-Resnick, 2003).<br />
Fpn1 is negatively regulated by hepcidin antimicrobial<br />
peptide (Hamp1), thus effectively reducing iron efflux<br />
(Nguyen et al., 2006). Hepcidin is significantly<br />
upregulated 3.88-fold (F=118.54, P=0.0004) in infections<br />
with ST at 1 h with accompanying unchanged in Fpn1
2248 Afr. J. Microbiol. Res.<br />
(1.04-fold, F=0.32, P=0.6030) as compared with control,<br />
and Hamp1 increase continued (3.1-fold, F=32.90,<br />
P=0.0046) at 24 h infection with decreased in Fpn1 (0.60fold,<br />
F=192.64, P=0.0002) as compared with 1 h<br />
infection. Hamp1 is increased (2.64-fold, F=73.42,<br />
P=0.0010) in infections with STA at 1 h with<br />
accompanying increased in Fpn1 (1.42-fold, F=30.77,<br />
P=0.0052) as compared with control, and Hamp1<br />
moderately decreased (0.51-fold, F=41.16, P=0.0030) at<br />
24 h infection with decreased in Fpn1 (0.33-fold,<br />
F=498.78, P=0.0001) as compared with 1h infection.<br />
This suggests a stronger effect for iron retention in the<br />
host cell during infection with ST. Heme oxygenase<br />
(Hmox1) catalyzes the conversion of heme to biliverdin,<br />
iron, and carbon monoxide. In macrophages it has an<br />
important antioxidative protective function, presumably by<br />
reducing pro-oxidant or proapoptotic hemoproteins<br />
(Orozco et al., 2007). The mRNA level for Hmox1 is<br />
moderately increased 1.3-fold (F=23.42, P=0.0084) in<br />
macrophages infected by ST at 1 h. This increase<br />
continued over a 24 h infection period (5.13-fold,<br />
F=886.43, P=0.0001) as compared with 1 h ST infection.<br />
In STA infection sample, mRNA levels for Hmox1 at 1h<br />
were increased (2.87-fold, F=109.54, P=0.0005) as<br />
compared with control, and the increase continued (2.21fold,<br />
F=1324.96, P=0.0001) at 24 h infection as<br />
compared with 1 h infection.<br />
The components of the ferritin iron storage system,<br />
ferritin heavy chain 1(Fth1), ferritin light chain 1 (Ftl1) and<br />
ferritin light chain 2 (Ftl2), are moderately decrease by<br />
infection with ST at 1 h (0.77-fold, F=32.39, P=0.0047;<br />
0.81-fold, F=51.57, P=0.0020; 0.88-fold, F=61.71,<br />
P=0.0014, respectively) as compared with control, and<br />
increased over a 24 h infection period (2.05-fold,<br />
F=2037.88, P=0.0001; 1.45-fold, F=867.86, P=0.0001;<br />
1.40-fold, F=369.23, P=0.0001, respectively) as<br />
compared with 1h ST infection. In STA infection sample,<br />
these three mRNA levels at 1 h were increased (1.34fold,<br />
F=31.65, P=0.0049; 1.16-fold, F=45.63, P=0.0025;<br />
1.18-fold, F=972.00, P=0.0001) as compared with<br />
control, and still increased (1.24-fold, F=576.00,<br />
P=0.0001; 1.24-fold, F=782.29, P=0.0001; 1.27-fold,<br />
F=182.25, P=0.0002) at 24 h infection as compared with<br />
1 h infection.<br />
Thus, wild-type S. typhimurium appears to drive an<br />
active transferrin-mediated iron uptake program after<br />
infection 1 or 24 h. This was supported by increased<br />
mRNA levels for Irp1 and Irp2, induction of genes<br />
required for transfer of iron to the cytosol via Dmt1 and<br />
Steap3, and by not too much iron efflux changing through<br />
Fpn1 and Hamp1. The spiA - Salmonella mutant strain<br />
used in our studies caused an increase in Tfr1 at 1 or 24<br />
h, and led to decrease in Fpn1 and Hamp1 at 24 h as<br />
compared with 1 h. The assessment was that the labile<br />
iron pool increased after infection with spiA - Salmonella<br />
for 24 h. Of interest in this context is that the spiA -<br />
Salmonella mutant strain used in our studies behaves<br />
quite different to the spiC - strain by lacking an increase in<br />
Tfr1, but leading to an increase in Fpn1 (Pan et al.,<br />
2010). Macrophage iron overload inhibits the transcription<br />
of iNOS and the generation of NO (Weiss et al., 1994)<br />
and became one of the reasons for Salmonella survival<br />
inside the macrophage.<br />
ACKNOWLEDGMENT<br />
This work was supported by the National Natural Science<br />
Foundation of China (Contract No. 30972633).<br />
REFERENCES<br />
Andrews NC, Schmidt PJ (2007). Iron homeostasis. Annu. Rev.<br />
Physiol., 69: 69-85.<br />
Braun V (2001). Iron uptake mechanisms and their regulation in<br />
pathogenic bacteria. Int. J. Med. Microbiol., 291(2): 67-79.<br />
Bullen JJ, Rogers HJ, Spalding PB, Ward CG (2006). Natural<br />
resistance, iron and infection: a challenge for clinical medicine. J.<br />
Med. Microbiol., 55(Pt 3): 251-258.<br />
Eaton JW, Qian M (2002). Molecular bases of cellular iron toxicity. Free.<br />
Radic. Biol. Med., 32(9): 833-840.<br />
Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira<br />
S, Aderem A (2004). Lipocalin 2 mediates an innate immune<br />
response to bacterial infection by sequestrating iron. Nature,<br />
432(7019): 917-921.<br />
Galy B, Ferring-Appel D, Kaden S, Gröne HJ, Hentze MW (2008). Iron<br />
regulatory proteins are essential for intestinal function and control key<br />
iron absorption molecules in the duodenum. Cell. Metab., 7(1): 79-85.<br />
Hentze MW, Muckenthaler MU, Andrews NC (2004). Balancing acts:<br />
molecular control of mammalian iron metabolism. Cell, 117(3): 285-<br />
297.<br />
Knutson M, Wessling-Resnick M (2003). Iron metabolism in the<br />
reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol., 38(1): 61-<br />
88.<br />
Nguyen NB, Callaghan KD, Ghio AJ, Haile DJ, Yang F (2006). Hepcidin<br />
expression and iron transport in alveolar macrophages. Am. J.<br />
Physiol. Lung. Cell. Mol. Physiol., 291(3): L417- 425.<br />
Ochman H, Soncini FC, Solomon F, Groisman EA (1996). Identification<br />
of a pathogenicity island required for Salmonella survival in host cells.<br />
Proc. Natl. Acad. Sci. USA., 93(15): 7800–7804.<br />
Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen<br />
J, Sharp JJ, Fujiwara Y, Barker JE, Fleming MD (2005). Identification<br />
of a ferrireductase required for efficient transferrin-dependent iron<br />
uptake in erythroid cells. Nat. Genet., 37(11): 1264-1269.<br />
Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong<br />
J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis<br />
AJ, Araujo JA (2007). Heme oxygenase-1 expression in<br />
macrophages plays a beneficial role in atherosclerosis. Circ. Res.,<br />
100(12): 1703-1711.<br />
Pan X, Tamilselvam B, Hansen EJ, Daefler S (2010). Modulation of iron<br />
homeostasis in macrophages by bacterial intracellular pathogens.<br />
BMC. Microbiol., 10: 64.<br />
Tobar JA, Carreño LJ, Bueno SM, González PA, Mora JE, Quezada<br />
SA, Kalergis AM (2006). Virulent Salmonella enterica serovar<br />
typhimurium evades adaptive immunity by preventing dendritic cells<br />
from activating T cells. Infect. Immun., 74(11): 6438-6448.<br />
Weiss G, Werner-Felmayer G, Werner ER, Grünewald K, Wachter H,<br />
Hentze MW (1994). Iron regulates nitric oxide synthase activity by<br />
controlling nuclear transcription. J. Exp. Med., 180(3): 969-976.
African Journal of Microbiology Research Vol. 5(16), pp. 2249-2253, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.570<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Expanding drug resistance through integron<br />
acquisition in Salmonella spp. isolates obtained in<br />
Iran<br />
Bahareh Rajaei 1 , Seyed Davar Siadat 1,2* , Mohamad Reza Razavi 3 ,<br />
Mohammad Reza Aghasadeghi 2 , Nahid Sepehri Rad 1 , Farzad Badmasti 4 ,<br />
Somieh Khanjani Jafroodi 3 , Taraneh Rajaei 5 , Arfa Moshiri 6 and Saifuddin Javadian 7<br />
1 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.<br />
2 Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.<br />
3 Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran.<br />
4 Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran.<br />
5 Department of Immunology and Allergy, Mashhad University of Medical Sciences, Mashhad, Iran.<br />
6 Department of Biotechnology, Faculty of Allied Sciences, Tehran University of Medical Sciences, Tehran, Iran.<br />
7 Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran.<br />
Accepted 15 July, 2011<br />
A total eighty four epidemiologically unrelated clinical isolates of Salmonella enterica serovars were<br />
subjected to antimicrobial susceptibility testing and molecular detection of class 1 and 2 integrons.<br />
Eleven isolates (13.1%) which were resistant to at least 4 groups of antimicrobial agents considered<br />
as MDR (multidrug resistant) Salmonella serovars. PCR assays detected intI1 and intI2 genes in 50<br />
(59.5%) and 14 (16.7%) of Salmonella clinical isolates respectively. Emergence of MDR Salmonella<br />
serovars demonstrates that antimicrobial selection pressure is widespread and increased distribution<br />
of integron carrying gene cassettes which confer resistance to different antibiotics confirms that<br />
integron-mediated antibiotic resistance is considerable in our clinical settings.<br />
Key words: Salmonella spp., integron, multidrug resistance (MDR).<br />
INTRODUCTION<br />
Salmonella is involved in a wide variety of infections<br />
ranging from life-threatening typhoid to gastroenteritis<br />
and bacteremia (Boyd and Hartl, 1998). Antibiotic<br />
resistance in Salmonella is an emerging problem during<br />
the last decades. The intensive use of antibiotics in both<br />
human and veterinary medicine, as well as in agriculture,<br />
has caused bacteria to develop resistance mechanisms<br />
against therapeutic drugs (Stokes and Hall, 1989;<br />
Rodriguez et al., 2008). Dissemination of antibiotic<br />
resistance genes by horizontal gene transfer has led to<br />
the rapid emergence of antibiotic resistance among<br />
bacteria, thus complicating the treatment of infections<br />
(Gu et al., 2008). The worldwide emergence of multidrugresistant<br />
(MDR) phenotypes among Salmonella<br />
*Corresponding author. E-mail: d.siadat@gmail.com. Tel:<br />
00982144865100. Fax: 00982144865105.<br />
serotypes is of increasing concern for both the scientific<br />
community and the general public (Havlickova et al.,<br />
2009; Yang et al., 2009).<br />
Acquired resistance evolves via horizontal transfer of<br />
antimicrobial resistance genes located on various types<br />
of mobile DNA elements (Yang et al., 2009). A key genetic<br />
system involved in spreading antibiotic multiresistance<br />
is the integron, a genetic element that, although normally<br />
immobile itself, can be transferred in companion with<br />
mobile genetic elements (Tamang et al., 2007)<br />
Integrons were first identified by virtue of their<br />
important role in the acquisition and expression of genes<br />
conferring antibiotic resistance. Integrons are composed<br />
of three key elements necessary for the capture of<br />
exogenous genes: a gene (intI) encoding an integrase<br />
belonging to the tyrosine-recombinase family; a primary<br />
recombination site (attI) located immediately adjacent to<br />
intI; and a strong promoter (Pc) that directs transcription<br />
of the captured genes (Carattoli, 2001; Mazel, 2006).
2250 Afr. J. Microbiol. Res.<br />
Table 1. Information about number of MDR and resistant isolates on the basis of the MIC determination according to guidelines of CLSI<br />
(2009).<br />
Integron positive isolates<br />
No. of resistant isolates to the following antibiotics a on the basis of MIC<br />
SMX SXT TMP CIP NAL AMP CAZ CHL STR<br />
intI1 positive isolates(50) 20 45 22 1 32 5 2 21 20 11<br />
intI2 positive isolates(14) 10 12 11 0 11 0 1 4 6 1<br />
a Abbreviation of mentioned antibiotics and breakpoint for resistance (µg/ml) : AMP, ampicillin ( 32); CAZ, ceftazidime ( 16); CHL, chloramphenicol<br />
( 32); CIP, ciprofloxacin ( 4); NAL, nalidexic acid ( 32); STR, streptomycin ( 64); TMP, trimethoprim ( 4); SMX, sulfamethoxazole ( 512); SXT,<br />
sulfamethoxazole-trimethoprim ( 4/76). Breakpoints were adopted from CLSI (Clinical and Laboratory Standards Institute), except for streptomycin,<br />
which has no CLSI breakpoint.<br />
b In this study isolates which were resistant to at least 4 groups of antimicrobial agents considered as MDR Salmonella isolates.<br />
On the basis of nucleotide sequence of the integrase<br />
gene (intI), nine classes of integrons have been identified<br />
(Moura et al., 2007; Macedo-Vinas et al., 2009) but, to<br />
date, only those of class 1 and 2 have been reported in<br />
S. enterica (Rodriguez et al., 2008).<br />
The objective of this study was to evaluate the<br />
antimicrobial resistance profile and to investigate the<br />
contribution of class 1 and 2 integrons in multidrug<br />
resistant Salmonella isolates.<br />
MATERIALS AND METHODS<br />
Isolation and identification of bacteria<br />
A total of eighty four S. enterica isolates attributed to Typhi (n=40),<br />
Paratyphi A (n=2), Typhymurium (n=12), and non Typhi (n=30)<br />
serovars were studied. The clinical isolates were recovered from<br />
stool (n= 69), blood (n= 6), bone marrow (n= 3), synovial fluid (n=<br />
3), ascites (n= 1), abces (n= 1), urine (n= 1). All isolates were<br />
identified by standard microbiological techniques as previously<br />
described (Martin et al., 2008; Ahmed et al., 2009). The serogroup<br />
was checked with O antisera by the slide agglutination method<br />
(Difco Laboratories, Detroit, MI).<br />
Antimicrobial susceptibility test<br />
The antimicrobial susceptibility test was performed using the<br />
standard disk diffusion method on Muller-Hinton agar and the<br />
Minimum Inhibitory Concentrations (MICs) were determined by<br />
broth microdilution method according to the guidelines of the<br />
Clinical and Laboratory Standards Institute (CLSI, 2009). Disks<br />
prepared by MAST company (Mast Co, Merseyside, UK) were<br />
used to determine the susceptibility of isolates to ampicillin (10 µg),<br />
tetracycline (30 µg), chloramphenicol (30 µg), trimethoprim (5 µg),<br />
sulfamethoxazole-trimethoprim (30 µg), streptomycine (10 µg),<br />
nalidexic acid (30 µg), ciprofloxacin (5 µg), ofloxacin (5 µg),<br />
levofloxacin (5 µg), norfloxacin (5 µg), gatifloxacin (5 µg),<br />
moxifloxacin (5 µg), cefotaxime (30 µg), cefixime (5 µg), ceftriaxone<br />
(30 µg), cefepime (30 µg), ceftazidime (30 µg), amikacin (30 µg),<br />
azithromycin (15 µg), spectinomycin (100 µg), gentamicin (10 µg),<br />
colistin-sulfate (10 µg), imipenem (10 µg). The MICs of ampicillin,<br />
chloramphenicol, streptomycin, nalidixic acid, ciprofloxacin,<br />
ceftazidime, trimethoprim, sulfamethoxazole and sulfamethoxazoletrimethoprim<br />
were carried out against all clinical isolates. The<br />
breakpoints used were those defined by the CLSI for<br />
Enterobacteriaceae, with the exception of streptomycin (32_g/mL)<br />
(CLSI, 2009) (Table 1). E. coli ATCC 25922 was used as a quality<br />
control organism in antimicrobial susceptibility test.<br />
Detection of class 1 and 2 integrons<br />
MDR b<br />
Chromosome and plasmid DNA templates were prepared by<br />
phenol-chloroform methods as previously described (Sambrook et<br />
al., 1989). All isolates were screened for detection of class 1 and 2<br />
integrons by the primers described by Goldstein et al. (2001)<br />
designed for the intI1 and intI2 genes respectively. The<br />
amplification program was performed by termocycler (Eppendorf<br />
Mastercycler®, MA) and started with initial denaturation of 4 min at<br />
94°C and programmed with 35 cycles of each: 1min at 94°C, 30 s<br />
at 60°C, 1 min at 72°C. The program finished with the final<br />
extension of 10min at 72°C.<br />
RESULTS<br />
Disk diffusion and minimum inhibitory concentration<br />
(MIC)<br />
A total of eighty four Salmonella isolates including S.<br />
Typhi (n = 40), S.Typhymurium (n=12), S. Paratyphi A (n<br />
= 2), non-Typhi (n=30) serovars were studied. According<br />
to the Disk diffusion and minimum inhibitory concentration<br />
(MIC), antimicrobial resistance patterns were as<br />
follow: 25 isolates (29.8%) were resistant to<br />
streptomycin, 25 isolates (29.8%) to sulfamethoxazoletrimethoprim,<br />
30 isolates (35.7%) to trimethoprim, 23<br />
isolates (27.4%) to chloramphenicol, 57 isolates (67.9%)<br />
to tetracycline, 6 isolates (7.1%) to ampicillin, 54 isolates<br />
(64.3%) to nalidexic acid, 1 isolate (1.2%) to ciprofloxacin,<br />
6 isolates (7.2%) to cefotaxime, 8 isolates (9.5%)<br />
to cefexime, 6 isolates (7.2%) to ceftriaxon, 2 isolates<br />
(2.4%) to ceftazidime, 2 isolates (2.4%) to colistinsulfate,<br />
3 isolates (3.6%) to gentamicin, 24 isolates<br />
(28.6%) to spectinomycin, 5 isolates (5.9%) to azithromycin,<br />
2 isolates (2.4%) to amikacin. All the isolates were<br />
sensitive to imipenem, ofloxacin, levofloxacin,<br />
norfloxacin, gatifloxacin, moxifloxacin. Of the 84 isolates<br />
only 4 isolates (4.7%) were sensitive to the all of the<br />
tested antimicrobial agents.<br />
Identification of multidrug resistant (MDR) isolates<br />
Multi-drug resistance was defined as resistance to at<br />
least 4 groups of antimicrobial agents. Of the eighty four
Figure 1. PCR Amplification of intl1 Gene. Lane M: 200bp DNA Ladder. Lane 1: int1 PCR product.<br />
Figure 2. PCR Amplification of intl2 Gene. Lane M: 100bp DNA Ladder. Lane 1: int2 PCR product.<br />
isolates, eleven isolates (13.1%) were considered as<br />
MDR Salmonella serovars (1). These MDR isolates were<br />
attributed to S. Typhi (n=3), S. Typhimurium (n=3), other<br />
non-Typhi serovars (n=5). One of the MDR isolates were<br />
recovered from bone marrow and the rest ten MDR<br />
isolates were originated from stool.<br />
Detection of class 1 and 2 Integrons<br />
Rajaei et al. 2251<br />
Fifty (59.5%) isolates amplified intI1 gene with the amplicon<br />
size of 280bp and fourteen (16.7%) isolates carried<br />
intI2 gene with the amplicon size of 232bp (Figures 1 and<br />
2). Of 50 isolates carrying class 1 integrons, 8 (16%)
2252 Afr. J. Microbiol. Res.<br />
Table 2. Information about integron positive isolates among different sources of Salmonella isolates.<br />
Isolation<br />
source<br />
No. of intI1 positive isolates<br />
(%)<br />
No. of inti2 positive isolates<br />
(%)<br />
No. of intI1 and inti2 positive isolates<br />
(%)<br />
Stool(69) 41 13 13<br />
Blood(6) 3 0 0<br />
Bone marrow(3) 2 0 0<br />
Synovial fluid(3) 1 0 0<br />
Abces(1) 1 0 0<br />
Ascites(1) 1 0 0<br />
Urine(1) 1 1 1<br />
Total(84) 50(59.5) 14(16.7) 14(16.7)<br />
Table 3. Information about integron positive isolates among serovars of Salmonella spp.<br />
Serovars (No.)<br />
No. of intI1 and intI2positive<br />
isolates (%) c<br />
No. of intI2-positive<br />
isolates (%) b<br />
No. of intI1-positive<br />
isolates (%) a<br />
S. Typhi (40) 5 5 21<br />
Non-typhi serovars (30) 8 8 20<br />
S. Typhimurium (12) 1 1 7<br />
S. Paratyphi A (2) 0 0 2<br />
Total (84) 14(16.7) 14(16.7) 50 (59.5)<br />
a indicates the number and percentage of intI1-posetive in Salmonellae serovars<br />
b indicates the number and percentage of intI2-posetive in Salmonellae serovars<br />
c indicates the number and percentage of serovars carrying both intI1 and intI2 genes.<br />
isolates amplified class 1 integrons exclusively on<br />
chromosome, 12 (24%) isolates exclusively on plasmid,<br />
30 (60%) isolates both on plasmid and chromosome.<br />
Among fourteen isolates harbored class 2 integrons, 3<br />
(21.4%) isolates carried class 2 integrons only on<br />
plasmids and 11 (78.6%) isolates both on plasmid and<br />
chromosome (Tables 2 and 3).<br />
DISCUSSION<br />
The worldwide emergence of multidrug-resistant (MDR)<br />
phenotypes among Salmonella serotypes is causing an<br />
increasing concern. Use of antimicrobials in clinical and<br />
veterinary medicine is a recognized driving force for the<br />
selection of resistant bacteria. Selective pressure has<br />
resulted in the development of strains that are resistant<br />
to more than one antimicrobial agent (Miriagou et al.,<br />
2006; Yang et al., 2009). Integrons are genetic elements<br />
able to recognize and capture mobile gene cassettes<br />
carrying antibiotic resistance genes leading to MDR<br />
distribution and subsequently limitation of treatment<br />
options for infections (Stokes and Hall, 1989).<br />
In this study eighty four clinical isolates of Salmonella<br />
spp. were subjected to molecular investigations to detect<br />
integron-associated multidrug resistance.<br />
Of 84 isolates, 11 (13.1%) isolates were resistant to<br />
more than 4 groups of antimicrobial agents and considered<br />
as MDR Salmonella serovars (Table 1). Most of<br />
the MDR isolates were recovered from stool and related<br />
to the non-Typhi serovars of Salmonella enterica. Fifty<br />
(59.5%) isolates harbored class 1 integrons and<br />
amplified intI1 gene more detected in Typhi serovar and<br />
14 (16.7%) isolates contained class 2 integrons carrying<br />
intI2 gene as well as intI1 gene which were more<br />
considered in non–Typhi serovars of Salmonella enterica<br />
(Table 3).<br />
Our study indicates that all the MDR isolates harbored<br />
class 1 integrons and one of the MDR isolates carried<br />
class 2 in addition to class 1 integrons. This result<br />
highlights the integron role in MDR distribution (Table 1).<br />
To confirm the previous studies, according to the<br />
results of MIC determination, most of the intI-positive<br />
isolates showed high resistance to nalidixic acid,<br />
trimethoprim and trimethoprim–sulphamethoxazole<br />
(Chang et al., 2007) and indicated increased MIC to be<br />
higher than 512 µg/ml. Limitless use of these antibiotics<br />
in hospitals and other health care environments may be<br />
involved in the selection and consequently distribution of<br />
integron-carrying Salmonella. These antibiotics are at<br />
risk for future use and would be prescribed with more<br />
consideration.<br />
In agreement with other studies, fluoroquinolones,<br />
third-generation cephalosporins and imipenem are
suggested to be used as frontline therapeutic drugs in<br />
treatment of Salmonella infections. Carbapenems are the<br />
main class of drugs used for treatment of infections<br />
caused by MDR and extended-spectrum -lactamaseproducer<br />
Gram-negative bacteria such as Salmonella<br />
(Ahmed et al., 2009).<br />
In conclusion our results support the hypothesis that<br />
integron acquisition may lead to dissemination of new<br />
antibiotic resistance determinants and high levels of<br />
multidrug resistance. Epidemiological studies on the<br />
distribution of integrons would be of great use in<br />
detecting MDR isolates.<br />
REFERENCES<br />
Ahmed AM, Younis EA, Ishida Y, Shimamoto T (2009). Genetic basis<br />
of multidrug resistance in Salmonella enterica serovars Enteritidis<br />
and Typhimurium isolated from diarrheic calves in Egypt. Acta Trop.,<br />
111: 144-149.<br />
Boyd EF, Hartl DL (1998). Salmonella virulence plasmid: Modular<br />
acquisition of the spv virulence region by an F-plasmid in Salmonella<br />
enterica subspecies I and insertion into the chromosome of<br />
subspecies II, IIIa, IV and VII isolates. Genetics, 149: 1183-1190.<br />
Carattoli A (2001). Importance of integrons in the diffusion of<br />
resistance. Vet. Res., 32: 243-259.<br />
Chang YC, Shih DYC, Wang JY, Yang SS (2007). Molecular<br />
characterization of class 1 integrons and antimicrobial resistance in<br />
Aeromonas strains from foodborne outbreak-suspect samples and<br />
environmental sources in Taiwan. Diagn. Microbiol. Infect. Dis., 59:<br />
191-197.<br />
Clinical and Laboratory Standards Institute (CLSI) (2009). Performance<br />
standards for antimicrobial susceptibility testing; nineteenth<br />
informational supplement. M100-S19, CLSI, Wayne, PA.<br />
Goldstein C, Lee MD, Sanchez S, Hudson C, Phillips B, Register B,<br />
Grady M, Liebert C, Summers AO, White DG, Maurer JJ (2001).<br />
Incidence of Class 1 and 2 Integrases in Clinical and Commensal<br />
Bacteria from Livestock, Companion Animals, and Exotics.<br />
Antimicrob. Agents Chemother., 45: 723–726.<br />
Gu B, Pan S, Wang T, Zhao W, Mei Y, Huang P, Tong M (2008). Novel<br />
cassette arrays of integrons in clinical strains of Enterobacteriaceae<br />
in China. Int. J. Antimicrob. Ag., 32: 529–533.<br />
Rajaei et al. 2253<br />
Havlickova H, Hradecka H, Bernardyova I, Rychlik I (2009). Distribution<br />
of integrons and SGI1 among antibiotic-resistant Salmonella enterica<br />
isolates of animal origin. Vet. Microbiol., 133: 193-198.<br />
Macedo-Vinas M, Cordeiro NF, Bado I, Herrera-Leon S, Vola M,<br />
Robino L, Gonzalez-Sanz R, Mateos S, Schelotto F, Algorta G,<br />
Ayala JA, Echeita A, Vignoli R (2009). Surveillance of antibiotic<br />
resistance evolution and detection of class 1 and 2 integrons in<br />
human isolates of multi-resistant Salmonella Typhimurium obtained<br />
in Uruguay between 1976 and 2000. Int. J. Infect. Dis., 13: 342-348.<br />
Martin BS, Lapierre L, Cornejo J, Bucarey S (2008). Characterization of<br />
antibiotic resistance genes linked to class 1 and 2 integrons in<br />
strains of Salmonella spp. isolated from swine. Can. J. Microbiol., 54:<br />
569-576.<br />
Mazel D (2006). Integrons: agents of bacterial evolution. Nat. Rev.<br />
Microbiol., 4:608-620.<br />
Miriagou V, Carattoli A, Fanning S (2006). Antimicrobial resistance<br />
islands: resistance gene clusters in Salmonella chromosome and<br />
plasmids. Microbes Infect., 8: 1923-1930.<br />
Moura A, Henriques I, Ribeiro R, Correia A (2007). Prevalence and<br />
characterization of integrons from bacteria isolated from a<br />
slaughterhouse wastewater treatment plant. J. Antimicrob.<br />
Chemother., 60: 1243-1250.<br />
Rodriguez I, Rodicio MR, Herrera-Leon S, Echeita A, Mendoza MC<br />
(2008). Class 1 integrons in multidrug-resistant non-typhoidal<br />
Salmonella enterica isolated in Spain between 2002 and 2004. Int. J.<br />
Antimicrob. Ag., 32: 158-164.<br />
Sambrook J, Fritsch EF, Manaiatis T (1989). Molecular Cloning: A<br />
Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press,<br />
Cold Spring Harbor, NY.<br />
Stokes HW, Hall RM (1989). A novel family of potentially mobile DNA<br />
elements encoding site- specific gene-integration functions:<br />
integrons. Mol. Microbiol., 3: 1669-1683.<br />
Tamang MD, Oh JY, Seol SY, Kang HY, Lee JC, Lee YC, Cho DT, Kim<br />
J (2007). Emergence of multidrug-resistant Salmonella enterica<br />
serovar Typhi associated with a class 1 integron carrying the dfrA7<br />
gene cassette in Nepal. Int. J. Antimicrob. Ag., 30: 330-335.<br />
Yang BW, Zheng J, Brown EW, Zhao SH, Meng JH (2009).<br />
Characterisation of antimicrobial resistance-associated integrons and<br />
mismatch repair gene mutations in Salmonella serotypes. Int. J.<br />
Antimicrob. Ag., 33: 120-124.
African Journal of Microbiology Research Vol. 5(16), pp. 2254-2260, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.580<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
The synthesis and role of hydroxyectoine in halophilic<br />
bacterium Halomonas ventosae DL7<br />
Daochen Zhu 1,2 *, Chenxiang Wang 3 , Shoko Hosoi-Tanabe 4 , Weimin Zhang 2 and<br />
Shinichi Nagata 4<br />
1 School of Environmental Engineering, Jiangsu University, 301 Xuefu Road Zhenjiang 212013, China.<br />
2 Guangdong Provincial Open Laboratory of Applied Microbiology, Guangdong Provincial, Key Laboratory of Microbial<br />
Culture Collection and Application, Guangdong Institute of Microbiology, Guangzhou 510070, China.<br />
3 Environmental Science and Engineering College, Dalian Maritime University, 1 Linghai Road, Dalian 116026, China.<br />
4 Environmental Biochemistry Division, Research Center for Inland Seas, Kobe University, 5-1-1 Fukae, Higashinada-ku,<br />
Kobe 658-0022, Japan.<br />
Accepted 30 July, 2011<br />
Hydroxyectoine and ectoine were accumulated in the moderately halophilic bacterium Halomonas<br />
ventosae DL7 as dominant compatible solutes in response to the external thermo- and osmo-stresses<br />
(30-42°C, 1-3 M NaCl). As the byproduct of ectoine, hydroxyectoine was directly converted from ectoine<br />
mediated by the ectoine hydroxylase in DL7, and the hydroxylase gene sequence was obtained by PCR.<br />
Further, the activity of ectoine hydroxylase of strain DL7 cells in vitro was determined at 30 to 42°C, and<br />
the thermo-stress conduce the inhibition of this enzyme activity. In addition, DL7 cells showed similar<br />
growth level when grown in presence of same level ectoine or hydroxyectoine (1 mM) in medium with<br />
high salinity (2-2.7 M NaCl). However, the presence of hydroxyectoine showed higher growth level than<br />
ectoine when DL7 cells were incubated at 42°C. The results showed that the alteration of temperature<br />
instead of salinity stress obviously stimulated the expression of ectoine hydroxylase, but inhibited its<br />
activity, and hydroxyectoine with ectoine together played an important role as thermo- and osmoprotectants<br />
in strain DL7 to cope with high temperature and salinity environment.<br />
Key words: Halomonas ventosae DL7, compatible solutes, hydroxyectoine, ectoine hydroxylase, thermostress,<br />
osmo-stress.<br />
INTRODUCTION<br />
To cope with a variety of high osmotic environments,<br />
halophilic and halotolerant bacteria developed a strategy<br />
to accumulate a particular class of highly soluble, small<br />
molecular organic compounds which named compatible<br />
solutes (Kunte, 2006; Roberts, 2005). Among compatible<br />
solutes, ectoine and its hydroxylated derivative,<br />
hydroxyectoine are one of the most widely produced<br />
solutes. And ectoines are increasingly concerned for their<br />
superior function on the enzyme, nucleic acid and cell<br />
wall protective ability against a variety of stress factors<br />
such as heating, freeze-thawing and freeze-drying<br />
*Corresponding author. E-mail: dczhucn@hotmail.com. Tel/fax:<br />
+86-511-88796122.<br />
(Lippert and Galinski, 1992; Louis et al., 1994). The OH<br />
group of hydroxyectoine can partly replace the loss of<br />
water molecules from hydrate shell to further stabilize the<br />
native structure of the biopolymers compare to ectoine<br />
(Graf et al., 2008). Hydroxyectoine is proposed as<br />
suitable healthy cells protectant during chemotherapy<br />
and molecular chaperon for Alzheimer's disease treatment,<br />
and it can protect skin cells against the aging and<br />
function as the PCR enhancer to improve the yield of<br />
target production (Furusho et al., 2005; Kanapathipillai et<br />
al., 2005). It would have a significantly applicable value in<br />
the field of bio-industry, medical therapy, and cosmetic<br />
ingredients, etc. Therefore, the synthesis pathway of<br />
hydroxyectoine and its physiological role in microorganisms<br />
were interesting to researchers. Studies have<br />
suggested that the biosynthesis of hydroxyectoine as
thermo-protectant has been proved to parallel with high<br />
environmental temperature (García-Estepa et al., 2006;<br />
Prabhu et al., 2004). The biosynthetic pathway of hydroxyectoine<br />
was directly converted via ectoine hydroxylase<br />
from ectoine in halophilic or halotolerant bacteria and<br />
induced by osmotic stress of high salinity, and ectoine<br />
hydroxylase has been found in strains Streptomyces<br />
chrysomallus, Streptomyces coelicolor and<br />
Chromohalobacter salexigens (Bursy et al., 2008; García-<br />
Estepa et al., 2006; Prabhu et al., 2004). Further study<br />
revealed that the ectoine hydroxylase is a member of the<br />
non-heme-containing iron (II) and 2-oxoglutaratedependent<br />
dioxygenase superfamily, and its in vitro<br />
activity depends on iron (II), molecular oxygen, and 2oxoglutarate<br />
(Bursy et al., 2008; Reuter et al., 2010). The<br />
chemical synthesis of hydroxyectoine, however, is still<br />
difficult at present. Therefore, the production of hydroxyectoine<br />
by microorganisms is currently a simple and<br />
meaningful method. To produce hydroxyectoine using<br />
halophilic bacteria, the fed-batch and milking method has<br />
been developed and the effective factors for the<br />
synthesis of hydroxyectoine in the production process<br />
were studied. For example, the carbon source xylose can<br />
significantly improve the conversion of ectoine to<br />
hydroxyectoine in recombinant E. coli BL21, which<br />
carries ectoine hydroxylase gene (thpD) (Nagata et al.,<br />
2008b).<br />
Moderately halophilic bacterium, Halomonas ventosae<br />
DL7, which has been isolated from Dalian saltern, China,<br />
displays the ability to synthesize a large amount of<br />
ectoine as well as minor hydroxyectoine under hyperosmolality<br />
(Zhu et al., 2007). And the synthesized amount<br />
of hydroxyectoine significantly increased in strain DL7<br />
when subjected to heat stimulation (Zhu et al., 2008b).<br />
Strain DL7 as an excellent ectoine or hydroxyectoine<br />
producer has a potential application value for producing<br />
ectoines in factory on a larger scale. But there is still<br />
unclear for the effect factor of hydroxyectoine synthesize<br />
and activity of ectoine hydroxylase in DL7. Therefore, to<br />
elucidate the role and synthesis characteristics of<br />
hydroxyectoine in DL7 is an interesting work.<br />
The goal of this study was to investigate the effects of<br />
hydroxyectoine and ectoine on the growth of strain DL7<br />
when subjected to high salinity and temperature environments.<br />
And the in vitro activity of ectoine hydroxylase<br />
with the fluctuant salinity and temperature were<br />
determined. We also evaluated hydroxyectoine as a vital<br />
protectant for strain DL7 cells to defend off the<br />
environmental thermo-stress.<br />
MATERIALS AND METHODS<br />
Bacteria and growth media<br />
H. ventosae DL7 was aerobically grown in a nutrient medium (g/l):<br />
Bacto peptone (Difco Laboratories, Detroit, MI, USA), 5.0 and Bacto<br />
yeast extract (Difco), 3.0. Glucose mineral medium (MM63) was<br />
also used in this study: 100 mM KH2PO4, 75 mM KOH, 15 mM<br />
Zhu et al. 2255<br />
(NH4)2SO4, 1 mM MgSO4, 3.9 µM FeSO4, and 20 mM glucose as<br />
carbon source. NaCl was added as described in the text and pH<br />
was adjusted to 7.2 with NaOH.<br />
PCR amplification and gene analysis<br />
To isolate the gene encoding ectoine hydroxylase of H. ventosae<br />
DL7, we designed degeneration of oligonucleotides for PCR. Based<br />
on the ectD conservation regions from Virgibacillus salexigens<br />
(AY935522) and Chromohalobacter salexigens (AM231629), the<br />
universal degenerate primers (5’-GAMAGCMAKGASATCCGKT-3’<br />
and 5’-GARCCATGCAKYGTRTT-3’) were employed. Genomic<br />
DNA of H. ventosae DL7 and C. salexigens DSM 3043T were<br />
isolated using Genomic DNA Purification Kit (Promega, Madison,<br />
WI, USA) according to the manufacturer’s protocol. PCR was<br />
performed under the following condition: 5 min at 94°C, 30 cycles of<br />
30 s at 94°C plus 1 min at 55°C plus 30 s at 72°C, and finally 5 min<br />
at 72°C. Electrophoresis was performed on 1% (w/v) agarose gel in<br />
TAE buffer at 100 V for 30 min. The PCR product on the gel was<br />
extracted by using a PCR Purification Kit (QIAGEN, Hilden,<br />
Germany), cloned into the pGEM-T Vector System (Promega), and<br />
sequenced using an ABI PRISMA 377 sequencer. The nucleotide<br />
sequence of the PCR product has been deposited in the GSDB,<br />
DDBJ, EMBL, and NCBI databases (Accession No. EU732521).<br />
Enzyme assay and the conversion of ectoine to<br />
hydroxyectoine<br />
Ectoine hydroxylase activity in the extracts of DL7 cells were<br />
assayed as described before (Bursy et al., 2007), 70 µl protein<br />
fractions were suspended in 100 µl reaction mixture that contained<br />
10 mM TES buffer, pH 7.5, 10 mM 2-oxoglutarate, 5 mM ectoine, 1<br />
mM FeSO4 . 7H2O, 1.3 kilo units beef liver catalase (Roche,<br />
Germany). The reaction mixture was incubated at 30 or 42°C for 20<br />
min and stopped by adding 100 µl acetonitrile. Supernatant was<br />
analyzed by HPLC. One unit of ectoine hydroxylase activity is<br />
defined as the conversion of 1 µM of ectoine to 1 µM of<br />
hydroxyectoine per min.<br />
Release of hydroxyectoine and ectoine by downshock<br />
H. ventosae DL7 was aerobically grown in the nutrient medium<br />
containing 3 M NaCl until stationary phase of growth and harvested.<br />
The pellets were washed once by KPi buffer with the same NaCl<br />
concentration as that of corresponding nutrient medium, and then<br />
resuspended in deionized water or 2% NaCl solution. The cells<br />
were incubated for 10-120 min at 30°C. After centrifugation the<br />
supernatant fractions were analyzed by HPLC. Release rate of<br />
hydroxyectoine and ectoine from the cells were calculated as<br />
described previously (Nagata et al., 2008a).<br />
Extraction and determination of compatible solutes<br />
Cells were aerobically grown in the nutrient medium containing 1-3<br />
M NaCl at 30 or 42°C. Cells were harvested by centrifuging<br />
(10,000×g, 4°C, 10 min), and then the pellets were washed once<br />
with 50 mM potassium phosphate (KPi) buffer (pH 7.2) containing<br />
the same concentration of NaCl corresponding to growth medium.<br />
Extraction of intracellular compatible solutes was carried out as<br />
described previously (Zhu et al., 2008a). Fraction of 80% (v/v)<br />
ethanol extraction as well as supernatant after osmotic downshock<br />
analyzed and quantified by HPLC system (L-5020, Hitachi, Tokyo,<br />
Japan) with a Bio-Sil C8 90-5S reversed phase column (Bio-Rad
2256 Afr. J. Microbiol. Res.<br />
Growth (OD600)<br />
3.5<br />
3<br />
2.5<br />
2<br />
1.5<br />
1<br />
0.5<br />
Laboratories, Hercules, CA, USA) as described previously (Nagata<br />
et al., 2006; Zhu et al., 2010). Five microliters of samples were<br />
eluted with 50 mM KPi buffer at pH 6.0 with a flow rate of 1 ml/min<br />
at 35°C and detected by UV absorbance at 210 nm. Concentrations<br />
of ectoine and hydroxyectoine were expressed as milligram per<br />
gram CDW.<br />
RESULTS AND DISCUSSION<br />
Effect of temperature on the growth of H. ventosae<br />
DL7<br />
The influence of temperature on the cells growth of strain<br />
DL7 was examined using the nutrient medium containing<br />
3 M NaCl at 30-42°C. Results showed that the growth of<br />
cells was severely inhibited with the increasing of<br />
incubation temperature, and reached stationary phase at<br />
36 h of incubation at 30°C, which prolonged to 57 and 66<br />
h with the incubation temperature of 37 and 42°C,<br />
respectively. Optical density (OD600) was significantly<br />
reduced from 3.3 at 30°C to 2.8 at 37°C and 2.1 at 42°C,<br />
respectively (Figure 1). In our previous report, the amount<br />
of hydroxyectoine synthesized was very low comparing<br />
with ectoine when cells grown at 30°C and the<br />
concentration of hydroxyectoine in the cells remarkably<br />
increased with the increase of temperature and reached<br />
the maximum of 36.6 mg/g CDW at 42°C, (Zhu et al.,<br />
0<br />
A<br />
0 10 20 30 40 50 60 70 80<br />
Incubation Time time (h) (h)<br />
Figure 1. The growth of strain DL7 cells at different incubation<br />
temperatures. Strain DL7 was pre-incubated in a nutrient medium<br />
containing 3 M NaCl for 18 h at 30°C and then separately incubated<br />
at 30°C (cycles), 37°C (diamonds), or 42°C (triangles). Values are<br />
the averages ± SD from three independent experiments.<br />
2008a). It suggests that the synthesis of hydroxyectoine<br />
was a strategy of strain DL7 cells to defend off the<br />
environmental thermo-stress.<br />
Ectoine hydroxylase in H. ventosae DL7<br />
Ectoine hydroxylase catalyzing the conversion of ectoine<br />
into hydroxyectoine had been proved in several halophilic<br />
bacteria (Bursy et al., 2007; García-Estepa et al., 2006;<br />
Nagata et al., 2008a). The PCR strategy was carrying out<br />
to clarify whether this hydroxylase was present in strain<br />
DL7, and we assumed that a homologous hydroxylase<br />
gene to those of C. salexigens and V. salexigens was<br />
existed in this strain to design a pair of degenerated<br />
primers for PCR amplification, and a 480-bp gene<br />
fragment was obtained and subsequently sequenced<br />
(EU732521), the amino acid sequence deduced from the<br />
DNA sequence of this fragment showed 54.8% identity<br />
with the ectoine hydroxylases from C. salexigens and V.<br />
salexigens (Figure 2). These data confirmed the presence<br />
of hydroxylase in H. ventosae DL7, by which the<br />
conversion of ectoine should be the important pathway<br />
for the synthesis of hydroxyectoine. To prove this opinion,<br />
the activity of ectoine hydroxylase of strain DL7 was<br />
determined.<br />
To investigate the activity of ectoine hydroxylase under
Zhu et al. 2257<br />
Figure 2. Alignment of the sequences of reading frame ectD (EU732521) of H. ventosae DL7 with the sequences of the ectoine<br />
hydroxylases of V. salexigens (AY935522) and C. salexigens (AM231629). Identical positions and conservative fragments are shown<br />
against a dark and gray background, respectively.<br />
Table 1. Ectoine hydroxylase activity (cell free extract) from DL7*<br />
Reaction temperature (°C) NaCl (M) Activity (Unit) Protein (mg)**<br />
30 0 43.7 916.5<br />
42 0 29.5 920.3<br />
30 1 42.1 918.4<br />
*Cell free extract was prepared from 20 g cell pellets grown in 3 M NaCl at 30°C.<br />
** Protein (mg): the protein content of 70 µl protein fractions extract from DL7 cells.<br />
the heat or salt stress, we assayed the cell-free extracts<br />
from strain DL7 cells in vitro at 30 or 42°C, without or with<br />
1 M NaCl. Results showed that the activity of hydroxylase<br />
was reduced from 43.7 to 29.5 U, when the temperature<br />
was increased from 30 to 42°C (Table 1). However, the<br />
activity was stable with the fluctuation of NaCl concentration<br />
(0-1 M) at 30°C. It revealed that the conversion of<br />
ectoine to hydroxyectoine was inhibited by the higher<br />
incubation temperature. On the other hand, the activity of<br />
hydroxylase had no obviously fluctuation with or without<br />
salt. In addition, similar result has also been found in our<br />
previous research, i.e., the in vivo activity of hydroxylase<br />
was inhibited by high temperature, and hydroxyectoine<br />
showed similar conversion rate in the presence of<br />
different NaCl concentrations (0.5-1 M) (Zhu et al.,<br />
2008a). Therefore, these in vivo and in vitro data<br />
supported our suggestion that the hydroxylase activity<br />
was sensitive to temperature but was not disturbed by<br />
salinity.<br />
Based on these data, we could deduce that the<br />
increased amount of hydroxyectoine synthesized<br />
following the enhancing of thermo-stress might be that<br />
the heat stimulated the cells to produce more amount of<br />
ectoine hydroxylase instead of induction of the increasing<br />
of the enzyme activity. Further, to detect whether there is<br />
a high temperature intermediated operon to trigger the<br />
synthesis of hydroxylase in DL7 is an interesting work in<br />
future.<br />
Release of hydroxyectoine and ectoine by osmotic<br />
downshock<br />
To investigate the role of hydroxyectoine and ectoine for
2258 Afr. J. Microbiol. Res.<br />
Release rate (%)<br />
96<br />
92<br />
88<br />
84<br />
80<br />
10 20 40 60 120<br />
Time (min)<br />
Figure 3. Releases of hydroxyectoine and ectoine by H. ventosae DL7 subjected to<br />
osmotic downshock. Downshock procedures were handled in deionized water to<br />
release ectoine (white bars) and hydroxyectoine (hatched bars), or in 2% NaCl to<br />
release ectoine (black bars) and hydroxyectoine (macula bars) during 10-120 min<br />
incubation. Values are the averages ± SD from three independent experiments.<br />
strain DL7 in response to the salt or heat stress, it is<br />
necessary to use the “clearing cells”, which have no<br />
intracellularly compatible solutes. Therefore, the release<br />
of compatible solutes from cells and at the same time to<br />
keep alive of cells was concerned for preparation of the<br />
compatible solutes free cells. When halophilic bacteria<br />
are confronted with a rapid osmotic downshock, most of<br />
the small components in the cytoplasm were released<br />
into the environments (Frings et al., 1995; Nagata et al.,<br />
1996; 1998; Sauer et al., 1998). In this consideration, we<br />
tried to examine the release rates of hydroxyectoine and<br />
ectoine following a shift in medium osmolarity, that is,<br />
cells were suspended in 2% (0.34 M) NaCl or deionized<br />
water from 3 M NaCl medium. When the strain was<br />
downshocked in deionized water, both intracellular<br />
ectoine and hydroxyectoine were rapidly released to<br />
environment. During less than 10 min of downshock<br />
treatment, 90.8 and 89.9% of release rates were<br />
achieved for ectoine and hydroxyectoine, respectively<br />
(Figure 3). However, since strain DL7 is a moderately<br />
halophilic bacterium and a minimum concentration of Na +<br />
is essential for growth, the cells would burst by osmotic<br />
downshock from high salinity environment to deionized<br />
water and could not be recovered to use for further study.<br />
To remain the growth of cells after downshock, we tried<br />
to examine 2% NaCl solution instead of deionized<br />
water. As a consequence, the cells were kept intact after<br />
re-incubation in 2% NaCl solution for 1 h (data not<br />
shown). Release rates of ectoine and hydroxyectoine<br />
reached maximum at 60 min of treatment, and resulted in<br />
90.1 and 88.4%, respectively. The survival rates of cells<br />
treated by downshock (3 M NaCl to 2% NaCl and 2 M<br />
NaCl to 2% NaCl) were determined as 95.3 and 97.6%,<br />
respectively. It was suggested that the numbers of<br />
damaged cells were negligible for the present condition,<br />
and 2% NaCl solution was chosen to prepare the solutes<br />
free cells for the following study.<br />
Thermo- and osmo-protection of compatible solutes<br />
To gain insight into the role of hydroxyectoine and<br />
ectoine in strain DL7 when cells were subjected to<br />
thermo-stress, we tried to examine the behavior of strain<br />
DL7 under high temperature and salinity in the presence<br />
or absence of compatible solutes. Cells were osmotic<br />
downshock treated by 2% NaCl solution to avoid the<br />
interference of intracellular solutes, and pellets were then<br />
resuspended in MM63 medium containing 1-2.7 M NaCl<br />
without or with 1 mM each of ectoine or hydroxyectoine at<br />
30 or 42°C. We obviously observed that the presences of<br />
hydroxyectoine and ectoine significantly promoted the
Growth (OD600)<br />
3.5<br />
3<br />
2.5<br />
2<br />
1.5<br />
1<br />
A<br />
A<br />
0 10 20 30 40 50 60 70<br />
Time (h)<br />
Growth (OD600)<br />
2.5<br />
2.25<br />
2<br />
1.75<br />
1.5<br />
1.25<br />
1<br />
B<br />
B<br />
0 12 24 36 48 60 72<br />
Incubation Time (h) time (h)<br />
Figure 4. Supplement effects of hydroxyectoine and ectoine on the growth of H. ventosae DL7 under high<br />
temperatures or high salinities. A. Cells were grown in MM63 medium containing 1 M NaCl at 42°C (open symbols)<br />
or 30°C (closed symbols) without (triangles), with 1 mM ectoine (circles) or 1 mM hydroxyectoine (squares). B.<br />
Cells were grown in MM63 medium containing 2 M (open symbols) or 2.7 M NaCl (closed symbols) at 30°C with 1<br />
mM ectoine (circles) and 1 mM hydroxyectoine (squares). Values are the averages ± SD from three independent<br />
experiments.<br />
Table 2. The accumulation of ectoine and hydroxyectoine by downshocked cells of H. ventosae DL7*<br />
Compatible solutes NaCl (M)<br />
Ectoine<br />
Hydroxyectoine<br />
Concentrations (µM /g CDW)<br />
Incubation time (h)<br />
1 3 5 10<br />
1 241±14.8 245±10.6 253±3.5 258±7.8<br />
2 327±10.6 368±12.7 395±5.6 411±4.2<br />
1 234±12.7 244±2.8 241±7.1 244±10.6<br />
2 304±9.1 355±4.2 369±5.7 390±4.9<br />
*Downshock treatment was performed according to the method described in Materials and Methods. The<br />
downshocked cells were incubated in MM63 medium at 42°C with 1 mM each ectoine or hydroxyectoine. The values<br />
are the means ± SD from three independent experiments.<br />
growth of cells at 42°C from the growth curve, and the<br />
optical density of hydroxyectoine showed 1.5 times<br />
higher than ectoine after 24 h of incubation (Figure 4A).<br />
However, there was no obviously difference between the<br />
growth of DL7 in presence of hydroxyectoine and ectoine<br />
at 30°C. In addition, the downshocked compatible solutes<br />
free DL7 cells to accumulate hydroxyectoine and ectoine<br />
reached almost same level with 1 M or 2 M NaCl<br />
concentrations (Table 2). It suggests that the presence of<br />
hydroxyectoine result in the growth of cells higher than<br />
ectoine were not induced by different concentrations of<br />
hydroxyectoine and ectoine accumulated in cells. The<br />
above data elucidated that hydroxyectoine protected DL7<br />
Zhu et al. 2259<br />
cells more effectively than ectoine at 42°C.<br />
To investigate the protection functions of hydroxyectoine<br />
and ectoine on H. ventosae DL7 to defend off<br />
high salinity, the compatible solutes free cells were<br />
incubated in MM63 medium containing 2 or 2.7 M NaCl in<br />
presence of 1 mM each of hydroxyectoine or ectoine and<br />
the growth was detected. Results verified that the<br />
supplementation of ectoine or hydroxyectoine conferred a<br />
similar cell growth both in presence of 2 and 2.7 M NaCl<br />
(Figure 4B), that is, ectoine and hydroxyectoine have<br />
similar protection effect for cells grown under high salinity<br />
environment.<br />
It was understood that the accumulation of compatible
2260 Afr. J. Microbiol. Res.<br />
solutes was osmo-adapted by environmental stresses for<br />
halophilic bacteria. In this study, we described the<br />
synthesis of hydroxyectoine and activity of hydroxylase in<br />
strain DL7, showed that thermo-stress stimulated the<br />
yield of hydroxyectoine but inhibited the activity of<br />
hydroxylase. We also noticed the hydroxylase express<br />
system might be induced by thermo-stress instead of<br />
osmotic-stress. The study for charactering the<br />
hydroxylase in structure and exploring its molecular<br />
mechanism are interesting work in the near future.<br />
ACKNOWLEDGEMENT<br />
This work was supported by a grant (Code:<br />
9451007002003073) from the Natural Science<br />
Foundation of Guangdong Province, China, and by the<br />
Project Startup Fundation for Distinguished Scholars of<br />
Jiangsu University (Code: 10JDG084).<br />
REFERENCES<br />
Bursy J, Pierik AJ, Pica N, Bremer E (2007). Osmotically induced<br />
synthesis of compatible solute hydroxyectoine is mediated by an<br />
evolutionarily conserved ectoine hydroxylase. J. Biol. Chem., 282:<br />
31147-31155.<br />
Bursy J, Kuhlmann AU, Pittelkow M, Hartmann H, Jebbar M, Pierik AJ,<br />
Bremer E (2008). Synthesis and uptake of the compatible solute<br />
ectoine and 5-hydroxyectoine by Streptomyces coelicolor A3(2) in<br />
response to salt and heat stresses. Appl. Environ. Microbiol., 74:<br />
7286-7296.<br />
Frings E, Sauer T, Galinski EA (1995). Production of hydroxyectoine:<br />
high cell-density cultivation and osmotic downshock of Marinococcus<br />
strain M52. J. Biotechnol., 61: 117-158.<br />
Furusho K, Yoshizawa T, Shoji S (2005). Ectoine alters subcellular<br />
localization of inclusions and reduces apoptotic cell death induced by<br />
the truncated Machado-Joseph disease gene product with an<br />
expanded polyglutamine stretch. Neurobiol. Dis., 20: 170-178.<br />
García-Estepa R, Argandoña M, Reina-Bueno M, Capote N, Iglesias-<br />
Guerra F, Nieto JJ, Vargas C (2006). The ectD gene, which is<br />
involved in the synthesis of the compatible solute hydroxyectoine, is<br />
essential for thermoprotection of the halophilic bacterium<br />
Chromohalobacter salexigens. J. Bacteriol., 188: 3774-3784.<br />
Graf R, Anzali S, Buenger J, Pfluecker F, Driller H (2008). The<br />
multifunctional role of ectoine as a natural cell protectant. Clin.<br />
Dermatol., 26: 326-333.<br />
Kanapathipillai M, Lentzen G, Sierks M, Park CB (2005). Ectoine and<br />
hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer’s -<br />
amyloid. FEBS Lett., 579: 4775-4780.<br />
Kunte HJ (2006). Osmoregulation in bacteria: compatible solute<br />
accumulation and osmosensing. Environ. Chem., 3: 94-99.<br />
Lippert K, Galinski EA (1992). Enzyme stabilization by ectoine-type<br />
compatible solutes: protection against heating, freezing and drying.<br />
Appl. Microbiol. Biotechnol., 37: 61-65.<br />
Louis P, Truper HG, Galinski EA (1994). Survival of Escherichia coli<br />
during drying and storage in the presence of compatible solutes.<br />
Appl. Microbiol. Biotechnol., 41: 684-688.<br />
Nagata S, Adachi K, Sano H (1996). NMR analyses of compatible<br />
solutes in a halotolerant Brevibacterium sp. Microbiology., 142: 3355-<br />
3362.<br />
Nagata S, Adachi K, Sano H (1998). Intracellular changes in ions and<br />
organic solutes in halotolerant Brevibacterium sp. strain JCM 6894<br />
after exposure to hyperosmotic shock. Appl. Environ. Microbiol., 64:<br />
3641-3647.<br />
Nagata S, Wang C (2006). Effect of duration of osmotic downshock and<br />
coexisting glutamate on survival and uptake of ectoine in halotolerant<br />
Brevibacterium sp. JCM 6894. J. Biosci. Bioeng., 91: 288-293.<br />
Nagata S, Wang Y, Oshima A, Zhang L, Miyake H, Sasaki H, Ishida A.<br />
(2008a). Efficient cyclic system to yield ectoine using Brevibacterium<br />
sp. JCM 6894 subjected to osmotic downshock. J. Biotechnol.<br />
Bioeng., 99: 941-948.<br />
Nagata S, Zhu D, Cui S, Sasaki H (2008b). Yield of compatible solute<br />
hydroxyectoine through direct synthesis and conversion from ectoine.<br />
In: Schafer HA, Wohlbier LM (eds) Biamino Amino Acid Research.<br />
New York, Nova Science Publishers, pp. 139-153.<br />
Prabhu J, Schauwecker F, Grammel N, Keller U, Bernhard M (2004).<br />
Functional expression of the ectoine hydroxylase gene (thpD) from<br />
Streptomyces chrysomallus in Halomonas elongata. Appl. Environ.<br />
Microbiol., 70: 3130-3132.<br />
Reuter K, Pittelkow M, Bursy J, Heine A, Craan T, Bremer E (2010).<br />
Synthesis of 5-Hydroxyectoine from Ectoine: Crystal Structure of the<br />
Non-Heme Iron(II) and 2-Oxoglutarate-Dependent Dioxygenase<br />
EctD. PLoS One., 5: e10647.<br />
Roberts MF (2005). Organic compatible solutes of halotolerant and<br />
halophilic microorganisms. Saline Syst., 1: 5.<br />
Sauer T, Galinski EA (1998). Bacterial milking: A novel bioprocess for<br />
production of compatible solutes. Biotechnol. Bioeng., 57: 306-313.<br />
Zhu D, Niu L, Wang C, Nagata S (2007). Isolation and characterisation<br />
of moderately halophilic bacterium Halomonas ventosae DL7<br />
synthesizing ectoine as compatible solute. Ann. Microbiol., 57: 401-<br />
406.<br />
Zhu D, Osman O, Nagata S (2008a). Physiological role of compatible<br />
solute hydroxyectoine, synthesized in the halophilic Halomonas<br />
ventosae DL7. Proceedings in OCEANS'08 MTS/IEEE.4530985, pp.<br />
1-3.<br />
Zhu D, Cui S, Nagata S (2008b). Isolation and characterization of saltsensitive<br />
mutants of the moderately halophilic bacterium Salinivibrio<br />
costicola subsp. yaniae. Biosci. Biotechnol. Biochem., 72: 1977-1982.<br />
Zhu D, Zhang W, Nagata S (2010). Accumulation and role of compatible<br />
solutes in bacterium Salinivibrio costicola subsp. yaniae with fast<br />
growth rate. Can. J. Microbiol., 56: 1020-1027.
African Journal of Microbiology Research Vol. 5(16), pp. 2261-2265, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.585<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Virulence and characteristics of a new<br />
nucleopolyhedrovirus strain of Dendrolimus kikuchii<br />
(Lepidoptera: Lasiocampidae)<br />
Miao Miao Yang 1,2,6, Meng Lou Li 1 , Yu Zhu Wang 2 , Liang Jian Qu 2 , Ke Yue Huai 3 ,<br />
Xue Wen Nie 4 , Lu Qin Qiao 5 , Jin Ying Ding 6 and Yong An Zhang 2 *<br />
1 Forestry Entomology Laboratory of <strong>Academic</strong> Forestry, Northwest Agriculture and Forest University,<br />
Yangling 712100 China.<br />
2 The Key Laboratory of Forest Protection, State Forestry Administration of China, Research Institute of Forest Ecology,<br />
Environment and Protection, Chinese Academy of Forestry, Beijing 100091 China.<br />
3 Forestry Research Institute of Yunnan, Yunnan 650000 China.<br />
4 Forest Protection Station Mile County of Yunnan, Yunnan 652300 China.<br />
5 College of Plant Protection, Shandong Agricultural University, Tai’an 271018 China.<br />
6 Ningxia agricultural school, Yinchuan 750000 China.<br />
Accepted 30 June, 2011<br />
In present study, a nucleopolyhedrovirus was isolated from the infected larvae of Dendrolimus kikuchii,<br />
which is a serious pest for a variety of conifers in China. Ultrastructural observation revealed that this<br />
virus is a multiple-nucleocapsid nucleopolyhedrovirus (MNPV), which was encapsulated within the<br />
envelope of each virion. Based on the morphological characteristics, it was identified as a new virus<br />
and named as DkNPV. It exhibited high potential as a biocontrol agent to protect the forest because of<br />
the high virulence against the third-instar larvae of D. kikuchii. The virus passage in the host after 4<br />
generations, toxicity and ultrastructural morphology were stable.<br />
Key words: Dendrolimus kikuchii, multiple-nucleocapsid nucleopolyhedrovirus, Dendrolimus Kikuchii<br />
Matsumura nuclear polyhedrosis virus (DkNPV), virulence, ultrastructure, biological control.<br />
INTRODUCTION<br />
Dendrolimus kikuchii (Matsumura) (Lepidoptera:<br />
Lasiocampidae), is a serious pest for a variety of<br />
conifers, including Pinus kesiya, Pinus yunnanensis,<br />
Pinus massoniana, Pinus armandi, Pinus fenzeliana,<br />
Cedrus deodara and Keteleeria evelyniana (Figure 1a).<br />
In China, D. kikuchii mainly occurs in the south part and<br />
chemical pesticides were primarily used as the first<br />
control method (Chen, 1990). However, chemical insecticides<br />
may poison the non-target organisms (e.g.,<br />
humans, livestock and natural enemy), pollute<br />
environment, and induce insecticide-resistant pests.<br />
*Corresponding author. zhangyab@caf.ac.cn. Tel: +86-<br />
1062889520. Fax: +86-10 62884972.<br />
These problems proved that the application of chemical<br />
insecticides to be less than an ideal method to controll D.<br />
kikuchii (Yasuhisa, 2007).<br />
The insect virus is one kind of pathogenic<br />
microorganism in nature and may influence the quantity<br />
of insect population by causing the epidemic disease of<br />
insect. It has high host specificity, so that it is safe to<br />
other non-target species and can maintain dynamic<br />
balance of insect population for a long term by horizontally<br />
and vertically spreading epidemic disease in the<br />
pest population (Fuxa, 1989; Laird et al., 1990; Heinz et<br />
al., 1995). Moreover, it causes no environmental<br />
pollution. Therefore, it is realized that the use of virus to<br />
control pest insects is an ideal and sustainable means. In<br />
1986, a nucleopolyhedrovirus of D. kikuchiii, named as<br />
Dendrolimus Kikuchii Matsumura Nuclear Polyhedrosis
2262 Afr. J. Microbiol. Res.<br />
Virus (DKMNPV), was isolated and its morphological<br />
characteristics and toxicity were described, however, D.<br />
kikuchii larvae were not sensitive to DKMNPV (Yang et<br />
al., 1986). Therefore, the screening of high toxicity and<br />
strong stability virus is an imperative work for the<br />
biological control of D. kikuchii. In present study, a<br />
nucleopolyhedrovirus was isolated from diseased D.<br />
kikuchii larvae in Mile county, Yunnan province, China.<br />
Based on its ultrastructural morphological characteristics<br />
and the virulence against the third-instar larvae of D.<br />
kikuchii, it was identified as a new virus and named as<br />
DkNPV (multiple-nucleocapsid nucleopolyhedrovirus of<br />
D. kikuchii). This virus exhibited high virulence against<br />
the third-instar larvae of D. kikuchii, and high potential as<br />
a biocontrol agent to protect the forest from these insects.<br />
MATERIALS AND METHODS<br />
Virus isolation and purification from D. kikuchii<br />
Diseased D. kikuchii larvae were collected from P. yunnanensis<br />
forest in Mile, Yunnan Province, China, and kept frozen at -20°C<br />
until use. Virus occlusion bodies (OBs) were isolated and purified<br />
from the larval cadavers according to the method developed by EI-<br />
Salamouny (1998). Briefly, 200 g larvae cadavers were<br />
homogenized in 500 ml distilled water and filtered through five<br />
layers of muslin. The filtrate was subjected to centrifugation<br />
alternated between low and high speed several times until the clear<br />
off-white OBs were obtained. For further purification, the obtained<br />
OBs were centrifuged through sucrose gradient of 40-60% (w/w) at<br />
10,000 g for 30 min at room temperature. The bands containing<br />
virus were collected, washed with sterile water, and then<br />
centrifuged at 12,000 g for 30 min at 4°C with three replications.<br />
The pellets of purified OBs were stored at 4°C for the next study.<br />
Ultrastructural studies of virus isolated from D. kikuchii<br />
As to scanning electron microscopy (SEM), the following method<br />
was used. Firstly, pellets of purified virus were diluted in distilled<br />
water and the concentration of virus was adjusted to 10 9 PIB·ml -1<br />
(polyhedral inclusion bodies/ ml -1 ). Secondly, 20-30 l of viral<br />
suspensions were mounted on a clear coverslip and dried naturally<br />
in the ventilate place. After that, the coverslip was placed on an<br />
aluminous specimen stub and coated with gold. Finally, the<br />
specimen was observed by using a scanning electron microscope<br />
(Hitachi 3400N, Japan). One hundred OBs were measured to<br />
determine their mean size.<br />
The transmission electron microscopy (TEM) was carried out<br />
according to the method described by Luft (1961). Briefly, pellets of<br />
purified OBs were fixed directly in 2.5% glutaraldehyde for 2.5 h,<br />
dehydrated in a graded ethanol series (30, 50, 70, 80, 90, 100%),<br />
and then embedded in Epon-Araldite resin. Ultrathin sections were<br />
cut with ultractome, slice sizes range from 50 - 60 nm, double<br />
strained with uranyl acetate and lead citrate, and then examined<br />
with a transmission electron microscope (Hitachi JEM-1230,<br />
Japan).<br />
Preparation of D. kikuchii larvae<br />
Larvae of D. kikuchii were reared from surface-sterilized eggs.<br />
Briefly, the pupae of D. kikuchii were collected from the P.<br />
yunnanensis forest and kept in the clear cages (30 × 30 × 40 cm) in<br />
the laboratory. Once emergence, adults were provided with 50 gl -1<br />
sugar solution as food source and some fresh shoots of P. armandi<br />
as an oviposition substrate. Eggs were collected and sterilized with<br />
10% methanal for 0.5 h. After hatch, larvae were group reared on<br />
fresh needles of the P. armandi within the clear plastic jars (15 × 15<br />
× 20 cm) with some holes in the bottom until the third-instars. The<br />
above experiments were carried out at 20°C, 50-65% relative<br />
humidity and a 18:6 h (day : night) photoperiod (Guo et al., 2007).<br />
Infection studies of isolated virus against the D. kikuchii larvae<br />
The infection activity of isolated virus was tested against the thirdinstars<br />
larvae of D. kikuchii by following the method developed for<br />
Cydia pomonella granulovirus (Huber, 1981). The pellets of purified<br />
virus were diluted in distilled water. Five virus suspensions at<br />
different concentrations (2.2×10 4 , 2.2×10 5 , 2.2×10 6 , 2.2×10 7 and<br />
2.2×10 8 PIB·ml -1 ) were prepared respectively and used for this<br />
infection study. For each concentration, fifty larvae were used and<br />
300 µl of viral suspensions were sprayed onto pine needles, which<br />
were used as food of D. kikuchii larvae and filled into a plastic jar<br />
(20 × 20 × 20 cm) with some holes in the bottom. The tested larvae<br />
were kept at 20°C, 50-65% relative humidity and a 18:6 h (light :<br />
night) photoperiod. As soon as the treated needles were eaten, the<br />
tested larvae were provided with fresh, untreated needles, and<br />
continuously reared in the plastic jar. Larvae with the typical<br />
symptoms of NPV infection such as a bloated body, hanging upside<br />
down from the branches and fragile cuticle were recorded as dying<br />
of virus infection. Mortality of larvae due to the infection of virus was<br />
recorded from the third day and up to the 13th day at a one day<br />
interval. Three repetitions were carried out and as control, pine<br />
needles were treated with distilled water exactly according to the<br />
above method.<br />
Stability studies of isolated virus in toxicity and ultrastructural<br />
morphology<br />
The virus has been propagated in the fourth-instars larvae of D.<br />
kikuchii, for 4 generations. Stability of ultrastructural morphological<br />
and the virulence of the virus were tested according to the above<br />
method.<br />
Statistical analysis<br />
The median lethal time (LT50), the median lethal concentration<br />
(LC50) and the toxicity regression equations of D. kikuchii virus were<br />
estimated by probit analysis software SPSS package 17.0 (Yu and<br />
He, 2003). Death rate and corrected mortality of insect larvae were<br />
calculated based on bioassays.<br />
RESULTS<br />
Ultrastructural characteristics of D. kikuchii virus<br />
The SEM results showed that OBs of D. kikuchii are<br />
mostly polyhedral shape, 0.79~2.31 (1.64 ± 0.1) µm<br />
[minimum~maximum (mean ±SE)] in diameter (n = 100),<br />
with a lots of small holes on their surface, 173.00~254.00<br />
nm × 55.10~116.00 nm in size (Figure 2a). Ultrathin<br />
sections revealed that each OB contains many virions,<br />
252.00~359.00 nm × 70.18~200.00 nm in size (Figure
Figure 1. (a) Image showing the conifers damaged by D. kikuchii larvae; (b) OBs in D. kikuchii larvae body fluids,<br />
and for image (b) the bar represents 20 µm.<br />
Figure 2. The ultrastucture characteristics of DkNPV. (a) Scanning electron micrograph of the DkNPV OBs; (b) The<br />
ultrastructural section of OBs showing the virions (V) inside it. Each virion contains multiple nucleocapsids (N); for images a<br />
and b the bar represents 5.00 µm and 500 nm respectively.<br />
2b). The virion is rod-shaped shaped with the truncated or obtuse<br />
ends, consists of multiple nucleocapsids (up to 9) within a<br />
single viral envelope (Figure 2b). b). The size of nucleo-<br />
capsid is approximately 25.80 ± 0.86 nm (mean ±SE) in<br />
width and 265.00 ± 12.66 nm in length (n = 50) (Figure<br />
2b).<br />
Yang et al. 2263<br />
Based on the ultrastructural observation, the<br />
morphological characteristics aracteristics and the virulence of the D.<br />
kikuchii virus was identified as a new virus in<br />
nucleopolyhedrovirus of Baculoviridae, and named as<br />
DkNPV according to the universal system of virus<br />
taxonomy in the 8th ICTV report (Hong, 2006).
2264 Afr. J. Microbiol. Res.<br />
Table 1. The virulence of DkNPV on 3 rd instars larvae of D. kikuchii.<br />
Concentration (PIB·mL -1 ) Regression equation Correlation coefficient LT50(d) LC50 (PIB·mL -1 )<br />
2.2×10 8 Y=10.457x+9.219 0.976 6.89 1.72×10 5<br />
2.2×10 7 Y=10.051x+8.156 0.986 7.18 —<br />
2.2×10 6 Y=8.633x+5.487 0.947 8.16 —<br />
2.2×10 5 Y=6.536x+2.237 0.980 10.31 —<br />
2.2×10 4 Y=6.039x+0.890 0.988 11.13 —<br />
Table 2. The difference between DkNPV and DKMNPV.<br />
Virus name OBs surface Both ends of rod-shape<br />
The size of nucleocapsids<br />
(nm)<br />
Diameter<br />
(µm)<br />
LC50<br />
(PIB·mL -1 )<br />
DkNPV Lots of small holes Truncate or obtuse ends 265.00 ± 12.66 × 25.80 ± 0.86 0.79~2.31 1.72×10 5<br />
DKMNPV The even surface Obtuse both ends only 410 ± 10 × 40 ± 3 1.3~3.0 1×10 5.9<br />
Infection studies of DkNPV against the D. kikuchii<br />
larvae<br />
The results of infection study showed that DkNPV could<br />
infect and kill the third-larvae of D. kikuchii (Table 1). LC50<br />
was 1.72 × 10 5 OBs·ml -1 . At the tested five concentrations<br />
(from 2.2 × 10 8 to 2.2 × 10 4 PIB·ml -1 ), LT50 were 6.89,<br />
7.18, 8.16, 10.31 and 11.13 days, respectively (Table 1).<br />
A large number of D. kikuchii larvae begin to die from the<br />
seven day of infection, and peak mortality from 7 to 10<br />
days. A large number of virus was found in D. kikuchii<br />
larvae with the typical symptoms of NPV infection by<br />
optical microscope (Figure 1b). Therefore, DkNPV is<br />
virulent to the third-instar larvae of D. kikuchii.<br />
Our research demonstrates that the virus has been<br />
propagated 4 generations and the fourth-instars larvae of<br />
D. kikuchii has stable ultrastructural morphological and<br />
virulence.<br />
DISCUSSION<br />
In present study, a nucleopolyhedrovirus was isolated<br />
from D. kikuchii. The main morphological characteristics<br />
of this virus is consistent with the NPVs. When it was<br />
compared with the reported D. kikuchii virus DKMNPV,<br />
several significant differences were observed between<br />
them (Table 2). It is interesting that lots of small holes<br />
were observed on the surface of DkNPV. Firstly, we<br />
thought they were caused by the process of sample<br />
preparation. Other four samples (HcNPV, BusuNPV,<br />
DnNPV and CzNPV) therefore were prepared exactly<br />
according to the same method. However, no holes were<br />
observed on their OBs surface. One difference lied in<br />
small holes on the surface of DkNPV and the even<br />
surface of DKMNPV. The second difference existed on<br />
the both ends of rod-shape virions. DkNPV had truncate<br />
or obtuse in both ends, but the DKMNPV had obtuse both<br />
ends only. The third difference was that the size of<br />
nucleocapsids of DkNPV was smaller than DKMNPV<br />
(265.00 ± 12.66 nm × 25.80 ± 0.86 nm of DkNPV, 410 ±<br />
10 nm × 40 ± 3 nm of DKMNPV). Besides, the diameter<br />
of OBs differed widely, the diameter of DKMNPV was<br />
1.3~3 µm, but the diameter of DkNPV was 0.79~2.31 µm.<br />
The shape and size of OBs, the size of nucleocapsids<br />
and the features of both ends of visions were the<br />
important basis for the identification of a baculoviruses<br />
(Xie and Hu, 2000). The fourth difference shows the<br />
DkNPV is more virulent than DKMNPV against the larvae<br />
of D. kikuchii. Based on the morphological characteristics,<br />
the virulence of this virus and the difference between<br />
DkNPV and DKMNPV, it was proposed as a new strain<br />
nuclepoyhedrovirus of D. kikuchii and named as DkNPV.<br />
In the next step, the structure of its nucleic acid and<br />
biological characteristics will be further studied to confirm<br />
its identification. Dendrolimus cytoplasmic polyhedrosis<br />
virus (CPV) were used to biologically control the pest of<br />
Dendrolimus in China since the first DpCPV (D.<br />
punctatus Cytoplasmic Polyhedrosis virus) was isolated<br />
in China in 1973. However, as is well known the time<br />
required for CPVs to kill the insect larvae was longer than<br />
that for NPVs obviously. The new isolated DkNPV was<br />
virulent for the third-instar larvae of D. kikuchii and<br />
exhibited high infection activity (Table 1). Therefore, this<br />
virus was very precious for the biological control of D.<br />
kikuchii.<br />
ACKNOWLEDGMENTS<br />
We sincerely thank Yan-Li Duan and Jian-Jie Xue for<br />
assistance both in field research and virus propagation;<br />
Chun-Yan Wang for suggestions of revising the<br />
manuscript. This work was supported financially by<br />
National Natural Science Foundation of China (No.<br />
30671688), and Forestry Industry Special Foundation of
China (No. 200904029; No. 200704003).<br />
REFERENCES<br />
Chen CJ (1990). Integrated Management pine Caterpillars. Beijing,<br />
China Forestry Publishing House Press, pp. 201-210.<br />
EI-Salamouny S (1998). Increasing efficacy of nucleopolyhedroviruses<br />
and a comparative study of an Egyptian isolate. PhD dissertation,<br />
Faculty of Agriculture, Cairo University, Egypt, pp. 216-233.<br />
Fuxa JR (1989). Fate of released entomopathogens with reference to<br />
risk assessment of genetically engineered microorganisms, Bull.<br />
Entomol. Soc. Am., 35: 122-124.<br />
Guo HF, Fang JC, Liu BS, Wang JP, Zhong WF (2007). Enhancement<br />
of the biological activity of nucleopolyhedrovirus through disruption of<br />
the peritrophic matrix of insect larvae by chlorfluazuron. Pest<br />
Manage. Sci., 63: 68-74.<br />
Heinz KM, McCutchen BF, Herrmann R, Parrella MP, Hammock BD<br />
(1995). Direct effects of recombinant nuclear polyhedrosis viruses on<br />
selected non-target organisms. J. Econ. Entomol., 88: 259-246.<br />
Yang et al. 2265<br />
Hong J (2006). The Universal System of Virus Taxonomy in the 8th<br />
ICTV Report. Virol. Sin., 21(1): 84-96.<br />
Huber J (1981). Apfelwickler granulosevirus: production and Biotests.<br />
Mitt. Dtsch. Ges. Allg. Angew. Ent., 2: 141-145.<br />
Laird M, Lacey LA, Davidson EW (1990). Safety of Microbial<br />
Insecticides. Boca Raton. FL. USA, CRC Press, pp. 76-80.<br />
Luft JH (1961). Improvements in epoxy resin embedding methods. J.<br />
Biophys. Biochem. Cytol., 9: 409-414.<br />
Xie TE, Hu ZH (2000). General Virology. Beijing, Science Press. pp.<br />
119-120.<br />
Yang DZ, Wang YX, Li YQ (1986). Studies on the nuclear polyhedrosisvirus<br />
disease of simao pine caterpil-lcar infected by Dendrolimus<br />
kikuchii Matsumura (Lepidoptera: Lasiocampidae). J. Yunnan Univ.,<br />
1: 105-110.<br />
Yasuhisa K (2007). Current status and prospects on microbial control in<br />
Japan. J. Invertebr. Pathol., 95: 181–186.<br />
Yu JY, He XH (2003). Data statistical analysis and SPSS applications.<br />
Beijing, People's Post and Telecommunication Publishing House<br />
Press, pp. 178-182.
African Journal of Microbiology Research Vol. 5(16), pp. 2266-2272, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Characterization of Staphylococcus spp strains<br />
isolated from hospital, community and environmental in<br />
Puebla city, Mexico<br />
Ana Marta de los Ángeles Lobo-Sánchez 1 , Patricia Lozano-Zaraín 2 ,<br />
Ygnacio Martínez-Laguna 1,2 , Zita Gutiérrez-Cázarez 3 , Antonio Rivera-Tapia 2 , Carmen Torres 4<br />
and Rosa del Carmen Rocha-Gracia 1,2 *<br />
1 Posgrado en Ciencias Ambientales, Área de la Salud, Centro de Investigaciones en Ciencias Microbiológicas, Instituto<br />
de Ciencias, Benemérita Universidad Autónoma de Puebla. Complejo de Ciencias, edificio No. 103 J. Ciudad<br />
Universitaria, colonia San Manuel, Puebla 72570, México.<br />
2 Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de<br />
Puebla. Complejo de Ciencias, edificio No. 103 J. Ciudad Universitaria, colonia San Manuel, Puebla 72570, México.<br />
3 Hospital para el Niño Poblano, Blvd. del Niño Poblano No. 5207 Col. Concepción la Cruz, 72190 Puebla, Pue., México.<br />
4 Área Bioquímica y Biología Molecular, Universidad de la Rioja, Logroño, Spain.<br />
Accepted 30 July, 2011<br />
We investigated the prevalence of methicillin-resistant staphylococci (MRS) and evaluated the<br />
antimicrobial resistance patterns of 284 Staphylococcus strains isolated from two hospitals, as well as<br />
from community and the environment in Puebla City, Mexico. Isolates were identified by Gram-stain and<br />
biochemical reactions and antimicrobial susceptibility testing was performed by Kirby-Bauer and in<br />
some cases by determination of minimal inhibitory concentrations of antimicrobial agents. Result<br />
showed that from 284 strains studied, 32% (90 strains) were multidrug-resistant, of which 82% (74<br />
strains) were methicillin-resistant. From 154 Staphylococcus aureus isolates tested, 41 strains showed<br />
methicillin-resistance (27%) and 84 of 130 coagulase-negative staphylococci showed methicillinresistance<br />
(65%). The mecA gene was detected in 38 of 43 oxacillin-resistant staphylococci tested<br />
(14/14 S. aureus and 24/29 coagulase negative staphylococci). Nevertheless, this gene was also<br />
identified in 14 S. aureus that exhibited oxacillin and cefoxitin susceptibility. The percentages of<br />
resistance detected among S. aureus and coagulase negative staphylococcal isolates were: penicillin<br />
(79 and 67%, respectively), oxacillin (27 and 65%), erythromycin (18 and 36%), tetracycline (6 and 24%),<br />
gentamicin (71 and 45%), and trimethoprim sulfamethoxazole (19 and 37%). The �-lactamase production<br />
was positive in more than 80% of isolates. These results show the presence of multiresistant strains in<br />
these three sources, which supports the control measures taken by health authorities with respect to<br />
avoiding the misuse and abuse of antibiotics.<br />
Key words: Staphylococcus, methicillin resistance Staphylococcus aureus (MRSA), methicillin resistance<br />
coagulase-negative staphylococci (MRCoNS), emerging infections.<br />
INTRODUCTION<br />
In the 60's, Staphylococcus aureus was identified as the<br />
*Corresponding author. E-mail: rochagra@yahoo.com. Tel: 00<br />
(52) 2222295500 ext 2546.<br />
main cause of nosocomial infections in the world (Klimek<br />
et al., 1976; Crossley et al., 1979; Doebbeling, 1995). At<br />
present, the methicillin-resistant Staphylococcus (MRS)<br />
and multiresistant Staphylococcus are the leading cause<br />
of infections in hospitals and community (Schaberg et al.,<br />
1991; Ponce de León, 1996; Diekema et al., 2000; Wu et
al., 2006; Martins et al., 2007; David and Daum, 2010).<br />
Resistance to methicillin is due to the presence of<br />
Staphylococal Chromosomal Cassette mec (SCCmec)<br />
which in addition to carrying mecA gene that encodes a<br />
penicillin-binding protein (PBP2a) (Hartman and Tomasz,<br />
1984; De Lencastre et al., 1994; Pinho et al., 2001), also<br />
can contains genes of resistance for non-beta-lactam<br />
agents, causing multidrug resistant strains (Katayama et<br />
al., 2000; Hiramatsu et al., 2001).<br />
It is reported that S. aureus is the causal agent of more<br />
than 20% of bacteremias in USA, Canada and Latin<br />
America (Pfaller et al., 1998; 1999; Diekema et al., 2000;<br />
Wisplinghoff et al., 2003; Chen et al., 2010), skin<br />
infections and soft tissue (Gales et al., 2009; Doern et al.,<br />
1999) and pneumonia (Sader et al., 1998; Gales et al.,<br />
2009). Coagulase-negative staphylococci (CoNS) are the<br />
third most common type of isolates in bacteremias<br />
(Schaberg et al., 1991; Edmond et al., 1999; Diekema et<br />
al., 2001; Wisplinghoff et al., 2003; Chen et al., 2010,<br />
Rosa et al., 2009). In the environment, staphylococci are<br />
the most frequently isolated bacteria in both open and<br />
closed areas (Górny et al., 1999; Górny and Dutkiewicz,<br />
2002; Tsai and Macher, 2005; Eames et al., 2009; Tang,<br />
2009).<br />
The emergence of multidrug-resistant staphylococci,<br />
prompted a warning from the health centers and<br />
organizations, because epidemiological changes, clinical<br />
manifestations and their control can become a significant<br />
Public Health problem in both developed and developing<br />
countries. In Latin America, it was reported a prevalence<br />
of 40% of methicillin resistant Staphylococcus aureus<br />
(MRSA) and over 80% methicillin resistant coagulase<br />
negative Staphylococcus (MRCoNS) and most of these<br />
strains were multidrug resistant (Sader et al., 2009). The<br />
World Health Organization (WHO) has seen the<br />
emergence and spread of antimicrobial resistance as a<br />
priority issue and therefore since September 2001<br />
established a global measure for the containment of<br />
antimicrobial resistance, which includes as a fundamental<br />
measure the surveillance of antimicrobial resistance<br />
caused among other factors by self-medication (WHO,<br />
2002). In Mexico, a law was issued in which the<br />
guidelines to which the sale and dispensing of antibiotics<br />
as a preventive measure to misuse of these drugs would<br />
be subjected (Official Gazette, 2010).<br />
The aim of this study was to determine the methicillin<br />
resistance and other associated resistances of<br />
staphylococci strains isolated from two general hospitals,<br />
the community and the environment of the city of Puebla,<br />
Mexico.<br />
MATERIALS AND METHODS<br />
Bacterial isolates<br />
284 staphylococci were included in this study. One-hundred-andseventeen<br />
strains were obtained in two hospitals of Puebla, México<br />
(Pediatric Hospital in 2003; University Hospital of Puebla City in<br />
Lobo-Sánchez et al. 2267<br />
1998-2000) and they were collected from wound and articulation<br />
secretions, sepsis, pleural and cerebrospinal fluids, peritoneal<br />
dialysis fluids, catheter tips, post-mortem and throat swabs. Onehundred-and-twelve<br />
strains were obtained from community during<br />
2002-2003 and they were collected from outpatients with clinically<br />
reported staph infections (vulvar swabs, throat, skin and conjunctiva)<br />
as well as from hospital personnel and community carriers by<br />
means of throat swabs. By other side, 55 strains from the environment<br />
were collected in 2004, through the Gravity Sedimentation<br />
Technique (Frankland and Hart, 1887); specifically, blood agar and<br />
mannitol salt agar plates, were exposed for a period of approximately<br />
15 and 45 minutes respectively, at a height of between 1.5<br />
and 2.0 m (Lighthart and Shaffer, 1995; De la Rosa and Ullán,<br />
2002; Rosas et al., 2004). Staphylococcus strains were identified by<br />
standard methods, such as colonial morphology, Gram-stain,<br />
catalase, coagulase, clumping factor, urease, DNase, hemolysis on<br />
blood agar and bacitracin test (Finegold and Baron, 1996).<br />
Antimicrobial susceptibility test and �-lactamase production<br />
All obtained staphylococci were tested by Kirby-Bauer test (CLSI,<br />
2008) for susceptibility to the following antimicrobials oxacillin (OX,<br />
(1 �g/disk), penicillin (PE, 10 U), erythromycin (E, 15 �g),<br />
tetracycline (TE, 30 �g), gentamicin (GE, 10 �g), vancomycin (VA,<br />
30 �g) and trimethoprim sulfamethoxazole (SXT, 25 �g) (Sanofi<br />
Diagnostics Pasteur, SA, Mexico City, Mexico). Mueller-Hinton agar<br />
(Oxoid, Cambridge, England) supplemented with 4% NaCl was<br />
used in these assays. The susceptibility of cefoxitin (FOX, 30<br />
�g/disk) (Difco Laboratories, Detroit, MI, USA) was checked in a<br />
group of mecA-positive strains (n=14) that appeared as oxacillinsusceptible.<br />
Additionally, a minimum inhibitory concentration (MIC)<br />
test of oxacillin using the agar dilution method with Steers<br />
Replicator was performed for 90 staphylococci isolated from<br />
different origins (30 from each source). The results of disk diffusion<br />
tests and MICs were interpreted according to CLSI criteria (CLSI,<br />
2008).<br />
The �-lactamase production was performed by Cefinase disks<br />
(Becton Dickinson) according to manufacturer's instructions.<br />
mecA gene amplification by polymerase chain reaction (PCR)<br />
Specific PCR of the mecA gene was performed in 90 staphylococci<br />
from different origins that were also analyzed by MIC. Because the<br />
content of A + T in mecA gene is high (70%) and in order to<br />
minimize the amplification of DNA regions not related to the gene<br />
(Ubukata et al., 1990; Ryffel et al., 1990; Unal et al., 1992), we<br />
chose two sets of primers combined in two reactions, the sense<br />
primer P1, 5'-(911) GGTCCCATTAACTCTGAAG (929)-3' and<br />
antisense P3, 5'-(1956) AGTTCTGCAGTACCGGATTTGC (1935)-3'<br />
(Petinaki et al., 2001) and a pair designed in this study, MMecAF<br />
sense primer, 5'-(539) TCCAGAATGCAGAAAGACC (558)-3'and<br />
antisense MMecAR, 5'-(1076) TGTATGTGCGATTGTATTGCTATT<br />
(1053)-3', giving rise to PCR products of 1046 and 538 bp<br />
respectively.<br />
RESULTS<br />
From 284 isolates studied, 154 of them were identified as<br />
S. aureus (54%), isolated mostly from hospital and<br />
community sources and 130 isolates (46%) were CoNS,<br />
mainly obtained from environment and hospital sources.<br />
Methicillin-resistance in this study was firstly checked by<br />
the study of the susceptibility to oxacillin. Table 1 shows
2268 Afr. J. Microbiol. Res.<br />
Table 1. Species distribution and methicillin resistance (MR) in Staphylococcus strains from three sources analyzed.<br />
Origin<br />
(n isolates)<br />
Studied isolates<br />
a Methicillin-resistance<br />
OXA/FOX-susceptible<br />
mecA-positive S. aureus<br />
S. aureus CoSCN S. aureus (%) CoSCN (%)<br />
Hospital (117) 71 46 24 (34) 36 (78) 5<br />
Community (112) 80 32 17 (21) 15 (47) 6<br />
Environmental (55) 3 52 0 33 (63) 3<br />
Total: 284 154 (54%) 130 (46%) 41 (27) 84 (65) 14<br />
CoSCN: coagulase negative staphylococci; OXA: oxacillin; FOX: cefoxitin<br />
a Isolates included were those that presented oxacillin resistance (by Kirby Bauer or MIC).<br />
Figure 1. mecA gene detection by PCR, amplified in agarose gel and subjected to electrophoresis. A. P1F-P3R<br />
primers (Petinaki et al., 2001) to amplify 1046 bp. Line 1: Marker �X174; 2, 3-5, 7: mecA positive strains; 6: mecA<br />
negative strain and 8: ATCC 25923 (negative control). B. MmecAF-MmecAR primers to amplify 538 bp. Line 1: Marker<br />
�X174; 2, 3-8, 10 and 11: mecA positive strains; 9, 12 and 13: mecA negative strains and 14: ATCC 25923 (negative<br />
control).<br />
the percentage of methicillin resistance among our<br />
isolates using this criterium. Forty-one S. aureus isolates<br />
of the 154 tested showed methicillin-resistance (27%),<br />
and isolates of hospital origin showed higher percentage<br />
of resistance than those of the community (34 and 21%,<br />
respectively). On the other hand, 84 of 130 coagulasenegative<br />
staphylococci showed methicillin-resistance<br />
(65%) and percentages were higher among hospital and<br />
environmental isolates (78 and 63%, respectively) (Table<br />
1).<br />
The presence of mecA gene was analyzed in a group<br />
of 90 staphylococci that included isolates of the three<br />
sources and also isolates with different oxacillin susceptibilities<br />
(Figure 1). The mecA gene was detected in 38 of<br />
43 oxacillin-resistant staphylococci tested (14/14 S.<br />
aureus and 24/29 coagulase negative staphylococci, data<br />
not showed). Nevertheless, this gene was also identified<br />
in 14 S. aureus that exhibited oxacillin and cefoxitin<br />
susceptibility, observing a phenotypic-genotypic discrepancy<br />
(Table 1). From 90 selected strains and tested by<br />
�-lactamase production it was found that 100% hospital<br />
isolates, 83% community isolates and 93% environmental<br />
isolates were positive.<br />
Figure 2 shows the percentages of resistance to<br />
different antimicrobial agents of S. aureus and<br />
coagulase-negative staphylococci. All strains tested were<br />
resistant to two or more agents and it was considered as<br />
multidrug-resistant strains those that were resistant to<br />
more than four antibiotics. From 284 strains studied, 32%<br />
(90 strains) were multidrug-resistant, of which 82% (74<br />
strains) were methicillin-resistant. The percentages of<br />
resistance detected among S. aureus and coagulase<br />
negative staphylococcal isolates were: penicillin (79 and<br />
67%, respectively), oxacillin (27 and 65%), erythromycin<br />
(18 and 36%), tetracycline (6 and 24%), gentamicin (71<br />
and 45%), and trimethoprim sulfamethoxazole (19 and<br />
37%).<br />
DISCUSSION<br />
As expected, the percentages of methicillin resistance<br />
detected among S. aureus and CoSCN in this study were<br />
higher in the hospital isolates in relation to those of the
Figure 2. Resistance staphylococci strains isolated from Hospital, Community and<br />
Environmental by Kirby-Bauer test. PE: penicillin; OX: oxacillin; E: erythromycin; TE:<br />
tetracycline; GE: gentamicin; SXT: trimethoprim-sulfamethoxazole and VA: vancomycin.<br />
RSA, Resistant Staphylococcus aureus strains; RCoNS, Resistant Coagulase Negative<br />
Staphylococcus strains. Intermediate Resistance: a GE SA 8% and CoNS 6%; b TE CoNS 2%<br />
and c SXT 1%.<br />
community. Hospital isolates presented high percentages<br />
of resistance (34 and 78% for S. aureus and CoSCN,<br />
respectively), what indicate that this type of resistant<br />
microorganisms can be a problem in the hospitals tested.<br />
These percentages are similar to other data previously<br />
published for Mexican hospitals and in other Latin<br />
American countries (Guzmán-Blanco et al., 2009).<br />
The results of this study show that in our community<br />
Staphylococcus is a major concern for public health as a<br />
cause of emerging infections, due to the presence of<br />
multiresistant strains with ability to survive and spread.<br />
Among 284 strains collected in this study, the highest<br />
percentage was S. aureus isolated from community,<br />
which is consistent with that reported by the Centers for<br />
disease control and prevention (CDC) in USA (Kuehnert<br />
et al., 2006) and the Instituto Mexicano del Seguro Social<br />
(IMSS) in México (García-Contreras et al., 2000). The<br />
SCoN were isolated mostly from environmental sources,<br />
probably because they are found in greater numbers in<br />
skin and mucous membranes of both human animals as<br />
compared with S. aureus (Bischoff et al., 2004; 2007).<br />
The resistance rates observed in this study agree with<br />
those reported in other regions (Diekema et al., 2001;<br />
Cuevas et al., 2004; Gales et al., 2009; Sader et al.,<br />
2009) and may be related to selective pressure to which<br />
Lobo-Sánchez et al. 2269<br />
bacteria are subjected in our community, because in the<br />
hospitals the committee epidemiological surveillance sets<br />
that the treatment of staphylococcal infections begins<br />
with �-lactam antibiotics, which in some cases, antimicrobial<br />
therapy of choice is subject to the standard antibiotic<br />
treatments available or unfinished treatments due to lack<br />
of resources of both health institutions and patients. In<br />
community, easy access to this type of antibiotics until<br />
2010 year (Official Gazette, 2010) allowed the selfmedication,<br />
resulting in inadequate doses or unfinished<br />
treatments (Dreser et al., 2008), favoring the spread of<br />
multiresistant strains in the community.<br />
The GE resistance above 45%, consistent with that<br />
reported in 2005 by Public Health in Mexico (Benavides-<br />
Plascencia et al., 2005), where GE is among the seven<br />
antibiotics account for 80% of the observed resistance. In<br />
recent years, glycopeptides have been the mainstay of<br />
treatment of infections due to MRS. However, the isolation<br />
of CoNS with decreased susceptibility (Schwalbe et<br />
al., 1987), the report heteroresistant S. aureus strains<br />
(Hiramatsu et al., 1997) and the presence of strains<br />
resistant to VA (CDC, 2002; Palazzo et al., 2005; Tiwari<br />
and Sen, 2006), led that the treatment options for<br />
infections by MRS are committed and required of new<br />
antimicrobial agents (Appelbaum, 2006; Menezes et al.,
2270 Afr. J. Microbiol. Res.<br />
2008). In this paper, strains with intermediate susceptibility<br />
to VA were not identified however; the results<br />
emphasize the need for continuous monitoring of the<br />
levels of MIC to this antibiotic in the MRS, since these<br />
results alert of the risks and implications of the indiscriminate<br />
use of this drug. The E and SXT has been widely<br />
used in the treatment of staphylococcal infections<br />
(Huovinen et al., 1995; Schlegelová et al., 2002),<br />
however, clinical experience has shown that resistance to<br />
both drugs has developed worldwide (Huovinen, 2001;<br />
Gales et al., 2009; Sader et al., 2009). The TE is a<br />
relatively cheap antibiotic, has therefore been widely<br />
used in prophylaxis, treatment of infections and as animal<br />
growth promoter, so the selective pressure for its use,<br />
has led to resistant bacterial strains (Committee on Drug<br />
Use in Food Animals, 1999; Chopra and Roberts, 2001).<br />
The worldwide prevalence of resistance to TE in S.<br />
aureus is higher than CoNS (Diekema et al., 2001; Gales<br />
et al., 2009). However, in Spain was reported a<br />
resistance less than 5% in S. aureus and between 5%<br />
and 15% in CoNS (Pérez-Trallero and Iglesias, 2003).<br />
The TE resistance observed in this study is relatively low 6%<br />
for S. aureus and 24% for CoNS, which could be related<br />
to the TE is one of the lowest drug consumption in<br />
Mexico (Benavides-Plascencia et al., 2005) and is not<br />
considered a treatment of choice for serious<br />
staphylococcal infections (WHO, 1999). It is interesting<br />
intermediate susceptibility to GE, TE and SXT, while not<br />
reaching high levels, confirming the need for selection<br />
and rational use of these antibiotics.<br />
The MRSA and MRCoNS mecA positive showed<br />
uniformity in the expression of resistance (Chambers,<br />
1988), so that might be considered strains with homogeneous<br />
resistant (Weller, 1999). In the MSSA-mecA<br />
positive, the results confirmed with FOX could coincide<br />
with that reported by Hososaka et al. (2007), so the<br />
absence of the phenotypic expression of resistance in<br />
these strains, suggests new molecular targets that could<br />
be related to susceptibility to ME (Rohrer et al., 2003), or<br />
the presence of mutations in the fem genes, which are<br />
essential factors for ME resistance expression<br />
(Chambers, 1997), contributing to low levels of resistant<br />
to this antibiotic, without any alteration in the mecA gene<br />
(Giannouli et al., 2010). In MRCoNS-mecA negative, the<br />
expression of resistance to ME, could be related to<br />
different mechanisms for the production of PBP2a<br />
(McDougal and Thornsberry, 1986; Tomasz et al., 1989;<br />
Suzuki et al., 1993; Weller, 1999), resulting in the<br />
presence of extremely heteroresistant strains (Chambers,<br />
1988). The MSCoNS-mecA positive strains reported as<br />
MR by test MIC, could be pre-MRCoNS (Hiramatsu,<br />
1995), because mutations in regulatory genes of mecA<br />
would originate phenotypically methicillin resistant strains<br />
(Suzuki et al., 1993; Kobayashi et al., 1996; 1998).<br />
In most of the strains tested the �-lactamase production<br />
was detected, suggesting that the regulatory genes blaR1<br />
and blaI could also be related to the phenotypic<br />
expression of resistance (Cohen et al., 1972; Boyce et<br />
al., 1990; Hiramatsu et al., 1990; Ryffel et al., 1992;<br />
Hackbarth and Chambers, 1993; Hackbarth et al., 1994;<br />
Chambers, 1997; Rosato et al., 2003).<br />
Finally, the results of this study confirm the presence of<br />
MRS strains, which are also multiresistant, whose<br />
mechanisms of resistance may not only be related to the<br />
interaction of the mec genes, but with much more<br />
complex regulatory mechanisms, so its worth conducting<br />
more detailed studies and further epidemiological<br />
surveillance of Staphylococcus strains isolated from<br />
different sources, to show the behavior over time of<br />
resistance in these strains, based on the measure<br />
introduced from August 2010 on the sale of antibiotics in<br />
pharmacies throughout Mexico through prescription<br />
(Official Gazette, 2010).<br />
ACKNOWLEDGEMENT<br />
Ana Marta de los Ángeles Lobo Sánchez was supported<br />
by a student scholarship from Consejo Nacional de<br />
Ciencia y Tecnología, México (CONACYT 174306).<br />
REFERENCES<br />
Appelbaum PC (2006). The emergence of vancomycin-intermediate and<br />
vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect.<br />
Dis., 12(1): 16-23.<br />
Benavides-Plascencia L, Aldama-Ojeda AL, Vázquez HJ (2005).<br />
Surveillance of antibiotic utilization and bacterial resistance profiles in<br />
tertiary level hospitals in Mexico City. Salud Publica Mex., 47(3): 219-<br />
226.<br />
Bischoff WE, Bassetti F, Bassetti-Wyss BA, Wallis ML, Tucker BK,<br />
Reboussin BA, D’Agostino RB, Pfaller MA, Gwaltney JM, Sherertz RJ<br />
(2004). Airborne dispersal as a novel transmission Route of<br />
coagulase-negative staphylococci: Interaction between coagulasenegative<br />
staphylococci and rhinovirus infection. Infect. Control. Hosp.<br />
Epidemiol., 25(6): 504-511.<br />
Bischoff WE, Tucker BK, Wallis ML, Reboussin BA, Pfaller MA, Hayden<br />
FG, Sherertz RJ (2007). Preventing the Airborne Spread of<br />
Staphylococcus aureus by Persons with the Common Cold: Effect of<br />
Surgical Scrubs, Gowns, and Masks. Infect. Control Hosp.<br />
Epidemiol., 28(10): 1148-1154.<br />
Boyce JM, Medeiros AA, Papa EF, O’Gara CJ (1990). Introduction of<br />
beta-lactamase and methicillin resistance in unusual strains of<br />
methicillin-resistant Staphylococcus aureus. J. Antimicrob.<br />
Chemother., 25(1): 73-81.<br />
Centers for Disease Control and Prevention (CDC) (2002).<br />
Staphylococcus aureus resistant to vancomycin, United States. Morb<br />
Mortal Wkly Rep (MMWR), 51(26): 565-567.<br />
Chambers HF (1988). Methicillin-Resistant staphylococci. Clin.<br />
Microbiol. Rev., 1(2): 173-186<br />
Chambers HF (1997). Methicillin resistance in staphylococci: molecular<br />
and biochemical basis and clinical implications. Clin. Microbiol. Rev.,<br />
10(4): 781-791.<br />
Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang, SC, Hsueh PR<br />
(2010). Epidemiology of bloodstream infections in patients with<br />
haematological malignancies with and without neutropenia.<br />
Epidemiol. Infec., 138(7): 1044-1051<br />
Chopra I, Roberts M (2001). Tetracycline Antibiotics: Mode of Action,<br />
Applications, Molecular Biology, and Epidemiology of Bacterial<br />
Resistance. Microbiol. Molec. Biol. Rev., 65(2): 232-260.<br />
Clinical and Laboratory Standards Institute (CLSI). 2008. Performance<br />
Standards for Antimicrobial Disk Susceptibility Test. Approved<br />
Standard. Document M100-S18. NCCLS, Wayne, PA.<br />
Cohen SC, Gibson J, Sweeney HM (1972). Phenotypic suppression of
methicillin resistance in Staphylococcus aureus by mutant noninducible<br />
penicillinase plasmids. J. Bacteriol., 112(2): 682-689<br />
Committee on Drug Use in Food Animals (1999). Food-Animal<br />
Production Practices and drug use. In: Committee on Drug Use in<br />
Food Animals, Panel on Animal Health, Food Safety, and Public<br />
Health, National Research Council (eds), The use of drugs in food<br />
animals, benefits and risks, National Academy Press, Washington,<br />
D.C., pp. 27-68.<br />
Crossley K, Loesch D, Landesman B, Mead K, Chern M, Strate R<br />
(1979). An outbreak of infections caused by strains of<br />
Staphylococcus aureus resistant to methicillin and aminoglycosides I.<br />
Clinical studies. J. Infect. Dis., 139(3): 273-279.<br />
Cuevas O, Cercenado E, Videl A, Guinea J, Sánchez-Conde M,<br />
Sánchez-Somolinos M, Bouza E (2004). The Spanish Group for the<br />
Study of Staphylococcus. Evolution of the Antimicrobial Resistance<br />
of Staphylococcus spp. in Spain: Five Nationwide Prevalence<br />
Studies, 1986 to 2002. Antimicrob. Agents Chemother., 48(11): 4240-<br />
4245.<br />
David MZ, Daum RS (2010). Community-Associated Methicillin-<br />
Resistant Staphylococcus aureus: Epidemiology and Clinical<br />
Consequences of an Emerging Epidemic. Clin. Microbiol. Rev., 23(3):<br />
616-687.<br />
De la Rosa MAM, Ullán C (2002). Air: Habitat and mode of<br />
microorganism’s transmission. Rev. Observ. Medioamb., 5: 375-402.<br />
De Lencastre H, De Jonge BL, Matthews PR, Tomasz A (1994).<br />
Molecular aspects of methicillin resistance in Staphylococcus aureus.<br />
J. Antimicrob. Chemother., 33(1): 7-24.<br />
Official Gazette (2010). SECRETARÍA DE GOBERNACIÓN (SEGOB).<br />
José Ángel Córdova Villalobos, Secretary of Health. Law that<br />
determination of guidelines to which it subjects the sale and<br />
dispensation of antibiotics. Date Publication law in the Official<br />
Gazette May 27, 2010. Mexico, D.F.<br />
Diekema DJ, Pfaller MA, Jones RN (2000). Trends in antimicrobial<br />
susceptibility testing of bacterial pathogens isolated from patients<br />
with bloodstream infections in the USA, Canada and Latin America:<br />
report from the SENTRY Antimicrobial Surveillance Program, 1998.<br />
Int. J. Antimicrob. Agents, 13(4): 257-271.<br />
Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN,<br />
Beach M (2001). Survey of Infections Due to Staphylococcus<br />
Species: Frequency of Occurrence and Antimicrobial Susceptibility of<br />
Isolates Collected in the United States, Canada, Latin America,<br />
Europe, and the Western Pacific Region for the SENTRY<br />
Antimicrobial Surveillance Program, 1997–1999. Clin. Infect. Dis.,<br />
32(2): S114-S132.<br />
Doebbeling BN (1995). The epidemiology of methicillin-resistant<br />
Staphylococcus aureus infection and colonization. J. Chemother.,<br />
7(3): 99-103.<br />
Doern GV, Jones RN, Pfaller MA, Kugler KC, Beach ML (1999).<br />
Bacterial pathogens isolated from patients with skin and soft tissue<br />
infections: frequency of occurrence and antimicrobial susceptibility<br />
patterns from the SENTRY Antimicrobial Surveillance Program<br />
(United States and Canada, 1997). SENTRY Study Group (North<br />
America). Diagn. Microbiol. Infect. Dis., 34(1): 65-72.<br />
Dreser A, Wirtz VJ, Corbett KK, Echániz G (2008). Use of antibiotics in<br />
Mexico: review of problems and policies. Salud Publica Mex., 50(4):<br />
S480-S487.<br />
Eames I, Tang JW, Li Y, Wilson P (2009). Airborne transmission of<br />
disease in hospital. J. R Soc. Interface, 6(6): S697-S702.<br />
Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel<br />
RP (1999). Nosocomial bloodstream infections in United States<br />
hospitals: a three-year analysis. Clin. Infect. Dis., 29(2): 239-244.<br />
Finegold SM, Baron EJ (1996). Identification Methods for etiologic<br />
agents of infectious diseases. In Baron EJ, Drew WL, Edelstein MAC,<br />
García LS, Roberts GD (eds) Bailey and Scott's Diagnostic<br />
Microbiology, The C. V. Mosby Company, St. Louis, Toronto,<br />
Princeton, pp. 339-340.<br />
Frankland PF, Hart TG (1887). Further experiments on the distribution<br />
of micro-organisms in air (by Hesse's method). Proc. Roy. Soc.<br />
London., 42: 267-282.<br />
Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari, AC(2009).<br />
Antimicrobial Susceptibility of Gram-Positive Bacteria Isolated in<br />
Brazilian Hospitals Participating in the SENTRY Program (2005-<br />
Lobo-Sánchez et al. 2271<br />
2008). Brazilian J. Infect. Dis., 13(2): 90-98.<br />
García-Contreras F, Del Angel-García G, Ramírez-Cuenca A, Malváez-<br />
Valdes M, Vega-Yáñez A, Amato-Martínez JD (2000). Costeffectiveness<br />
study of ceftriaxone and cefotaxime for the treatment of<br />
community acquired pneumonia. Rev. Invest. Clin., 52(4): 418-426.<br />
Giannouli S, Labrou M, Kyritsis A, Ikonomidis A, Pournaras S,<br />
Stathopoulos C, Tsakris A (2010). Detection of mutations in the<br />
FemXAB protein family in oxacillin-susceptible mecA-positive<br />
Staphylococcus aureus clinical isolates. J. Antimicrob. Chemother.,<br />
65(4): 626-633.<br />
Górny RL, Dutkiewicz J (2002). Bacterial and Fungal Aerosols in Indoor<br />
Environment In Central And Eastern European Countries. Ann. Agric.<br />
Environ. Med., 9(1): 17-23.<br />
Górny RL, Dutkiewicz J, Krysińska-Traczyk E (1999). Size distribution<br />
of bacterial and fungal bioaerosols in indoor air. Ann. Agric. Environ.<br />
Med., 6(2): 105-113.<br />
Guzmán-Blanco M, Mejía C, Isturiz R, Álvarez C, Bavestrello L,<br />
Gotuzzo E, Labarca J, Luna CM, Rodríguez-Noriega E, Salles MJ,<br />
Zurita J, Seas C (2009). Epidemiology of methicillin-resistant<br />
Staphylococcus aureus (MRSA) in Latin America. Int. J. Antimicrob.<br />
Agents, 34(4): 304-308.<br />
Hackbarth CJ, Chambers HF (1993). blaI and blaR1 regulate betalactamase<br />
and PBP 2a production in methicillin-resistant<br />
Staphylococcus aureus. Antimicrob. Agents Chemoter., 37(5): 1144-<br />
1149.<br />
Hackbarth CJ, Miick C, Chambers HF (1994). Altered production of<br />
penicillin-binding protein 2a can affect phenotypic expression of<br />
methicillin resistance in Staphylococcus aureus. Antimicrob. Agents<br />
Chemother., 38(11): 2568-2571.<br />
Hartman BJ, Tomasz A (1984). Low-affinity penicillin-binding protein<br />
associated with beta-lactam resistance in Staphylococcus aureus. J.<br />
Bacteriol., 158(2): 513-516.<br />
Hiramatsu K, Suzuki E, Takayama H, Katayama Y, Yokota T (1990).<br />
Role of penicillinase plasmids in stability of the mecA gene in<br />
methicillin-resistant Staphylococcus aureus. Antimicrob. Agents<br />
Chemother., 34(4): 600-604.<br />
Hiramatsu K (1995). Molecular evolution of MRSA. Microbiol. Immunol.,<br />
39(8): 531-543.<br />
Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S,<br />
Fukuchi Y, Kobayashi I (1997). Dissemination in Japanese hospitals<br />
of strains of heterogeneously resistant to vancomycin. Lancet,<br />
350(9092): 1670-1673.<br />
Hiramatsu K, Cui L, Kuroda M, Ito T (2001). The emergence and<br />
evolution of methicillin-resistant Staphylococcus aureus. Trends.<br />
Microbiol., 9(10): 486-493.<br />
Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y,<br />
Nakae T, Sunakawa K (2007). Characterization of oxacillinsusceptible<br />
mecA-positive Staphylococcus aureus: a new type of<br />
MRSA. J. Infect. Chemother., 13(2):79-86.<br />
Huovinen P, Sundström L, Swedberg G, Sköld O (1995). Trimethoprim<br />
and sulfonamide resistance. Antimicrob. Agents Chemother., 39(2):<br />
279-289.<br />
Huovinen P (2001). Resistance to Trimethoprim-Sulfamethoxazole.<br />
Clin. Infect. Dis., 32(11): 1608-1614.<br />
Katayama Y, Ito T, Hiramatsu K (2000). A new class of genetic element,<br />
Staphylococcus casette chromosome mec, encodes methicillinresistance<br />
in Staphylococcus aureus. Antimicrob Agents<br />
Chemotheer., 44(6): 1549-1555.<br />
Klimek JJ, Marsik FJ, Bartlett RC, Weir B, Shea P, Quintiliani R (1976).<br />
Clinical, epidemiologic and bacteriologic observations of an outbreak<br />
of methicillin-resistant Staphylococcus aureus at a large community<br />
hospital. Am. J Med., 61(3): 340-345.<br />
Kobayashi N, Taniguchi K, Kojima K, Urasawa S, Uehara N, Omizu Y,<br />
Kishi Y, Yagihashi A, Kurokawa I, Watanabe N (1996). Genomic<br />
diversity of mec regulator genes in methicillin-resistant<br />
Staphylococcus aureus and Staphylococcus epidermidis. Epidemiol.<br />
Infect., 117(2): 289-295.<br />
Kobayashi N, Taniguchi K, Urasawa S (1998). Analysis of diversity of<br />
mutations in the mecI gene and mecA promoter/operator region of<br />
methicillin-resistant Staphylococcus aureus and Staphylococcus<br />
epidermidis. Antimicrob. Agents Chemother., 42(3): 717-720.<br />
Kuehnert MJ, Kruzon-Moran D, Hill HA, McQuillan G, McAllister SK,
2272 Afr. J. Microbiol. Res.<br />
Fosheim G, McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore<br />
G, Tenover FC (2006). Prevalence of Staphylococcus aureus nasal<br />
colonization in the United States, 2001-2002. J. Infect. Dis., 193(2):<br />
172-179.<br />
Lighthart B, Shaffer BT (1995). Airbone bacteria in the atmospheric<br />
surface layer: temporal distribution above a grass seed field. App.<br />
Environ. Microbiol., 61(4): 1492-1496.<br />
Martins A, Cunha M de L (2007). Methicillin resistance in<br />
Staphylococcus aureus and coagulase-negative staphylococci:<br />
epidemiological and molecular aspects. Microbiol. Immunol., 51(9):<br />
787-795.<br />
McDougal LK, Thornsberry C (1986). The role of �-Lactamase in<br />
Staphylococcal Resistance to Penicillinnase-Resistant Penicillins and<br />
Cephalosporins. J. Clin. Microbiol., 23(5): 832-839.<br />
Menezes GA, Harish BN, Sujatha S, Vinothini K, Parija SC (2008).<br />
Emergence of vancomycin-intermediate Staphylococcus species in<br />
southern India. J. Med. Microbiol., 57(7): 911-912.<br />
Palazzo ICV, Araujo MLC, Darini ALC (2005). First report of<br />
vancomycin-resistant staphylococci isolated from healthy carriers in<br />
Brazil. J. Clin. Microbiol., 43(1): 179-185.<br />
Pérez-Trallero E, Iglesias L (2003). Tetracyclines, sulfonamides and<br />
metronidazole. Enferm. Infect. Microbiol. Clin., 21(9): 520-529.<br />
Petinaki E, Arvaniti A, Dimitracopoulos G, Spiliopoulou I (2001).<br />
Detection of mecA, mecRI and mecI genes among clinical isolates of<br />
methicillin-resistant Staphylococci by combined polymerase chain<br />
reactions. J. Antimicrob. Chermother., 47(3): 297-304.<br />
Pfaller MA, Jones RN, Doern GV, Kugler K (1998). Bacterial pathogens<br />
isolated from patients with bloodstream infection: frequencies of<br />
occurrence and antimicrobial susceptibility patterns from the<br />
SENTRY Antimicrobial Surveillance Program (United States and<br />
Canada, 1997). Antimicrob. Agents Chemother., 42(7): 1762-1770.<br />
Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML<br />
(1999). Survey of blood stream infections attributable to Grampositive<br />
cocci: frequency of occurrence and antimicrobial<br />
susceptibility of isolates collected in 1997 in the United States,<br />
Canada, and Latin America from the SENTRY Antimicrobial<br />
Surveillance Program. SENTRY Participants Group. Diagn. Microbiol.<br />
Infect. Dis., 33(4): 283-297.<br />
Pinho MG, Filipe SR, De Lencastre H, Tomasz A (2001).<br />
Complementation of essential peptidoglycan transpeptidase function<br />
of penicillin-binding protein 2 (PBP2) by the drug resistance protein<br />
PBP2A in Staphylococcus aureus. J. Bacteriol., 183(2): 6525-6531.<br />
Ponce de León S (1996). New and old pathogens in nosocomial<br />
infections. In: prevention and control of hospital infections Manual.<br />
(HSP Serie / PALTEX Manuals) Pan Am. Health Organ. (PAHO),<br />
4(13): 52-68.<br />
Rohrer S, Maki H, Berger-Bächi B (2003). What makes resistance to<br />
methicillin heterogeneous? J. Med. Microbiol., 52(8): 605-607.<br />
Rosa J de O, De Moura JP, Palos MA, Gir E, Reis C, Kipnis A, Canini<br />
SR, Belissimo-Rodríguez F, Pimenta FC (2009). Detection of mecA<br />
gene in oxacillin-resistant coagulase-negative staphylococci isolated<br />
from the saliva of nursing professionals. Rev. Soc. Bras. Med. Trop.,<br />
42(4): 398-403.<br />
Rosas I, Cravioto A, Ezcurra E (2004). Environmental Microbiology. In:<br />
Ministry Environment and Natural Resources, Ecology National<br />
Institute (eds), Bacteria in the Atmosphere, University Program of<br />
Environment-UNAM: Program SA Mexico, pp. 1-134.<br />
Rosato AE, Kreiswirth BN, Craig WA, Eisner W, Climo MW, Archer GL<br />
(2003). mecA-blaZ corepressors in clinical Staphylococcus aureus<br />
isolates. Antimicrob. Agent Chemother., 47(4): 1460-1463.<br />
Ryffel C, Tesch W, Birch-Machin I, Reynolds P E, Barberis-Maino L,<br />
Kayser FH, Berger-Bächi B (1990). Sequence comparison of mecA<br />
genes isolated from methicillin-resistant Staphylococcus aureus and<br />
Staphylococcus epidermidis. Gene., 94(1): 137-138.<br />
Ryffel C, Kayser FH, Berger-Bächi B (1992). Correlation between<br />
regulation of mecA transcription and expression of methicillin<br />
resistance in staphylococci. Antimicrob. Agents. Chemother., 36(1):<br />
25-31.<br />
Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA,<br />
Doern GV (1998). Antimicrobial susceptibility patterns for pathogens<br />
isolated from patients in Latin American medical centers with a<br />
diagnosis of pneumonia: analysis of results from the SENTRY<br />
Antimicrobial Surveillance Program (1997). SENTRY Latin America<br />
Study Group. Diagn. Microbiol. Infect. Dis., 32(4): 289-301.<br />
Sader HS, Moet GJ, Jones RN (2009). Antimicrobial resistance among<br />
Gram-positive bacteria isolated in Latin American hospitals. J.<br />
Chemother., 21(6): 611-620.<br />
Schaberg DR, Culver DH, Gaynes RP (1991). Major trends in the<br />
microbial etiology of nosocomial infection. Am. J. Med., 91(3B): 72S–<br />
75S.<br />
Schlegelová J, Babák V, Klímová E, Lukásová J, Navrátilová P,<br />
Sustáckova A, Sedivá I, Rysánek D (2002). Prevalence of and<br />
resistance to anti-microbial drugs in selected microbial species<br />
isolated from bulk milk samples. J. Vet. Med. B. Infect. Dis. Vet.<br />
Public Health, 49(5): 216-225.<br />
Schwalbe RS, Stapleton JT, Gilligan PH (1987). Emergence of<br />
vancomycin resistance in coagulase-negative staphylococci. N. Engl.<br />
J. Med., 316: 927-931.<br />
Suzuki E, Kuwahara-Arai K, Richardson JF, Hiramatsu K (1993).<br />
Distribution of mec regulator genes in methicillin-resistant<br />
Staphylococcus clinical strains. Antimicrob. Agents Chemother.,<br />
37(6): 1219-1226.<br />
Tang JW (2009). The effect of environmental parameters on the survival<br />
of airborne infectious agents. J. R. Soc. Interface, 6(6): S737-S746.<br />
Tiwari HK, Sen MR (2006). Emergence of vancomycin resistant<br />
Staphylococcus aureus (VRSA) from a tertiary care hospital from<br />
northern part of India. BMC. Infect. Dis., 6: 156.<br />
Tomasz A, Drugeon HB, De Lencastre HM, Jabes D, McDougal L, Bille<br />
J (1989). New mechanism for methicillin resistance in<br />
Staphylococcus aureus: clinical isolates that lack the PBP 2a gene<br />
and contain normal penicillin-binding proteins with modified penicillinbinding<br />
capacity. Antimicrob. Agents Chemother., 33(11): 1899-1874.<br />
Tsai FC, Macher JM (2005). Concentrations of airborne culturable<br />
bacteria in 100 large US office buildings from. The base study. Indoor<br />
Air., 15(9): 71-81.<br />
Ubukata K, Nonoguchi R, Song MD, Matsuhashi M, Konno M (1990).<br />
Homology of mecA gene in methicillin-resistant Staphylococcus<br />
haemolyticus and Staphylococcus simulans to that of Staphylococcus<br />
aureus. Antimicrob. Agents Chemother., 34(1): 170-172.<br />
Unal S, Hoskins J, Flokowitsch JE, Wu CY, Preston DA, Skatrud PL<br />
(1992). Detection of methicillin-resistant staphylococci by using the<br />
polymerase chain reaction. J. Clin. Microbiol., 30(7): 1685-1691.<br />
Weller TMA (1999). The distribution of mecA, mecR1 and mecI and<br />
sequence analysis of mecI and the mec promoter region in<br />
staphylococci expressing resistance to methicillin. J. Antimicrob.<br />
Chemother., 43(1): 15-22.<br />
Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003). Current<br />
Trends in the Epidemiology of Nosocomial Bloodstream Infections in<br />
Patients with Hematological Malignancies and Solid Neoplasms in<br />
Hospitals in the United States. Clin. Infect. Dis., 36(9): 1103-1110.<br />
World Health Organization (WHO) (1999). WHO Model Prescribing<br />
Information: Drugs Used in Skin Diseases. Bacterial infections.<br />
Geneva: World Health Organization, pp. 1-132.<br />
World Health Organization (WHO) (2002). Antimicrobial resistance. Fact<br />
sheet N°194.<br />
Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, Ko WC (2006).<br />
Predominance of Gram-negative bacilli and increasing antimicrobial<br />
resistance in nosocomial bloodstream infections at a university<br />
hospital in southern Taiwan, 1996-2003. J. Microbiol. Immunol.<br />
Infect., 39(2): 135-143.
African Journal of Microbiology Research Vol. 5(16), pp. 2273-2277, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.590<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Interaction of severe acute respiratory syndrome<br />
(SARS) nucleocapsid protein with macrophage<br />
migration inhibitory factor protein (MIF)<br />
Yang Lin 1,2 *, Baohua Wang 3 *, Yijun Liu 1 , Zhigang Yu 1 , Manhua Cui 2 and Haichun Ma 1<br />
1 The First Hospital of Jilin University, Changchun130021, China.<br />
2 Department of Gynaecology and Obstetrics, the Second Hospital of Jilin University, Changchun 130041 China.<br />
3 Department of Anesthesia, the Affiliated Hospital of Changchun University of Traditional Chinese Medicine,<br />
Changchun 130021, China.<br />
Accepted 30 July, 2011<br />
The nucleocapsid (N) protein of SARS coronavirus (SARS-CoV) is a major structural component of<br />
virions, which appears to be a multifunctional protein involved in viral RNA replication and translation.<br />
However, how N protein interacts with host protein remains largely elusive. To identify cellular proteins<br />
that interact with the N protein and to elucidate the possible involvement of N protein in SARS-Cov<br />
replication and translation, a human lung cDNA library was screened using a yeast two-hybrid system<br />
assay. In this study, we have identified Macrophage migration inhibitory factor protein (MIF) as a novel<br />
interaction partner of N protein by yeast two-hybrid system. The direct interaction and co-localization of<br />
N protein with MIF were confirmed by immunoprecipitation and confocal microscopy analysis,<br />
respectively. The mapping studies localized the critical N sequences for this interaction to amino acid<br />
140-210 including SR motif by yeast two-hybrid system. To the best of our knowledge, this is the first<br />
report that SARS-N protein interacts with the MIF within host cells, which enhance our understanding of<br />
the molecular mechanisms of SARS replication.<br />
Key words: Severe acute respiratory syndrome (SARS) coronavirus, nucleocapsid protein, Macro|phage<br />
migration inhibitory factor protein, yeast two-hybrid.<br />
INTRODUCTION<br />
Severe acute respiratory syndrome (SARS) is a novel<br />
worldwide infectious disease, which is caused by a newly<br />
identified member of the coronaviridae family, SARS<br />
coronavirus (SARS-CoV) (Ksiazek et al., 2003; Marra et<br />
al., 2003; Peiris et al., 2003; Rota et al., 2003). Like other<br />
known coronaviruses, SARS-CoV is an enveloped virus<br />
containing three outer structural proteins, namely the<br />
membrane (M), nucleocapsid (N), and spike (S) proteins<br />
(Lai et al., 1997; Versteeg et al., 2007). The N protein is<br />
the most abundant viral protein in coronaviruses which is<br />
produced throughout infection and is an important<br />
multifunctional protein. Several functions have been postulated<br />
for the coronavirus N protein throughout the<br />
*Corresponding author. E-mail: Haichun514@yahoo.cn. Fax:<br />
+86-0431-845-14166.<br />
virus life cycle, including viral packaging, viral core<br />
formation, and signal transduction (He et al., 2004;<br />
Hiscox et al., 2001).<br />
Mapping virus–host protein interactions can provide<br />
important clues on the initial stages of infection. For coronaviruses,<br />
the N protein plays an important role during<br />
host cell entry and virus particle assembly and release<br />
(Hatakeyama et al., 2008; Narayanan et al., 2001). It has<br />
been reported that the N protein of SARS interacts with<br />
human cellular heterogeneous nuclear ribonucleoprotein<br />
A1 (hnRNPA1) (Wang et al., 1999), which shown that N<br />
protein plays a crucial role in viral RNP assembly and<br />
replication by interaction with host proteins. However,<br />
how N protein interacts with host protein is still unclear.<br />
To obtain a more detailed insight into the N protein and<br />
host relationship, a yeast two-hybrid system was<br />
employed in the present study to identify host proteins<br />
which bind to N protein of SARS.
2274 Afr. J. Microbiol. Res.<br />
MATERIALS AND METHODS<br />
Strains and general techniques<br />
The strain of Saccharomyces cerevisiae used in this study was<br />
AH109 from Clontech (USA). Yeast cells were cultured at 30°C<br />
either in a complete YPD medium (1% yeast extract, 1% peptone,<br />
2% glucose) or in a synthetic defined (SD) medium supplemented<br />
with required essential nutrients. Plates contained 2% agar.<br />
Transformation of yeast cells was performed by the lithium acetate.<br />
Escherichia coli KC8 were used for general cloning. DNA manipulation<br />
was performed according to established protocol. Betagalactosidase<br />
assays were carried out according to the<br />
CLONTECH Matchmaker manual (PT3024-1, Clontech, USA).<br />
Plasmids and construction of recombinant vectors<br />
For bait construction, the full-length N gene of the SARS was PCRamplified<br />
from a genomic construct of clone, and cloned into the<br />
pMD18-T vector (Takara, China). The full-length N gene was<br />
subjected to DNA sequencing, and the inserts were verified against<br />
the corresponding region of the SARS coronavirus. The full-length<br />
N gene was excised from the pMD18-T –N construct using the<br />
restriction enzymes EcoRI and BamHI, and ligated into the pGBKT7<br />
vector to generate an N-terminal in frame fusion with the GAL4<br />
activation domain (BD), and the resultant plasmid was named as<br />
pGBKT7-N. To identify the putative domain of amino acid sequence<br />
required for MIF/N interaction. The truncated mutants N1–139,<br />
N140–280, N281–422, N140–210 and N211–280 were subcloned<br />
into the yeast two-hybrid vector pGBKT7. The MIF gene was<br />
obtained by PCR from the rat liver cDNA library, and subcloned into<br />
the yeast vector pGADT7. For mammalian cell expression, the fulllength<br />
N gene and MIF were subcloned into the pCMV-Myc vector<br />
(Clontech, USA) and pCMV–HA, and fluorescence vector pEGFP-<br />
N1 and pDsRed-N1, respectively. All DNA manipulations were<br />
performed as described by Sambrook et al. (2001). All constructs<br />
were verified by restriction digestion and sequencing.<br />
Yeast two-hybrid screening<br />
Yeast two-hybrid experiments were performed as described in the<br />
Clontech manual for the MATCHMAKER GAL4 two-hybrid system<br />
and in the Clontech yeast protocols handbook (Clontech, USA).<br />
The rat liver Matchmaker cDNA library (Clontech, USA) cloned in<br />
frame with the GAL4 activation domain in the PGAD vector was<br />
used as a prey. The bait pGBKT7-N was transformed into yeast<br />
strain AH109. The bait construct did not show any toxic effect and<br />
autonomous transcriptional activation on the host strain. The prey<br />
PGAD-library was then transformed into the bait-transformed<br />
AH109 cells, and the cells were incubated on minimal synthetic<br />
dropout medium for yeast (SD)/-His/-Leu/-Trp at 30°C. The fresh<br />
growing clones were assayed for -galactosidase activity by replica<br />
plating the yeast transformants onto Whatman filter papers; the<br />
filters were snap-frozen in liquid nitrogen for 10 sec twice and<br />
incubated in a buffer containing 5-bromo-4-chloro 3-indolyl- -Dgalactopyranoside<br />
solution at 30°C for 1–8 h. Positive interactions<br />
were detected by the appearance of blue clones. The liquid -<br />
galactosidase activity was determined using the substrate ONPG as<br />
described standard Protocols Handbook (PT3024-1, Clontech,<br />
USA). Data for quantitative assays were collected for yeast cell<br />
number and are the mean ± S.E.M. of triplicate assays. Appropriate<br />
positive/negative controls and buffer blanks were used. The positive<br />
pGAD-cDNA plasmids were isolated from positive yeast transformants<br />
by culture in leucine-deficient medium, which resulted in<br />
spontaneous loss of the plasmid pGBK-N and transformed into E.<br />
coli KC8 for sequence analysis. Auto sequencing assay was<br />
performed in Takara Company (China) and the resulting sequence<br />
was analyzed in the database of EMBL\Gene Bank by the BLAST<br />
program.<br />
In vivo co-immunoprecipitation and western blotting<br />
To reaffirm the results observed from yeast two-hybrid assays, another<br />
independent assay, co-immunoprecipitation was carried out.<br />
Vero cells were co-transfected with the plasmids expressing pCMV-<br />
Myc-MIF and pCMA-HA-N using the Iipofectamine TM transfaction<br />
reagent (Invitrogen, USA). At 48 h post-transfection, cells were<br />
washed with PBS and then lysed in lysis buffer. Cell lysate was<br />
then mixed with anti-HA magnetic microbeads for 30 min on ice.<br />
100 l of 10% suspension of protein A–Sepharose was then added<br />
to the samples. The mixture was allowed to shake for 1 h at 4°C,<br />
after following which the beads were washed four times in lysis<br />
buffer, and protein was eluted in 2×SDS dye by boiling the sample<br />
for 5 - 10 min. Samples were resolved by 10% SDS-PAGE and<br />
transferred to a nitrocellulose membrane. The membrane was<br />
blocked using 0.5% BSA in PBST for 1 h, and incubated overnight<br />
with anti-Myc antibodies (1:1000; Clontech, USA). The blot was<br />
then washed three times in PBST, incubated with anti-mouse IgG<br />
HRPO for 1 h and washed three times in PBST and the proteins<br />
were visualized with 5-bromo-4-chloro-3-indolyl phosphate and<br />
nitroblue tetrazolium. The Vero cells transected with the pCMV-Myc<br />
and pCMV-HA vectors were used as negative controls.<br />
Confocal microscopy<br />
Hela cells were grown on coverslips in a 6-well chamber and<br />
simultaneously transfected with the recombinant fluorescence<br />
plasmids pEGFP-N and pDsRed-MIF. After 24 h transfection, the<br />
cells were washed with PBS three times and fixed in 4% paraformaldehyde<br />
for 20 min at room temperature. The coverslips were<br />
then washed with PBS and mounted. Intracellular localization of the<br />
N protein and MIF was observed under a Leica confocal<br />
microscope (Germany).<br />
RESULTS<br />
Yeast two-hybrid identified MIF as an N interacting<br />
protein<br />
A yeast two-hybrid approach was used to identify host<br />
proteins that interact with N protein. For this purpose, the<br />
complete N gene was cloned into a two-hybrid bait<br />
expression vector. The resulting Gal4-N fusion protein<br />
was used to screen a human lung cDNA library. Approximate<br />
2.2 × 10 6 transformants were screened for His-Ade-<br />
Trp-Leu independent growth and blue colony formation in<br />
the -galactosidase assay. Thirty-six positive clones were<br />
obtained. As some AD-cDNA fusion products can activate<br />
reporter gene transcription without interacting with<br />
the BD-N fusion protein, this false-positive clone can be<br />
identified using the technique of segregation analysis.<br />
Only 4 of 36 clones survived all genetic tests and were<br />
considered to be genuine positive clone, DNA sequence<br />
analysis of the fragment revealed that the four cDNA<br />
fragments inserted have a high identity with four genes in<br />
the GeneBank database. One of these clones was identified<br />
as MIF, which encodes a 158-amino acid protein.
Figure 1. MIF protein was immunoprecipitated with the MHV-N protein. Indicated<br />
plasmids were simultaneously transfected into Vero cells. Twenty-four hours after<br />
transfection, coimmunoprecipitation was per-formed using anti-HA magnetic<br />
microbeads, the proteins immuno-precipitated (IP) were assayed with an anti-myc<br />
monoclonal antibody. Cell lysates were immunoblotted (IB) with anti-Myc to confirm<br />
the expression of the object proteins. M: MIF protein; N : N protein.<br />
Lin et al. 2275<br />
Figure 2. Co-localization of the N protein and MIF. pEGFP-N (green) and pDsRed-RACK1 (red) were co-transfected into<br />
HeLo cells. After 24 h, cells were fixed, mounted, and the localization of the proteins was observed with a Leica confocal<br />
microscope. As shown, the N protein and MIF were colocalized in the cytoplasm.<br />
As shown in Figure 3B, the protein encoded by the<br />
pGAD-MIF clones interacted specifically with the N<br />
protein and did not interact with the unfused GAL4-BD<br />
protein expressed from the parental pGBKT7 vector.<br />
Co-immunoprecipitation determined the interaction<br />
of the N protein and MIF<br />
To confirm the specific interaction between N protein and<br />
MIF, co-immunoprecipitation was performed. The N protein<br />
was fused at the amino terminus with a Myc-tag, and<br />
MIF was fused at the carboxyl terminus with a HA tag.<br />
The two plasmids were cotransfected into Vero cells and<br />
immunoprecipitated. The immunoprecipitated complexes<br />
were separated on SDS–PAGE, and analyzed by Western<br />
blot with anti-Myc monoclonal antibodies. As shown<br />
in Figure1, the Myc-fused N protein immunoprecipitates<br />
with HA-MIF. However, it does not immunoprecipitate<br />
with HA alone. These findings indicate that N protein<br />
interacts with MIF in mammalian cells<br />
Confocal microscopy assay the N protein and MIF<br />
To further confirm the interaction between N and MIF<br />
proteins, the localization patterns of the N protein and<br />
MIF were investigated in Vero cells using confocal microscopy<br />
technology. pEGFP-N and pDsRed-MIF were<br />
transfected simultaneously into Vero cells. As shown in<br />
Figure 2, MIF and N protein mainly were localized in the<br />
cytoplasm. The merged image revealed that the N protein<br />
and MIF co-localized in the cytoplasm of Vero cells indicating<br />
that N protein interacts with MIF in cells.
2276 Afr. J. Microbiol. Res.<br />
MIF+N281-422<br />
MIF+N211-280<br />
MIF+N140-210<br />
MIF+N140-280<br />
MIF+N1-139<br />
MIF+N<br />
Negative<br />
Postive<br />
0 20 40 60 80 100<br />
Figure 3. Mapping the interaction domain of N protein. The<br />
empty vectors pGBKT7 and pGADT7 co-transformed were used<br />
as the negative control and the pGBKT7-53 and pGADT7- T cotransformed<br />
were used as the postive con-trol. Every<br />
experiment was repeated for at least three times and the data<br />
were obtained by average. The error bars represent standard<br />
error of the mean. -galactosidase activity assay.<br />
Mapping the MIF binding region of the N Protein by<br />
yeast two-hybrid assays<br />
To map the involved regions of N protein in the N/MIF<br />
interaction, the full-length N protein was divided into three<br />
domains to study the binding domain of the N protein: the<br />
N-terminal domain N1–139, the middle domain N140–<br />
280 containing the SR-rich motif and the C-terminal<br />
domain N281–422 (Figure 3). These three truncated<br />
proteins were tested for MIF binding using yeast twohybrid<br />
assay. The results indicated that N140–280, the<br />
middle domain of the N protein, is responsible for the<br />
interaction (Figure 3). To determine further the region of<br />
the N protein involved in MIF binding, the middle domain<br />
was divided into two parts, N140–280 containing the SRrich<br />
motif and N140–210, In the yeast two-hybrid assay,<br />
the -galactosidase activity of N140–210 fragment is<br />
much higher than the activity of N211–280 fragment<br />
(Figure 3). These results implied that the SR-rich motif of<br />
the N protein is responsible for the majority of the binding<br />
to MIF.<br />
DISCUSSION<br />
In the present study, by employing a series of biochemical<br />
and biophysical methods, we have firstly reported<br />
that SARS-N protein has a specific binding to human MIF<br />
protein, and the further yeast two-hybrid assay demonstrated<br />
that the fragment amino acid 140–210 of SARS-N<br />
probably contribute to the N/MIF interaction. MIF was first<br />
discovered as a lymphokine involved in delayed hypersensitivity<br />
and various macrophage functions, including<br />
phagocytosis, spreading, and tumoricidal activity. It has<br />
been reported that MIF is associated with the pathogenesis<br />
of a variety of diseases (Crichlow et al. , 2009;<br />
Oddo et al., 2005). Multiple clinical studies have indicated<br />
the utility of MIF as a biomarker for different diseases that<br />
have an inflammatory component; these include systemic<br />
infections and sepsis, autoimmune diseases, cancer, and<br />
metabolic disorders such as type 2 diabetes and obesity<br />
(Shen et al., 2003; Wistow et al., 2005). Over the past<br />
few years, the significance of the role of MIF in a variety<br />
of both solid and hematologic tumors has been<br />
established. Both circulating and intracellular MIF protein<br />
levels are elevated in cancer patients and MIF expression<br />
reportedly correlates with stage, metastatic spread and<br />
disease-free survival.<br />
To our knowledge, the fragment amino acid 140–210<br />
contains SR-rich motif (containing rich serine and<br />
arginine) that is multifunctional and conserved in N<br />
protein of coronaviruses (Toney et al., 2004). SR-related<br />
proteins are often involved in protein-RNA and protein–<br />
protein interactions (Blencowe et al., 1999), and the SRrich<br />
motif is conserved in the N protein of coronavirus. It<br />
has been reported that SR-rich motif is indispensable for<br />
SARS N oligomerization and for N protein interaction with<br />
SARS-CoV membrane protein. The SR-rich motif is also<br />
responsible for the interaction with hnRNPA1 in SARS<br />
(Haibin et al., 2005). In addition, this motif is also involved<br />
in interaction with Hubc9 in SARS (Fan et al., 2006). All<br />
of these facts indicate that the SR-rich motif of the N<br />
protein might play a crucial role in SARS infection.<br />
In conclusion, our data have shown for the first time<br />
both in vitro and in vivo that the nucleocapsid protein of<br />
SARS has a high binding affinity to human MIF and such<br />
a protein–protein interaction involves the region amino<br />
acid 140–210 of MHV-N. However, the pathophysiological<br />
significance of the interaction between N and MIF<br />
is largely unknown; elucidation of these questions will<br />
depend on further studies. Moreover, the disruption of<br />
interaction between N and MIF proteins using RNA<br />
interference technology may provide further clues to the<br />
specific function of N and MIF protein. This current<br />
research contributes useful data that will shed light on the<br />
molecular mechanism of N phosphorylation and provide<br />
valuable clues for mutagenic studies in disrupting virion<br />
assembly and replication and developing antiviral agents.<br />
ACKNOWLEDGEMENT<br />
The authors gratefully acknowledge the financial support<br />
provided by Jilin administration of traditional Chinese<br />
medicine TCM science project (20090461042).<br />
REFERENCES<br />
Blencowe BJ, Bowman JA, McCracken S, Rosonina E (1999). SR<br />
related proteins and the processing of messenger RNA precursors.<br />
Biochem. Cell. Biol., 77:257-271.<br />
Crichlow GV, Lubetsky JB, Leng L, Bucala R (2009).Structural and<br />
kinetic analyses of macrophage migration inhibitory factor active site<br />
interactions. Biochem., 48:132-139.<br />
Fan Z, Zhuo Y, Tan X, Zhou Z, Yuan J, Qiang B, Yan J, Peng X, Gao GF
(2006). SARS-CoV Nucleocapsid Protein Binds to hUbc9, a Ubiquitin<br />
Conjugating Enzyme of the Sumoylation System. Med. Virol.,<br />
78:1365-1373.<br />
Haibin L, Qing C, Shen X, Hualiang J (2005). The nucleocapsid protein<br />
of SARS coronavirus has a high binding affinity to the human cellular<br />
heterogeneous nuclear ribonucleoprotein. FEBS. Lett., 579:2623-<br />
2628.<br />
Hatakeyama S, Matsuoka Y, Ueshiba H (2008). Dissection and<br />
identification of regions required to form pseudoparticles by the<br />
interaction between the nucleocapsid (N) and membrane (M) proteins<br />
of SARS coronavirus. Virology, 380:99-108.<br />
He R, Dobie F, Ballantine M, Leeson A, Yan L, Batien N, Cutts T,<br />
Andonov A, Jingxin C, Booth TF, Plummer FA, Tyier S, Baker L, Li XG<br />
(2004). Analysis of multimerization of SARS coronavirus<br />
nucleocapsid protein. Biochem. Biophys. Res. Commun., 316:476-<br />
483.<br />
Hiscox JA, Wurm T, Wilson L, Britton P, Cavanagh D, Brooks G<br />
(2001).The coronavirus infectious bronchitis virus nucleoprotein<br />
localizes to the nucleolus. J. Virol., 75:506-512.<br />
Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR (2003). A novel<br />
coronavirus associated with severe acute respiratory syndrome. N.<br />
Engl. J. Med., 348 (20):1953-1966.<br />
Lai M, Cavanagh D (1997). The molecular biology of coronaviruses.<br />
Advances. Virus. Research., 48:1-100.<br />
Marra MA, Jones SJ, Astell CR, Holt RA (2003). The Genome sequence<br />
of the SARS-associated coronavirus. Science, 300(5624):1399-1404.<br />
Narayanan K, Maeda A, Maeda J, Makino S (2000). Characterization of<br />
the coronavirus M protein and nucleocapsid interaction in infected<br />
cells. J. Virol., 74:8125-8134.<br />
Oddo M, Calandra T, Bucala R, Meylan PR (2005).Macrophage<br />
migration inhibitory factor reduces the growth of virulent<br />
Mycobacterium tuberculosis in human macrophages. Infect. Immun.,<br />
73:3783-3786.<br />
Lin et al. 2277<br />
Peiris JS, Lai ST, Poon LL, Guan Y (2003). Coronavirus as a possible<br />
cause of severe acute respiratory syndrome. Lancet,<br />
361(9366):1319-1325.<br />
Rota PA, Oberste MS, Monroe SS, Nix WA (2003). Characterization of a<br />
novel coronavirus associated with severe acute respiratory<br />
syndrome. Science, 300(5624):1394-1399.<br />
Sambrook J, Russell DW (2001). Molecular cloning: A laboratory<br />
manual. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor<br />
Laboratory Press.<br />
Shen L, Hu J, Lu H, Wu M, Qin W, Wan D(2003).The apoptosisassociated<br />
protein BNIPL interacts with two cell proliferation-related<br />
proteins, MIF and GFER.FEBS. Lett., 540:86-90.<br />
Toney J, Navas-Martin S, Weiss S, Koeller A (2004). Sabadinine: a<br />
potential non-peptide anti-severe acute-respiratory-syndrome agent<br />
identified using structure-aided design. J. Med. Chem., 47(5):1079-<br />
1080.<br />
Versteeg G, Bredenbeek P, Spaan W (2007). Group 2 coronaviruses<br />
prevent immediate early interferon induction by protection of viral<br />
RNA from host cell recognition. Virology, 361(1):18-26.<br />
Wang Y, Zhang X(1999).The nucleocapsid protein of coronavirus<br />
mouse hepatitis virus interacts with the cellular heterogeneous<br />
nuclear ribonucleoprotein A1 in vitro and in vivo. Virology., 265(1):96-<br />
109.<br />
Wistow GJ, Shaughnessy M, Lee DC, Hodin J(1993).A macrophage<br />
migration inhibitory factor is expressed in the differentiating cells of<br />
the eye lens. Proc. Natl. Acad. Sci., 90:1272-1275.
African Journal of Microbiology Research Vol. 5(16), pp. 2278-2286, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.611<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Isolation and characterization of high caffeine-tolerant<br />
bacterium strains from the soil of tea garden<br />
Fang-Yuan Fan 1 , Yan Xu 1 , Yue-Rong Liang 1 , Xin-Qiang Zheng 2 , Devajit Borthakur 1,3 and<br />
Jian-Liang Lu 1 *<br />
1 Tea Research Institute, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.<br />
2 Key Laboratory of Horticultural Plants Growth, Development and Biotechnology, Agricultural Ministry of China,<br />
Hangzhou 310058, China.<br />
3 Tocklai Experimental Station, Tea Research Association, Jorhat, Assam 785001, India.<br />
Accepted 30 July, 2011<br />
Microbial biodegradation is an important and promising decaffeination approach because of its low<br />
cost and high security. The efficiency of this approach mainly depends on the characteristics of the<br />
strain. Twenty bacterium strains were isolated from soil of tea garden and exhibited high caffeinetolerance,<br />
and these strains could grow on the medium supplemented with 20 g L -1 caffeine as the sole<br />
source for nitrogen and carbon. According to the physiological-biochemical characteristics and 16S<br />
rRNA gene sequence blast, two of them (CT25 and CT75) were identified as Pseudomonas putida. The<br />
results also showed that caffeine was not the preferential nutrition source for growth of strain CT25,<br />
and high level caffeine inhibited the bacterium amplification although caffeine could be metabolized by<br />
this strain. The CT25 grew well in agitated liquid medium when the incubation temperature was around<br />
30°C. High initial concentration of strain inoculums would improve the efficiency of caffeine<br />
degradation.<br />
Key words: Caffeine-tolerant bacterium, identification, 16S rRNA gene, caffeine biodegradation, growth<br />
condition.<br />
INTRODUCTION<br />
Caffeine (1,3,7-trimethylxanthine), a member of purine<br />
alkaloids, was isolated first from tea and coffee in the<br />
early 1820s and then reported in the beans, leaves and<br />
fruits of more than 60 plants, such as coffee, tea, mate,<br />
guarana, cola and cocoa (Heckman et al., 2010).<br />
Medicinally, caffeine is used as a cardiac, cerebral and<br />
respiratory stimulant (Buerge et al., 2003). However, it<br />
can also produce adverse effects on human health<br />
unavoidably. Caffeine consumption during pregnancy is<br />
associated with an increased risk of fetal growth<br />
restriction (CARE Study Group, 2008). Excessive intake<br />
of caffeine can increase the risk of miscarriage,<br />
independent of pregnancy-related symptoms (Weng et<br />
*Corresponding author. E-mail: jllu@zju.edu.cn. Tel: 86-571-<br />
88982704.<br />
al., 2008). Statistically significantly higher risk of ovarian<br />
cancer among women who reported drinking five or more<br />
cups of caffeinated coffee per day compared to nonconsumers<br />
of coffee (Lueth et al., 2008). The ingestion of<br />
either a high or low glycemic index meal with caffeinated<br />
coffee significantly impairs acute insulin sensitivity<br />
compared with the effect of decaffeinated coffee (Moisey<br />
et al., 2008). Large sample and population-based studies<br />
indicated that regular daily dietary caffeine intake is<br />
associated with disturbed sleep and associated daytime<br />
sleepiness (Roehrs and Roth, 2008). For older women,<br />
blood pressure response is augmented, and subjective<br />
feelings of behavioral mood state are attenuated to a<br />
greater degree following acute caffeine ingestion (Arciero<br />
and Ormsbee, 2009). Higher level of caffeine also leads<br />
to higher risk of developing bone problems, such as<br />
osteoporosis (Hallstrom et al., 2006), alveolar bone loss<br />
in ligature-induced periodontitis (Bezerra et al., 2008), an
d disturbing the early stages of bone healing (Duarte et<br />
al., 2009). Tea polyphenols, an excellent antioxidant<br />
extracted from tea (Panza et al., 2008), is always contaminated<br />
with amount of caffeine because of the technical<br />
constraints of decaffeination, which hampers their<br />
application in the field of pharmaceutical and functional<br />
food.<br />
Environmentally, caffeine has been suggested as a<br />
chemical indicator of ecosystem since it is difficultly<br />
metabolized (Ogunseitan, 2002). When the exposure<br />
dosage of caffeine in water was higher than 300 mg L -1 ,<br />
no zebrafish embryos could survive, and caffeine-treated<br />
embryos exhibited significantly reduced tactile sensitivity<br />
frequencies of touch-induced movement even when<br />
exposure dosages were very low (Chen et al., 2008).<br />
Reports also showed that caffeine is toxic to most of the<br />
aquatic organism such as Ceriodaphnia dubia (Moore et<br />
al., 2008) and coral algae (Pollack et al., 2009). Therefore,<br />
release of some caffeine-containing wastes, such as<br />
coffee pulp/husk from coffee producing factory, infused<br />
tea leaves and sewage from the factory of tea<br />
polyphenols preparation, leads serious ecological<br />
pollutions and becomes a big disposal problem (Pandey<br />
et al., 2000).<br />
To date, four major approaches for reducing caffeine<br />
content from caffeine-containing products are conventional<br />
breeding, physicochemical methods, genetic<br />
engineering and microbial degradation, whilst approach<br />
for wastes decaffeination is rarely concerned. Decaffeination<br />
through conventional breeding is difficult to achieve<br />
because of non-availability of the low-caffeine containing<br />
germplasms. Genetically-modified (GM) plants with low<br />
caffeine can be directly obtained either by down-regulating<br />
the caffeine synthesis pathway or by up-regulating<br />
the caffeine degradation pathway (Yadav and Ahuja,<br />
2007). However, this approach can not be applied<br />
recently because of their instability and ecological risk of<br />
GM plants, even though successful study in laboratory<br />
scale was reported (Kato et al., 2000). Decaffeination<br />
with special reagents extraction (Sun et al., 2010) and<br />
chromatograph separation is usually adopted in practices<br />
(Dong et al., 2011; Lu et al., 2010; Ye et al., 2009)<br />
although these techniques need to be optimized furthermore<br />
since their lack of security or/and yield. Comparatively,<br />
decaffeination through microbial degradation is more<br />
beneficial and attractive than other methods since it can<br />
be conducted safely and at a low budgetary requirement<br />
(Gummadi and Santhosh, 2006; Ramarethinam and<br />
Rajalakshmi, 2004).<br />
Microbial decaffeination, mainly including bacteria and<br />
fungi, was reported first in the early 1970’s (Kurtzman<br />
and Schwimmer, 1971). Reports showed that Aspergillus<br />
and Penicillium (Hakil et al., 1998), Rhizopus delemar<br />
(Tagliari et al., 2003) and Aspergillus tamari (Gutierrez-<br />
Sanchez et al., 2004) can effectively degrade caffeine.<br />
Major bacteria with capability of caffeine degradation<br />
belong to Pseudomonas (Gokulakrishnan et al., 2005;<br />
Mazzafera, 2004; Sarath Babu et al., 2005; Dash and<br />
Fan et al. 2279<br />
Gummadi, 2006a), beside some other species within the<br />
genera Alcaligenes, Rhodococcus, Klebsiella (Dash and<br />
Gummadi, 2006b), Acinetobacter, Enterobacter,<br />
Stenotrophomonas, Pantoea spp. (Padmanabhan et al.,<br />
2003) and Serratia marcescens (Mazzafera et al., 1996).<br />
The characteristic and mechanism of caffeine biodegradation<br />
were investigated in many Pseudomonas strains<br />
which were isolated from the wastewater (Ogunseitan,<br />
1996, 2002) and from the soils of coffee plantation area<br />
(Dash and Gummadi, 2007, 2008; Gokulakrishnan and<br />
Gummadi, 2006; Gokulakrishnan et al., 2007; Gummadi<br />
et al., 2009b) and normal agricultural land (Topp et al.,<br />
2006; Yu et al., 2008, 2009). Comparatively, the<br />
Pseudomonas isolated from coffee plantation area<br />
exhibits the highest caffeine tolerance, indicating that<br />
caffeine content in the growth environment might affect<br />
the caffeine tolerance capability of the strains. Recently,<br />
bioreactor for decaffeination was also developed<br />
(Gummadi et al., 2009a, 2009b) and optimized<br />
(Gummadi and Santhosh, 2010) by using Pseudomonas<br />
strains isolated from coffee plantation area. However,<br />
researchers never stop exploring the new strains with<br />
high caffeine tolerance and efficient caffeine degradation<br />
since the strain is the one of most important factors for<br />
developing caffeine biodegradation technique. In this<br />
study, twenty strains with high caffeine-tolerant capability<br />
were isolated from the caffeine-containing soil of tea<br />
garden, and two of them were identified as Pseudomonas<br />
putida based on the physiological-biochemical tests and<br />
16S rRNA gene analysis. Effect of caffeine concentration<br />
and other culture conditions on the strain growth was also<br />
investigated.<br />
MATERIALS AND METHODS<br />
Preparation mediums for screening and amplifying the<br />
caffeine-tolerant bacteria<br />
Solution with mineral substances, including KCl (0.370 g L -1 ),<br />
MgSO4 (0.205 g L -1 ), Fe2(SO4)3 (0.710 g L -1 ), Na2HPO4·12H2O<br />
(0.205 g L -1 ), CaCl2 (80 mg L -1 ), ZnSO4·7H2O (15 g L -1 ),<br />
NaMoO4·2H2O (12 g L -1 ), MnSO4 (11 g L -1 ), CuSO4 (10 g L -1 )<br />
and H3BO4 (10 g L -1 ), was prepared and centrifuged (Beckman J2<br />
HS; Beckman Instruments Inc., Fullerton, CA, USA) at 5000 ×g for<br />
10 min after its pH value was adjusted to 7.0. The supernatant was<br />
collected and used for preparation of different culture mediums.<br />
Solid screening medium (SSM) for isolating the caffeine-tolerant<br />
bacteria was prepared by mixing the mineral solution with caffeine<br />
(2.5 g L -1 ) and agar (1.5%) and autoclaved at 121°C for 10 min.<br />
Solid purifying medium (SPM) was also prepared as SSM except<br />
20.0 g L -1 caffeine was supplemented. Liquid amplifying medium<br />
(LAM) was obtained after addition of caffeine (0.5 g L -1 ) and<br />
sucrose (5.0 g L -1 ) in the mineral solution and disinfection.<br />
Isolation, purification and amplification of caffeine-tolerant<br />
bacteria<br />
Soils were collected randomly from experimental tea garden of<br />
Zhejiang University. Some of them (100 g) were soaked in 1 L<br />
distilled water for 30 min. Solution containing microorganisms were
2280 Afr. J. Microbiol. Res.<br />
obtained by filtration and diluted 10 3 -10 6 times, and spread over the<br />
SSM surface in Petri dishes (0.5 ml solution for each dish). After<br />
incubation at 30°C for 2-3 d, the fast-growing single colony was<br />
picked up with tooth tip and inoculated on SPM surface for further<br />
purification. Twenty colonies, which could grow normally on the<br />
SPM, were separately picked up again and transferred to the tubes<br />
containing 1.0 ml LAM medium (each colony for one tube), then<br />
incubated at 150 r min -1 and 30°C in a shaking incubator (Taicang<br />
Experimental Instruments Factory, Jiangsu, China) for amplification.<br />
Three days later, 0.3 ml of bacterial solution was mixed with 0.1 ml<br />
dimethyl sulfoxide and stored at -70°C, and the remaining solution<br />
was used for further tests.<br />
Physiological-biochemical identification of caffeine-tolerant<br />
bacteria<br />
Two of the above twenty strains with high-caffeine tolerant<br />
capability, recorded as CT25 and CT75, were randomly selected for<br />
physiochemical identification. The capability to metabolize carboncontaining<br />
compounds was assessed by glycolysis test, methyl red<br />
test (MR) and Voges-Proskauer test (VP), citrate utilization test,<br />
oxidase activity and starch hydrolysis test. The activity of<br />
metabolizing nitrogen-containing compounds was assessed by<br />
indole production, hydrogen sulfide production, urease production<br />
tests and gelatin liquefaction test. In order to make further<br />
determination of the objective strains, the arginine dihydrolase<br />
activity test was also performed. The identification was carried out<br />
in detail according to the “Bergey's Manual of Determinative<br />
Bacteriology” (Buchanan and Gibbons, 2000).<br />
16S rRNA gene identification of caffeine-tolerant bacteria<br />
Amplified caffeine-tolerant bacteria solution (0.5 ml) of strain CT25<br />
and CT75 was centrifuged at 2000 ×g for 5 min and washed with<br />
PBS buffer, and suspended in distilled water (0.1 ml). Degenerate<br />
primers (forward primer: 5’-agagtttgatcmtggctcag; reverse primer:<br />
5’-ggytaccttgttacgactt, predicted length 1498 bp) were used to<br />
amplify the partial 16S rRNA gene fragments. PCRs were carried<br />
out in a 25 l mixture containing 17.3 l double-distilled water, 2.5<br />
l 10×PCR buffer, 1.5 l 25 mM MgCl2, 0.5 l 10 mM dNTPs, 0.5 l<br />
each primer, 0.2 l Taq DNA polymerase (2.5 U l -1 ) and 2 l strain<br />
resuspension. Amplification was performed on Veriti 96-well Fast<br />
Thermal Cycler (Applied Biosystems, Inc., Carlsbad, CA, USA)<br />
according to the following time program: predenaturation at 94°C<br />
for 5 min, 1 cycle; denaturation at 94°C for 45 s, annealing at 50°C<br />
for 60 s and extension at 72°C for 90 s, 30 cycles; and final<br />
extension at 72°C for 10 min, 1 cycle. Partial amplified solutions (10<br />
l) were subjected to electrophoresis for checking presence of the<br />
target band, the remaining was sent to Invitrogen (Shanghai) Life<br />
Science Corporation for sequencing. The obtained sequences were<br />
deposited in GenBank (www.ncbi.nlm.nih.gov) after blasting with<br />
known sequences by using the tool of “blastn”.<br />
Effect of culture conditions on the growth of isolated strain<br />
For evaluating the effect of oxygen, the amplified bacteria (50 l) of<br />
strain CT25 was inoculated in a conical flask containing 50 ml<br />
mineral solution supplemented with 2.0 g L -1 caffeine, and<br />
incubated in a shaking incubator at 150 r min -1 and 25ºC for 30-72<br />
h. Static culture (without shaking) was also carried out as control.<br />
For evaluating the effect of nitrogen source, the CT25 strain was<br />
inoculated in a mineral medium supplemented with 2.0 g L -1<br />
peptone instead of 2.0 g L -1 caffeine, and incubated at 150 r min -1<br />
and 25°C for 14 to 42 h.<br />
For evaluating the effect of caffeine concentration, the CT25<br />
strain was incubated in mineral medium with supplement of different<br />
concentration caffeine (0.1, 0.5, 1.0, 2.0, 5.0, 10.0 and 20.0 g L -1 ) at<br />
150 r min -1 and 25°C for 30 h.<br />
For evaluating the effect of temperature, the CT25 strain was<br />
inoculated in a caffeine-supplemented (2.0 g L -1 ) medium and<br />
shook (150 r min -1 ) at different temperature (20, 25, 30 and 35°C)<br />
for 12-72 h.<br />
After incubation, the optical density of bacterium solutions was<br />
measured at 600 nm (OD600) with a HP8453 UV-visible<br />
spectrophotometer (Hewlett Packard, CA, USA), and the residue<br />
level of caffeine in caffeine supplemented medium was also<br />
monitored by HPLC (LC20A, Shimadzu Corporation, Tokyo, Japan)<br />
method as described previously (Liang et al., 2007).<br />
Data analysis<br />
Observations were made in triplicates and the mean ± standard<br />
deviation (SD) was presented. Statistics was carried out on Version<br />
8.1 SAS System for Windows (SAS Institute Inc, Cary, NC, USA)<br />
software.<br />
RESULTS<br />
The isolated high caffeine-tolerant bacteria<br />
After screening, a total of 103 colonies were obtained<br />
based on rapid proliferation on the SSM medium<br />
containing 2.5 g L -1 caffeine. These colonies exhibited a<br />
similar appearance, circular in shape and ivory-white in<br />
colour. Twenty strains of them could grow normally but<br />
somewhat slowly on the SPM medium supplemented with<br />
20.0 g L -1 caffeine after further purification, and were<br />
recorded as CT03, CT12, CT25, CT26, CT33, CT38,<br />
CT39, CT42, CT45, CT47, CT55, CT57, CT66, CT70,<br />
CT75, CT78, CT79, CT80, CT94 and CT97 respectively.<br />
These strains can be barely differentiated from each<br />
other according to their appearances and growths,<br />
suggesting they might belong to a same genus.<br />
The characteristics of high caffeine-tolerant bacteria<br />
A series of determinative tests were carried out for<br />
identifying the randomly selected caffeine-tolerant strains<br />
(CT25 and CT75) because different genera have specific<br />
metabolic characteristics and different capacities to utilize<br />
amino acids, carbohydrates and proteins (Harley, 2008).<br />
Table 1 summarized the physiological-biochemical<br />
characteristics of the strains CT25 and CT75. Both CT25<br />
and CT75 were preliminary identified as Pseudomonas<br />
putida after comparison with Bergey’s Manual of<br />
Determinative Bacteriology (Buchanan and Gibbons,<br />
2000).<br />
The partial gene (1498bp) of 16S rRNA genes from<br />
strains of CT25 and CT75 were amplified and sequenced<br />
(Figures 1 and 2), then deposited in GenBank<br />
(GU828029 for CT25 and GU828030 for CT75).
Table 1. Physiological-biochemical characteristics of caffeine-tolerant bacteria*.<br />
Items CT25 CT75<br />
Glucose fermentation + +<br />
Lactose fermentation + +<br />
VP & MR - -<br />
Citrate utilization test - -<br />
Starch hydrolysis - -<br />
Oxidase + +<br />
Indole production - -<br />
Hydrogen sulfide production - -<br />
Gelatin hydrolysis - -<br />
Urease + +<br />
Nitrate reduction + +<br />
Arginine dihydrolase + +<br />
“+” for positive and “-” for negative.<br />
Figure 1. Partial sequence of 16S rRNA gene from CT25 strains (GU828029).<br />
Homology search with the tool of “blastn” showed that the<br />
sequences of 16S rRNA gene from CT25 and CT75 were<br />
99% identical with corresponding sequences of<br />
Pseudomonas putida (Table 2). The result confirmed the<br />
previous identification on the basis of physiologicalbiochemical<br />
characteristics, therefore, the isolated twenty<br />
strains, including randomly selected CT25 and CT75,<br />
were the Pseudomonas putida strains with high caffeinetolerant<br />
capability.<br />
Fan et al. 2281<br />
The growth of high caffeine-tolerant bacteria<br />
Incubation results showed that the OD600 value of CT25<br />
strain under shaking culture condition was significantly<br />
higher than that undern static culture condition (Table 3),<br />
suggesting the strain CT25 is an aerobe and its growth<br />
depends obviously on oxygen concentration in medium.<br />
Different source of N and C test showed that the OD600<br />
value of CT25 cultured in mineral medium with addition of
2282 Afr. J. Microbiol. Res.<br />
Figure 2. Partial sequence of 16S rRNA gene from CT75 strains (GU828030).<br />
Table 2. Blast result of 16S rRNA gene from CT25 and CT75.<br />
Accession Description E-Value Consistency (%)<br />
GU828029 Pseudomonas putida strain 25 16S ribosomal RNA gene, partial sequence Sequence from CT25<br />
GU828030 Pseudomonas putida strain 75 16S ribosomal RNA gene, partial sequence Sequence from CT75<br />
CP002290 Pseudomonas putida BIRD-1, complete genome 0.0 99<br />
CP000926 Pseudomonas putida GB-1, complete genome 0.0 99<br />
AE015451 Pseudomonas putida KT2440 complete genome 0.0 99<br />
CP000712 Pseudomonas putida F1, complete genome 0.0 99<br />
AM411058 Pseudomonas putida partial 16S rRNA gene, strain 5zhy 0.0 99<br />
DQ657850 Pseudomonas sp. ND9 16S ribosomal RNA gene, partial sequence 0.0 99<br />
Table 3. Effect of oxygen on growth of CT25 in the medium with<br />
2.0gL -1 caffeine * .<br />
Items 30 h 72 h<br />
Static culture 0.0633±0.0034 a 0.0634±0.0067 a<br />
Shaking culture 0.1461±0.0032 b 0.2827±0.0029 b<br />
* The OD600 was used as growth indicator of bacterium, and the<br />
different letters in column indicated significant difference at p
600<br />
OD<br />
Table 4. Comparison of CT25 growth cultured with different sources for nitrogen and carbon * .<br />
Nitrogen source 14 h 30 h 42 h<br />
Caffeine (2.0g L -1 ) 0.0305±0.0012a 0.1461±0.0032a 0.2514±0.0033a<br />
Peptone (2.0g L -1 ) 0.8911±0.0045b 1.0084±0.0049b 1.3896±0.0174b<br />
* The OD600 was used as growth indicator of bacterium, and the different letters in column indicated significant<br />
difference at p
2284 Afr. J. Microbiol. Res.<br />
Percentage of residual caffeine in %)<br />
110<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
%)<br />
30 C<br />
35°C<br />
0 20 40 60 80<br />
Time (h)<br />
Figure 5. Caffeine-degrading efficiency of CT25 cultured in medium<br />
supplemented with 2.0 g L-1 initial caffeine at different temperature.<br />
The bar shows the standard deviation.<br />
DISCUSSION<br />
The isolated twenty strains could grow normally on the<br />
medium supplemented with 20 g L -1 caffeine, indicating<br />
these strains can tolerate high concentration of caffeine<br />
and metabolize it as sole nitrogen (N) and carbon (C) for<br />
their growth demand since no other source of N and C<br />
was present in that medium. Previous reports showed<br />
that some Pseudomonas sp. strains isolated from coffee<br />
plantation area could survive in the mediums<br />
supplemented with caffeine at initial concentration of 10 g<br />
L -1 (Gokulakrishnan and Gummadi, 2006; Gummadi and<br />
Santhosh, 2006; Dash and Gummadi, 2008), 15 g L -1<br />
(Dash and Gummadi, 2007; Dash et al., 2008) and 20 g<br />
L -1 (Gummadi et al., 2009b; Gummadi and Santhosh,<br />
2010) and degrade the caffeine sufficiently in short<br />
period. From this view, the isolated strains in this study<br />
might possess similar high caffeine-tolerant capability to<br />
the reported ones although some investigation should be<br />
further conducted with these strains. It was also<br />
suggested that soil microorganisms have the ability for<br />
natural enrichment under different ecological condition<br />
according to their chemotaxis (Mazzafera, 2002). High<br />
caffeine-tolerant bacteria can be isolated from caffeinecontaining<br />
soils such as tea and coffee garden where<br />
caffeine is continuously released from the litters of these<br />
plants.<br />
Series physiological-biochemical reactions (Buchanan<br />
and Gibbons, 2000) and the sequence of 16S rRNA gene<br />
(Garrity et al., 2004) are widely used for bacterial<br />
identification. The randomly selected strains (CT25 and<br />
CT75) with high caffeine-tolerant capability were<br />
identified as Pseudomonas putida according to the<br />
similarity of physiochemical characteristics and 16S rRNA<br />
gene sequences. It seemed that all of the isolated twenty<br />
strains might belong to Pseudomonas putida since the<br />
appearance of the colonies was quite similar, and this<br />
species might be a dominant bacterium in soil of tea<br />
garden because special metabolic pathway(s) related to<br />
caffeine degradation were reported to be present<br />
inherently in many Pseudomonas strains (Dash and<br />
Gummadi, 2006b; Mazzafera, 2004; Yamaoka-Yano and<br />
Mazzafera, 1999; Yu et al., 2009).<br />
The growth of strain CT25 was highly depended on<br />
oxygen in liquid medium, which is consistent with other<br />
reports on the growth of Pseudomonas strains (Beltrán et<br />
al., 2006; Gummadi and Santhosh, 2006; Gummadi et<br />
al., 2009b; Middelhoven and Lommen, 1984; Woolfolk,<br />
1975). Although caffeine could be used as sole source for<br />
N and C, the strain CT25 amplified more slowly in<br />
medium supplemented with caffeine than that with<br />
peptone, and its growth was significantly inhibited especially<br />
when high level caffeine was supplemented. Similar<br />
results were reported previously in the studies about<br />
other caffeine-degrading strains (Sarath Babu et al.,<br />
2005; Gokulakrishnan and Gummadi, 2006; Dash and<br />
Gummadi, 2007, 2008; Gummadi et al., 2009b). It was<br />
suggested that the isolated bacteria can utilize the<br />
caffeine as their nonpreferential N and C sources and<br />
may take time to activate their metabolic pathway(s) to<br />
transform the caffeine into some components directly<br />
used for growth. This result agrees with some findings<br />
that the caffeine-degrading enzymes of bacteria were<br />
induced (Dash and Gummadi, 2007; Gummadi and<br />
Santhosh, 2006; Sarath Babu et al., 2005; Ogunseitan,<br />
2002; Woolfolk, 1975). The fastest amplification was<br />
observed when the strain CT25 was incubated at around<br />
30°C, while amplification would dramatically decrease<br />
when the strain was incubated at 35°C, which coincides<br />
with the previous observations on the growth of other<br />
Pseudomonas strains (Dash and Gummadi, 2007; Sarath<br />
Babu et al., 2005) and the optimum catalytic temperature<br />
of caffeine-degrading enzyme (Beltrán et al., 2006;<br />
Yamaoka-Yano and Mazzafera, 1999). However, this<br />
result is not in accordance with another report in which<br />
the optimum temperature for the growth of Pseudomonas<br />
sp. strain was 35°C (Gummadi and Santhosh, 2006). The<br />
difference might be explained as different strain or other<br />
culture parameters such as caffeine concentration.<br />
Caffeine was metabolized rapidly when the CT25 was<br />
incubated at 30°C, while slowly at 35°C (Figures 4 and<br />
5), indicating that the caffeine degradation was positively<br />
correlated with the bacterial growth as more bacterial<br />
cells would metabolize much more caffeine into nutrition<br />
for further bacterial growth. Thus, in order to improve the<br />
decaffeination efficiency, the initial inoculums concentration<br />
should be optimized. Compared with the caffeine<br />
residue, metabolites of caffeine were barely detected in<br />
the incubated medium (Figure 4), suggesting that initial<br />
degradation of caffeine might be a rate-limiting step and
the metabolites might be instantly broken down<br />
furthermore.<br />
The bacteria isolated from soil of tea garden (such as<br />
CT25) have high capability for caffeine-tolerance and<br />
caffeine-degradation, and can be used as an alternative<br />
for decaffeination of tea products or caffeine-containing<br />
wastes. Further studies like usage method<br />
(immobilization or not), optimization of decaffeination<br />
efficiency and assessment of products quality and<br />
security, should be conducted prior to exploitation of the<br />
bacterial strains for caffeine degradation purpose.<br />
ACKNOWLEDGMENT<br />
This study was financed by the National Natural Science<br />
Foundation of China and “R&D Project” of Education<br />
Office of Zhejiang Province.<br />
REFERENCES<br />
Arciero PJ, Ormsbee M J (2009). Relationship of blood pressure,<br />
behavioral mood state, and physical activity following caffeine<br />
ingestion in younger and older women. Appl. Physiol. Nutr. Metab.,<br />
34: 754-762.<br />
Beltrán JG, Leask RL, Brown WA (2006). Activity and stability of<br />
caffeine demethylases found in Pseudomonas putida IF-3. Biochem.<br />
Eng. J., 31: 8-13.<br />
Bezerra JP, da Silva LR, de Alvarenga Lemos VA, Duarte PM, Bastos<br />
MF (2008). Administration of high doses of caffeine increase alveolar<br />
bone loss in ligature-induced periodontitis in rats. J. Periodontol., 79:<br />
2356-2360.<br />
CARE Study Group (2008). Maternal caffeine intake during pregnancy<br />
and risk of fetal growth restriction: a large prospective observational<br />
study. BMJ, 337: a2332.<br />
Buchanan RE, Gibbons NE (2000). Bergey's manual of determinative<br />
bacteriology. Williams & Wilkins Co., Baltimore.<br />
Buerge IJ, Poiger T, Muller MD, Buser HR (2003). Caffeine, an<br />
anthropogenic marker for wastewater contamination of surface<br />
waters. Environ. Sci. Technol., 37: 691-700.<br />
Chen YH, Huang YH, Wen CC, Wang Y H, Chen WL, Chen LC, Tsay<br />
HJ (2008). Movement disorder and neuromuscular change in<br />
zebrafish embryos after exposure to caffeine. Neurotoxicol. Teratol.,<br />
30: 440-447.<br />
Dash SS, Gummadi SN (2006a). Biodegradation of caffeine by<br />
Pseudomonas sp. NCIM 5235. Res. J. Microbiol., 1: 115-123.<br />
Dash SS, Gummadi SN (2006b). Catabolic pathways and<br />
biotechnological applications of microbial caffeine degradation.<br />
Biotechnol. Lett., 28: 1993-2002.<br />
Dash SS, Gummadi SN (2007). Degradation kinetics of caffeine and<br />
related methylxanthines by induced cells of Pseudomonas sp. Curr.<br />
Microbiol., 55: 56-60.<br />
Dash SS, Gummadi SN (2008). Inducible nature of the enzymes<br />
involved in catabolism of caffeine and related methylxanthines. J.<br />
Basic Microbiol., 48: 227-233.<br />
Dong ZB, Liang YR, Fan FY, Ye JH, Zheng XQ, Lu JL (2011).<br />
Adsorption behavior of the catechins and caffeine onto<br />
polyvinylpolypyrrolidone. J. Agric. Food Chem., 59: 4238–4247.<br />
Duarte PM, Marpues MR, Bezerra JP, Bastos MF (2009). The effects of<br />
caffeine administration on the early stage of bone healing and bone<br />
density: A histometric study in rats. Arch. Oral. Biol., 54: 717-722.<br />
Garrity GM, Bell JA, Lilburn TG (2004). Bergey’s manual of systematic<br />
bacteriology. Springer, New York. Gokulakrishnan S, Chandraraj K,<br />
Gummadi SN (2005). Microbial and enzymatic methods for the<br />
removal of caffeine. Enzyme Microb. Technol., 37: 225-232.<br />
Gokulakrishnan S, Gummadi SN (2006). Kinetics of cell growth and<br />
Fan et al. 2285<br />
caffeine utilization by Pseudomonas sp. GSC 1182. Process Biochem.,<br />
41: 1417-1421.<br />
Gokulakrishnan S, Chandraraj K, Gummadi SN (2007). A preliminary<br />
study of caffeine degradation by Pseudomonas sp. GSC 1182. Int. J.<br />
Food Microbiol., 113: 346-350.<br />
Gummadi SN, Santhosh D (2006). How induced cells of Pseudomonas<br />
sp. increase the degradation of caffeine. Cent. Eur. J. Biol., 1: 561-<br />
571.<br />
Gummadi SN, Santhosh D (2010). Kinetics of growth and caffeine<br />
demethylase production of Pseudomonas sp. in bioreactor. J. Ind.<br />
Microbiol. Biotechnol., 9: 901-908.<br />
Gummadi SN, Dash SS, Devarai S (2009a). Optimization of production<br />
of caffeine demethylase by Pseudomonas sp. in a bioreactor. J. Ind.<br />
Microbiol. Biotechnol., 36: 713-720.<br />
Gummadi SN, Ganesh KB, Santhosh D (2009b). Enhanced degradation<br />
of caffeine by immobilized cells of Pseudomonas sp. in agar-agar<br />
matrix using statistical approach. Biochem. Eng. J., 44: 136-141.<br />
Gutierrez-Sanchez G, Roussos S, Augur C (2004). Effect of the<br />
nitrogen source on caffeine degradation by Aspergillus tamarii. Lett.<br />
Appl. Microbiol., 38: 50-55.<br />
Hakil M, Denis S, Viniegra-Gonzalez G, Augur C (1998). Degradation<br />
and product analysis of caffeine and related dimethylxanthines by<br />
filamentous fungi. Enzyme Microb. Tech., 22: 355-359.<br />
Hallstrom T, Wolk A, Glynn A, Michaelsson K (2006). Coffee, tea and<br />
caffeine consumption in relation to osteoporotic fracture risk in a<br />
cohort of Swedish women. Osteoporo.s Int., 17: 1055–1064.<br />
Harley JP (2008). Laboratory exercises in microbiology (7 th ed.).<br />
McGraw-Hill Co., New York.<br />
Heckman MA, Weil J, Mejia G (2010). Caffeine (1, 3, 7trimethylxanthine)<br />
in foods: a comprehensive review on consumption,<br />
functionality, safety, and regulatory matters. J. Food Sci., 75: 77-87.<br />
Kato M, Mizuno K, Crozier A, Fujimura T, Ashihara H (2000). Plant<br />
biotechnology: caffeine synthase gene from tea leaves. Nature, 406:<br />
956-957.<br />
Kurtzman RH, Schwimmer S (1971). Caffeine removal from growth<br />
media by microorganism. Experientia, 27: 481-482.<br />
Liang HL, Liang YR, Dong JJ, Lu JL, Xu HR, Wang H (2007).<br />
Decaffeination of fresh green tea leaf (Camellia sinensis) by hot<br />
water treatment. Food Chem., 101: 1451-1456.<br />
Lu JL, Wu MY, Yang XL, Dong ZB, Ye JH, Borthakur D, Sun QL, Liang<br />
YR (2010). Decaffeination of tea extracts by using poly (acrylamideco-ethylene<br />
glycol dimethylacrylate) as adsorbent. J. Food Eng., 97:<br />
555-562.<br />
Lueth NA, Anderson KE., Harnack LJ, Fulkerson JA, Robien K (2008).<br />
Coffee and caffeine intake and the risk of ovarian cancer: the Iowa<br />
women’s health study. CCC, 19: 1365-1372.<br />
Mazzafera P, Olsson O, Sandberg G (1996). Degradation of caffeine<br />
and related methylxanthines by Serratia marcescens isolated from<br />
soil under coffee cultivation. Microb. Ecol., 31: 199-207.<br />
Mazzafera P (2002). Degradation of caffeine by microorganisms and<br />
potential use of decaffeinated coffee husk and pulp in animal feeding.<br />
Sci. Agric., 59: 815-821.<br />
Mazzafera P (2004). Catabolism of caffeine in plants and<br />
microorganisms. Front. Biosci., 9: 1348-1359.<br />
Middelhoven WJ, Lommen A (1984). Degradation of caffeine by<br />
Pseudomonas putida C3024: the effect of oxygen concentration. J.<br />
Microbiol., 50: 298-300.<br />
Moisey LL, Kacker S, Bickertom AC, Robinson LE, Graham TE (2008).<br />
Caffeinated coffee consumption impairs blood glucose homeostasis<br />
in response to high and low glycemic index meals in healthy men.<br />
Am. J. Clin. Nutr., 87: 1254-1261.<br />
Moore MT, Greenway SL, Farris JL (2008). Assessing caffeine as an<br />
emerging environmental concern using conventional approaches.<br />
Arch. Environ. Contam. Toxicol., 54: 31-35.<br />
Ogunseitan OA (1996). Removal of caffeine in sewage by<br />
Pseudomonas putida: implications for water pollution index. World J.<br />
Microbiol. Biotechnol., 12: 251-256.<br />
Ogunseitan OA (2002). Caffeine-inducible enzyme activity in<br />
Pseudomonas putida ATCC 700097. World J. Microbiol. Biotechnol.,<br />
18: 423-428.<br />
Padmanabhan P, Padmanabhan S, Derito C, Gray A, Gannon D, Snape<br />
JR, Tsai CS, Park W, Jeon C, Madsen EL (2003). Respiration of 13 C-
2286 Afr. J. Microbiol. Res.<br />
labeled substrates added to soil in the field and subsequent 16S rRNA<br />
gene analysis of 13 C-labeled soil DNA. Appl. Environ. Microbiol., 69:<br />
1614-1622.<br />
Pandey A, Soccol CR, Nigam P, Brand D, Mohan R, Roussos S (2000).<br />
Biotechnological potential of coffee pulp and coffee husk for<br />
bioprocesses. Biochem. Eng. J., 6: 153-162.<br />
Panza VSP, Wazlawik E, Schütz GR, Comin L, Hecht KC, Silva EL<br />
(2008). Consumption of green tea favorably affects oxidative stress<br />
markers in weight-trained men. Nutrition, 24: 433-442.<br />
Pollack K, Balazs K, Ogunseitan O (2009). Proteomic assessment of<br />
caffeine effects on coral symbionts. Environ. Sci. Technol., 43: 2085-<br />
2091.<br />
Ramarethinam S, Rajalakshmi N (2004). Caffeine in tea plants<br />
[Camellia sinensis (L.) O. Kuntze]: in situ lowering by Bacillus<br />
licheniformis (Weigmann) Chester. Indian J. Exp. Biol., 42: 575-580.<br />
Roehrs T, Roth T (2008). Caffeine: sleep and daytime sleepiness. Sleep<br />
Med. Rev., 12: 153-162.<br />
Sarath Babu VR, Patra S, Thakur MS, Karanth NG, Varadaraj MC<br />
(2005). Degradation of caffeine by Pseudomonas alcaligenes CFR<br />
1708. Enzyme Microb. Technol., 37: 617-624.<br />
Sun QL, Shu H, Ye JH, Lu JL, Zheng XQ., Liang YR (2010).<br />
Decaffeination of green tea by supercritical carbon dioxide. J. Med.<br />
Plants Res., 4: 1161-1168<br />
Tagliari CV, Sanson RK, Zanette A, Franco TT, Soccol CR (2003).<br />
Caffeine degradation by Rhizopus delemar in packed bed column<br />
bioreactor using coffee husk as substrate. Braz. J. Microbiol., 34:<br />
102-104.<br />
Topp E, Hendel JG, Lu ZX, Chapman R (2006). Biodegradation of<br />
caffeine in agricultural soils. Can. J. Soil Sci., 86: 533-544.<br />
Weng XW, Odouli R, Li DK (2008). Maternal caffeine consumption<br />
during pregnancy and the risk of miscarriage: a prospective cohort<br />
study. Am. J. Obstet. Gynecol., 198: 279.e1 - 279.e8.<br />
Woolfolk CA (1975). Metabolism of N-methylpurines by a Pseudomonas<br />
putida strain isolated by enrichment on caffeine as sole source of<br />
carbon and nitrogen. J. Bacteriol., 123: 1088-1106.<br />
Yadav SK, Ahuja PS (2007). Towards generating caffeine-free tea by<br />
metabolic engineering. Plant Foods Hum. Nutr., 62: 185-191.<br />
Yamaoka-Yano DM, Mazzafera P (1999). Catabolism of caffeine and<br />
purification of a xanthine oxidase responsible for methyluric acids<br />
production in Pseudomonas putida L. Rev. Microbiol., 30: 62-70.<br />
Ye JH, Jin J, Liang HL, Lu JL, Du YY, Zheng XQ, Liang YR (2009).<br />
Using tea stalk lignocellulose as an adsorbent for separating<br />
decaffeinated tea catechins. Bioresour. Technol., 100: 622-628.<br />
Yu CL, Kale Y, Gopishetty S, Louie TM, Subramanian M (2008). A<br />
novel caffeine dehydrogenase in Pseudomonas sp. strain CBB1<br />
oxidizes caffeine to trimethyluric acid. J. Bacteriol., 190: 772-776.<br />
Yu C L, Louie TM, Summers R, Kale Y, Gopishetty S, Subramanian M<br />
(2009). Two distinct pathways for metabolism of theophylline and<br />
caffeine are coexpressed in Pseudomonas putida CBB5. J.<br />
Bacteriol., 191: 4624-4632.
African Journal of Microbiology Research Vol. 5(16), pp. 2287-2296, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.613<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Biopreservative potential of marine lactobacillus spp<br />
K. Indira*, S. Jayalakshmi, A. Gopalakrishnan and M. Srinivasan<br />
Centre of Advanced Study in Marine Biology, Faculty of Marine Sciences,<br />
Annamalai University Parangipettai – 608 502, Tamil Nadu – India.<br />
Accepted 30 July, 2011<br />
Bacteriocins are of special interest due to their potential value as natural preservative. The present<br />
study is a trial for production of such bacteriocin from a marine Lactobacillus sp. Lactic acid bacteria<br />
(LBA) was isolated from fish gut (Mugil cephalus) and prawn muscle (Peneaus monodon) samples and<br />
their density were found to be 5.2 x 10 7 and 6.4 x 10 7 CFU/g respectively. Various pathogens were<br />
isolated from ready to eat pickle samples (bottled). The LAB strains were tested against 10 different<br />
commercial antibiotics. Among them Vancomycin was the only antibiotic that showed a minimum of<br />
40% resistance to the LAB strains tested. LAB strains were optimized at different parameters and<br />
maximum bacteriocin production was at pH 6, temperature of 35°C, 3.5% of salt concentration, 24th h of<br />
incubation period. Bacteriocin produced by these strains were precipitated from the culture filtrate<br />
using methanol and TCA which was further dialyzed, centrifuged and lyophilized. Lactobacillus<br />
fermentum was selected as the most potential strain for both bacteriocin production as well as<br />
antimicrobial activity. sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis<br />
proved that the obtained protein is homologous with a molecular weight of 18 kDa. FT-IR spectrum also<br />
confirmed the obtained protein as a bacteriocin. The study revealed that Lactobacillus strains of marine<br />
origin are having the potential to be used as biopreservatives especially in seafood industries. The<br />
production of bacteriocin from L. fermentum was found to be ideal for industrial scale production and<br />
commercial utilization.<br />
Key words: Bacteriocin, Lactobacillus fermentum, biopreservative, fourier transform infrared (FT-IR).<br />
INTRODUCTION<br />
Food fermentation has a great economic value and the<br />
products obtained through this process put in improving<br />
human health. In this way LAB has contributed in a lot to<br />
fermented foods worldwide. The major genera of LAB is<br />
of importance in the food industry are Bifidobacterium,<br />
Enterococcus, Lactobacillus, Lactococcus, Leuconostoc,<br />
Oenococcus, Pediococcus, Streptococcus and<br />
Tetragenococcus. They are significant in production and<br />
preservation of milk and dairy products, meat and meat<br />
products, vegetable products and as forage crops for<br />
animals (Lee, 2004).<br />
Mankind had exploited lactic acid bacteria (LAB) for the<br />
production of fermented foods because of their ability to<br />
produce desirable changes in taste, flavor and texture as<br />
well as to inhibit pathogenic and spoilage microbes.<br />
Since they are involved in numerous food fermentations<br />
*Corresponding author. E. mail: microind03@yahoo.co.in. Tel:<br />
04144 – 243070 – 243071. Fax: 04144-243555.<br />
for millennia, it is assumed that most representatives of<br />
this group do not pose any health risk to man and are<br />
designated as GRAS (generally recognized as safe)<br />
organisms (Holzapfel et al., 1995). Different antimicrobials,<br />
such as lactic acid, acetic acid, hydrogen peroxide,<br />
carbon dioxide and bacteriocins produced by these<br />
bacteria, can inhibit pathogenic and spoilage microorganisms,<br />
extending the shelf-life and enhancing the<br />
safety of food products (Aymerich et al., 2000).<br />
One important attribute of LAB is their ability to produce<br />
antimicrobial compound called bacteriocin. Bacteriocins<br />
are proteinaceous compound, inhibitory effects towards<br />
sensitive strains produced by both Gram-positive and<br />
Gram-negative bacteria (Tagg et al., 1976). Bacteriocins<br />
producing lactic acid bacteria are used in food fermentations<br />
especially in dairy products. In USA, only nisin<br />
produced by Lactobacillus lactis has been permitted as a<br />
food preservative (FDA, 1988). It has also been used in<br />
health care products and cosmetics for treatment of acne.<br />
They are also being used in toothpaste and mouthwash<br />
for the inhibition of dental caries and periodontal diseases
2288 Afr. J. Microbiol. Res.<br />
(Harlander, 1993). Bacteriocins can be exploited to inhibit<br />
undesirable microorganisms in the fermentation of wine<br />
(Navarro et al., 2000), beer (Ogden et al., 1985), vegetables<br />
(Daeschel and Fleming, 1984) and dairy products<br />
(Castla et al., 1996; Ross et al., 1999). The present study<br />
is on bacteriocin production by LAB of marine environment<br />
and its use as a biopreservatives in sea foods.<br />
MATERIALS AND METHODS<br />
The fin fish and prawn samples were collected from the Annan koil<br />
landing centre (Latitude 11° 29 ’N; Longitude 79° 46’ E) for the<br />
isolation of lactic acid bacteria. The pickle samples were collected<br />
from Tuticorin. Tuna and Prawn pickles were analyzed in the<br />
present study. Homogenized extract of the fish and prawn samples<br />
were serially diluted up to 10 -5 dilutions and were plated on MRS<br />
agar (HI-MEDIA) by spread plate technique and incubated at 28 ±<br />
2°C for 24 h. The isolated potential strains were identified based on<br />
Bergey’s manual of systematic bacteriology (Buchanan et al.,<br />
1974). Approximately 10 g of sample (pickle) was homogenized in a<br />
sterile mortar and pestle using 90 ml of sterile 50% sea water and<br />
then serially diluted. About 0.1ml of the serially diluted samples was<br />
inoculated into the selective media to isolate the specific<br />
pathogens. The isolated pathogens were identified based on<br />
Bergey’s manual of systematic bacteriology (Buchanan et al.,<br />
1974).<br />
Primary screening for antibacterial activity<br />
A preliminary test for inhibitory assay of LAB against food borne<br />
pathogens, isolated from the seafood pickles was done.<br />
Well diffusion method (Reinheimer et al., 1990)<br />
After swabbing the pathogens on the Muller Hinton agar plates, 0.1<br />
ml of cell free culture broth of Lactic acid bacteria (LAB) centrifuged<br />
at 10,000 rpm for 20 min, poured into the wells and plates were<br />
incubated at 37°C for 24 h. The bacterial culture filtrate inhibiting<br />
the growth of pathogen was assessed based on the inhibition zone<br />
around the well and the results were recorded.<br />
Test for antibiotic resistance of LAB<br />
Muller Hinton Agar was used to check the antibiotic resistance of<br />
LAB against antibiotics like Ampicillin (A), Bacitracin (B),<br />
Cephotaxime (Ce), Ciprofloxacin (Cf), Erythromycin(E), Nalidixic<br />
acid (Na), Novobiocin (Nv), Penicillin-G(P), Tetracyclin (T) and<br />
Vancomycin (Va). After swabbing the LAB on MHA plates, the<br />
selected antibiotic discs were placed onto the agar medium and the<br />
incubated plates were observed for antibiotic assay.<br />
Screening of bacteriocin producing bacteria<br />
Screening was done by well diffusion method using the crude<br />
extract. The inhibitory activity was tested against the seafood borne<br />
pathogens.<br />
Optimization of cultural condition for bacteriocin production<br />
The effect of incubation period on growth and bacteriocin<br />
production was studied for 0 - 52h with 12 h intervals. The pH<br />
ranges (3, 4, 5, 6 and 7) were tested. A temperature range 20, 25,<br />
30, 35 and 40°C were optimized to find out the optimum<br />
temperature. The range of 3-5% of salt concentration was<br />
optimized. Based on the results observed in the optimization the<br />
mass scale culture was carried out with the ideal parameters.<br />
Extraction and partial purification of bacteriocins<br />
The precipitation was made by the solvent extraction method. To<br />
the filtrate obtained 70% Methanol and 10% of Tri chloroacetic acid<br />
(TCA) were added in equal proportion and kept for 48 h at room<br />
temperature. This precipitate was dissolved in deionized water and<br />
dialyzed through a 1000 molecular weight cut of dialysis membrane<br />
against deionized water. The dialysis was done for 24 h and then<br />
centrifuged. The precipitate was lyophilized and used for further<br />
analysis.<br />
Protein estimation<br />
The Folin-Ciocalteu phenol method (Lowry et al., 1951) was used<br />
for the estimation of the total protein content in the sample.<br />
FT-IR analysis<br />
In the study of molecular vibrations, Infrared spectroscopy has<br />
contributed more to this field than Raman due to the rapid<br />
developments in Infrared instrumentation (Merritt et al., 1986). The<br />
vibrational spectra can be utilized directly and simply as molecular<br />
“finger prints” to characterize and identify the molecule (Roberts et<br />
al., 1985). The lyophilized bacteriocin sample from LAB6 was<br />
subjected to FT-IR analysis. The IR spectrum of the bacteriocin was<br />
recorded with a perkin-Elmer model 297 IR spectrophotometer. One<br />
part of the extract was mixed with 99 part of dried potassium<br />
bromide and it was scanned between 600-4000 wave number (cm -<br />
1 ) at a speed of 1 micron. and with a programmed slit opening 2x<br />
and air as reference.<br />
RESULTS<br />
The total heterotrophic and lactic acid bacterial count in<br />
fish gut was found to be 2.14 x 10 9 and 5.2 x 10 7 CFU/g<br />
respectively. Similarly, the total heterotrophic and lactic<br />
acid bacterial count in prawn muscle was found to be 2 x<br />
10 9 and 6.4 x 10 7 CFU/g respectively. A total of 116<br />
morphologically distinct strains were isolated from the<br />
serially diluted fish gut and prawn muscle samples. 4<br />
strains from fish gut and 6 strains from prawn muscle<br />
samples were identified as potent strains for bacteriocin<br />
production. After the screening procedures the potential<br />
strains were identified. They are LAB1 Corynebacterium<br />
bovis, LAB2 Corynebacterium xerosis, LAB3<br />
Lactobacillus alimentarius, LAB4 Lactobacillus animalis,<br />
LAB5 Lactobacillus casei, LAB6 Lactobacillus fermentum,<br />
LAB7 Lactobacillus plantarum, LAB8 Micrococcus<br />
varians, LAB9 Staphylococcus epidermidiis, and LAB10<br />
Streptococcus mitis.<br />
Selective media used for the isolation of seafood<br />
pathogens are EMB agar, MRS agar, Listeria isolation<br />
agar, SS agar, TCBS agar, Yersinia identification agar
Figure 1. Antibiotic activity against LAB strains.<br />
Table 1. Antibiotic activity of lactic acid bacteria.<br />
LAB A B Ce Cf E Na Nv P T Va<br />
LAB1 R R R R R R R R R -<br />
LAB2 R R R R R R R R R -<br />
LAB3 R R R R R R R R R -<br />
LAB4 R R R R R R R R R -<br />
LAB5 R R R R R R R R R R<br />
LAB6 R R R I R R R R R R<br />
LAB7 R R R R R R R R R -<br />
LAB8 R R R R R R R R R -<br />
LAB9 R R R R R R R R R R<br />
LAB10 R R R R R R R R R R<br />
*I- intermediate; R- resistant.<br />
Figure 2. Antibacterial activity of bacteriocin<br />
against Vibrio parahaemolyticus<br />
where in the density of E. coli, Lactobacillus spp, Listeria<br />
spp, Salmonella, Vibrio spp and Yersinia spp were<br />
enumerated to be in the fish pickle 1.9x10 4 , 2.7x10 4 ,<br />
2.1x10 4 , 3.2x10 4 , 1.5x10 4 CFU/g. Likewise in the prawn<br />
pickle the pathogens were enumerated to be 1.3x10 4 ,<br />
1.7x10 4 , 2.2 x10 4 , 1.5 x10 4 , 2.8 x10 4 and 1.0 x10 4 CFU/g.<br />
Isolated pathogens were identified as FBP1 E.coli, FBP2<br />
Indira et al. 2289<br />
Lactobacillus vulgaris, FBP3 Listeria monocytogenes,<br />
FBP4 Listeria spp, FBP5 Salmonella spp, FBP6 Shigella<br />
spp, FBP7 Staphylococcus aureus, FBP8 Vibrio cholera,<br />
FBP9 Vibrio parahaemolyticus and FBP10 Yersinia spp.<br />
All the 10 LAB strains isolated were found to be<br />
resistant to Ampicillin (A), Bacitracin (B), Cephotaxime<br />
(Ce), Erythromycin (E), Nalidixic acid (Na), Novobiocin<br />
(Nv), Penicillin-G(P), and Tetracyclin (T) (Figure 1). The<br />
resistance against Ciproflaxacin (Cf) was shown by all<br />
the LAB strains except LAB6, which showed an intermediate<br />
activity. Resistance to Vancomycin (Va) was shown<br />
by LAB 5, LAB 6, LAB 9 and LAB 10, these results are<br />
given in Table 1.<br />
The bacteriocin obtained from LAB6 showed the<br />
maximum zone of inhibition compared to all the other<br />
strains. It showed a zone of inhibition of 7 mm against V.<br />
parahaemolyticus (Figure 2), 6 mm against L.<br />
monocytogenes, Listeria spp. 5 mm against E. coli,<br />
Salmonella spp. S. aureus and Yersinia spp and 4mm<br />
against Shigella spp. Vibrio cholerae and Lactobacillus<br />
vulgaris, whereas the supernatant of the same strain<br />
showed zone of inhibition of 5 mm against Vibrio<br />
paraheamolyticus (Figure 3), 4 mm against L.<br />
monocytogenes, S. aureus and Yersinia spp and 3 mm<br />
against E. coli, Listeria spp, Salmonella spp, Vibrio
2290 Afr. J. Microbiol. Res.<br />
Figure 3. Antibacterial activity of LAB strains against Vibrio parahaemolyticus.<br />
Figure 4. Antibacterial activity of LAB cell free extracts (Zone of clearance in mm).<br />
cholerae and Lactobacillus vulgaris. These results are<br />
given in Figures 4 and 5 respectively.<br />
The bacteriocin production was found maximum at an<br />
incubation period of 24 h. The results were depicted in<br />
(Figure 6). Among the various pH ranges studied, the<br />
growth of the potential strain was found to be highest at<br />
pH 6 (Figure 7). The optimum temperature for bacteriocin<br />
production was found to be 30 - 35°C (Figure 8). The<br />
optimum salt concentration for bacteriocin production was<br />
found to be 3.5% salt concentration (Figure 9).<br />
The amount of protein was estimated to be 0.36 mg/ml.<br />
The FT-IR Spectrum of the protein revealed the presence<br />
of peaks at the wave numbers of 3288, 3090, 2958, 2924<br />
and 2849 cm -1 which indicated the presence of NH, NH3,<br />
CH3, CH2 and CH2 groups respectively. The wave<br />
numbers 1660, 1632, 1589 and 1540 cm -1 indicated the<br />
presence of their bending mode of amide, methyl, and<br />
amide groups respectively. The asymmetric mode of the<br />
NH band occurred at the wave number 827 cm -1 . The<br />
molecular weight of bacteriocin from L. fermentum was<br />
found to be 18 kDa.<br />
DISCUSSION<br />
In the present study the isolation, partial characterization<br />
and activity of bacteriocin produced by L. fermentum was<br />
done. The bacteriocin producing lactic acid bacteria<br />
(LAB) were isolated from the fresh meat of marine fin fish<br />
and shell fish. It is interesting to note that majority of the<br />
Lactobacillus spp. that have been isolated from fresh and<br />
frozen fish/prawns were those species which were commonly<br />
found in animals and human beings (Kandler and<br />
Weiss, 1986). There are only a few reports available on<br />
isolation of LAB from fresh and seawater fish (Cone,<br />
1982; Okafor and Nzeako, 1985). The LAB strains were<br />
evaluated for the production of inhibitory substances<br />
against various food borne pathogens. The pathogens<br />
used in the present were isolated from fish pickle. All the<br />
LAB strains showed a moderate inhibitory activity against<br />
the pathogens isolated from pickle samples. The use of<br />
bacteriocinogenic starter/protective cultures could<br />
improve the quality and increase safety by inhibiting the<br />
food-borne pathogens and spoilage microorganisms.
Figure 5. Activity of bacteriocins against pathogens (Zone of clearance in mm).<br />
Figures 6. Bacteriocin activity at (a)12th h (b) 24th h (c) 36th h (d) 48th h (e) 60th h of incubation period.<br />
Indira et al. 2291
2292 Afr. J. Microbiol. Res.<br />
Figures 7. Bacteriocin activity between pH range of (a) 3, (b) 4, (c) 5, (d) 6 and 7 (e).<br />
Recent outbreaks of emerging pathogens such as L.<br />
monocytogenes that has caused severe illness through<br />
food ingestion have prompted the scientific community to<br />
focus their studies on the anti-Listeria activity of<br />
bacteriocins produced by Lactobacillus and Pediococcus<br />
strains (Todorov et al., 1999; Aymerich et al., 2000;<br />
Messens et al., 2002).<br />
In the present investigation 100% of the isolated LAB<br />
strains were resistance to Ampicillin, Bacitracin,<br />
Cephotaxime, Erythromycin, Nalidixic acid, Novobiocin,<br />
Penicillin-G and T etracyclin. However only 40% of the<br />
strains showed resistance to Vancomycin. Generally<br />
many LABs are resistant to antibiotics. This resistance<br />
attributes are often intrinsic and non transmissible<br />
(Curragh and Collins, 1992). Among antibiotics,<br />
Vancomycin is one of the last antibiotics broadly<br />
efficacious against clinical infections caused by multidrug<br />
resistant pathogens (Johnson et al., 1990).<br />
The effect of incubation period, pH, temperature and<br />
salinity of medium on the production of bacteriocin was<br />
also investigated in all LAB strains. The pH 6, temperature<br />
of 35°C, salinity of 35 ppt, 24 h of incubation was
Indira et al. 2293<br />
Figures 8. Bacteriocin activity between (a) 20°C, (b) 25°C, (c) 30°C, (d) 35°C, and (e) 40°C of temperature ranges with 5°C interval.<br />
found to be the optimal parameters for the most potential<br />
producers of bacteriocin (that is) L. fermentum. According<br />
to Ogunbanwo et al. (2003) the use of constituted<br />
medium at 30°C of incubation temperature, initial pH of<br />
5.5 and 48 to 60 h fostered the best production of<br />
bacteriocin by Lactobacillus brevis OG1 which seemed to<br />
differ from the results of the present study.<br />
L. fermentum produced bacteriocin in high level and the<br />
strain showed the maximum inhibitory activity against<br />
Vibrio parahaemolyticus, L. monocytogenes , Listeria sp.<br />
and S. aureus. Besides, the productions of bacteriocins<br />
having a wide spectrum of antibacterial activity against<br />
seafood borne pathogens like Listeria, Clostridium and<br />
even Gram-negative pathogens like Pseudomonas and<br />
E. coli to employ as biopreservatives. Accordingly L.<br />
acidophilus and L. casei (Stiles and Holzapfel, 1997) may<br />
be of great interest as probiotics strains because of their<br />
ability to adhere to intestinal epithelial cells and being of<br />
human origin.<br />
The protein purification was done by methanol and<br />
trichloroacetic acid precipitation followed by dialysis<br />
against deionised water. Extraction of bacteriocin using<br />
organic solvents indicated that bacteriocin was removed<br />
from the aqueous phase and could be recovered from the<br />
organic phase. This suggested that part of the bacteriocinmolecule<br />
has a hydrophobic character, and shares this<br />
property with most other bacteriocins (Klaenhammer,<br />
1993). In the present study also Trichloroacetic acid
2294 Afr. J. Microbiol. Res.<br />
Figures 9. Bacteriocin activity between (a) 3%, (b) 3.5%, (c) 4%, (d) 4.5% and to (e) 5% of salt concentration with 0.5% of interval.<br />
precipitation at the rate of 70% methanol and 10% tri<br />
chloroacetic acid aggregated bacteriocin from cell free<br />
broth and the antibacterial activity was also observed<br />
which the same in the bacteriocin R from L. fermentum.<br />
In the present study FT-IR Spectrum of the protein<br />
revealed the presence of peaks at the wave numbers of<br />
3288, 3090, 2958, 2924 and 2849 cm -1 which indicated<br />
the presence of NH, NH3, CH3, CH2 and CH2 groups<br />
respectively. The wave numbers 1660, 1632, 1589 and<br />
1540 cm -1 indicated the presence of their bending mode<br />
of amide, methyl, and amide groups respectively.<br />
Comparing the results with the nisin standard, the protein<br />
in the sample was confirmed as a bacteriocin. The peak<br />
at 1546 cm -1 indicated a secondary amide was reported<br />
(Silverstein et al., 1991; Yakimov et al., 1995). The FT-IR<br />
spectrum offered concrete evidence that the substance<br />
contained a peptide in its structure. Acidocin 8912<br />
(Tahara et al., 1992) and lactacin B (Barefoot and<br />
Klaenhammer, 1984) were reported to be 5.4 and 6.5<br />
kDa, respectively. In the present study the molecular<br />
weight determination thorough SDS-PAGE showed that<br />
the molecular weight of bacteriocin as 18 kDa protein.<br />
Compared to many other studies the molecular weight<br />
obtained in the present study seemed to be high.
Conclusion<br />
Figure 10. The FT-IR spectrum of Bacteriocin from L. fermentum.<br />
Lane 1 Lane 2<br />
Figure 11. SDS-PAGE of partially<br />
purified protein Lane 1-Marker,<br />
Lane 2-Partial purified Bacteriocin.<br />
The present study showed that the bacteriocin of L. fer<br />
effects on some clinically important food borne<br />
Indira et al. 2295<br />
pathogens. This revealed the potential application of<br />
bacteriocin produced by L. fermentum as a biopreservatives<br />
for the improvement of the microbial safety of<br />
fermented foods and reduction in food contamination<br />
which causes illness to human beings. The study<br />
revealed that Lactobacillus strains of marine origin are<br />
having the potential to use as biopreservatives especially<br />
in seafoods. The production of bacteriocin from L.<br />
fermentum, seems to be ideal for industrial scale<br />
production and commercial utilization.<br />
ACKNOWLEDGMENT<br />
We thank Dr. T. Balasubramanian, Dean, Faculty of<br />
Marine Sciences, Annamalai University, Parangipettai for<br />
providing facilities.<br />
REFERENCES<br />
Aymerich MT, Garriga M, Monfort JM, Nes I, Hugas M (2000).<br />
Bacteriocin-producing lactobacilli in Spanishstyle fermented<br />
sausages: Characterization of bacteriocins. Food Microbiol., 17: 33–<br />
45.<br />
Barefoot SF, Klaenhammer TR (1984). Purification and characterization<br />
of the Lactobacillus acidophilus bacteriocin lactacin B. Antimicrob.<br />
Agents Chemother., 26: 328–334.<br />
Buchanan RE, Gibbons NE, Cowan ST, Holt TG, Liston J, Murry RGE,<br />
Niven CF, Ravin AW, Stainer RY (1974). Bergey’s Manual of<br />
Determinative Bacteriology. Eds: Williams and Wilkins Co: Baltimore.<br />
Castla D, Requena T, Gomez R (1996). Antimicrobial activity of lactic<br />
acid bacteria isolated from goats milk and artisanal cheeses:<br />
characteristics of a bacteriocin produced by Lactobacillus curvatus.
2296 Afr. J. Microbiol. Res.<br />
IFPL 105. J. Appl. Bacteriol., 81: 35–41.<br />
Cone DK (1982). A Lactobacillus spp. from diseased female rainbow<br />
trout, Salmo gairdneri Richardson, in Newfoundland, Canada. J. Fish<br />
Dis., 5: 479-485.<br />
Curragh HJ, Collins MA (1992). High levels of spontaneous drug<br />
resistance in Lactobacillus. J. Appl. Bacteriol., 73: 31-36.<br />
Daeschel MA, Fleming HP (1984). Selection of lactic acid bacteria for<br />
use in vegetable fermentations. Food Microbiol., 1: 303–313.<br />
Food and Drug Administration (1988). Nisin preparation: Affirmation of<br />
GRAS status as direct human food ingredient. Federal Register., 53:<br />
11247.<br />
Harlander SK (1993). Regulatory aspects of bacteriocin used. In:<br />
Bacteriocin of LAB, ed by DG Hoover and LR Steinson San Diego,<br />
California. <strong>Academic</strong> Press Inc.<br />
Holzapfel WH, Geisen R, Schillinger U (1995). Biological preservation of<br />
foods with reference to protective cultures, bacteriocins and food<br />
grade enzymes. Inter. J. Food Microbiol., 24: 343-362.<br />
Johnson AP, Uttley AHC, Woodford N (1990). Resistance to<br />
Vancomycin and Teicoplanin: an emerging clinical problem. Cl<br />
Microbiol Rev., 3: 280-291.<br />
Kandler O, Weiss N (1986). In: Bergey's Manual of Systematic<br />
Bacteriology Vol. 2, Baltimore: Williams and Wilkins., pp.1209–1234.<br />
Klaenhammer TR (1993). Genetics of bacteriocins produced by lactic<br />
acid bacteria. FEMS Microbiol Rev., 12: 39-86.<br />
Lee YK (2004). Microbial Biotechnology principles and applications.,<br />
pp.124.<br />
Lowry OH, Rosenberg HJ, Farr AL, Randall RF (1951). Protein<br />
measurement with Foiln phenol reagent. J. Bio. Chem., 193: 265-<br />
275.<br />
Merritt WM, Dean JA, Settle FA (1986). Instrumental method of<br />
analysis. CBS, New Delhi.<br />
Messens W, Neysens P, Vansieleghem W, Vanderhoeven J, De Vuyst<br />
L (2002). Modeling Growth and Bacteriocin Production by<br />
Lactobacillus amylovorus DCE 471 in Response to Temperature and<br />
pH Values Used for Sourdough Fermentations. Appl. Env. Microbiol.,<br />
68: 1431-1435.<br />
Navarro L, Zarazaga M, Saenz J, Ruiz-Larrea F, Torres C (2000).<br />
Bacteriocin production by lactic acid bacteria isolated from Rioja red<br />
wines. J. Appl. Microbiol., 88: 44–51.<br />
Ogden K, Waites MJ, Hammond JRM (1985). Nisin and brewing. J. Inst.<br />
Brew., 94: 233–238.<br />
Ogunbanwo ST, Sanni AI, Onilude AA (2003). Characterization of<br />
bacteriocin produced by Lactobacillus plantarum F1 and<br />
Lactobacillus brevis OG1. Afr. J. Biotechnol., 2: 219-227.<br />
Okafor N, Nzeako BC (1985). Microbial flora of fresh and smoked fish<br />
from Nigerian fresh waters. Food Microbiol., 2: 71-75.<br />
Reinheimer JA, Demkow MR, Candioti MC (1990). Inhibition of coliform<br />
bacgeria by lactic cultures. Austr. J. Dairy Technol., 5-9.<br />
Roberts RM, Gilbert JC, Waldb BR, Wingrove AS (1985). Evidence for<br />
cyclic bromonium ion transfer in electrophilic bromination of alkenes:<br />
Reaction of -alkenyl glycosides with aqueous N-bromosuccinimide.<br />
Mod. Exp. Organic Chem., 52: 7663-7678.<br />
Ross RP, Galvin M, McAuliffe O, Morgan SM, Ryan MP, Twomey DP,<br />
Meaney WJ, Hill C (1999). Developing applications for lactococcal<br />
bacteriocins. Antonie van Leeuwenhoek., 76: 337–346.<br />
Silverstein RM, Bassler GC, Morrill TC (1991). Spectrometric<br />
identification of organic compounds, 5 th ed., John Wiley and Sons,<br />
New York., 512.<br />
Stiles ME, Holzaphel WH (1997). Lactic acid bacteria of foods and their<br />
current taxonomy. Int. J. Food Microbiol., 36: 1 –29.<br />
Tagg JR, Dajani AS, Wannamaker LW (1976). Bacteriocins of Gram<br />
positive bacteria. Bacteriol. Rev., 40: 722-756.<br />
Tahara T, Kanatani K, Yoshida K, Miura H, Sakamoto M, Oshimura M<br />
(1992). Purification and some properties of acidocin 8912, a novel<br />
bacteriocin produced by Lactobacillus acidophilus TK8912. Biosci.<br />
Biotechnol. Biochem., 56: 1212–1215.<br />
Todorov S, Onno B, Sorokine O, Chobert JM, Ivanova I, Dousset X<br />
(1999). Detection and characterization of a novel antibacterial<br />
substance produced by Lactobacillus plantarum ST 31 isolated from<br />
sourdough. Int. J. Food Microbiol., 48: 167-177.<br />
Yakimov MM, Timmis KN, Wray V, Fredrickson HL (1995).<br />
Characterization of a new lipopeptide surfactant produced by<br />
thermotolerant and halotolerant subsurface Bacillus licheniformis<br />
BAS50. Appl. Environ. Microbiol., 61: 1706–1713.
African Journal of Microbiology Research Vol. 5(16), pp. 2297-2303, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.616<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Ephedra alata as biologically-based strategy inhibit<br />
aflatoxigenic seedborne mold<br />
Al-Qarawi, A. A. 1 , Abd_Allah, E. F. 1 * and Hashem Abeer 2<br />
1 Department of Plant Production, College of Food and Agricultural Sciences, King Saud University, Saudi Arabia.<br />
2 Department of Botany and Microbiology, Faculty of Science, King Saud University, Saudi Arabia.<br />
Accepted 30 July, 2011<br />
Investigation has been carried out to evaluate the effect of range plant Ephedra alata as biologicallybased<br />
strategy inhibit growth characters and aflatoxin production (in vitro and in vivo) of Aspergillus<br />
flavus. The aqueous extract of E. alata had significant inhibitory potential against growth as well as<br />
aflatoxin production by aflatoxigenic seedborne mold (Aspergillus flavus). Moreover, it has been found<br />
that, the addition of 1 and 2% (w/w) of plant powder material of E. alata to corn grains and soybean<br />
seeds respectively decreased the aflatoxin contamination and improve their nutritional value (total<br />
nitrogen content, fiber content, total lipids content and ash content) under storage conditions. The<br />
results observed here suggest employment of E. alata as an alternative non-chemical mean to control<br />
aflatoxin contamination of fodder in Saudi Arabia.<br />
Key words: Biocontrol, Aflatoxins, Aspergillus flavus, Ephedra alata, nutritional value, Saudi Arabia.<br />
INTRODUCTION<br />
Aflatoxins are secondary metabolites produced by many<br />
strains of Aspergillus flavus, known to be potent<br />
carcinogens as well as hepatotoxic agents and pose<br />
serious hazards to human, animal health and milk<br />
production in many countries including Saudi Arabia.<br />
Aspergillus flavus are widely distributed in agricultural<br />
commodities like maize (Giorni et al., 2007) and soybean<br />
(Gupta and Venkitasubramanian, 1975). The death of<br />
thousands of camels in Saudi Arabia may have been<br />
caused by the consumption of these aflatoxinscontaminated<br />
fodders (Bokhari, 2010). Bioremediation of<br />
mycotoxins has been carried out by bacteria (Abd_allah<br />
and Ezzat, 2004), fungi (Abd_allah and Ezzat, 2005) and<br />
friendly chemicals such as chitosan (Abd_Allah and<br />
Hashem, 2006). Recently, impacts of natural products of<br />
plant origin have been introduced as non-chemical mean<br />
for biocontrol and bioremediation of mycotoxins in<br />
agricultural commodities (Parsaeimehr et al., 2010).<br />
Ephedra, a medicinal plant belonging to the Ephedraceae<br />
is a genus of non-flowering seed plants belonging to the<br />
Gnetales, the closest living relative of the angiosperm<br />
(Friedman, 1996). The antimicrobial potential of some<br />
*Corresponding author. E-mail: eabdallah@ksu.edu.sa.<br />
Epedhra species such as E. altissima Defs (Tricker et al.,<br />
1987), E. transitorai (Al-Khalil, 1998), E. nebrodensis<br />
(Cottiglia et al., 2005), E. major (Bagheri et al., 2009) and<br />
E. breana (Feresin et al., 2001) has been recognized.<br />
Ephedra alata is a range plant with medicinal application,<br />
belonging to ephedra native of Asia including Saudi<br />
Arabia (Abourashed et al., 2003). Additionally, the foliage<br />
of E. alata has acceptable aroma and used as food stuff<br />
during animal grazing in Saudi Arabia (Al-Taisan et al.,<br />
2010).<br />
The objective of the current study was to describe the<br />
antifungal activity of E. alata (aqueous extract of shoot<br />
system) grown in Saudi Arabia, against growth<br />
characters and aflatoxin production of local seedborne<br />
isolate of Aspergillus flavus in vitro and on both maize<br />
grains and soybean seeds under storage conditions.<br />
Also, the relevance of nutritional value of stored<br />
agricultural commodities (maize grains and soybean<br />
seeds) was studied in relation to storage treatments.<br />
MATERIALS AND METHODS<br />
Experimental mold<br />
Local aflatoxin producing isolate similar to Aspergillus flavus link<br />
was isolated from soybean seed samples collected from Derab
2298 Afr. J. Microbiol. Res.<br />
Agriculture Research Station, Riyadh, Saudi Arabia. The mold was<br />
identified using current universal keys of identification (Domsch et<br />
al., 1993) by Dr. Abeer Hashem, Botany and Microbiology<br />
Department, Faculty of Science, King Saud University, Riyadh,<br />
Saudi Arabia.<br />
Plant extract and antifungal evaluation<br />
Fresh aerial parts (shoot system) of E. alata Decne were collected<br />
from wildlife Research and Development at Thumama, Riyadh,<br />
Saudi Arabia. Plant materials were dried in dark at room<br />
temperature (25±1°C) and powdered. Known weight of powdered<br />
material was extracted with aqueous ethanol (10:90, v/v) at 30°C<br />
for overnight and filtered through double layers of Whatman no. 1<br />
filter paper. The extract was completed to known volume using<br />
aqueous ethanol as above. The extract was filtered using 0.22<br />
micron cellulose acetate filter units (Whatman, Dassel, Germany)<br />
for sterilization. The antifungal activity of plant extract was<br />
determined by disc method (Roberts and Selitrenikoff, 1988), agar<br />
plate method (Bobbarala et al., 2009) and broth culture flask using<br />
glucose-ammonium nitrate salt medium (Brain et al., 1961). The<br />
production and germination of conidia were estimated according to<br />
the methods described by Wilson et al. (2004) and Ghaly et al.<br />
(1998) respectively.<br />
Mycelial dry weight<br />
At the end of incubation period, the culture broths were filtered<br />
through pre-weighed filter papers (Whatman no. 1). The filter<br />
papers with mycelial growth washed carefully with distilled water<br />
followed by drying at 80°C up to two successive constant weights<br />
were obtained. The net dry weight of mycelia was then determined.<br />
Aflatoxin analysis<br />
Replicated samples (each 50 ml of culture growth medium or 100 g<br />
of both maize grains and soybean seeds) were extracted using<br />
chloroform and cleaned up as described by Dutton and Westlake<br />
(1985). Column chromatography (AOAC, 1970) was carried out on<br />
silica gel G-60 mesh 0.02- 0.2 (BDH Chemicals, Poole, UK).<br />
Chemical and biological confirmatory tests to aflatoxin B1 were<br />
carried out according to AOAC (1970) and Madhyastha et al.<br />
(1994), respectively. The sensitive strain of Bacillus subtilis was<br />
used throughout for biological confirmatory test (Abd_Allah and<br />
Ezzat (2004). Thin layer chromatography (TLC) plates (20 x 20 cm)<br />
coated with 0.5-mm-thick silica gel DG (Kieselgel-DG, Riedel- De<br />
Haen, Seelze-Hannover, Germany) were used for chromatographic<br />
separation of aflatoxin B1 followed with elusion of aflatoxin B1 spots<br />
using benzene: acetonitrile (98:2 [v/v]). Quantitative determination<br />
of aflatoxin B1 was done spectrophotometrically according to<br />
Nabney and Nesbitt (1965). Standard aflatoxin B1 (Sigma) was<br />
used as reference in all experiments.<br />
Storage experiments<br />
Storage experiment was carried out in polyethylene pouches (200 x<br />
150 mm) each containing 100 g of blend consisted of powdered E.<br />
alata, mixed well with powdered maize grains or soybean seeds to<br />
give final concentration of 0.5, 1.0 and 2.0% (w/w). The pouches<br />
were inoculated with A. flavus (10 6 spores/pouch). Control pouches<br />
were used as reference. The moisture content was expressed as<br />
percentage of net weight (Abd_Allah and Hashem, 2006). The<br />
storage experiment continued for six months at room temperature<br />
(25 ± 1°C) in dark.<br />
Estimation of nutritional values<br />
The nutritional values (total lipid content, ash content, fiber content,<br />
total nitrogen content) of all plant materials were estimated<br />
according to AOAC (1995).<br />
Statistical analysis<br />
All experiments were repeated at least three times and treatment<br />
means were compared using Least Significant Difference (LSD)<br />
analysis according to Daniel (1987).<br />
RESULTS<br />
Thin layer chromatographic examinations indicated that,<br />
Rf -values and color of spots developed from both<br />
chloroform extract of A. flavus and standard aflatoxin B1<br />
were the same before and after chemical confirmatory<br />
tests. The first conformity test (addition of HCl) indicated<br />
the presence of one blue spot (under UV light 366 mm)<br />
with Rf -value 0.66. The second conformity (addition of<br />
conc. HCl + Acetanhydride) test indicated the presence of<br />
two spots with Rf -values were 0.10 and 0.42<br />
respectively. Bioautographic examination (for both<br />
chloroform extract and standard aflatoxin B1) against<br />
Bacillus subtilis (Biological indicator) indicated the<br />
presence of one inhibitor zone with Rf value was 0.78.<br />
Preliminary experiment was carried out (in vitro) to<br />
demonstrate the antifungal potential of the plant (E. alata)<br />
extract against A. flavus using disc diffusion plate<br />
bioassay (Figure 1). The results in Table 1 revealed that<br />
the gradual concentrations of plant extract caused<br />
significant inhibition in both radial growth rate by percent<br />
of 41.55, 67.98, 88.83 and conidial production (Figure 2)<br />
by percent of 13.82, 50.00 and 90.42 of A. flavus,<br />
respectively .<br />
Data in Table 2 shows the inhibitory effect of plant<br />
extract on the number of germinated conidia especially<br />
after 6 h (absolutely inhibition was observed). It was<br />
noted that, the prolongation of incubation period<br />
decrease the inhibitory effect potential of plant extract at<br />
all concentrations used (Table 2).<br />
The results in Table 3 indicated clearly that all concentrations<br />
of plant extract induced significant inhibition in<br />
both mycelial growth (Figure 3) and aflatoxin B1<br />
production by percent of 33.49, 58.90, 79.76 and 65.75,<br />
83.90, 100 respectively. It is worthy to mention that such<br />
inhibitory effect of plant extract was more intense towards<br />
aflatoxin B1 production compared with mycelial growth at<br />
the same concentrations.<br />
A storage experiment was carried out to investigate the<br />
antagonistic potential of E. alata against aflatoxin<br />
production by A. flavus on maize grains and soybean<br />
seeds (in vivo) with special reference to their nutritional<br />
value. The obtained data indicated that employment of E.<br />
alata at concentrations 0.5 and 1.0% caused significant<br />
inhibition in the accumulation of aflatoxin B1 on maize<br />
grains and soybean seeds (Table 4) by percent of 63.81,
Figure 1. The antifungal activity of plant (E. alata) extract (arraw)<br />
against radial growth of A. flavus (A) using disc assay method.<br />
Table 1. Effect of different concentrations of E. alata (w/v) on radial growth rate (cm day -1 ) and conidial<br />
production ([conidia mm -2 ] X 10 4 ) of A. flavus grown at 28±°C for 96 h in dark.<br />
Treatment<br />
(E. alata w/v)<br />
Radial growth rate<br />
(cm day -1 )<br />
Conidial production<br />
(conidia mm -2 X 10 4 )<br />
Control 1.362 9.382<br />
E. alata 0.5% 0.796 8.102<br />
E. alata 1.0% 0.436 4.708<br />
E. alata 2.0% 0.152 0.584<br />
LSD at: 05 0.066 0.475<br />
Figure 2. Effect of different concentrations (A: control; B: 0.5%; C: 1.0%; D:<br />
2.0%) of plant (E. alata) extract on conidial production of A. flavus.<br />
Al-Qarawi et al. 2299
2300 Afr. J. Microbiol. Res.<br />
Table 2. Effect of different concentrations of E. alata (w/v) on number of germinated conidia (out of 50 conidia) after different<br />
incubation periods (hours).<br />
Treatment<br />
(E. alata w/v)<br />
Number of germinated conidia (out of 50 conidia) after different incubation periods (h)<br />
6 h 12 h 24 h<br />
Control 20.67 49.33 50.00<br />
E. alata 0.5% 11.00 42.83 49.17<br />
E. alata 1.0% 6.17 36.67 48.67<br />
E. alata 2.0% 0.00 32.17 47.17<br />
LSD at: 05 4.7884 3.4099 2.4237<br />
Table 3. Effect of different concentrations of E. alata (w/v) on mycelial dry weight (g 50 ml -1 culture medium) and<br />
aflatoxin B1 production (µg 50 ml -1 culture medium).<br />
Treatment<br />
(E. alata w/v)<br />
Mycelial dry weight<br />
(g 50 ml -1 culture medium)<br />
Aflatoxin B1 production<br />
µg 50 ml -1 culture medium µg g -1 dry weight<br />
Control 0.50154 351.6 701.04<br />
E. alata 0.5% 0.33354 120.4 360.97<br />
E. alata 1.0% 0.21616 56.6 261.84<br />
E. alata 2.0% 0.1015 0.0 0.0<br />
LSD at: 05 0.0331 22.192<br />
Figure 3. Effect of different concentrations [w/v] (A, control, B, 0.5%, C, 0.1%, D, 0.2%) of plant (E. alata) extract on<br />
mycelial growth of A. flavus.<br />
84.89 and 59.57, 89.72, respectively. Absolute inhibition<br />
of aflatoxin B1 accumulated in both maize and soybean<br />
grains was observed accompany with employment of<br />
2.0% (w/w) E. alata (Table 4).<br />
The results show that A. flavus caused significant<br />
deterioration in the nutritional value of maize grains<br />
(Table 5) and soybean seeds (Table 6). Such deterioration<br />
in the nutritional value of agricultural commodities<br />
was aware as significant decrease in their total lipids,<br />
crude fibre and crude protein accompanied with a<br />
significant increase in ash content (Table 5 and 6). The<br />
employment of powdered E. alata succeeded to
Al-Qarawi et al. 2301<br />
Table 4. Effect of different concentrations of E. alata (w/w) on aflatoxin B1 production (µg kg -1 ) on both maize<br />
grains and soyabean seeds stored under biological stress of A. flavus.<br />
Treatment<br />
Aflatoxin B1 production (µg /kg<br />
(E. alata w/w)<br />
-1 )<br />
Maize grains Soyabean seeds<br />
control 212.22 131.20<br />
E. alata 0.5% 76.79 53.04<br />
E. alata 1.0% 32.06 13.48<br />
E. alata 2.0% 0.0 0.0<br />
LSD at: 05 23.096 17.137<br />
Table 5. Effect of different concentrations of E. alata (w/w) on nutritional value of maize grains stored under biological stress of<br />
A. flavus.<br />
Treatment<br />
( E. alata w/w)<br />
Total lipids*<br />
Nutritional value of maize grains Z<br />
Crude fiber*<br />
Ash content* Crude protein**<br />
Control (maize before storage) 4.7752 6.3021 4.2205 2.8240<br />
Maize + A. flavus 2.2577 1.0217 6.3914 1.8387<br />
E. alata 0.5% 3.6204 2.4314 5.3093 2.1400<br />
E. alata 1.0% 4.1111 4.7984 5.4991 2.7304<br />
E. alata 2.0% 4.1139 5.3666 5.6747 3.0224<br />
LSD at: 05 0.3725 0.5438 0.1567 0.3331<br />
*= Total lipids, crude fiber and ash content expressed as percentage (%).<br />
**= Crude protein = total nitrogen (mg/g dry wieght) X 6.25.<br />
Z= Total lipids, crude fiber, ash content and crude protein of E. alata (shoot system) were 1.0425, 4.2463, 7.7599 and 3.1341,<br />
respectively.<br />
Table 6. Effect of different concentrations of E. alata (w/w) on nutritional value of soyabean seeds stored under biological stress<br />
of A. flavus.<br />
Treatment<br />
(E. alata w/w)<br />
Total lipids*<br />
Nutritional value of maize grains Z<br />
Crude fiber*<br />
Ash content* Crude protein**<br />
Control (maize before storage) 18.5986 4.3731 6.4366 34.1012<br />
Maize + A. flavus 15.4252 1.9727 7.5799 12.2231<br />
E. alata 0.5% 16.3723 2.5918 6.8635 18.0028<br />
E. alata 1.0% 17.7983 3.5118 6.4536 24.6835<br />
E. alata 2.0% 18.2606 4.0598 6.3337 30.7081<br />
LSD at: 05 0.7713 0.2725 0.6477 11.735<br />
*= Total lipids, crude fiber and ash content expressed as percentage (%).<br />
**= Crude protein = total nitrogen (mg/g dry wieght) X 6.25.<br />
Z = Total lipids, crude fiber, ash content and crude protein of E. alata (shoot system) were 1.0425, 4.2463, 7.7599 and 3.1341,<br />
respectively.<br />
protect the maize grains (Table 5) and soybean seeds<br />
(Table 6) against the destroyer effect of A. flavus. The<br />
constrictive role of E. alata was directly proportional with<br />
its employed concentrations.<br />
DISCUSSION<br />
Aflatoxins are highly toxic secondary metabolites<br />
produced by certain strains of Aspergillus flavus caused<br />
many diseases for animals as well as humans. In our<br />
investigation, the chemical and biological confirmatory<br />
tests demonstrated the production of aflatoxins B1 by our<br />
experimental mold (A. flavus). Aflatoxins contamination of<br />
foodstuffs and agricultural commodities is a worldwide<br />
problem in tropical and subtropical regions where climatic<br />
conditions and storage practices are conducive to fungal<br />
growth and mycotoxin production (Thompson and Henke,<br />
2000). Many strategies including employment of biological<br />
products from plant origin are being investigated to
2302 Afr. J. Microbiol. Res.<br />
manage deterioration of agricultural commodities<br />
including animal fodder. In the same connection,<br />
investigations of antifungal potential of Ephedra were<br />
carried out recently (Bagheri et al., 2009; Parsaeimehr et<br />
al., 2010). In our results, the aqueous extract of E. alata<br />
was found to be effective in controlling the growth rate<br />
and conidial production by A. flavus. The antifungal<br />
potential of E. alata (aqueous extract) was extended to<br />
inhibit number of germinated conidia, mycelial growth<br />
(mycelial dry weight) and aflatoxin B1 production by A.<br />
flavus in variable percentages. In the same concept, the<br />
results of storage experiment indicated that application of<br />
plant (E. alata) powder was accompanied with significant<br />
decrease in contamination of both maize grains and<br />
soybean seeds with aflatoxin. The antimicrobial potential<br />
of E. alata noted here in the present study has been attributed<br />
to presence of Cis-314-methanoproline (Caveney<br />
et al., 2001), Citronellol (Rosato et al., 2007) and<br />
Heptadecane (Bagheri et al., 2009) which are recorded<br />
as photochemicals possess antimicrobial activity found in<br />
Ephedra.<br />
In geneal, oil seeds introduced into animal feeds as<br />
source of fiber, lipids and fat soluble vitamins, however<br />
the fungal contamination lead to significant deterioration<br />
in their nutritional value due to substrate utilization by<br />
molds. Previous studies indicated the decrease in fat,<br />
protein and fiber contents of many seeds and grains<br />
involved sorghum and soybean infected with different<br />
seedborne fungi and this was accompanied with an<br />
increase in ash content (Fapohunda and Olajuyiabe,<br />
2006; Ezekiel et al., 2010). In this regard, fiber content<br />
with available protein and fat formed ready substrate for<br />
fungal activities including production of hydrolytic<br />
enzymes (Mellon et al., 2007). The results of our study<br />
recorded similar significant decrease in protein, fiber, and<br />
lipids accompanied with an increase in ash content of<br />
both maize grains and soybean seeds due to the<br />
inoculation with A. flavus. The application of plant (E.<br />
alata) powder succeeded to decrease the deterioration of<br />
the nutritional value (fat, protein, fiber, ash contents) of<br />
both maize grains and soybean seeds due to infection<br />
with A. flavus. Regarding the justification manner, our<br />
results showed E. alata possess highly antagonistic<br />
potential against growth and aflatoxin production of A.<br />
flavus in agree with Bagheri et al. (2009) and<br />
Parsacimehr et al. (2010).<br />
Furthermore, with respect to E. alata, it has been<br />
shown that range plant contain suitable contents of<br />
protein and fiber (Nawwar et al., 1985) able to<br />
compensate the decrease in nutritional value of maize<br />
grain and soybean seeds due to mold contamination. Our<br />
results provide evidence for the first time to application of<br />
E. alata as naturally additive control aflatoxin contamination<br />
of fodder in addition to improve its nutritional<br />
value. This may be a novel non-chemical strategy to<br />
protect thousands of camels in Saudi Arabia against the<br />
mystery of fodder contamination with aflatoxins, the main<br />
reason for camels' death in our country.<br />
ACKNOWLEDGMENT<br />
The authors wish to acknowledge Research Centers in<br />
both college of Science and college of food sciences and<br />
agriculture, King Saud University, Riyadh, Saudi Arabia.<br />
At the same time, we acknowledge Deanship of Scientific<br />
Research, King Saud University, Riyadh, Saudi Arabia.<br />
REFERENCES<br />
Abd_Allah EF, Ezzat SM (2004). Role of lipid metabolism through<br />
bioremediation of fusaric acid in germinating peanut seedlings.<br />
Phytoparasitica, 32: 38-42.<br />
Abd_Allah EF, Ezzat SM (2005). Natural occurrence of citrinin in rice<br />
grains and its biocontrol by Trichoderma hamatum. Phytoparasitica,<br />
33: 73-84.<br />
Abd_Allah EF,Hashem Abeer (2006). Seed mycoflora of Lens<br />
esculenta and their biocontrol by chitosan. Phytoparasitica, 34: 213-<br />
218.<br />
AOAC [Association of Official Analytical Chemists] (1970). Official<br />
Methods of Analysis (11 th ed.), Section 26.019 (a), 429. AOAC,<br />
Washington, D.C.<br />
AOAC [Association of Official Analytical Chemists] (1995). Official<br />
Methods of Analysis of AOAC International. 16 th edition, vol. 2,<br />
Arlington, Virginia.<br />
Abourashed EA, EL-Alfy Abir T, Khan IA, Walker L (2003). Ephedra in<br />
perspective- a current review. Phytother. Res., 17: 703-712.<br />
AL-Khalil S (1998). Transtorine, a new quinoline alkaloid from Ephedra<br />
transitoria. J. Natl. Prod., 61: 262–263.<br />
Al-Taisan Wafaa A, AL-Qarawi AA, Alsubiee Moodi S (2010). Effect of<br />
water stress by polyethylene glycol 8000 and sodium chloride on<br />
germination of Ephedra alata Decne seeds. Saudi J. Biol. Sci., 17:<br />
253-257.<br />
Bagheri G, Bigdeli M, Shams GM, Razzaghi AM (2009). Inhibitory<br />
Effects of Ephedra major Host on Aspergillus parasiticus Growth and<br />
Aflatoxin Production. Mycopathologia, 168: 249-255.<br />
Bobbarala V, Chadaram RK, Vadlapudi V, Katikala PK (2009).<br />
Medicinal plants as alternative biocontrol agents in the control of<br />
seed borne pathogen Macrophomina phaseolina. J. Pharm. Res., 2:<br />
1045-1048.<br />
Bokhari FM (2010). Implications of fungal infections and mycotoxins in<br />
camel diseases in Saudi Arabia. Saudi J. Biol. Sci., 17: 73-81.<br />
Brain PW, Dowkins AW, Grove JF, Hemming DL, Norris GLF (1961).<br />
Phytotoxic compounds produced by Fusarium equiseti. J. Bot., 12: 1-<br />
12.<br />
Caveney S, Charlet DA, Freitag H, Maier-Stolte M and Starratt A<br />
(2001). New observations on the secondary chemistry of world<br />
Ephedra (Ephedraceae). Am. J. Bot., 88: 1199-1208.<br />
Cottiglia F, Bonsignore L, Casu L, Deidda D (2005). Phenolic<br />
constituents from Ephedra nebrodensis. Natl. Prod. Res., 19: 117-23.<br />
Daniel WW (1987). Biostatistics: A foundation for Analysis in the Health<br />
Science. 4 th ed., John Wiley and Sons, New York, NY., pp. 292-293.<br />
Domsch KH, Gams W, Anderson TH (1993). Compendium of Soil<br />
Fungi. <strong>Academic</strong> Press, London, pp. 860.<br />
Dutton MF, Westlake K (1985). Occurrence of mycotoxins in cereals<br />
and animal feedstuffs in Natal, South Africa. J. Assoc. Off. Anal.<br />
Chem., 86: 839-842.<br />
Ezekiel CN, Kolawole DO, Olufuwa OA, Odu IA (2010). Shelf-life and<br />
pattern of deterioration in firm Tofu. Acta Satrch J. Life Phys. Sci., 3:<br />
40-47.<br />
Feresin GE, Tapia A, Lopez SN, Zacchino SA (2001). Antimicrobial<br />
activity of plants used in traditional medicine of Sun Juan Province,<br />
Argentine. J. Ethnopharmacol., 78: 103-107.<br />
Fapohunda S, Olajuyigbe OO (2006). Studies on stored cereals degradation<br />
by Alternaria tenuissima. Acta Botanica Mexicna, 77: 31-40.<br />
Friedman WE (1996). Introduction to biology and evolution of the<br />
Gnetales. Int. J. Plant Sci., 157: S1-S2.<br />
Ghaly MF, Ezzat SM, Sarhan MM (1998). Use of propolis and ultragriseofulvin<br />
to Inhibit aflatoxigenic fungi. Folia Microbiol., 43:156-160.
Giorni P, Magan, N, Pietri A, Bertuzzi T, Battilani P (2007). Studies on<br />
Aspergillus section Flavi isolated from maize in northern Italy. Int. J.<br />
Food Microbiol., 113: 330–338<br />
Gupta SK, Venkitasubrmanian TA (1975). Production of aflatoxin on<br />
soybeans. Appl. Microbiol., 29: 834-836.<br />
Madhyastha MS, Marquardi RR, Masi A, Borsa J, Froshlich AA (1994).<br />
comparison of toxicity of different mycotoxins to several species of<br />
bacteria and yeast: Use of Bacillus brevis in a disc diffusion assay. J.<br />
Food Protect, 57: 48-53.<br />
Mellon JE, Cotty PJ, Dowd MK (2007). Aspergillus flavus hydrolases:<br />
their roles in pathogenesis and substrate utilization. Appl. Microbiol.<br />
Biotechnol., 77: 497–504.<br />
Nabney J, Nesbitt BF (1965). A spectophotometric method for<br />
determining the aflatoxins. Analyst, 90: 155-160.<br />
Nawwar MAM, Barakat HH, Buddrus J, Linscheid M (1985). Alkaloidal,<br />
lignan and phenolic constituents of Ephedra alata. Phytochemistry,<br />
24: 878-879.<br />
Parsaeimehr A, Sargsyan E, Javidnia K (2010.) A comparative study of<br />
the antibacterial, antifungal and antioxidant activity and total content<br />
of phenolic compounds of cell cultures and wild plants of three<br />
endemic species of Ephedra. Molecules, 15: 1668-1678.<br />
Al-Qarawi et al. 2303<br />
Roberts WK, Selitrenikoff CP (1988). Plant cell and bacterial chitinase<br />
differ in antifungal activity. J. Gen. Microbiol., 134: 169-176.<br />
Rosato A, Vitali C, De Laurentis N (2007). Antibacterial effect of some<br />
essential oils administered alone or in combination with Norfloxacin.<br />
Phytomedicine, 14: 727–732.<br />
Thompson C, Henke SE (2000). Effect of climate and type of storage<br />
container on aflatoxin production in corn and its associated risks to<br />
wildlife species. J. Wildl. Dis., 36: 172-179.<br />
Tricker AR, Wacker CD, Preussmann R (1987). Nitrosation products<br />
from the plant Ephedra altissima and their potential endogenous<br />
formation. Cancer Lett., 35: 199-206.<br />
Wilson RA, Calvo Ana M, Chang Perng-Kuang and Keller Nancy P<br />
(2004). Characterization of the Aspergillus parasiticus 12 -desaturase<br />
gene: a role for lipid metabolism in the Aspergillus–seed interaction.<br />
Microbiol., 150: 2881–2888.
African Journal of Microbiology Research Vol. 5(16), pp. 2304-2310, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.619<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Primary resistance rates of Mycobacterium<br />
tuberculosis complex strains isolated from new<br />
tuberculosis cases: A 6-year observation<br />
Servet Kayhan*, Alper Akgüne , Hikmet Tereci and Ümit Tutar<br />
Samsun Chest Diseases and Thoracic Surgery Hospital, Turkey.<br />
Accepted 30 July, 2011<br />
The aim of the study was to evaluate the automated mycobacteria growth ındicator tube (MGIT) for drug<br />
susceptibility testing of Mycobacterium tuberculosis and to determine resistance patterns. We used<br />
BACTEC MGIT 960 System to determine the susceptibility of M. tuberculosis complex isolates to major<br />
anti tuberculous agents. Patients with single and first positive isolates were enrolled in the study. We<br />
have performed our drug susceptibility study between January 2005 and December 2010 for monitoring<br />
of drug resistance patterns in six years. A total of 1240 (77.16%) of the 1607 isolates were susceptible to<br />
all four of the antimycobacterial agents while 369 (22.96%) were found to be resistant to one or more of<br />
the drugs. The rate of isolates resistant to streptomycin (SM) was 6.84%, the other rates were 17.17% to<br />
isoniazid (INH), 5.28% to rifampicin (RIF) and 4.10% to ethambutol (ETM). Single drug resistance rates<br />
were found to be 12.13% for INH, 0.99% for RIF, 5.6% for SM, and 1.74% for ETM. The ratio of resistant<br />
isolates to all four drugs was 0.74% (n=12) and the prevalence of multidrug resistant isolates was 3.92%<br />
(n=63). It was concluded that resistance to INH and RIF continues almost in a straight line in the present<br />
study. Monitoring of drug resistance patterns is essential for accurate drug regimen in management of<br />
tuberculosis.<br />
Key words: Mycobacterium tuberculosis complex, primary resistance, ısoniazid, rifampicin.<br />
INTRODUCTION<br />
The World Health Organisation estimated the global<br />
burden of tuberculosis disease in 2009 as 9.4 million<br />
incident patients, 14 million prevalent cases and 2.38<br />
million deaths in the 2010 TB report<br />
(WHO/HTM/TB/2010-3; WHO/HTM/STB/2010-2). An<br />
estimated 11–13% of incident cases were HIV-positive.<br />
Among TB patients notified in 2009, an estimated 250,<br />
000 had multidrugresistant TB (MDR-TB). There were an<br />
estimated 440,000 cases of MDR-TB in 2008. The four<br />
countries that had the largest number of estimated cases<br />
*Corresponding author. E-mail: servet-kayhan@hotmail.com.tr.<br />
Tel: +903624400038. Fax: +903624400042.<br />
Abbrevations: MGIT, Mycobacterium growth indicator tube;<br />
MTC, Mycobacterium tuberculosis complex; TB, tuberculosis;<br />
INH, ısoniazid; RIF, rifampicin; ETM, ethambutol; SM,<br />
streptomycin; MDR-TB, multi drug resistant tuberculosis; XDR-<br />
TB, extensively drug-resistant tuberculosis.<br />
of MDR-TB in absolute terms in 2008 were China, India,<br />
the Russian Federation and South Africa. Primary<br />
resistance is the resistance pattern seen in new patients<br />
who have not previously been exposed to anti-TB drugs.<br />
Secondary resistance is the resistance pattern in patients<br />
with a previous history of anti-TB treatment and is due to<br />
ineffective chemotherapy. Fifty eight countries and<br />
territories have reported at least one case of extensively<br />
drug-resistant TB (XDR-TB). XDR-TB is defined as<br />
resistance to isoniazid and rifampicin (that is, MDR-TB)<br />
plus resistance to a fluoroquinolone and, at least, one<br />
second-line injectable agent (amikacin, kanamycin and/or<br />
capreomycin) (Bozkurt et al., 2010; EuroTB, 2007). Surveillance<br />
of primary and secondary resistance patterns is<br />
important in assessing the quality of chemo-therapy<br />
programs over several years and detecting errors in past<br />
treatments respectively. The resistant strains are<br />
characterised by a unique, lipid- containing and rigid core<br />
of the cell wall. The mycobacterial cell wall is less<br />
permeable to hydrophilic molecules than other
Table 1. Concentrations of drugs used in this study.<br />
Drug<br />
Concentration of drug after<br />
reconstitution (µg/mL)<br />
Volume added to MGIT<br />
Tubes for test (µL)<br />
Kayhan et al. 2305<br />
Final concentration in<br />
MGIT tubes (µg/mL)<br />
MGIT Streptomycin 83 100 1.0<br />
MGIT Isoniazid 8.3 100 0.1<br />
MGIT Rifampicin 83 100 1.0<br />
MGIT Ethambutol 415 100 5.0<br />
bacteria. That is why mycobacteria are resistant against<br />
the majority of drugs commonly used against bacteria<br />
(De Rossi et al., 2006). Anti tuberculous agents interfere<br />
with enzymes involved in cell wall biosynthesis (isoniazid,<br />
ethambutol, ethionamide), protein synthesis<br />
(streptomycin, other aminoglycosides, macrolides),<br />
transcription (rifampin), or DNA replication (quinolones).<br />
In M. tuberculosis spontaneous mutations occur at a<br />
frequency of approximately 10 -5 to 10 -8 (Inderlied and<br />
Nash, 1996). Since resistances to various drugs arise<br />
independently, the likelihood of spontaneous mutation to<br />
isoniazid and rifampin, for instance, is one in 10 -14 . The<br />
threat of dual mutations is one of the rationales for why<br />
an anti-tuberculosis therapy should consist of a<br />
combination of drugs (Brennan and Draper, 1994). To be<br />
successful in the management of tuberculosis, rapidly<br />
detecting the susceptibility of MTC strains to first line<br />
drugs is very important (Aydın et al., 2011).<br />
Many studies performed in Turkey confirmed that the<br />
resistance rates and patterns of MTC may show different<br />
characters in different regions (Talay et al., 2003; Ta ova<br />
et al., 1997). We aimed in this study to observe the<br />
regional and current rates of primary drug susceptibilities<br />
for MTC strains in active pulmonary tuberculosis by using<br />
clinical specimens (bronchial fluid and sputum).<br />
MATERIALS AND METHODS<br />
American Center for Disease Control (CDC) recommends<br />
performing susceptibility tests on specimens, within, 28 to 30 days<br />
after they are submitted to a laboratory, as we have done in this<br />
study (CDCP, 1993).<br />
Strains<br />
1607 MTC strains isolated from sputum and bronchial fluid samples<br />
of active pulmonary tuberculous patients who were diagnosed and<br />
treated in Samsun Pulmonary Disease and Chest Surgery Hospital<br />
from 2005 to 2010. We have reproduced positive samples by<br />
Lowenstein- Jehnsen (LJ) culture examination in a microbiology<br />
laboratory; then the single and first positive isolates from each<br />
patient enrolled in the study were used.<br />
Homogenisation and decontamination<br />
The bronchioloalveolar lavage fluids (BAL) and sputum samples of<br />
suspected tuberculosis patients were subjected to homogenisation<br />
and decontamination process by N-Acetyl-L-Cistein (NALC) and<br />
sodium hydroxide (NaOH) mixture and then to LJ culture .<br />
Culture and identification<br />
The resistance characteristics related to the primary antituberculous<br />
drugs (SM, INH, RIF, ETM) of 1607 units of MTC strains which<br />
were produced in Solid (Lowenstein-Jensen) and liquid (BACTEC<br />
12B and the Mycobacteria Growth IndicatorTube (MGIT)) nutrient<br />
media were detected by the BACTEC 960 (Becton Dickinson, USA)<br />
system. After the reproduction process, MTC and nontuberculous<br />
mycobacteria (MOTT) separation was made by a p-nitro- - -<br />
hydroxy-asetilamino-propiofen (NAP) test.<br />
Susceptibility test against primary antituberculous drugs<br />
We used BACTEC MGIT 960 System to determine the susceptibility<br />
of M. tuberculosis Complex isolates to major anti tuberculous<br />
agents. The susceptibility test was performed according to the<br />
manufacturer's recommendations (Becton, Dickinson and Company<br />
USA). This research is the result of several years study but we used<br />
same method (Trade mark; Becton, Dickinson and Company USA)<br />
and same drug concentrations in six years overall susceptibility<br />
tests. So there was not any change in the brand of drugs. Dilutions<br />
of drugs used in this study are shown in Table 1.<br />
Quality control<br />
For quality control of susceptibility tests, the ATCC 27294 (H37Rv)<br />
strain was used. The Rome Supranational Tuberculosis Reference<br />
Laboratory of World Health Organization and Turkey’s Refik<br />
Saydam Hygiene Center Tuberculosis Research Laboratories,<br />
cooperated in the preparation of a quality control program which<br />
was implemented in this study.<br />
Statistical analysis<br />
We used SSPS.15 and minitab.16 programme for statistic analysis<br />
on INH and MDR ratios by years.<br />
RESULTS AND DISCUSSION<br />
We introduced the state of primary resistance in MTC to<br />
four major antituberculous agents in the last six years in<br />
Samsun province (the central city of Turkey’s Middle<br />
Black sea region, with a population of 1.3 million) and we<br />
also retrospectively compared these values with the other<br />
regional and national determinants on drug resistance. In<br />
this study, 16,932 patient specimens were sent to our
2306 Afr. J. Microbiol. Res.<br />
Table 2. The primary resistance rates of Mycobacterium tuberculosis complex isolates according to years.<br />
Type of resistance 2005 2006 2007 2008 2009 2010 Total (n)<br />
Single drug resistance<br />
SM (%) 1(0.32) 5(1.67) 12(5) 7(2.99) 5(2.02) 13(4.69) 43(2.67)<br />
INH (%) 27(8.64) 25(8.38) 32(13.33) 26(11.11) 21(8.46) 33(11.91) 164(10.20)<br />
RIF (%) 1(0.32) 5(1.67) 6(2.50) - 2(0.80) 2(0.72) 16(0.99)<br />
ETM (%) - 7(2.34) 7(2.91) 11(4.7) 2(0.80) 1(0.36) 28(1.74)<br />
Any (total) monodrug resistance<br />
SM(%) 7(2.25) 14(4.70) 28(11.67) 14(5.98) 23(9.27) 24(8.66) 110(6.84)<br />
INH(%) 49(15.80) 39(13.08) 58(24.17) 39(16.66) 41(16.53) 50(18.05) 276(17.17)<br />
RIF(%) 19(6.12) 11(3.69) 20(8.33) 5(2.13) 15(6.04) 15(5.41) 85(5.28)<br />
ETM(%) 5(1.61) 9(3.02) 20(8.33) 23(9.82) 4(1.61) 5(1.80) 66(4.10)<br />
Resistance to 2 drugs<br />
INH-RIF(%) 13(4.19) 3(1.01) 5(2.08) 1(0.42) 4(1.61) 5(1.80) 31(1.93)<br />
INH-SM(%) 3(0.96) 6(2.01) 5(2.08) 1(0.42) 7(2.82) 5(1.80) 27(1.68)<br />
INH-ETM(%) 1(0.32) 2(0.67) 6(2.50) 5(2.13) 1(0.40) 0 15(0.93)<br />
RIF-SM(%) 0 0 0 0 3(1.20) 0 3(0.18)<br />
RIF-ETM(%) 0 0 0 1(0.42) 0 1(0.36) 2(0.12)<br />
SM-ETM(%) 0 0 1(0.42) 0 0 0 1(0.06)<br />
Resistance to 3 drugs<br />
INH-RIF-SM(%) 1(0.32) 3(1.01) 4(1.67) 0 5(2.02) 4(1.44) 17(1.05)<br />
INH-RIF-ETM(%) 2(0.64) 0 0 0 0 1(0.36) 3(0.18)<br />
INH-SM-ETM(%) 0 0 1(0.42) 3(1.28) 1(0.40) 0 5(0.31)<br />
RIF-SM-ETM(%) 0 0 0 0 0 0 0<br />
Resistance to 4 drugs<br />
INH-RIF-SM-ETM(%) 2(0.64) 0 5(2.08) 3(1.28) 0 2(0.72) 12(0.74)<br />
MDR strains<br />
MDR(%) 21(6.77) 6(2.01) 14(5.83) 4(1.70) 9(3.62) 12(4.33) 63(3.92)<br />
Total(n) n:310 n:298 n:240 n:234 n:248 n:277 n:1607<br />
microbiology laboratory. Only the single and first isolates<br />
of each new patient enrolled in the drug susceptibility<br />
study were used. The test was performed on a total of<br />
1607 isolates from January 2005 to December 2010.<br />
Three hundred and eighty nine (24.20%) isolates were<br />
obtained from females and 1218 (75.80%) were obtained<br />
from male patients. All of the isolates were obtained from<br />
respiratory samples consisting of 113 (7.03%)<br />
bronchioloalveolar lavage (BAL) and 1494 (92.7%)<br />
sputum samples. 1240 (77.16%) of isolates showed sensitivity<br />
to all four drugs. The distribution of the samples<br />
studied over the years, and resistance profiles are<br />
presented completely in Table 2.<br />
Because of global increasing in multidrug resistance<br />
rates we used statistical analysis on type of drug and<br />
years to see the changes in our province. Statistic results<br />
for INH and MDR ratios were analysed by SSPS.15 and<br />
minitab.16 programmes (Table 3). INH drug resistance<br />
rates between 2005-2007 differed a 5% significance level<br />
according to the dual rate comparison over the years.<br />
INH drug resistance rates differed between 2005-2008,<br />
2006-2007 and 2007-2008, and these were statistically<br />
significant according to the dual rate comparison over the<br />
years. The relationship between INH drug sensitivity and<br />
years was determined (chi-square, p=0.025). MDR drug<br />
resistance rates differed between 2005-2008, 2006-2007<br />
and 2007-2008 and these were statistically significant<br />
according to the dual rate comparison over the years.<br />
Between 2005 and 2006, MDR resistance rates differed<br />
at a 5% significance level according to the same method.<br />
Due to previously predicted MDR-TB rates of 20% fort<br />
he present year(2011) in the world, resistance testing in<br />
all high risk cases for drug resistance is recommended by<br />
WHO (WHO/HTM/TB/2010,3). MDR-TB diagnosis and
Table 3. Statistical analysis of isoniazid and multidrug resistance of the study (with SSPS.15 and<br />
minitab.16).<br />
Years<br />
INH resistance<br />
MDR resistance<br />
Z account P Z account P<br />
2005-2006 0.94 0.348 2.34 0.019<br />
2005-2007 -2.44 0.015 -0.25 0.806<br />
2005-2008 -0.29 0.775 2.44 0.015<br />
2005-2009 0.01 0.992 1.11 0.268<br />
2005-2010 -0.76 0.447 0.69 0.491<br />
2006-2007 -3.27 0.001 -2.27 0.023<br />
2006-2008 -1.15 0.252 0.20 0.841<br />
2006-2009 -0.87 0.383 -1.13 0.259<br />
2006-2010 -1.66 0.097 -1.59 0.113<br />
2007-2008 2.04 0.042 2.37 0.018<br />
2007-2009 2.34 0.019 1.23 0.219<br />
2007-2010 1.68 0.093 0.86 0.390<br />
2008-2009 0.28 0.779 -1.26 0.207<br />
2008-2010 -0.43 0.667 -1.71 0.088<br />
2009-2010 -0.73 0.465 -0.42 0.676<br />
treatment must be done according to international<br />
guidelines (WHO/HTM/TB/2010-3; WHO/HTM/STB/2010-<br />
2). The World Report 2008 on antituberculosis drug<br />
resistance’ reported global risks for one or more drug<br />
resistance rates 0-56.3% in new cases, 0- 85.9% in<br />
patients treated previously, and 0-68.9% in all cases<br />
(WHO, 2009). According to the Turkish Ministry of<br />
Health’s 2008 report, 18,452 tuberculous patients were<br />
recorded. The incidence of tuberculosis in Samsun<br />
province in 2008 was 25.8 and the case speed was 28.0<br />
in Samsun. 414 new tuberculosis cases were diagnosed<br />
in 2005, 384 in 2006, 327 in 2007 and 346 in 2008<br />
(Bozkurt et al., 2010).<br />
According to the results in the Turkey (2008) TB report,<br />
a total of 4,963 drug susceptibility patient test were<br />
examined and 19.1% were found to be resistant to at<br />
least one drug. The highest rate of resistance among<br />
drugs belonged to isoniazid. Drug susceptibility tests<br />
detected the total multidrug resistant (MDR-TB) ratio to<br />
be 5.3% (263 people), 3% in new cases and 18.6% in<br />
cases having been previously treated (Table 4) (Bozkurt<br />
et al., 2010). We found 15.74% primary resistance to at<br />
least one drug in this study. Mono drug primary<br />
resistance rates for SM, INH, RIF, ETM were 6.84, 17.17,<br />
5.28 and 4.10% respectively. INH primary resistance<br />
rates are higher than the other major drugs in the present<br />
study and much greater than Turkey’s rates. MDR-TB<br />
has been identified as 3.92%. This rate is lower than the<br />
global estimated average ratio (20%) and Turkey’s ratio<br />
(5.3%) but higher than national primaries (3.0%)<br />
(WHO/HTM/STB/2010-2; Bozkurt et al., 2010). Due to a<br />
low ratio of susceptibility testing in the area (4963 tests in<br />
18452 cases 26.89% for 2008), these results for the<br />
country may not reflect the real resistance state in<br />
Kayhan et al. 2307<br />
Turkey; however, this study reflects the real and nearly<br />
exact drug resistance rates of provincial tuberculosis. The<br />
limitation of our study is not having the secondary<br />
resistance rates at the same time.<br />
In recent years, a variety of resistance test studies<br />
against major drugs have been performed in our country<br />
and the comparative results are shown in Table 4.<br />
We have also analysed the rates of primary, secondary<br />
and total resistance in Turkey in Table 5, by using the<br />
2005-2008 data of Turkish Ministry of Health (Bozkurt et<br />
al., 2010). Secondary resistance rates were extremely<br />
higher than primaries. The ratio of drug resistance to INH<br />
was high compared with the other major drugs. In<br />
addition, multiple and single drug resistances in these<br />
years were close to each other on some level in our<br />
country and in our study.<br />
Regional differences in the resistance prevalence<br />
studies were published by authors. Arseven and his<br />
colleagues reported results from the provinces of the<br />
Eastern Black Sea region between the years 1985 and<br />
1990. A total of 564 (40.6%) of the 1388 culture-positive<br />
TB patients were determined to be resistant to at least<br />
one of the following: INH, RIF, SM, and ETM. Drug<br />
resistance rates against INH, RIF, SM and ETM were<br />
29.6, 17.1, 23.3 and 8.8% respectively. They measured<br />
the poly (more than one) drug-resistance rate to be<br />
22.4%, and the rate of MDR strains to be 13% (Arseven<br />
et al., 1995). Saral and his colleagues found the rates of<br />
resistance to INH, RIF, SM and ETM in a study as 24.6,<br />
15.8, 9.9 and 18.8% respectively. In the same study, the<br />
rate of MDR-MTC was reported as 14.7% (Saral et al.,<br />
2007). Aydın et al. (2011) performed a similar study in<br />
Trabzon and found the single drug resistance to INH to<br />
be 6.1%, RIF 0.5% , SM 5.2% and ETM 2.4%. In the
2308 Afr. J. Microbiol. Res.<br />
Table 4. Some study results about primary resistance in Turkey.<br />
Reference City/Region Date<br />
Number of isolates<br />
(susceptibility test studied)<br />
Primary resistance rates of major anti-TB drugs<br />
SM(%) RIF(%) INH(%) EMB(%)<br />
Turkey (2008) Whole country 2005-2008 15735 8.37 6.77 13.37 4.23<br />
Present study Samsun 2005-2010 1607 6.84 5.28 17.17 4.10<br />
Yolsal et al Regional metaanalysis 1984-1989 368 8.8 5.7 14.4 2.2<br />
Yolsal et al Regional metaanalysis 1990-1995 2848 10.1 8.9 8.8 3.0<br />
Do an et al Sivas 1999-2004 316 15.2 4.1 19.9 2.5<br />
Güneri et al Aegean region 1999-2001 387 0 5.7 12.4 0<br />
Çetinkaya et al Elazı 1989-1994 125 16.6 7.6 11.5 1.2<br />
Sürücüo lu et al Manisa 1997-2003 285 13.3 6.0 14.4 8.4<br />
Talay et al. (2003) stanbul 1997-2000 135 13.3 3.0 8.8 2.2<br />
Otkun et al (38) Edirne 1996 44 32.0 11.0 30.0 9.0<br />
Karada et al. (2004) Samsun 2004 50 4.0 4.0 8.0 2.0<br />
Aydın et al. (2011) Zonguldak 2003-2005 99 13.1 2.0 18.2 3.0<br />
Aydın et al. (2011) Trabzon 2005-2010 212 13.7 5.7 17.5 5.7<br />
Korkmaz et al. (2002) Gaziantep 2002-2003 104 2.89 10.58 25 18.27<br />
Korkmaz et al. (2002) Gaziantep 2002-2003 104 2.89 10.58 25.04 25.96<br />
same study, of the 212 isolates, 25 (11.8%)<br />
strains were multiple drug resistant 10(4,7%)<br />
(Aydın et al., 2011). Many studies have been<br />
performed on relevant city analysis of TB for<br />
mono drug and multidrug resistance ( enol et al.,<br />
2004; Uçar et al., 2010). For example Aydın et al.<br />
(2011) analysed 125 strains in the province of<br />
Zonguldak and reported the sensitivity rate to all<br />
drugs as 69.6%, resistance rate to INH as 23.2%<br />
and the rate of multidrug resistance as 8% in 2005<br />
(Aydın et al., 2008). In our country, it has been<br />
reported that INH+RIF resistant strains are 2.7%<br />
in Isparta, 7 and 3% (two studies done at different<br />
times) in Edirne, and 12.8 and 19.6% in<br />
Gaziantep (two different studies) (Yaylı et al.,<br />
2003; Tansel et al., 2003; Balcı et al., 1999; Gani<br />
et al., 2002). Another study reported resistance<br />
rates in our city (Samsun) as 8% to INH, 4% to<br />
RIF, 4% to SM, 4% to ETM, 2% to pyrazinamide<br />
and 4% to MDR-TB strains in 2004 (Karada et<br />
al., 2004).<br />
The prevalence of MTC drug resistance varies<br />
from one part of the world to another (Jaffar et al.,<br />
2005). In the United States, drug-resistant<br />
tuberculosis was detected in 14.2% in 1991 and<br />
10% in 1997 (Bloch et al., 1994; Espinal et al.,<br />
2001). In the United States, isoniazid resistance<br />
was the most prevalant and accounted for 8%.<br />
Isoniazid resistance has ranged from 0% in New<br />
Caledonia to 7.9% in Mozambique, and was 10%<br />
in India (Pereira et al., 2005). An article from<br />
Saudi Arabia reported the fact that the rate of<br />
resistance to isoniazid varied from one part of the<br />
country to another such as: 4.2-7.2% in Riyadh,<br />
6% in Dammam and Taif, 10.3- 28.7% in Jeddah<br />
and 41% in Gizan. A 15-year study found rates of<br />
resistance to INH in different drug concentrations<br />
as follows: 12.5% resistance in INH (1 g/mL),<br />
and 2.9% resistance in INH (5 g/mL) in Dhahran<br />
(Jaffar et al., 2005). The prevalence of MDR-TB<br />
among new TB cases may differ in diverse<br />
geographies such as 14% in Estonia, 9% in<br />
China, Henan province, 9% in Lithuania, 9% in<br />
Russia, Ivanovo province, 5% in Iran and 4.5% in<br />
China, Zhejiang province (Espinal et al., 2001). In<br />
the early stages of tuberculosis treatment, the<br />
most potent bactericidal drug is isoniazid. INH<br />
resistance may also be an indicator of success in<br />
the treatment of tuberculosis. Storla and<br />
colleagues reported a high treatment failure in<br />
areas with high resistance to INH in Bangladesh<br />
(Storla et al., 2007).<br />
Directly observed therapy (DOT) in TB patients<br />
has been successfully completed in some<br />
countries such as the United States and a significant<br />
fall in TB and MDR-TB cases was provided<br />
contrary to the global rising in the number of
Table 5. The rates of primary, secondary and total drug resistance types in Turkey in 2005-2008.<br />
Drugs Resistance type 2005 (%) 2006 (%) 2007 (%) 2008 (%)<br />
INH Primary 9.0 10.7 11.9 11.3<br />
secondary 27.4 23.8 27.6 27.9<br />
Total 11.5 12.6 14.4 13.8<br />
RIF Primary 4.4 4.5 4.9 3.9<br />
Secondary 21.1 19.8 18.7 21.8<br />
Total 6.7 6.7 7.1 6.6<br />
ETM Primary 3.0 3.6 2.8 3.4<br />
Secondary 10.0 13.2 8.3 9.6<br />
Total 4.0 5.0 3.6 4.3<br />
SM Primary 7.0 8.4 7.1 6.5<br />
Secondary 15.2 17.0 13.8 12.9<br />
Total 8.1 9.7 8.2 7.5<br />
MDR-TB Primary 3.1 3.2 2.9 3.0<br />
Secondary 17.7 16.6 15.5 18.6<br />
Total 5.1 5.1 4.9 5.3<br />
multidrug-resistant tuberculosis. WHO declared the fact<br />
that between 1995 and 2009, a total of 41 millionTB<br />
patients were successfully treated in DOT, and up to six<br />
million lives were saved, including two million women and<br />
children.<br />
In conclusion, resistance to INH and RIF continues,<br />
almost in a straight line in Samsun Province. DOT must<br />
not be disregarded due to global rises in drug resistant<br />
MTC strains. Surveillance of the primary resistance<br />
patterns is important in assessing the quality of<br />
chemotherapy programs over several years.<br />
REFERENCES<br />
Arseven O, Eraksoy H, Uzun Y, Sepkin C, Kalaycıoglu A, Ozmenoglu<br />
M, Bolukbası O (1995). The resistance rates of Mycobacterium<br />
tuberculosis strains to antituberculosis drugs in the Eastern Blacksea<br />
Region Turkey. J. Klimik, 8(2): 63-67.<br />
Aydın F, Kaklıkkaya N, Bayramoglu G, Ozkul G, Buruk K, Dinc U, Kose<br />
T, Dede R (2011). Resistance Rates of Mycobacterium tuberculosis<br />
complex strains isolated from Clinical Specimens. Mikrobiyol Bull.,<br />
45(1): 36-42.<br />
Aydın O, Begendik CF, Kulah C, Aktas E, Sumbuloglu V (2008).<br />
Determination of susceptibilities of Mycobacterium tuberculosis<br />
strains isolated in Zonguldak to primary anti-tuberculosis drugs via<br />
BACTEC MGIT 960 system. Mikrobiyol. Bull., 38(2): 61-70<br />
Balcı , Bayram A, Filiz A (1999). Resistance in Mycobacterium<br />
tuberculosis to first line drugs. Tur. J. Infect., 13(4): 521-525.<br />
Bloch AB, Cauthen GM, Onorato IM (1994). Nationwide survey of drugresistant<br />
tuberculosis in the United States. JAMA, 271: 665–671<br />
Bozkurt H, Türkkanı MH, Musaonba ıo lu S, Güllü Ü, Yıldırım A, Baykal<br />
A, Özkara (2010). Warfare against tuberculosis in Turkey, 2010<br />
Turkish Ministry for Health report.<br />
Brennan JP, Draper P (1994). Ultrastructure of Mycobacterium<br />
tuberculosis. In: Bloom BR, ed. Tuberculosis: Pathogenesis,<br />
Protection, and Control. Washington DC: ASM Press, pp. 271–84.<br />
Kayhan et al. 2309<br />
Centers for Disease Control and Prevention (1993). Initial therapy for<br />
tuberculosis in the era of multidrug resistance: recommendations of<br />
the advisory council for the elimination of tuberculosis. MMWR Mortal<br />
Morbid Weekly Rep., 42 (RR-7):1.<br />
De Rossi E, Ainsa JA, Riccardi G (2006). Role of mycobacterial efflux<br />
transporters in drug resistance: an unresolved question. FEMS<br />
Microbiol. Rev., 30(1): 36-52.<br />
EuroTB (2007). Definitions for the WHO/EuroTB Joint Tuberculosis<br />
Data Collection. EuroTB,www.eurotb.org .<br />
Espinal MA, Laszlo A, Simonsen L (2001). Global trends in resistance<br />
to anti-tuberculosis drugs: World Health Organization-International<br />
Union against Tuberculosis and Lung Disease Working Group on<br />
Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med.,<br />
344: 1294–1303.<br />
Gani O, Zer Y, Balcı , Bayram A, Korkmaz G (2002). Retrospective<br />
analysis of sample examined in Mycobacteriology laboratory.<br />
Mikrobiyol Bul., 32(3-4):225-9.38(2): 61-70.<br />
Inderlied CB, Nash KA (1996). Antimicrobial agents: in vitro<br />
susceptibility testing, spectra of activity, mechanisms of action and<br />
resistance, and assays for activity in biologic fluids. In: Lorian V, ed.<br />
Antibiotics in Laboratory Medicine. 3rd ed. Baltimore: Williams &<br />
Wilkins., pp. 127–175.<br />
Jaffar A, Amal A, Mahmoud S (2005). Susceptibility Pattern and<br />
Epidemiology of Mycobacterium tuberculosis in a Saudi Arabian<br />
Hospital: A 15-Year Study From 1989 to 2003. Chest, 128:5 3229-<br />
3232; doi:10.1378/chest.128.5.3229.<br />
Karada A, Tokaç M, Güvenli A, Sünbül M, Günaydın M, Saniç A<br />
(2004). Resistance Ratio to Major Antituberculosis Drugs of<br />
Tuberculosis Complex Bacilli Isolated from Clinical Samples ANKEM<br />
Derg., 18(4): 189-192.<br />
Pereira M, Tripathy S, Inamdar V (2005). Drug resistance pattern of<br />
Mycobacterium tuberculosis in seropositive and seronegative HIV-TB<br />
patients in Pune, India. Indian J. Med. Res., 121: 235–239.<br />
Saral BÖ, Sucu N, Aktoz Boz G, Erdem M, Köksal (2007). Evaluating<br />
drug resistance in 442 Mycobacterium tuberculosis strains with<br />
BACTEC method. Tur. J. Thorax, 8(3): 174-178.<br />
Storla DG, Rahim Z, Islam MA (2007). Drug resistance of<br />
mycobacterium tuberculosis in the Sunamganj district of Bangladesh.<br />
Scand. J.Infect. Dis., 39: 142-145.<br />
enol G, Kömürcüo lu B, Kömürcüo lu A (2004). Resistance rates to
2310 Afr. J. Microbiol. Res.<br />
anti-tuberculosis drugs in Mycobacterium tuberculosis strains. Tur. J.<br />
Infect., 18(4): 441-445.<br />
Talay F, Altın S, Karasulu L, Kümbetli (2003). Drug Resistance Rates<br />
In Eyup-Istanbul Tuberculous Struggle Dispensary Between 1997-<br />
2000. Van Med. j., 10(1): 9-15.<br />
Tansel Ö, Yüksel P, Kulo lu F, Akata F (2003). Resistance of<br />
Mycobacterium tuberculosis strains to anti-tuberculosis drugs: Two<br />
years results of Trakya University. Tur. J Infect., 17(1): 23-26.<br />
Ta ova Y, Yaman A, Salto lu N, Erdurak Ö, nal S, Dündar H (1997).<br />
The resistance rates of Mycobacterium tuberculosis strains to<br />
antituberculous drugs in Çukurova University Balcalı Hospital Central<br />
Laboratory. Tur. J. Infect., 11(2): 97-101.<br />
Ucar E, Kılıc A, Ceyhan I (2010). Resistance rates to major antituberculosis<br />
drugs in Mycobacterium tuberculosisstrains isolated from<br />
seven different regions of Turkey in the 2003-2006 period. Mikrobiyol<br />
Bul., 44(1): 11-19.<br />
Yaylı G, Sözen H, A alar C (2003). Susceptibilities of Mycobacterium<br />
tuberculosis strains isolated in Isparta Region to antituberculous<br />
drugs Mikrobiyol Bull., 33: 24-30.<br />
WHO (2010) global report on surveillance and response. Geneva,<br />
World Health Organization, 2010 (WHO/HTM/TB/2010-3).<br />
WHO (2010). The Global Plan to stop TB 2011-2015,Geneva, World<br />
Health Organization,2010 (WHO/HTM/STB/2010-2).<br />
WHO (2009). Anti-tuberculosis Drug Resistance in the World. Fourth<br />
Global Report. www.who.int/tb/publications/2008/<br />
drsreport4_26feb08.pdf.
African Journal of Microbiology Research Vol. 5(16), pp. 2311-2315, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.622<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Cytokine genes expression in mice hepatocytes during<br />
malaria infection<br />
Saad Alkahtani 1 *, AL-Farraj S. A. 1 , Saud A. Alarifi 2 , AL-Eissa Mohammed saad 3 and<br />
Al-Dahmash B. 4<br />
1 Department of Biology, Teachers College, King Saud University, Riyadh, Saudi Arabia.<br />
2 Department of Zoology, Science College, King Saud University, Riyadh, Saudi Arabia.<br />
3 Department of Biology, Science College, Hail University, Hail, Saudi Arabia.<br />
4 Department of Medical Laboratory, College of Health Sciences, King Saud University, Riyadh, Saudi Arabia.<br />
Accepted 30 July, 2011<br />
The aim of this study was to investigate the inflammation genes (IL-1 , IL-6, TNF- and iNos) responses<br />
to Plasmodium chabaudi malaria in the liver of female C57BL/6 hepatocytes via mRNA expression due<br />
to infection with P. chabaudi at different time points. Mice were injected intraperitoneally (ip) with 10 6 P.<br />
chabaudi-infected erythrocytes and then scarified at days (0, 1, 4 and 8 respectively). RT-PCR was used<br />
to quantify liver inflammation genes. The levels of IL-1 , IL-6 and TNF were significantly increased at<br />
days 1 and 8. The total iNos were significantly increased at all days after infection. In conclusion,<br />
present data has shown that infection with P. chabaudi stimulated infalammation genes in the liver.<br />
Thus, we suggest the implication of oxidative stress due to outcome of malaria in mice hepatocytes<br />
according to its natural function need to be confirmed with a larger number of samples to be used as a<br />
reliable inflammation detection method.<br />
Key words: Inflammation, malaria, mice, liver.<br />
INTRODUCTION<br />
Despite decades of intense research, malaria remains a<br />
major global health problem with an estimated mortality<br />
of 1-2 million (Alkahtani, 2011). Due to increasing the<br />
resistance of parasites no effective vaccine is available<br />
and all efforts to develop an effective anti-malaria vaccine<br />
have failed to date (Bergmann-Leitner et al., 2009;<br />
Alkahtani, 2010). However, several vaccine candidates<br />
and vaccine platforms have yielded encouraging results<br />
in animal models of malaria, but have not been<br />
sufficiently evaluated in clinical trials. A rather convenient<br />
malaria model system is the Plasmodium chabaudi blood<br />
stage infection in mice, since P. chabaudi shares several<br />
characteristics with P. falciparum, the most dangerous<br />
human malaria species (Hernandez-Valladares et al.,<br />
2005).<br />
Liver plays a very important role in malaria: It is the site<br />
*Corresponding author. E-mail: salkahtani@ksu.edu.sa.<br />
of pre-erythrocytic development of Plasmodium parasites,<br />
and also acts as an effector against malarial blood stages<br />
as recently shown (Krücken et al., 2005b; Wunderlich et<br />
al., 2005). Kupffer cells are able to eliminate parasitederived<br />
hemozoin and even Plasmodium-infected<br />
erythrocytes. As a result of this process, Kupffer cells<br />
become increasingly activated, which manifests itself as<br />
a production of NO (nitrogen oxide), diverse ROS (radical<br />
oxygen species), and the cytokines IL-1 and TNF . In<br />
addition, cytokines have primary roles in physiology,<br />
including neurophysiology, innate and acquired immune<br />
responses and wound healing, as well as pathogenesis.<br />
Some cytokines, such as TNF, LTs and IL-1 are proinflammatory,<br />
whereas others such as IL-4, IL-10 and the<br />
TGF family, are anti-inflammatory, being subsequently<br />
induced to inhibit these changes (Clark et al., 2010). NO,<br />
ROS and the cytokines result in enormous pathological<br />
complications in the liver. Indeed, IL-1 and TNF are<br />
thought to induce the acute phase response and a<br />
dramatic decrease in liver metabolism, both majorly
2312 Afr. J. Microbiol. Res.<br />
based on liver cells (Krücken et al., 2005a; Guha et al.,<br />
2006). Recent results with deficient mice in the<br />
expression of those cytokines indicate that they are in<br />
general more sensible to insults resulting in neural<br />
damage. Some of the actions induced by TNF- and IFNincluding<br />
both beneficial and detrimental, are mediated<br />
by inducible nitric oxide synthase (iNOS) -derived nitric<br />
oxide (NO) production (Munoz-Fernandez and Fresno.,<br />
1998).<br />
The present study was undertaken to investigate if the<br />
inflammation genes responses to Plasmodium chabaudi<br />
malaria in the liver of mice and to detect if these genes<br />
could be a good marker for inflammation and metabolism<br />
instability due to infection with Plasmodium chabaudi in<br />
mice hepatocytes.<br />
MATERIALS AND METHODS<br />
Animals and infection<br />
Normal female C57BL/6 mice 10-14 weeks old were obtained from<br />
the central animal facilities of Heinrich Heine University, Düsseldorf,<br />
Germany, and housed in plastic cages. Mice were bred and<br />
maintained under specified pathogen free conditions. Mice were fed<br />
with standard diet (Wohrlin, Bad Salzuflen, Germany) and water ad<br />
libitum. The experiments were approved by the State authorities<br />
and followed German law on animal protection.<br />
Blood stage malaria<br />
A non-clonal line of P. chabaudi was used (Wunderlich et al., 1988)<br />
exhibiting a very similar, but not identical restriction length<br />
polymorphism pattern to P. chabaudi (Kruecken et al., 2005b).<br />
Erythrocytic stages of P. chabaudi were passaged weekly in NMRI<br />
mice. From these mice, blood was taken and 10 6 P. chabaudiinfected<br />
erythrocytes were injected i.p. in the mice. Parasitemia was<br />
evaluated in Giemsa-stained blood smears. The total number of<br />
erythrocytes was determined in a Neubauer chamber. A total of five<br />
mice were scarified at each day (0, 1, 4 and 8 respectively) by<br />
cervical dislocation. Livers were removed and cut into smaller<br />
pieces and kept at -80°C.<br />
RNA-Isolation<br />
Approximately 250 mg frozen liver was homogenized with an<br />
ultraturrax in 5 ml Trizol (Peqlab Biotechnology, Erlangen,<br />
Germany) for one minute. After mixing with 1 ml chloroform for 15 s,<br />
the suspension was incubated for 15 min at room temperature and<br />
centrifugated at 3.000 x g for 45 min. After isopropanol precipitation<br />
of the supernatant, the pellet was washed twice with 80% ethanol<br />
and air-dried and dissolved in 200 µl RNase-free water. RNA<br />
concentrations were determined at 260 nm, and the purity of RNA<br />
was checked in 1% agarose gel.<br />
Quantitative real-time PCR<br />
All RNA samples were treated with DNase (Applied Biosystems,<br />
Darmstadt, Germany) for at least 1 h and then converted into cDNA<br />
following the manufacturer’s protocol using the Reverse<br />
Transcription Kit (Qiagen, Hilden, Germany). Quantitative real-time<br />
polymerase chain reaction (qRT-PCR) was performed using the ABI<br />
Prism ® 7500HT Sequence Detection System (Applied Biosystems,<br />
Darmstadt, Germany) with SYBR Green PCR Mastermix from<br />
Qiagen (Hilden, Germany). We investigated the genes encoding the<br />
mRNA for following proteins: 18S, Interleukin-1beta (IL-1 ), Tumor<br />
necrosis factor alpha (TNF ), Interleukin-6 (IL-6), Inducible nitric<br />
oxide synthase iNOS. All primers used for qRT-PCR were<br />
commercially obtained from Qiagen. PCR reactions were conducted<br />
as follows: 2 min at 50°C to activate uracil-N-gylcosylase, 95°C for<br />
10 min to deactivate UNG, 40 cycles at 94°C for 15 s, at 60°C for<br />
35 s and at 72°C for 30 s. Reaction specificity was checked by<br />
performing dissociation curves after PCR. For quantification, mRNA<br />
was normalized to 18S rRNA. The threshold Ct value is the cycle<br />
number selected from the logarithmic phase of the PCR curve in<br />
which an increase in fluorescence can be detected above<br />
background. The Ct is determined by subtracting the Ct of 18S<br />
rRNA from the Ct of the target ( Ct = Ct-target – Ct-18S rRNA).<br />
The relative mRNA levels of non-infected mice are described as a<br />
ratio of target mRNA copy to 18S rRNA copy = 2 – Ct . The fold<br />
induction of mRNA expression on days (0, 1, 4 and 8 p.i. was<br />
determined using the 2 - ct -method (- ct = ct day 0 p.i. - ct day<br />
8 p.i.).<br />
Blood analysis<br />
In sera, IL-1 , IL-6, TNF were measured using ELISA kits (R&D<br />
Systems, Minneapolis, USA) according to the manufacturer's<br />
protocols. Total iNOS was analyzed using a commercially available<br />
kit (R&D Systems).<br />
Statistical analysis<br />
Two-tailed Student’s t-test and Fisher’s exact test were used for<br />
statistical analysis.<br />
RESULTS<br />
Characteristics of P. chabaudi infection<br />
The parasitemia of mice with 10 6 P. chabaudi-infected<br />
erythrocytes became evident on day 4 and rocketed to<br />
reach its peak (48%) on day 8 and then reduced rapidly<br />
to about 0.4% on day 12 (Figure 1).<br />
Inflammation genes expression<br />
Quantitative real-time PCR was used to detect changes<br />
in mRNA levels of different inflammation genes. The<br />
levels of IL-1 , IL-6 and TNF were significantly (P
-Fold change in mRNA expression<br />
Alkahtani et al. 2313<br />
Figure 1. Parasitemia (48%) of female C57BL/6 mice (n=20) infected with 10 6 P. chabaudi-infected erythrocytes.<br />
Figure 2. RT-PCR of IL-1 , IL-6, TNF and iNOS genes expression in the liver of Plasmodium chabaudi infected<br />
mice. The expression of these genes was measured at different times. The data present are the mean ±SE (n=5).<br />
*: significant value at (P
2314 Afr. J. Microbiol. Res.<br />
Table 1. Serum parameters of control (day 0) and infected (day 8) mice with 10 6 P. chabaudi.<br />
Parameters in blood sera 0 day 8 days p.i. p-value 8d p. i. vs. 0d<br />
Parasitemia 0.00 % 48 % < 0.01<br />
IL-1 [ng/l] 1.17 ± 0.2 4.5 ± 1.3
Clark I, Alleva L, Vissel B (2010). The roles of TNF in brain dysfunction<br />
and disease. Pharmacol. Therap., 128(3): 519-548.<br />
Clarka I, Allevaa L, Cowdenb W (2008). Understanding the role of<br />
inflammatory cytokines in malaria and related diseases. Travel Med.<br />
Infect. Dis., 6: 67-81.<br />
Guha M, Kumar A, Choubey V, Maity P, Bandyopadhyay U (2006).<br />
Apoptosis in liver during malaria: role of oxidative stress and<br />
implication of mitochondrial pathway. The FASEB J., 20: E439-E449.<br />
Guha M, Maity P, Choubey V, Mitra K, Reiter R, Bandyopadhyay U<br />
(2007). Melatonin inhibits free radical-mediated mitochondriadependent<br />
hepatocyte apoptosis and liver damage induced during<br />
malaria infection. J. Pineal Rea., 43(4):372-381.<br />
Häussinger D, Schliess F (2008). Pathogenetic mechanisms of hepatic<br />
encephalopathy. Gut, 57: 1156-1165.<br />
Hernandez-Valladares M, Naessens J, Iraqi FA (2005). Genetic<br />
resistance to malaria in mouse models. Trends Parasitol., 21: 352-<br />
355.<br />
Krücken J, Dkhil MA, Braun JV, Schroetel RMU, El-Khadragy M,<br />
Carmeliet P, Mossmann H, Wunderlich F (2005)b. Testosterone<br />
suppresses protective responses of the liver to blood-stage malaria.<br />
Infect. Immun., 73: 436-443.<br />
Alkahtani et al. 2315<br />
Krücken J, Mehnert LI, Dkhil MA, El-Khadragy M, Benten WPM,<br />
Mossmann H, Wunderlich F (2005)a. Massive destruction of malariaparasitized<br />
red blood cells despite spleen closure. Infect. Immun., 73:<br />
6390-6398.<br />
Munoz-Fernandez M, Fresno M (1998). The role of tumour necrosis<br />
factor, interleukin 6, interferon- and inducible nitric oxide synthase in<br />
the development and pathology of the nervous system. Progress<br />
Neurobiol., 56(3): 307-340.<br />
Nussler A, Silvio M, Liu Z, Geller D, Freewick P, Dorko K, Bartoli F,<br />
Billiar T (1995). Further characterization and comparison of inducible<br />
nitric oxide synthase in mouse, rat, and human hepatocytes.<br />
Hepatology, 21(6): 1552-1560.<br />
Wunderlich F, Dkhil MA, Mehnert LI, El-Khadragy M, Borsch E,<br />
Hermsen D, Benten WPM, Pfeffer K, Mossmann H, Krücken J<br />
(2005).Testosterone-responsiveness of spleen and liver in female<br />
lymphotoxin receptor-deficient mice resistant to blood stage<br />
malaria. Microbes Infect., 7: 399-409.<br />
Wunderlich F, Mossmann H, Helwig M, Schillinger G (1988).<br />
Resistance to Plasmodium chabaudi in B10 mice: influence of the<br />
H2-complex and testosterone. Infect. Immun., 9: 2400-2406.
African Journal of Microbiology Research Vol. 5(16), pp. 2316-2324, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.625<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Phylogenetic analysis of the nematicidal actinobacteria<br />
from agricultural soil of China<br />
Xu Chuan Kun 1 , Lou Xiao Jun 1 , Xi Jia Qin 2 , Gu Lei 3 , Duan Chang Qun 1 , Mo Ming He 1 *,<br />
Zhang Ke Qin 1 , Yang Fa Xiang 4 and Fang Dun Huang 5<br />
1 Laboratory for Conservation and Utilization of Bio-Resources and Key Laboratory for Microbial Resources of the<br />
Ministry of Education, Yunnan University, Kunming, 650091, Yunnan Province, P. R. China.<br />
2 Zhengzhou Tobacco Research Institute of China Netherlands Trade Company (CNTC), Zhengzhou, 45000, P. R. China.<br />
3 Yunnan University Secondary School, Kunming, 650091, Yunnan Province, P. R. China.<br />
4 Yunnan Yunye Fertilizer Company Limited, Kunming, 650217, P. R. China.<br />
5 Yunnan Academy of Tobacco Agricultural Science, Yuxi 653100, P. R. China.<br />
Accepted 30 July, 2011<br />
The purpose of this study was to assess the diversity and biocontrol potential of nematicidal<br />
actinobacteria from agricultural soils. Two hundred soil samples were collected from 20 provinces<br />
(autonomous regions or municipalities) of China, and 4000 actinobacteria isolates were obtained. Of the<br />
4000 isolates evaluated, 533 (13.3% of total) and 488 (12.2%) respectively showed nematicidal<br />
properties to target nematodes Panagrellus redivivus and Bursaphelenchus xylophilus with nematicidal<br />
activities (NA) of more than 30%. The sum of strains with NAs of 90-100%, 80-90%, 60-80% and 30-60%<br />
was 55, 100, 127 and 251 to P. redivivus, while 37, 85, 111 and 255 to B. xylophilus, respectively. The<br />
most active isolates showed high host selectivity, in which only 101 isolates (5.1% of the total) were<br />
toxic to the both targets with NAs>30%. Additionally, 69 of the 101 isolates were randomly selected for<br />
species diversity analysis. Phylogenetic analysis placed the 69 actinobacteria in three families<br />
(Streptomycetaceae, Pseudonocardiaceae and Nocardiaceae) of the Actinobacteria with sequence<br />
similarity of 97.4-100%. The largest group was Streptomycetaceae, containing 58 isolates (84.1% of the<br />
total) that showed 97% to 100% sequence identity to 28 species of the genera Streptomyces (57<br />
isolates, 27 species) and Kitasatospora (1, 1). The Pseudonocardiaceae group contained 7 isolates<br />
(10.1% of the total) showing 98.5-99.7% homology to Amycolatopsis lurida (4 isolates) and A.<br />
niigatensis (3). The Nocardiaceae group included 4 isolates (5.8% of the total) with 99-99.6% sequence<br />
identity to one species N. fluminea.<br />
Key words: Nematicidal actinobacteria, nematode, biocontrol, phylogenetic analysis.<br />
INTRODUCTION<br />
Plant parasitic nematodes cause damages to a variety of<br />
agricultural crops throughout the world. Only the rootknot<br />
nematodes (Meloidogyne spp.) cause about US$100<br />
billion loss annually to a wide variety of crops worldwide<br />
(Oka et al., 2009). Currently, the application of chemical<br />
nematicides and fumigants is still the main strategy to<br />
*Corresponding author. E-mail: minghemo@yahoo.com.cn. Tel:<br />
+86871 5031396. Fax: +86871 5034838.<br />
control these pathogens. Although chemical nematicides<br />
are effective, easy to apply, and show rapid effects, they<br />
have begun to be withdrawn from the market in some<br />
developed countries owing to concerns about public<br />
health and environmental safety problems (Schneider et<br />
al., 2003). At present, several successful biocontrol<br />
agents mainly using nematophagous fungi have been<br />
used widely for nematode diseases (Tikhonov et al.,<br />
2002). As antagonists of parasitic nematodes,<br />
nematophagous fungi exhibited their biocontrol traits by
predation, parasitism or poisonous effects.<br />
Extracellular enzymes of nematophagous fungi, especially<br />
the serine protease, served as the vital virulence<br />
factor in the process of infection (Huang et al., 2004). A<br />
few species of antagonistic bacteria have been<br />
developed into agents against plant parasitic nematodes,<br />
e.g. Bacillus thuringiensis and Pasteuria penetrans (Chen<br />
and Dickson, 1998; Javed et al., 2008). B. thuringiensis<br />
exhibited toxic effects against invertebrate by its<br />
parasporal inclusion and has been used widely (Wei et<br />
al., 2003; Meadows et al., 1989). P. penetrans is an<br />
obligate parasite of root knot nematodes (Meloidogyne<br />
spp.), but its fastidious life cycle and the obligate nature<br />
of parasitism have inhibited its mass culturing and<br />
deployment in field conditions. Actinobacteria, however,<br />
have so far received relatively little attention as potential<br />
biocontrol agents against plant-parasitic nematodes.<br />
Actinobacteria is a group of gram positive bacteria with<br />
a G+C content of over 55%. More than 70% of bioactive<br />
compounds are produced from these microorganisms<br />
and they have shown significant applications in pharmacy,<br />
industry, agriculture and environmental protection.<br />
Members of this group are best known for their ability to<br />
produce lytic enzymes, various secondary metabolites,<br />
including antibiotics. For example, avermectins includes a<br />
series of macrocyclic lactone derivatives produced by<br />
Streptomyces avermitilis that belongs to a new family of<br />
potent antihelminthic agents (Burg et al., 1979). Since the<br />
early 1980s, the avermectins and their derivatives have<br />
been used widely in the world to control parasitic<br />
nematodes and pests. The discovery and the huge commercial<br />
market of avermectins promoted an increasing<br />
number of researchers to study the biocontrol potential of<br />
actinobacteria. For example, Mishra et al. (1987) found<br />
that metabolites from 15 isolates of aerobic<br />
actinobacteria (screened from 502 actinobacteria) were<br />
toxic to the free-living nematode Panagrellus redivivus<br />
(Mishra et al., 1987).<br />
A species of the genus Streptomyces isolated from<br />
nematode suppressive soil inhibited the reproduction of<br />
Caenorhabditis elegans in the laboratory test and<br />
reduced tomato root galling caused by M. incognita in the<br />
greenhouse experiment (Dicklow et al., 1993). Some<br />
nematicidal actinobacteria were observed in eggs and<br />
cysts of Heterodera glycines (Nour et al., 2003) and H.<br />
trifolii (Hay and Skipp, 1993). Sun et al. (2006) isolated<br />
30 actinobacteria from root-knot samples and found that<br />
47% of them were virulent to eggs and juveniles of M.<br />
hapla.<br />
These investigations indicated that nematicidal<br />
actinobacteria are abundant in agricultural environments.<br />
However, no study has been performed to analyze the<br />
diversity and phylogenetic relationships of nematicidal<br />
actinobacteria from a wide range of agricultural soils. The<br />
objective of this study was to estimate the relative<br />
biocontrol potential of actinobacteria isolated from 20<br />
provinces (municipalities or autonomous regions) of<br />
China. We also presented a phylogenetic analysis to<br />
Kun et al. 2317<br />
characterize these nematode-antagonistic microorganisms.<br />
MATERIALS AND METHODS<br />
Soil sampling<br />
A total of 200 agricultural soil samples were collected from 20<br />
provinces (municipality or autonomous regions) of China (Figure 1).<br />
In each province (municipality or autonomous region), 10 samples<br />
were collected. For each sample, approximately 1 kg of soil was<br />
sampled randomly from the top layer (2-15 cm) over an area of<br />
more than 5 m 2 per field. Soil samples were spread out to air dry at<br />
room temperature for 2-3 days and sieved through a 2 mm sieve,<br />
then stored in glass bottles at 4°C until used.<br />
Isolation of actinobacteria<br />
To isolate the soil actinobacteria, 1 g of each dry sample was<br />
suspended in 10 m1 sterile distilled water and diluted 1000-fold. 0. l<br />
ml of the dilutions was spread on ISP5 medium (ISP5 medium: Lasparagine<br />
1g, glycerol 10g, K2HPO4 1 g, trace salts 1 ml, agar 18<br />
g, pH 7.2, added to 1000 ml with ddH2O, where the trace salts<br />
including FeSO4•7H2O 0.2 g, MnCl2•2H2O 0.1 g, ZnSO4•7H2O 0.1 g,<br />
added to 100 ml with ddH2O). The plates were incubated at 28°C<br />
for 2 weeks and actinobacteria were purified from single colonies<br />
using the same medium.<br />
Nematode inocula<br />
In this study, a free-living nematode, Panagrellus redivivus, and a<br />
pinewood nematode, Bursaphelenchus xylophilus, were used as<br />
target hosts for assaying the in vitro nematicidal activity of the<br />
actinobacteria. P. redivivus was cultured on autoclaved oatmeal as<br />
previously described (Walker and Barrett, 1991) and B. xylophilus<br />
was fed with a fungus as described by Dong et al. (2004). The<br />
juveniles were separated from media through the Baermann funnel<br />
technique (Gray, 1984), and suspended in the water for use.<br />
Nematicidal activity assay of actinobacteria<br />
Each purified isolate was inoculated into 50 ml of ISP5 liquid<br />
medium in a 150 ml flask. After incubation of 2 weeks at 28°C, 200<br />
rpm, the culture suspension without actinobacteria was obtained by<br />
sterile filtration and used for nematicidal activity assay. Briefly, 1 ml<br />
of the culture suspension was added into a well of a 24-well cell<br />
culture plate, and 0.1 ml nematode suspension (approximate 150<br />
juveniles) was added and mixed. After incubation at 28°C for 24 h,<br />
the mobile (live) and immobile juveniles were recorded by counting<br />
>150 individuals under a microscope. Those immobile juveniles<br />
were taken as dead when they could not revive within 12 h after<br />
being transferred to fresh WA and subsequently to tap water. Each<br />
treatment was replicated three times, and the experiment was run<br />
three times.<br />
Sequence generation and phylogenetic analysis<br />
Genomic DNA of actinobacteria was extracted using a bacterial<br />
genomic DNA extraction kit (BioTeke Corporation, China,<br />
Cat#:DP2001) and their 16S rRNA genes were amplified by PCR<br />
using the universal primer combination 27f (5 AGA GTT TGA TCC<br />
TGG CTC AG 3 ) and 1492r (5 GGT TAC CTT GTT ACG ACT T 3 ).<br />
The amplified products were purified using the Agarose gel DNA
2318 Afr. J. Microbiol. Res.<br />
Figure 1. Location of the 20 sampling sites (∗) in this study distributed on the map of China, which including two<br />
municipalities (BJ and SH), six autonomous regions (GX, NM, NX, XJ and XZ), and twelve provinces<br />
(Abbreviation meanings on the map, BJ: Beijing, GS: Gansu, GD: Guangdong, GX: Guangxi, GZ: Guizhou, HN:<br />
Hainan, HeB: Hebai, HeN: Henan, HLJ: Heilongjiang, HuN: Hunan, JL: Jilin, JS: Jiangsu, LN: Liaoning, NM:<br />
Neimenggu, NX: Ningxia, SD: Shandong, SX: Shanxi, SH: Shanghai, SC: Sichuan, XZ: Xizang).<br />
purification kit (TakaRa, code DV805A) and submitted to Beijing<br />
Genomics Institute for sequencing. The resulting sequences of 16S<br />
rRNA gene were compared with those available in the GenBank<br />
using the BLAST network service to determine their phylogenetic<br />
affiliation. Multiple alignments and sequence evolutionary distance<br />
calculations were carried out using CLUSTAL X version 2.0<br />
(Thompson et al., 1997). Phylogenetic analysis was performed<br />
using the MEGA software packages (Kumar et al., 2004), with gaps<br />
treated as missing data. Clustering was performed using the<br />
Neighbour-Joining method (Saitou and Nei, 1987). Bootstrap<br />
analysis was used to evaluate the tree topology of the Neighbour-<br />
Joining data by performing 1,000 resamplings (Felsenstein, 1985).<br />
The 16S rRNA gene sequences have been deposited in the<br />
GenBank database under accession numbers GQ357927-<br />
GQ357995.<br />
Data analysis<br />
Nematicidal activity (NA) was calculated using the formula: NA =<br />
IN/SN×100%, where IN represents the number of immobile<br />
nematodes and SN represents the sum of all nematodes counted<br />
(SN 100). Data were analyzed using the analysis of variance<br />
(ANOVA), and means were compared by the test of least significant<br />
difference (LSD) at P=0.05 using SPSS 11.0 for Windows (SPSS<br />
Inc., Chicago, USA).<br />
RESULTS<br />
Nematicidal activity of actinobacteria<br />
From each soil sample, 20 strains of actinobacteria were<br />
selected for nematicidal bioassay and these strains were<br />
selected mainly based on the differences of colony<br />
features, or randomly picked if colony features were<br />
similar, which resulting in a total of 4000 strains from 200<br />
samples for virulence test. Of the 4000 isolates tested,<br />
533 (13.2% of total) exhibited nematicidal activities with<br />
NA values more than 30% against the free-living<br />
nematode P. redivivus. These isolates showed
Isolate sum<br />
Isolate sum<br />
���<br />
� �<br />
���<br />
� �<br />
���<br />
§ ¤<br />
§¦�<br />
¡ ¤<br />
¡¦�<br />
�<br />
�<br />
¤<br />
�<br />
¡£¢<br />
17<br />
¡¦�<br />
�<br />
¤ ¥<br />
¨ �<br />
§ ¨<br />
Figure 2. Statistics of nematicidal actinobacteria from different sampling sites with different nematicidal<br />
activity (NA) to nematodes P. redivivus (A) and B. xylophilus (B).<br />
significant differences on their NAs against P. redivivus,<br />
which consisted of 55 isolates with NAs of 90-100%, 100<br />
with NAs of 80-90%, 127 with NAs of 60-80%, and 251<br />
with NAs less than 60% but more than 30% (Figure 2).<br />
Bioassay of the 4000 actinobacteria to plant-parasitic<br />
nematode B. xylophilus also was performed and 488<br />
isolates (12.2% of total) showed nematicidal virulence<br />
with NAs of 30-100%. The numbers of active isolates with<br />
NAs of 90-100%, 80-90%, 60-80% and 30-60% were 37,<br />
85, 111 and 255, respectively (Figure 2).<br />
Among the 4000 actinobacteria evaluated, the most<br />
active isolates showed the highest host selectivity to P.<br />
redivivus or B. xylophilus. Only 101 isolates (2.5% of<br />
total) were toxic to both targets with NA>30%. Among the<br />
101 strains, 4 (SDYM18, SDYM7, NMYC10 and NMCG3)<br />
showed the most potency to produce nematicidal<br />
metabolites with high NAs of more than 80% against both<br />
nematodes. Of the 155 actinobacteria strains with NAs ><br />
80% to P. redivivus, only 18 displayed similar NAs to both<br />
targets without statistically significant differences (P<br />
>0.05), while 54 isolates had no nematicidal activity<br />
against B. xylophilus. Similarly, of the 125 strains with<br />
¡¦¥<br />
¡ ¡<br />
¢<br />
© ¢<br />
§¦¡<br />
¡¦¨<br />
¤ ¥ ¤ � ¤ ¤<br />
§ ¨ § ¨<br />
¡ ¡<br />
§ §<br />
¡¦©<br />
©<br />
¡£¢<br />
¡£� ¡£¡<br />
¥ �<br />
¤<br />
© � ©<br />
� � ¨ ¨ § § ¨<br />
¡£¥<br />
¡¦�<br />
¢<br />
� �<br />
¡¦�<br />
¡£§<br />
§¦�<br />
�<br />
¤ � ¤ ¤ � ¨ ¨<br />
¡£¡<br />
� �<br />
¤ ¤ ¥ ¤ ¥<br />
� � ¨ § § §<br />
BJ GD GS GX GZ HeB HeN HLJ HN HuN JL JS LN NM NX SC SD SH SX XZ<br />
8<br />
A<br />
B<br />
13<br />
�<br />
9<br />
26<br />
15<br />
17<br />
6<br />
8<br />
9<br />
Soil origin<br />
25<br />
8<br />
13<br />
9<br />
14<br />
21<br />
���£¨¦�¦�£�¦¥¦�£� �<br />
���£¥¦�¦�£�¦©¦�£� �<br />
���£©¦�¦�£�¦¢¦�£� �<br />
���£¢¦�¦�£�¦¡¦�£�¦� �<br />
�<br />
� �<br />
�<br />
�<br />
� �<br />
� � � �<br />
� � � � � �<br />
� � � �<br />
� �<br />
� � � � � � � � � � � � � � � � � � � �<br />
� � � � � � � � �<br />
BJ GD GS GX GZ HeB HeN HLJ HN HuN JL JS LN NM NX SC SD SH SX XZ<br />
Soil origin<br />
� �<br />
� �<br />
�<br />
9<br />
��� �£�¦�£� � �£� �<br />
���¦� �¦�£� � �£� �<br />
���¦� �¦�£� � �£� �<br />
���¦� �¦� � �¦�£� �<br />
Kun et al. 2319<br />
NAs>80% to B. xylophilus, the NAs of 11 isolates to the<br />
two tested nematodes were not significantly different<br />
(P>0.05) while 41 isolates had no nematicidal activity<br />
against P. redivivus.<br />
The four potential strains (SDYM18, SDYM7, NMYC10<br />
and NMCG3) causing high mortality against both hosts<br />
were assayed further after diluting the culture suspension<br />
by 2, 5 and 10 folds. Our results indicated that the<br />
original culture broths of the four actinobacteria exhibited<br />
powerful virulence (85.2% NA 100%) to both P. redivivus<br />
and B. xylophilus, but the former was more susceptible<br />
than the latter (P
2320 Afr. J. Microbiol. Res.<br />
Table 1. Nematicidal activity (NA) of four potential actinobacteria.<br />
Strain Nematode<br />
SDYM18<br />
SDYM7<br />
NMYC10<br />
NMCG3<br />
Mean NA (%)±SD under different diluent<br />
Origin broth 2 fold 5 fold 10 fold<br />
P. redivius 100±0 a 93.2±1.22 80.8±0.83 64.2±0.85<br />
B. xylophilus 95.7±0.72 b 89.3±0.52 78.2±1.04 50.6±0.91<br />
P. redivius 99.4±1.31 a 72.6±0.87 57.7±0.88 44.3±1.21<br />
B. xylophilus 88.3±0.89 c 71.7±1.11 51.6±0.62 37.2±0.82<br />
P. redivius 99.2±1.11 a 80.5±0.85 68.7±0.93 34.3±1.12<br />
B. xylophilus 83.2±1.14 d 79.8±1.21 50.8±1.08 34.8±0.94<br />
P. redivius 99.6±1.42 a 80.3±1.13 67.5±0.89 50.3±1.34<br />
B. xylophilus 85.2±0.26 c 75.6±0.92 56.8±1.22 41.3±0.82<br />
Means in the “Origin broth” column followed by the same letter do not differ significantly at p 0.05, according to multiple<br />
comparisons.<br />
amplified using primer pair of 27f and 1492r, and<br />
submitted for sequencing. The resulting sequences,<br />
about 1380 nucleotides, were compared with those<br />
available in GenBank using the BLAST network service<br />
(Table 2), and a phylogenetic tree was constructed to<br />
determine their approximate taxonomic affiliation (Figure<br />
3). Phylogenetic analysis placed the 69 strains in three<br />
families (Streptomycetaceae, Pseudonocardiaceae and<br />
Nocardiaceae) of the Actinobacteria with sequence<br />
similarity of 97-100% (Figure 3 and Table 2).<br />
The largest group was Streptomycetaceae and it consisted<br />
of 58 isolates (84.1% of the total) showing 97 to<br />
100% sequence identity to 27 species of the genera<br />
Streptomyces and 1 species of Kitasatospora. Among the<br />
Streptomyces strains, the isolates phylogenetically<br />
related to species of S. althioticus (8 isolates), S.<br />
flavotricini (7) and S. diastatochromogenes (6)<br />
dominated, with a total of 21 isolates (36.8% of the<br />
Streptomyces group). There were 13 isolates (accounting<br />
to 22.8% of Streptomyces members) respectively<br />
affiliated to S. xanthophaeus (4 isolates), S. lateritius (3),<br />
S. exfoliatus (3) and S. ciscaucasicus (3). Six isolates<br />
respectively identified as S. showdoensi (2 isolates), S.<br />
corchorusii (2) and S. viridochromogenes (2). The remaining<br />
17 isolates were respectively identified belonging<br />
to 17 different species of the genus Streptomyces.<br />
The Pseudonocardiaceae group contained 7 isolates<br />
(10.1% of the total) respectively showing 98.5-99.7%<br />
sequence identity to species of Amycolatopsis lurida (4<br />
isolates) and A. niigatensis (3). The last group,<br />
Nocardiaceae, only included 4 isolates (5.8% of the total)<br />
with 99-99.6% identity to a species N. fluminea.<br />
Of the four isolates showed strong nematicidal activity,<br />
NMYC10 and NMCG3 respectively showed 98.9 and<br />
99.3% sequence identity to S. diastatochromogenes and<br />
S. violaceochromogenes, while SDYM18 and SDYM7<br />
were assigned to the same species A. lurida with the<br />
homology more than 99%.<br />
DISCUSSION<br />
In this study, 4000 actinobacteria isolated from agricultural<br />
soils of a wide range of geographical regions were<br />
evaluated for their nematocidial activities. The proportions<br />
of strains capable of killing P. redivivus and B. xylophilus<br />
were 13.3 and 12.2% respectively when taking NAs 30%<br />
as a cutoff for virulence activity. These results indicated<br />
that there were a large number of nematocidial<br />
actinobacteria distributed in agricultural soils. Of the 69<br />
active actinobacteria submitted for phylogenetic analysis,<br />
57 (accounted to 82.6%) showed 97 to 100% homology<br />
to 27 species of the genus Streptomyces. Ruanpanun et<br />
al. (2010) isolated 83 actinobacteria from plant-parasitic<br />
nematode infested soils and found the predominant<br />
actinobacteria taxa was Streptomyces (97.6%). Similarly,<br />
Luo et al. (2006) reported that in the 20 actinobacteria<br />
isolated from eggs and females of root-knot nematodes,<br />
16 strains were members of Streptomyces. Most<br />
actinobacteria commonly isolated from soil belonged to<br />
the genus Streptomyces because they are more common<br />
in the environment and tend to have rapid growth rate<br />
and good sporulation compared to other actinobacteria<br />
(Williams and Vickers, 1988). This may explain why the<br />
nematicidal Streptomyces spp. had high occurrence<br />
frequencies. Beside the biocontrol application of S.<br />
avermitilis (Jayakumar, 2009; Wright et al., 1983), the<br />
producer of avermectins, many other species of<br />
Streptomyces also had the potential as biocontrol agents<br />
against parasitic nematodes. CR-43 T , a strain of S.<br />
costaricanus isolated from a nematode-suppressive soil,<br />
exhibited both antinematodal and antifungal activities in<br />
laboratory, greenhouse, and field trials (Dicklow et al.,<br />
1993). An application for a patent for CR-43 T as a
Kun et al. 2321<br />
Table 2. Nematicidal actinobacteria used for phylogenetic analysis in this study and their closest affiliation according to the partical 16S<br />
rRNA gene.<br />
Strain [Accession No.] Sample location The closest relative in the database [Accession No.] Similarity (%)<br />
SDYM9 [GQ357978] Shandong S. lateritius LMG 19372 T [AJ781326] 99.8<br />
BJH10 [GQ357963] Beijing S. lateritius LMG 19372 T [AJ781326] 99.9<br />
SCTS20 [GQ357973] Sichuan S. lateritius LMG 19372 T [AJ781326] 99.9<br />
HNHS7 [GQ357938] Henan S. exfoliatus NBRC 13191 T [AB184324] 99.8<br />
SXYC14 [GQ357967] Shanxi S. exfoliatus NBRC 13191 T [AB184324] 99.6<br />
HNYM7 [GQ357937] Henan S. exfoliatus NBRC 13191 T [AB184324] 99.9<br />
NXFQ8 [GQ357970] Ningxia S. griseoplanus AS 4.1868 T [AY999894] 99.9<br />
NMXM7 [GQ357930] Neimenggu S. kurssanovii NBRC 13192 T [AB184325] 99.9<br />
BJS2 [GQ357965] Beijing S. mauvecolor LMG 20100 T [AJ781358] 99.1<br />
GSPG8 [GQ357950] Gansu S. xanthophaeus NBRC 12829 T [AB184177] 99.7<br />
SCYT16 [GQ357972] Sichuan S. xanthophaeus NBRC 12829 T [AB184177] 99.7<br />
SCLZ7 [GQ357981] Sichuan S. xanthophaeus NBRC 12829 T [AB184177] 99.8<br />
SCL7 [GQ357982] Sichuan S. xanthophaeus NBRC 12829 T [AB184177] 99.9<br />
NXHG4 [GQ357980] Ningxia S. flavotricini NBRC 12770 T [AB184132] 99.9<br />
GSPT14 [GQ357949] Gansu S. flavotricini NBRC 12770 T [AB184132] 99.9<br />
HNDD1 [GQ357943] Henan S. flavotricini NBRC 12770 T [AB184132] 99.9<br />
NXHG3 [GQ357983] Ningxia S. flavotricini NBRC 12770 T [AB184132] 99.8<br />
HNGL19 [GQ357939] Henan S. flavotricini NBRC 12770 T [AB184132] 99.3<br />
NXLJ11 [GQ357979] Ningxia S. flavotricini NBRC 12770 T [AB184132] 99.9<br />
NXFQ2 [GQ357928] Ningxia S. flavotricini NBRC 12770 T [AB184132] 99.9<br />
GSSZ10 [GQ357948] Gansu S. showdoensis NBRC 13417 T [AB184389] 98.2<br />
GSSZ14 [GQ357953] Gansu S. showdoensis NBRC 13417 T [AB184389] 98.2<br />
BJL6 [GQ357961] Beijing S. ciscaucasicus NBRC 12872 T [AB184208] 99.8<br />
GZ22 [GQ357951] Guizhou S. ciscaucasicus NBRC 12872 T [AB184208] 99.7<br />
XZYM3 [GQ357971] Xizang S. ciscaucasicus NBRC 12872 T [AB184208] 99.9<br />
SHJ24 [GQ357969] Shanghai S. longwoodensis LMG 20096 T [AJ781356] 99.3<br />
HaNXJ7 [GQ357947] Hainan S. corchorusii NBRC 13032 T [AB184267] 97.9<br />
HaNYM16 [GQ357944] Hainan S. corchorusii NBRC 13032 T [AB184267] 97.4<br />
CZYS9 [GQ357960] Xizang S. mirabilis NBRC 13450 T [AB184412] 100<br />
SHDQ4 [GQ357977] Shanghai S. cinereoruber subsp. fructofermentans<br />
NBRC 15396 T [AB184647]<br />
BJH1 [GQ357966] Beijing S. phaeochromogenes NBRC 3180 T [AB184738] 99.9<br />
SHLJ2 [GQ357976] Shanghai S. diastatochromogenes ATCC 12309 T [D63867] 98.6<br />
BJS8 [GQ357964] Beijing S. diastatochromogenes ATCC 12309 T [D63867] 99.4<br />
SHLJ5 [GQ357975] Shanghai S. diastatochromogenes ATCC 12309 T [D63867] 99.1<br />
GXLY20 [GQ357952] Guangxi S. diastatochromogenes ATCC 12309 T [D63867] 98.7<br />
NMYC10 [GQ357929] Neimenggu S. diastatochromogenes ATCC 12309 T [D63867] 98.9<br />
SXTD7 [GQ357968] Shanxi S. diastatochromogenes ATCC 12309 T [D63867] 99.3<br />
NMCG3 [GQ357931] Neimenggu S. violaceochromogenes NBRC 13100 T [AB184312] 99.3<br />
JLLJ17 [GQ357927] Jilin S. flavoviridis NBRC 12772 T [AB184842] 99.9<br />
DLHG2 [GQ357958] Liaoning S. viridodiastaticus NBRC 13106 T [AB184317] 99.8<br />
DLDG2 [GQ357959] Liaoning S. longispororuber NBRC 13488 T [AB184440] 99.3<br />
GSL5 [GQ357956] Gansu S. coeruleofuscus NBRC 12757T [AB184840] 99.6<br />
BJL2 [GQ357962] Gansu S. alboflavus NBRC 3438T [AB184775] 99.9<br />
HaHD12 [GQ357942] Hainan S. coelicoflavus NBRC 15399T [AB184650] 99.9<br />
DLTS7 [GQ357957] Liaoning S. viridochromogenes NBRC 3113T [AB184728] 99.6<br />
JLIM5 [GQ357940] Jilin S. viridochromogenes NBRC 3113T [AB184728] 99.5<br />
HaNYM8 [GQ357945] Hainan S. malaysiensis ATB-11T [AF117304] 99.9<br />
98.8
2322 Afr. J. Microbiol. Res.<br />
Table 2. Contd.<br />
HaNXJ11 [GQ357946] Hainan S. glauciniger NBRC 100913 T [AB249964] 99.4<br />
JLGC14 [GQ357941] Jilin S. variabilis NBRC 12825 T [AB184884] 99.9<br />
JLYM14 [GQ357933] Jilin S. althioticus NRRL B-3981 T [AY999791] 98.3<br />
JLFQ8 [GQ357936] Jilin S. althioticus NRRL B-3981 T [AY999791] 97.5<br />
GSPG5 [GQ357954] Gansu S. althioticus NRRL B-3981 T [AY999791] 97.6<br />
JLYM15 [GQ357932] Jilin S. althioticus NRRL B-3981 T [AY999791] 97.8<br />
JLFQ12 [GQ357935] Jilin S. althioticus NRRL B-3981 T [AY999791] 97.6<br />
GSPG4 [GQ357955] Gansu S. althioticus NRRL B-3981 T [AY999791] 97.6<br />
JLYM2 [GQ357934] Jilin S. althioticus NRRL B-3981 T [AY999791] 97.8<br />
SHN26 [GQ357974] Shanghai S. althioticus NRRL B-3981 T [AY999791] 97.4<br />
BJY6 [GQ357985] Beijing N. fluminea S1 T [AF277204] 99<br />
SXYM10 [GQ357986] Shanxi N. fluminea S1 T [AF277204] 99.4<br />
SXS5 [GQ357987] Shanxi N. fluminea S1 T [AF277204] 99.6<br />
NMBC12 [GQ357988] Neimenggu N. fluminea S1 T [AF277204] 99.3<br />
DLYT2 [GQ357984] Liaoning K. arboriphila HKI 0189 T [AY442267] 99.7<br />
HaNHS4 [GQ357989] Hainan A. niigatensis LC11 T [AB248537] 98.5<br />
HaNHS8 [GQ357992] Hainan A. niigatensis LC11 T [AB248537] 98.5<br />
HaNHS12 [GQ357991] Hainan A. niigatensis LC11 T [AB248537] 99.1<br />
NXQZ2 [GQ357995] Ningxia A. lurida DSM 43134 T [AJ577997] 99.3<br />
SDYM18 [GQ357994] Shandong A. lurida DSM 43134 T [AJ577997] 99.4<br />
GSPG7 [GQ357993] Gansu A. lurida DSM 43134 T [AJ577997] 99.7<br />
SDYM7 [GQ357990] Shandong A. lurida DSM 43134 T [AJ577997] 99.7<br />
A: Amycolatopsis, K: Kitasatospora, N: Nocardia, S: Streptomyces.<br />
biocontrol agent for nematodes was filed by Research<br />
Corporation Technologies, Tucson, Ark, under exclusive<br />
license from the University of Massachusetts at Amherst<br />
(Esnard et al., 1995). Several strains of Streptomyces<br />
with antifungal activities also significantly reduced rootlesion<br />
nematode population densities in roots of both<br />
susceptible and resistant alfalfa varieties grown in field<br />
(Samac and Kinkel, 2004). Several species of<br />
Streptomyces, e.g. S. dicklowii (US Patent 5549889), S.<br />
cyaneogriseus (US Patent 5030650), have been patented<br />
as nematicidal biopesticides (http://www.patentstorm.us).<br />
Many other actinomycete genera also produced biologically<br />
active secondary metabolites of medical importance<br />
and showed promising biological activity including<br />
parasitism and antibiosis (Goodfellow and O’Donnell,<br />
1989). Rickards et al. (1998) reported that a strain belonged<br />
to the genera Amycolatopsis or Amycolata could<br />
produce the cyclic decapeptide antibiotic quinaldopeptin<br />
with nematicidal activity. A strain of Streptoverticillium<br />
albireticuli was found to show strong nematicidal activity<br />
against Caenorhabditis elegans and several fungal<br />
pathogens. This species exhibited hyphal growth on both<br />
external and internal surfaces of C. elegans and<br />
ultimately killed the nematode (Park et al., 2002). Of the 4<br />
isolates with strong nematicidal activity in this study,<br />
NMYC10 and NMCG3 showed 98.9 and 99.3% homology<br />
to S. diastatochromogenes and S. violaceochromogenes<br />
respectively, while the other two (SDYM18 and SDYM7)<br />
were assigned to A. lurida. To isolate a wider spectrum of<br />
actinobacteria, pretreating soils such as dry-heating<br />
(Nonomura and Ohara, 1969), using Streptomyces’<br />
specific lytic actinophage (Kurtböke et al., 1992), and<br />
applying selective media supplemented with antibiotics<br />
(Williams et al., 1993) could all be employed.<br />
In this study, we used a free-living nematode and a<br />
plant parasitic nematode as target for bioassay. Among<br />
the 533 isolates and 488 isolates respectively showed<br />
nematicidal activity to P. redivivus and B. xylophilus, only<br />
101 isolates showed nematicidal properties to both target<br />
hosts. The host selectivity or sensitivity between<br />
actinobacteria and nematodes suggested that the<br />
nematicidal pathways or microbial actions were diverse.<br />
To determine the control targets of a nematicidal<br />
biopesticide, the host specificity should be taken into<br />
account. Additionally, the nematicidal actinobacteria in<br />
this study were screened based on the bioassay using<br />
culture broth. The metabolite composition of the four<br />
potential strains and their control effects in fields warrant<br />
further studies.<br />
ACKNOWLEDGEMENTS<br />
This work was funded jointly by “National Key Sciences<br />
and Technology Program for Water Solutions”<br />
(2009ZX07102-004-04-01; 2012ZX07102-003), NSFC
Kun et al. 2323<br />
Figure 3. Phylogenetic dendrogram obtained by neighbour-joining method of 16S rRNA gene sequences. Numbers at nodes<br />
are bootstrap values based on 1000 resamplings. Bar, 1% sequence divergence. Bifidobacterium psychraerophilum T16 T<br />
(AY174108) and Bifidobacterium mongoliense DSM 21395 T (AB433856) are used as outgroups. GenBank Accession<br />
Numbers for each strain are indicated in parentheses adjacent to each strain name.
2324 Afr. J. Microbiol. Res.<br />
(30970100), ZhengZhou Tobacco Research Institute<br />
(122009CZ0420), Yunnan Corporation of CNTC<br />
(2011YN03), National Development and Reform<br />
Commission, and Department of Science and Technology<br />
of Yunnan Province.<br />
REFERENCES<br />
Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R,<br />
Kong YL, Richard L, Monaghan RL, Olsonm G, Putter I, Tunac JB,<br />
Wwllick H, Stapley EO, Oiwa R, Omura S (1979). Avermectins, new<br />
family of potent anthelmintic agents: producing organism and<br />
fermentation. Antimicrob. Agents Ch., 15: 361-367.<br />
Chen ZX, Dickson DW (1998). Review of Pasteuria penetrans: biology,<br />
ecology, and biological control potential. J. Nematol.,30: 313-340.<br />
Dicklow MB, Acosta N, Zuckerman BM (1993). A novel Streptomyces<br />
species for controlling plant-parasitic nematodes. J. Chem. Ecol., 19:<br />
159-173.<br />
Dong JY, Zhao ZX, Cai L, Liu SQ, Zhang HR, Duan M, Zhang KQ<br />
(2004). Nematicidal effect of freshwater fungal cultures against the<br />
pine-wood nematode Bursaphelenchus xylophilus. Fungal Divers.,<br />
15: 125-135.<br />
Esnard J, Potter TL, Zuckerman BM (1995). Streptomyces costaricanus<br />
sp. nov., isolated from nematode-suppressive soil. Int. J. Syst.<br />
Bacteriol., 45(4): 775- 779.<br />
Felsenstein J (1985). Confidence limits on phylogenies: an approach<br />
using the bootstrap. Evolution, 39: 783-789.<br />
Goodfellow M, O’Donnell AG (1989). Search and discovery of<br />
industrially significant actinomycetes. In: Baumberg S, Hunter IS,<br />
Rhodes PM. (eds), Microbial Products: New Approaches. Cambridge<br />
University Press, Cambridge, UK, pp. 343-383.<br />
Gray N (1984). Ecology of nematophagous fungi: comparison of the soil<br />
sprinkling method with the Baermann funnel technique in the isolation<br />
of endoparasites. Soil Biol. Biochem., 16: 81-83.<br />
Hay FS, Skipp RA (1993). Fungi and actinomycetes associated with<br />
cysts of Heterodera trifolii Goffart (Nematoda: Tylenchida) in pasture<br />
soils in New Zealand. Nematologica, 39: 376-384.<br />
Huang XW, ZhaoNH, Zhang KQ (2004). Extracellular enzymes serving<br />
as virulence factors in nematophagous fungi involved in infection of<br />
the host. Res. Microb., 155(10): 811-816.<br />
Javed N, El-Hassan S, Gowen S, Pemproke B, Inam-ul-Hap M (2008).<br />
The potential of combining Pasteuria penetrans and neem<br />
(Azadirachta indica) formulation as a management system for rootknot<br />
nematodes on tomato. Eur. J. Plant Pathol., 120: 53-60.<br />
Jayakumar J (2009). Streptomyces avermitilis as a biopesticide for the<br />
management of root knot nematode, Meloidogyne incognita in<br />
tomato. Karn. J. Agric. Sci., 22: 564-566.<br />
Kurtböke DI, Murphy NE, Sivasithamparam K (1992). Use of<br />
bacteriophage for the selective isolation of thermophilic<br />
actinomycetes from composted eucalyptus bark. Can. J. Microbiol.,<br />
39: 46-51.<br />
Kumar S, Tamura K, Nei M (2004). MEGA3: Integrated software for<br />
molecular evolutionary genetics analysis and sequence alignment.<br />
Brief. Bioinformatics, 5: 150-163.<br />
Luo HL, Sun MH, Xie JP, Liu ZH, Huang Y (2006). Diversity of<br />
actinomycetes associated with root-knot nematode and their potential<br />
for nematode control. Acta Mirobiol. Sinica, 46(4): 598-601.<br />
Meadows J, Gill SS, Bone LW (1989). Factors influencing lethality of<br />
Bacillus thuringiensis kurstaki toxin for eggs and larvae of<br />
Trichostrongylus colubriformis (nematode), J. Parasitol., 75: 191-194.<br />
Mishra SK, Keller JE, Miller JR, Heisey RM, Nair MG, Putnam AR<br />
(1987). Insecticidal and nematicidal properties of microbial<br />
metabolites. Indian J. Microbiol., 2: 267-276.<br />
Nonomura H, Ohara Y (1969). Distribution of actinomycetes in soil (VI).<br />
A culture method effective for both preferential isolation and<br />
enumeration of Microbispora and Streptosporangium strains in soil<br />
(part 1). J. Ferm. Tech., 47: 463-469.<br />
Nour SM, Lawrence JR, Zhu H, Swerhone GDW, Welsh M, Welacky<br />
TW, Topp E (2003). Bacteria associated with cysts of the soybean<br />
cyst nematode (Heterodera glycines). Appl. Environ. Microbiol., 69:<br />
607-615.<br />
Oka Y, Shuker S, Tkachi N (2009). Nematicidal efficacy of MCW-2, a<br />
new nematicide of the fluoroalkenyl group, against the root-knot<br />
nematode Myloidogyne javanica. Pest Manag. Sci., 65: 1082-1089.<br />
Park JO, El-Tarabily KA, Ghisalberti EL, Sivasithamparam L (2002).<br />
Pathogenesis of Streptoverticillium albireticuli on C. elegans and its<br />
antagonism to soil-borne fungal pathogens. Lett. Appl. Microbiol., 35:<br />
361-365.<br />
Rickards RW, Rothschild JM, Lacey E (1998). Structure of<br />
actinotetraose hexatiglate, a unique glucotetraose from an<br />
actinomycete bacterium. J. Antibiot., 52(12): 1093-1098.<br />
Ruanpanun P, Tangchitsomkid N, Hyde KD, Lumyong S (2010).<br />
Actinomycetes and fungi isolated from plant-parasitic nematode<br />
infested soils: screening of the effective biocontrol potential, indole-3acetic<br />
acid and siderophore production. World J. Microbiol. Biotech.,<br />
0959-3993 (Print) 1573-0972 (Online).<br />
Saitou N, Nei M (1987). The neighbor-joining method: a new method for<br />
reconstructing phylogenetic trees. Mol. Biol. Evol., 4: 406-425.<br />
Samac DA, Kinkel LL (2004). Suppression of the root-lesion nematode<br />
(Pratylenchus penetrans) in alfalfa (Medicago sativa) by<br />
Streptomyces spp. Plant Soil, 235: 35-44.<br />
Schneider SM, Rosskopf EN, Leesch JG, Chellemi DO, Bull CT,<br />
Mazzola M (2003). Research on alternatives to methyl bromide: preplant<br />
and post-harvest. Pest Manag. Sci., 59: 814-826.<br />
Sun MH, Li G, Shi YX, Li BJ, Liu XZ (2006). Fungi and actinomycetes<br />
associated with Meloidogyne spp. eggs and females in China and<br />
their biocontrol potential. J. Inv. Pathol., 93: 22-28.<br />
Tikhonov VE, Lopez-Llorca LV, Salinas J, Jansson HB (2002).<br />
Purification and characterization of chitinases from the<br />
nematophagous fungi Verticillium chlamydosporium and V.<br />
suchlasporium. Fungal Gen. Biol., 35: 67-78.<br />
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgens DG<br />
(1997). The Clustal X windows interface: flexible strategies for<br />
multiple sequence alignment aided by quality analysis tools. Nucleic<br />
Acids Res., 24: 4876-4882.<br />
Walker J, Barrett J (1991). Cystathionine b-synthase and gcystathionase<br />
in helminths. Parasitol. Res., 77: 709-713.<br />
Wei J, Hale K, Carta L, Platzer E, Wong C, Fang S, Aroian V (2003).<br />
Bacillus thuringiensis crystal proteins that target nematodes. PNAS,<br />
100: 2760-2765.<br />
Williams ST, Vickers JC (1988). Detection of actinomycetes in the<br />
natural environment. In: Okami Y, Beppu T, Ogawara H (eds.),<br />
Biology of Actinomycetes. Japan Scientific Societies Press, Tokyo,<br />
pp. 265-270.<br />
Wright DJ, Birtle AJ, Corps AE, Dybas R (1983). Efficacy of avermectins<br />
against a plant parasitic nematode. Ann. Appl. Biol., 103: 465-470.
African Journal of Microbiology Research Vol. 5(16) pp. 2325-2328, 18 August 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.638<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
A new recommended disinfectant for dental<br />
instruments<br />
Jamileh bigom Taheri 1 , Mahin Bakhshi 1 , Sedigheh Bakhtiari 1 *, Bahare Nazemi 2 , Fateme<br />
Fallah 3 , Sahand Rezaie 5 , Hamed Mortazavi 1 and Somayyeh Azimi 4<br />
1 Department of Oral Medicine, Faculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br />
2 Department of Pediatric Dentistry, Faculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br />
3 Department of Microbiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br />
4 Department of Oral Medicine, Faculty of Dentistry, Qazvin University of Medical Sciences, Qazvin, Iran.<br />
5 General Practitioner, Faculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br />
Accepted 30 July, 2011<br />
Enduro hand sanitizer is a new disinfecting agent that has recently been introduced as an effective<br />
antibacterial, antifungal and antiviral agent. Considering the importance of infection control in dentistry,<br />
this study aimed to evaluate the antimicrobial effects of the foam and its ability to disinfect dental<br />
surfaces and instruments. An experimental study was designed to evaluate the microbial load of 50<br />
samples which were obtained randomly from dental surfaces and instruments before and after<br />
application of the disinfecting foam. All samples were cultured in blood agar and nutrient agar culture<br />
media and incubated at 37°C for 24 h. Colony count was subsequently performed after an additional 24<br />
h. Furthermore, to evaluate the efficacy of the foam on different bacterial species, a blank disc was<br />
coated with foam and approximated with the bacteria. The clear zone around each disc was measured<br />
and reported (mm) after 48 h. The significance of differences between the data retrieved before and<br />
after applying the foam was determined using the non parametric Chi-square test. None of the species<br />
were colonized after the application of the foam. It was also shown to significantly reduce the<br />
colonization of resistant bacterial strains and the standard microbial species (P
2326 Afr. J. Microbiol. Res.<br />
species/strains. Its antimicrobial effect remains for two<br />
hours after spraying the agent. Moreover, due to its nonalcoholic<br />
nature, the subcutaneous adipose tissue is<br />
preserved which makes Enduro hand sanitizer foam<br />
suitable for daily hand washing usage without causing<br />
excessive dryness and skin irritability. Longevity and<br />
biocompatibility of this potent antimicrobial agent, makes<br />
it superior to other disinfectants (Enduro hand sanitizer<br />
wwwoiltechnics.co.uk/Animalhygiene/Sanitizers/index).<br />
Hence, this study was performed to assess the efficacy of<br />
this product in disinfecting dental instruments.<br />
MATERIALS AND METHODS<br />
This study was a joint project conducted in the department of oral<br />
medicine and Microbiology, Department of Shahid Beheshti<br />
University of Medical Sciences, Tehran, Iran in 2009-2010. The disinfecting<br />
foam (Enduro Hand Sanitizer) was a product of Biotechnic<br />
Company in England. Fifty samples were obtained from moist<br />
dental instruments (surgical forceps, elevator and periodontal<br />
scaling instruments) using a swab before and after the application<br />
of the foam and were placed in BHI broth. The BHI was subsequently<br />
incubated at 37°C for 24 h. The samples were cultures on<br />
nutrient blood agar (simple agar) and the plates were re-incubated<br />
for an additional 24 h. Positive plates marked bacterial growth. In<br />
order to confirm the presence of bacteria and identify the bacterial<br />
strains in contaminated samples, lamellas were obtained from the<br />
positive plates and subjected to Gram staining after drying and<br />
fixing. For this purpose, each lamella was thoroughly covered with<br />
crystal violet dye for 1 min. and then rinsed out. Each specimen<br />
was then covered with lugol solution immediately for 1 min, washed<br />
out and immersed into alcohol for 20 to 30 s. Fuchsine was<br />
ultimately poured on the lamellas and washed after 1 min. The<br />
specimens were stored in a dry place and observed under ×100<br />
magnification to verify the presence and type of bacterial strains.<br />
In order to evaluate the effect of the foam on MRSA, Bacillus<br />
Subtilis and Entrobacteriacea, these bacteria were cultured on<br />
Muller-Hinton agar. A blank disk was coated with foam and three<br />
antibiogram discs comprising of Penicillin, Ciprofloxacin and<br />
Tetracycline were subsequently placed next to each other on the<br />
agar plate. The plates were incubated at 37°C for 24 h and the clear<br />
zone around the blank discs on the culture plates were measured<br />
and recorded. Clear zones with a diameter of 10 mm or more would<br />
indicate the effectiveness of the foam. Furthermore colony count<br />
was performed to determine CFU with standard experimental<br />
strains. The following bacteria with standard ATCC were used as<br />
control species to verify the growth of contaminating samples in<br />
agar plates:<br />
1. Bacillus ATCC 6633.<br />
2. Staph Aureus 2923.<br />
3. Entrococcus 13047.<br />
4. Staph Epidermis ATCC 12228.<br />
5. Candida ATCC 2091.<br />
The significance of differences between the data retrieved before<br />
and after applying the foam was determined using the non<br />
parametric Chi-square test (P
Table 1. Colony count of standard bacterial species before administration of<br />
Enduro hand sanitiser foam.<br />
Bacterial species Number of positive samples<br />
Stap.h epidermidis 36<br />
Pseudomonas 1<br />
Streptococcus 5<br />
Bacillus 15<br />
Entrococcus 5<br />
Lactobacillus 3<br />
Table 2. Colony count of standard bacterial species after administration of Enduro<br />
hand sanitiser foam.<br />
Bacterial species Number of positive samples<br />
Staph. epidermidis 5<br />
pseudomonas 0<br />
streptococcus 0<br />
Bacillus 1<br />
Entrococcus 0<br />
Lactobacillus 0<br />
anti microbial effects on different bacterial, viral and<br />
fungal species and effectively diminishes microbial contamination<br />
on dental surfaces (Enduro hand sanitizer). The<br />
results of the present study demonstrated that Enduro<br />
hand Sanitizer can effectively eliminate all pathogen<br />
microorganisms from dental instruments including surgical<br />
forceps and periodontal scalers. The importance of<br />
this data is that the tested pathogens are among the<br />
extremely contagious species which if disinfected effectively<br />
between every patient, would significantly prevent<br />
the spread of diseases and infection. Furthermore, the<br />
diameter of clear zone around the blank disk immersed in<br />
the foam was reported 15 mm for Bacillus, 12 mm for<br />
MRSA and 8 mm for Entroccocus. This indicates the<br />
sensitivity of common oral pathogens such as S.<br />
Epidermidis, Bacillus subtitles and candida species to the<br />
new product and further confirms its efficacy in<br />
eliminating the microbial load in dental environments.<br />
However, further evaluations are required to assess the<br />
efficiency of the foam in clinical settings and on different<br />
bacterial and viral species.<br />
The present study failed to evaluate the antiviral effect<br />
of this product however, according to the information<br />
provided by the manufacturers, the foam seems to render<br />
satisfactory results against Avian Flue H5N1 infection<br />
according to UK DEFRA standard. It has further been<br />
claimed that the foam can destroy spores of Aspergillus<br />
niger and Clostridum difficile (EN 1650 and EN 13704<br />
standards respectively). On the other hand, considering<br />
its strong anti bacterial effect against gram positive as<br />
well as gram negative resistant strains of bacteria, the<br />
antiviral effect of the foam may also be justified.<br />
Taheri et al. 2327<br />
Furthermore, due to the fact that HIV and HBV are highly<br />
sensitive microorganisms compared to vegetative<br />
bacterial pathogens, the veridical effect of this new agent<br />
may be conceived (Enduro hand sanitizer). Nonetheless,<br />
it appears that the antiviral and antifungal effect of the<br />
foam should be further studied.<br />
This study demonstrated strong bactericidal effects of<br />
the product however; the important point is the sensitivity<br />
of specific species such as Bacillus Subtilis to Enduro<br />
Hand Sanitizer. This bacterial strain is capable of<br />
producing spores and long lasting infections if not treated<br />
effectively. According to in vitro studies, the efficacy of<br />
disinfecting agents may be altered by the substances in<br />
culture media and thus need to be reported with cautious<br />
(Sen et al., 2009). The basic shortcoming of this study is<br />
therefore hidden within its design that is, investigating the<br />
efficacy of the new foam in controlled laboratory<br />
conditions on specific isolated microorganisms. Hence, it<br />
appears that future robust clinical trials should be<br />
designed to further study the antimicrobial effects of the<br />
Enduro hand sanitizer foam in accurate clinical settings.<br />
It is also important to note that despite the acceptable<br />
results retrieved from different disinfecting agents<br />
irrespective of the form (foam or solution), all of them are<br />
solely capable of reducing the microbial load on the outer<br />
surfaces of the instruments; the inner chamber of the air<br />
motor and the inner wall of the air and water sprays<br />
which are major sources of infection transmission, are not<br />
thoroughly cleaned. Therefore, researchers recommend<br />
the combination of disinfection, lubrication and heat<br />
sterilization of the air motors and hand pieces between<br />
every patient as an ideal measure to minimize the risk of
2328 Afr. J. Microbiol. Res.<br />
cross contamination. In other words, researchers believe<br />
that despite the satisfactory results retrieved from<br />
different disinfecting solutions and foams, these products<br />
are solely used to reduce the microbial load prior to heat<br />
sterilization. Furthermore with constant change in the<br />
bacterial flora and the emergence of new highly resistant<br />
species of bacterial pathogens in health care environments,<br />
there is always a great concern regarding the<br />
resistance of microorganisms to the available antibiotics<br />
and disinfectants. Therefore, there is still room for further<br />
studies on new products and benefitting from successful<br />
experiences of leading companies.<br />
Conclusion<br />
The present study provided an overall evaluation of the<br />
Enduro hand sanitizer foam. Considering the fact that the<br />
manufacturer has provided a list of sensitive microorganisms<br />
to this product, studies should be designed to<br />
assess bacterial and viral pathogens independently.<br />
Once the efficacy of the foam is firmly documented, it can<br />
be widely used in dental environments.<br />
ACKNOWLEDGMENTS<br />
This article was based on a undergraduate thesis by Dr<br />
Rezaie, which was successfully completed under the<br />
supervision of Dr Taheri with the close cooperation of the<br />
Oral Medicine department of dental school of Shahid<br />
Beheshti University of Medical School.<br />
REFERENCES<br />
Bonten MJ (2002). Infection in the intensive care unit: Preventive<br />
stratrgies. Curr. Opin. Infect. Dis., 15: 401-405.<br />
CDC Guide line for infection in dental health care setting (2003).<br />
December, 14; 1-16. Available at http://www.cdc.gov/oral health<br />
/infection control /guidelines/index.htm<br />
Enduro hand sanitizer. Available at:<br />
http//wwwoiltechnics.co.uk/Animalhygiene/Sanitizers/index.html<br />
Oosthuysen J, Potgieter E, Blignaut E (2010). Compliance with infection<br />
control recommendations in South African dental practices: a review<br />
of studies published between 1990 and 2007. Int. Dent. J., 60: 181-<br />
189.<br />
Rauter S, Sigge A, Wiedeck H, Trantmann M (2002). Analysis of<br />
transmission pathway of pseudomonas aeroginos between patient<br />
and tap water outlets. Crit. Care Med., 30: 2222-2228.<br />
Sen B, Akdeniz BG, Denizci AA (2009). The effect of ethylenediaminetetraacetic<br />
acid on Candida albicans .Oral Surg. Oral Med. Oral<br />
Pathol. Oral Radiol. Endod., 90: 651-655.<br />
Silverman SJR (1987). Infection disease control and the dental office:<br />
Aids and other transmissible disease. Int. Dent. J., 37(2):108-113.<br />
Smith A, Creanor S, Hurrell D, Bagg J, McCowan M (2009).<br />
Management of infection control in dental practice. J. Hosp. Infect.,<br />
71: 353-358.<br />
Yüzbasioglu E, Saraç D, CanbazS, Saraç S, Cengiz S (2009). A survey<br />
of cross-infection control procedures: knowledge and attitudes of<br />
Turkish dentists. J. Appl. Oral Sci., 17: 565-569.<br />
Zanetti F, Vannini S, Bergamaschi A, Baldi E, Stampi S (2004).<br />
Infection control in dental health care setting:results of a survey on<br />
current disinfection practices. Ig Sanita Publ., 60: 229-242.
African Journal of Microbiology Research Vol. 5(16), pp. 2329-2337, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.642<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
The functional roles of the residue tyrosine at position<br />
26 in staphylococcal enterotoxin C2<br />
Hongbo Wang 1,2 , Junyi Zhou 3 , Mingkai Xu 1 *, Huiwen Zhang 1 and Chenggang Zhang 1<br />
1 Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang 110016, China.<br />
2 Graduate School of Chinese Academy of Science, Beijing 100039, China.<br />
3 Shenyang Pharmaceutical University, Shenyang 110016, China.<br />
Accepted 30 July, 2011<br />
Bacterial superantigen Staphylococcus aureus enterotoxin C2 (SEC2) is a very potent activator of T<br />
cells. Previous crystal studies on SEC2 showed that residue Tyr26 which is located near the T cell<br />
receptor (TCR) binding sites could potentially participate in T cell activating. In SEC1, a superantigen<br />
highly homologous to SEC2, the residue Val26 played a critical role in stimulating certain V expansion.<br />
Moreover, residues 20, 22 and 26 in SEC1 determined its serologic cross-reaction. In order to<br />
investigate the potential roles of Tyr26 in SEC2, two SEC2 mutants SEC2(Y26V) and SEC2(Y26A) were<br />
constructed by site-directed mutagenesis. The activities and toxicities of the two mutants were<br />
determined both in vivo and in vitro. Results showed that both SEC2(Y26V) and SEC2(Y26A) remained<br />
potent immune stimulating activities compared with native SEC2. SEC2(Y26V) had a decreased<br />
pyrogenic effect on rabbit model. Both of the two mutants had significantly decreased binding affinities<br />
to anti-SEC2 IgG. Our result indicated that Tyr26 is a critical site for the serological characters of SEC2<br />
rather than for its superantigen activity. This may also provide an insight in constructing a novel mutant<br />
to substitute native SEC2 in cancer immunotherapy avoiding being neutralized by anti-SEC2 IgG in<br />
vivo.<br />
Key words: Staphylococcal enterotoxin C2, Site-directed mutagenesis, superantigen, serological, property.<br />
INTRODUCTION<br />
Microbial superantigens are a family of enterotoxins that<br />
share the ability to trigger excessive and aberrant<br />
activation of T cells (Llewelyn and Cohen, 2002). Unlike<br />
conventional antigens, SAgs bind to invariant regions of<br />
MHC class molecules outside the antigen-binding<br />
groove and are presented as unprocessed proteins to T<br />
lymphocytes expressing appropriate motifs on the<br />
variable domain of the chain(V ) of the T cell receptor<br />
(TCR) (Müller-Alouf et al., 2001). As a consequence,<br />
SAgs can activate an unusually high percentage of T<br />
lymphocytes and initiate massive releasing of cytokines<br />
which plays a pivotal role in T cell-mediated immune<br />
responses. The best characterized SAgs are<br />
Staphylococcal enterotoxins (SEs) and Streptococcal<br />
*Corresponding author. E-mail: mkxu@iae.ac.cn. Tel: +86 24<br />
8397 0380. Fax: +86 24 8397 0381.<br />
pyrogenic exotoxins (Spes) to date. Staphylococcal<br />
enterotoxins (SEs), a series of serological types of heat<br />
stable enterotoxins, produced by S. aureus, are the<br />
leading causes of gastroenteritis resulting from consumption<br />
of contaminated food (Balaban and Rasooly,<br />
2000). These toxins share common phylogenetic relationship,<br />
structure, function, and sequence homology. SECs<br />
are a group of highly conserved proteins with significant<br />
immunological cross-reactivity (Marr et al., 1993).<br />
According to minor epitope differences, SECs were<br />
further classified into three subtypes (C1-C3), which differ<br />
in only several amino acid residues near the N terminus<br />
(Hovde et al., 1990).<br />
Staphylococcal enterotoxin C2 (SEC2) can effectively<br />
activate the immune system and result in tremendous<br />
releasing of cytokines such as tumor necrosis factors-<br />
(TNF- ), interleukin-2 (IL-2), and interferon- (INF- ).<br />
This attribute makes SEC2 an effective ingredient for<br />
cancer immunotherapy in clinic in China (Chen, 2007).
2330 Afr. J. Microbiol. Res.<br />
But as an enterotoxin produced by S. aureus, SEC2 can<br />
cause toxic shock syndrome (TSS) at certain concentration,<br />
which limits its clinical application. Moreover, anti-<br />
SEC2 antibodies in patients’ serum could neutralize<br />
injected SEC2 and impair its effects. In Sweden, a mutant<br />
SEA has been fused to the Fab-fragment of tumortargeted<br />
monoclonal antibody for treatment of solid<br />
tumors in phase II trial. But toxicity and anti-SEA antibody<br />
were also the limiting factors for therapy (Shaw et al.,<br />
2007). For construction of novel superantigen variants<br />
with decreased toxicity and low reactivity to human anti-<br />
SEC2 antibodies, it is necessary to give insight into the<br />
key residues in SEC2.<br />
In SEC1, valine in position 26 (Val26) was likely to<br />
interact with TCR directly and cause certain V expansion<br />
(Deringer et al., 1996). Previous researches on<br />
antigenic uniqueness indicated that residues 20, 22 and<br />
26 were critical for forming SECl- and SEC2-specific<br />
epitopes (Turner et al., 1992). While in SEC2, the<br />
crystallographical data showed that tyrosine in position<br />
26 (Tyr26) might locate in putative TCR binding site<br />
(Schad et al., 1997; Fields et al., 1996), and it was likely<br />
to expose on the molecular surface and influence<br />
molecular interaction between SEC2 and TCR (Turner et<br />
al., 1992; Papageorgiou et al., 1995).<br />
SEC2 and SEC1 are different in only seven residues<br />
near the N terminus (Bohach and Schlievert, 1989), while<br />
their superantigen activities exhibited some differences<br />
(Hovde et al., 1994; Wang et al., 2009a). Based on the<br />
high homology between SEC1 and SEC2, we<br />
hypothesize that the residue of Tyr26 might be important<br />
to the superantigen activities and serological characters<br />
of SEC2.<br />
In order to investigate the potential roles of Tyr26 in<br />
SEC2, in this study, two SEC2 mutants SEC2(Y26V) and<br />
SEC2(Y26A) have been constructed and their<br />
superantigen activities and toxicities were determined<br />
both in vivo and in vitro. Our results showed that the<br />
Tyr26 was not function-related with the immune stimulating<br />
activities of SEC2, but important for the serological<br />
characters of SEC2. The mutant SEC2(Y26V) with potent<br />
immune stimulating activities showed decreased toxicity<br />
and significantly reduced binding by SEC2-specific IgG,<br />
which suggested that the newly constructed mutant<br />
protein could be used as a potentially powerful candidate<br />
for cancer immunotherapy in the future.<br />
MATERIALS AND METHODS<br />
Plasmids, bacterial strains and cell line<br />
Expression vector pET28a(+) from Novagen (Darmstadt, Germany)<br />
was used to transform SEC2 mutant gene into the host. E. coli<br />
BL21(DE3) from Novagen was cultured in Luria–Bertani (LB)<br />
medium for expressing SEC2 mutant protein. Murine hepatoma<br />
Hepal-6 cell line used in this study was purchased from American<br />
Type Culture Collection (ATCC) and maintained in RPMI 1640<br />
medium with 10% (v/v) fetal bovine serum (Gibco, USA).<br />
Recombined plasmid pET-28a-SEC2 which contains the entire<br />
SEC2 cDNA (Accession number AY450554) was constructed and<br />
conserved in our lab (Xu and Zhang, 2006).<br />
Chemicals and enzymes<br />
All chemicals are analytical grade. Pfu DNA polymerase and<br />
restriction enzymes were purchased from Takara Biotechnology Co<br />
(Dalian, China); isopropyl-D-thiogalactopyranoside (IPTG) and<br />
methylthiazol tetrazolium (MTT) were from Sigma Chemical Co (St<br />
Louis, MO, USA); Ni-NTA His-Bind resin was from Qiagen<br />
(Germany); the DNA Gel Extract kit and Mini-preparation of plasmid<br />
kit were from BioDev-Tech Co (Beijing, China).<br />
Experimental animals<br />
Female BALB/c mice (6-8 weeks old, 20-25 g) and adult New<br />
Zealand white rabbits weighing 2.0-2.5 kg were purchased from the<br />
Experimental Animal Center, China Medical University (Shenyang,<br />
China).<br />
All experimental animals were maintained under specificpathogen-free<br />
conditions on a 12 h light/dark cycle. All experiments<br />
were carried out under the guiding principles for the care and use of<br />
laboratory animals approved by Animal Care Committee of China<br />
Medical University.<br />
Site-directed mutagenesis<br />
We constructed two mutant SEC2, SEC2(Y26V) and SEC2(Y26A),<br />
by converting the Tyr at position 26 to Val and Ala respectively. The<br />
conceptual ideas behind this substitution design were as follows:<br />
we introduce Val into position 26 of SEC2 because valine is the<br />
residue in position 26 in SEC1, furthermore we introduce Ala into<br />
position 26 of SEC2 to diminish the effect of Tyr in this position.<br />
The SEC2 mutant genes were constructed by sequence overlap<br />
extension. All the primers related with over-lap PCR were listed in<br />
Table 1. The PCR-generated fragments containing substituted<br />
oligonucleotides were digested by EcoR I and Xho I, and ligated<br />
into plasmid pET28a(+) digested with the same enzymes. The<br />
recombined expression plasmid was transformed into E. coli<br />
BL21(DE3) and positive clone was identified by DNA sequencing.<br />
Expression and purification of mutant protein<br />
For expressing SEC2 mutant protein, the positive clone of<br />
transformed E. coli BL21(DE3) was incubated in LB for 10 h. The<br />
culture was then inoculated at a ratio of 1:100 (v/v) into LB medium<br />
supplemented with 50 g kanamycin ml -1 and incubated at 37°C<br />
with vigorous shaking until the OD600 reached 0.7. Then 1.0mM<br />
IPTG was added into the culture and the incubation was continued<br />
for 4 h more with vigorous shaking at 30°C. The cells were<br />
harvested by centrifugation at 5,000 rpm and resuspended with icecold<br />
loading buffer (50 mM NaH2PO4, 500 mM NaCl, 10 mM<br />
imidazole, pH 7.9). The cells were disrupted by sonication on ice<br />
followed by centrifugation (10,000 rpm, 30 min). The supernatants<br />
were collected and loaded onto a Ni-saturated chelating Sepharose<br />
column pre-equilibrated with loading buffer. After removing nonspecifically<br />
binding protein with washing bufferl (50 mM NaH2PO4,<br />
500 mM NaCl, 40 mM imidazole, pH 7.9), SEC2 mutant protein was<br />
released from the column by washing buffer (50 mM NaH2PO4, 500<br />
mM NaCl, 250 mM imidazole, pH 7.9) and dialysed against PBS<br />
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4,<br />
pH 7.4) at 4°C for 48 h to remove the high concentration of
Table 1. Primers for amino acid substitution by over-lap PCR.<br />
Primers Amino acid substitution Primer sequence a<br />
P-1 5 -CGGAATTCGAGAGTCAACCAGA-3<br />
P-2 26Y V 5 -CATCATATAATACTTTCATATTACCCATCG-3<br />
P-3 5 -GGGTAATATGAAAGTATTATATGATGATC-3<br />
P-4 26Y A 5 -CATCATATAATGCTTTCGTATTACCCATCG-3<br />
P-5 5 -GGGTAATACGAAAGCATTATATGATGATC-3<br />
P-6 5 -TCGCTCGAGTTATCCATTCTTTGTTG-3<br />
a The primers were designed for special amino acid substitution. The sequences of mutant residues are stressed in<br />
boldface. The recognition sites of EcoR I and Xhol I are underlined.<br />
imidazole. The purity of SEC2 mutant protein was estimated by<br />
SDS-PAGE and the concentration of mutant protein was<br />
determined by Bradford assay using BSA as the standard.<br />
Stimulating murine T-cell proliferation assay<br />
To investigate the activity of stimulating T cell proliferation by<br />
mutant SEC2, splenocytes from 6- to 8-week-old BALB/c female<br />
mice were collected as experimental target. The mutant SEC2 and<br />
the native SEC2 dissolved in 1640 medium were filled into the wells<br />
of 96-well microtitre plates in four different concentrations (10, 100,<br />
1000, and 10,000 ng/ml). There were three repeated wells at each<br />
concentration. RPMI 1640 medium with 10% FBS was served as<br />
negative control. Murine T cells were seeded into the experimental<br />
and negative control wells at a density of 8×10 5 cells per well.<br />
The proliferation index (PI) was determined by MTT assay. The<br />
splenocytes were incubated at 37°C with 5% CO2 for 72 h. The<br />
incubation was continued for 4 h more after 25 l MTT (5 mg/ml,<br />
dissolved in PBS) had been added to each well. Then the T cells<br />
were collected by centrifugation at 1,000 rpm for 10 min. 120 l<br />
DMSO was added into each well to redissolve the pellet on the<br />
bottom. To fully dissolve the formazan produced by T cells, the<br />
plate was vigorously shaking for 20 min. The absorbance was<br />
measured with a microplate reader at 570 nm, using a reference<br />
wavelength of 630 nm. The final absorbance is the difference<br />
between these two readings. The proliferation index (PI) was<br />
calculated with the following equation:<br />
PI=Abs value of the experimental well / Abs value of the negative<br />
control well.<br />
Antitumor activity<br />
To further investigate the superantigen activity of mutant SEC2, the<br />
inhibitory effects on tumor cell was determined by MTT assay.<br />
Splenocytes from 6- to 8-week-old BALB/c female mice were<br />
served as effector cells and Hepal-6 cell as target. Native SEC2<br />
and the mutants diluted with RMPI 1640 containing 10% FBS were<br />
separately filled into the wells of 96-well microtitre plate at 10ng/ml,<br />
100 and 1,000 ng/ml in triplicate. In experimental wells, effector<br />
cells (5×10 5 cells/well) and target cells (2.5×10 4 cells/well) were<br />
mixed in the present of native SEC2 or the mutants in different<br />
concentrations. Wells contained protein and lymphocytes only were<br />
served as lymphocytes releasing control. Wells contained Hepal-6<br />
cells alone were served as unsettled tumor cell control. The blank<br />
wells were RMPI 1640 with 10% FBS only, and BSA was served as<br />
negative control.<br />
After incubation for 72 h at 37°C with 5% CO2, 25 l MTT was<br />
added into each well, and the cells were incubated for 4 h more.<br />
Wang et al. 2331<br />
The cells were collected by centrifugation and redissolve with<br />
DMSO. The absorbance was measured with a microplate reader at<br />
570 nm, using a reference wavelength of 630 nm. Tumor growth<br />
inhibition (%) was calculated with the equation: 100 - [(Abs value in<br />
protein-treated cells well - Abs value in lymphocytes-releasing well)<br />
/ (Abs value in unsettled tumor cells control wells - Abs value in<br />
blank control wells)] ×100.<br />
Rabbit model assay<br />
Rabbit model was used to compare the febrile response of SEC2<br />
and the mutants in vivo. Each of the experimental animals was<br />
fixed and the rectal temperature was measured for at least 90 min<br />
before injection. Qualified rabbits used in this assay must have<br />
stable body temperatures ranging from 38.6 to 39.5°C. Native<br />
SEC2 and the mutants dissolved in PBS were injected into rabbits<br />
at the does of 10 g/kg (body weight). Three animals were injected<br />
with each protein. PBS was served as negative. Rectal temperatures<br />
of rabbits were measured with indwelling rectal thermometers<br />
right after pyrogen administration continually for 3 h. The rectal<br />
temperature change ( T) of rabbit was accepted as an index of<br />
pyrogen effect in vivo, and it was calculated by subtracting the<br />
temperature immediately before injection from the temperature at<br />
each time point after the pyrogen injection.<br />
Proteolysis susceptibility assays<br />
To investigate whether the trypsin-resistance of SEC2 mutants<br />
were affected by amino acid substitution, purified mutanted proteins<br />
and native SEC2 (100 g/ml) were respectively incubated at 37°C<br />
with trypsin at a trypsin/protein ratio of 1:25 (w/w). After desired<br />
periods of time, the enzymolysis was terminated by boiling in SDS-<br />
PAGE sample buffer for 5 min and analyzed by SDS-PAGE.<br />
Detection of mutant SEC2 by ELISA<br />
ELISA assay was carried out in accordance with the instruction of<br />
the kit (National institute for the control of pharmaceutical and<br />
biological products, Beijing, China). Briefly, the polystyrene plates<br />
were coated with 100 l of 5 g/ml rabbit anti-SEC2 IgG diluted in<br />
carbonate buffer overnight. The excessive IgG which did not bind to<br />
the wells was washed off by PBS containing 0.05% Tween 20<br />
(PBS-T20), then unabsorbed sites were blocked with 1% gelatin in<br />
PBS for 30 min at 37°C. Mutant SEC2 and the native dissolved in<br />
PBS-T20 buffer were added into the wells separately. The plate<br />
was incubated for 2 h at 37°C. Then the wells were emptied and<br />
washed by PBS-T20 buffer. Rabbit anti-SEC2 IgG-HRP conjugate<br />
was added, and the plate was incubated for 1.5 h at 3 7°C. The
2332 Afr. J. Microbiol. Res.<br />
Figure 1. Results of murine T-cell proliferation by SEC2 mutants and native SEC2.<br />
Purified proteins of SEC2 mutants or the native were incubated with murine splenocytes<br />
for 72 h before the proliferation effects were determined by MTT assay. Value on the yaxis<br />
represents the average proliferation index (PI)± SD of triplicate values. Each<br />
purified protein was tested in at least three separate assays.<br />
uncombined enzyme-linked antibody was washed off by PBS-T20,<br />
and 100 l substrate (0.04% ortho-phenylene-diamine) was added<br />
into the wells and incubated for 30 min at 37°C. Reactions were<br />
terminated by addition of 50 l 2 mol/L H2SO4, and the absorbance<br />
was measured at 450 nm.<br />
Statistical analysis<br />
Results are presented as the mean ± SD. Statistical analysis was<br />
performed using Student’s t test. A P-value < 0.05 was considered<br />
statistically significant.<br />
RESULTS<br />
Construction and expression of the mutant SEC2<br />
To construct SEC2 mutant protein, over-lap PCR was<br />
employed. The mutant SEC2 genes were successfully<br />
constructed and cloned into the expression vector pET-<br />
28a (+). The recombinant expression vectors were<br />
transformed into E. coli BL21 (DE3) respectively for<br />
expressing mutant proteins. The positive clones were<br />
identified by DNA sequencing.<br />
For expressing SEC2 mutant proteins, the positive<br />
clones with the right mutagenesis introduced were<br />
respectively cultured in LB medium containing 50 mg<br />
kanamycin ml -1 till the OD 600 reached 0.7. The<br />
expressions of mutant proteins were performed by IPTG<br />
inducing at 30°C for 4 h. After purification with Ni-NTA<br />
His Bind Resin, both of the two mutant proteins shown as<br />
a single band on SDS-PAGE were of purity of more than<br />
95%.<br />
Murine T-cell proliferation activity<br />
The activities of stimulating T cell proliferation by SEC2<br />
and the mutants were investigated. Series of ten-fold<br />
dilutions of native SEC2 and the mutants dissolved in<br />
PBS were filled into the wells of a 96-well microtitre plate<br />
with murine T cells. After 72 h incubation, the proliferation<br />
index of murine T cell was determined by MTT assay. As<br />
the experimental data reflected, both native SEC2 and<br />
the mutants could induce murine T cells proliferation in a<br />
dose-dependent manner. The ability to induce T cell<br />
proliferation of SEC2 mutants were similar with that of the<br />
native, without significant differences at any concentration<br />
(P>0.05; Figure 1). This result indicated that the<br />
amino acid substitution at position 26 with Ala or Val had<br />
not significantly affected the stimulating activity of SEC2.<br />
Examination the antitumor activity<br />
To further investigate the superantigen activity of mutant<br />
SEC2, MTT assay was employed to compare the
Figure 2. MTT assay was employed to compare the tumor cell growth inhibition effects between<br />
SEC2 and the mutants. Tumor cells and the splenocytes were mixed and seeded into the wells at<br />
the density of 2.5×10 4 cells/well and 5×10 5 cells/well respectively. Different concentrations of SEC2<br />
or the mutants were incubated with the cells at 37°C for 72 h before the absorbance was<br />
measured. BSA was used as negative control. Data shown are representative of at least three<br />
separate experiments, and the values represent the mean ± standard error of the mean.<br />
anti-tumor activity of SEC2 and the mutants. Hepal-6<br />
cells (target cells) and splenocytes (effector cells) were<br />
incubated in the present of proteins in different concentrations<br />
for 72 h before the absorbance was measured.<br />
All the proteins tested in this study exhibited predominant<br />
anti-tumor abilities compared with negative control<br />
(P0.05). This indicated that the amino<br />
acid substitution in position 26 had little influence on the<br />
superantigen activity of SEC2.<br />
Toxicity<br />
The Rabbit model assay was carried out to investigate<br />
the pyrogenic effect of mutant SEC2. The rectal<br />
temperature of each experimental animal was continually<br />
measured for 3 h after pyrogen injection. The results<br />
showed that both SEC2 and the mutants could induce the<br />
enhancement of temperature in experimental animal<br />
significantly compared with negative control (P0.05). Whereas SEC2(Y26V) exhibited a<br />
decreased ability to induce fever at 2h, 2.5h, and 3h<br />
compared with SEC2. Furthermore, the enhancement of<br />
temperature in experimental animal injected with<br />
SEC2(Y26V) reached its top at 1.5 h after pyrogen<br />
injection. But it is noteworthy that the body temperature of<br />
animal injected with SEC2 or SEC2(Y26A) rose<br />
continually although the experiment.<br />
Susceptibility to trypsin<br />
In order to determine whether the minor decreased<br />
pyrogenic effect of SEC2(Y26V) in the later stage of<br />
pyrogen experiment was resulted from its degradation,<br />
trypsin digestion assay was performed to evaluate the<br />
stability of the two mutants. The result was determined by<br />
15% SDS-PAGE and showed that there was no significant<br />
difference in the trypsin susceptibility between native<br />
SEC2 and the mutants (Figure 4). This result suggested<br />
that the amino acid substitution at position 26 did not<br />
affect the instability of SEC2, and the decreased<br />
pyrogenic activity of SEC2(Y26V) was not resulted from<br />
its degradation.
2334 Afr. J. Microbiol. Res.<br />
Figure 3. The pyrogenicities of SEC2 and the mutants in rabbit model. The body<br />
temperature of experimental rabbit was continually measured for 3h right after<br />
protein injection. PBS solution was served as negative control. The value of y-axis<br />
represents the rise of temperature.<br />
Figure 4. Susceptibilities of SEC2(Y26V), SEC2(Y26A), and<br />
native SEC2 to trypsin were compared. Each protein was<br />
mixed with trypsin at a trypsin/protein ratio of 1:25 (w/w). The<br />
digestive reaction was performed at 37°C for time gradient<br />
and terminated by boiling for 5 min at 100°C. The result was<br />
analyzed by 15% SDS-PAGE.
Figure 5. Comparison the anti-SEC2 IgG binding affinity of native SEC2 and the mutants<br />
through ELISA. The absorbance was measured and calculated as the mean readings of<br />
triplicate samples ± SD.<br />
Evaluating epitope change of mutant SEC2 by ELISA<br />
ELISA assay was employed to investigate whether the<br />
Tyr at position 26 determines the epitope of SEC2. Both<br />
of the two mutants showed significant decreased binding<br />
affinities to SEC2-specific IgG compared with native<br />
SEC2 (P
2336 Afr. J. Microbiol. Res.<br />
side chain of Try26 was completely removed by Ala<br />
substitution in SEC2(Y26A). A reasonable explanation for<br />
this phenomenon is that Try26 was not the key residue<br />
for the immune stimulating activity of SEC2.<br />
Previous crystal structure study on SEC2 conveyed<br />
that residues 20, 22 and 26 potentially interacted with<br />
TCR (Papageorgiou et al., 1995). Although there was no<br />
direct evidence that Tyr26 in SEC2 participated in the<br />
interaction of SEC2 with TCR, some researchers<br />
reported that Val26 in SEC1 recognized the specificity of<br />
TCR V of SEC1. Mutant study in SEC1 showed that<br />
SEC1(V26 Y)with a single amino acid substitution at<br />
position 26 could significantly enhance the expansion of<br />
V 13.1 but decreased the expansion of V 3 (Deringer et<br />
al., 1996).<br />
So, on the basis of the high homology between SEC1<br />
and SEC2, we constructed SEC2(Y26V) and<br />
SEC2(Y26A) to respectively change and diminish the<br />
TCR V recognization ability of SEC2. It was widely<br />
accepted that the affinity of SAgs for TCR can<br />
significantly affect their mitogenic potency (Andersen et<br />
al., 2001). The weak affinity of the TCR-Sag interaction<br />
results in poor T cell response. But in this study, both of<br />
the two mutants exhibited comparable stimulating ability<br />
with SEC2, which suggested that substitution in position<br />
26 could not alter the TCR affinity of SEC2.<br />
In rabbit model assay, SEC2(Y26V) exhibited a<br />
decreased ability to induce fever at 2h, 2.5h, and 3h<br />
compared with SEC2. This promoted us to investigate<br />
whether the decreased toxicity in vivo was due to its<br />
instability resulted from amino acid substitution. Our<br />
result from proteolysis susceptibility assays has exhibited<br />
that both of the two mutants maintained comparable<br />
resistance to trypsin with SEC2, which indicates that the<br />
amino acid substitution in position 26 did not result in the<br />
exposure of additional tryptic cleavage sites. So it is<br />
suggested that the decreased toxicity of SEC2(Y26V)<br />
does not due to its degradation. SEC2(Y26V) has potent<br />
immune stimulating activities compared with SEC2 in all<br />
concentration, which is inconsistent with the previous<br />
theory that the febrile activity of SE is a direct<br />
consequence of T cell stimulation. On the other hand,<br />
macrophages and monocytes stimulated by superantigen<br />
could secrete some endogenous pyretogenic cytokines<br />
such as TNF- and IL-1, which was the major cause of<br />
immune-mediated diseases such as fever (Roggiani et<br />
al., 1997). Further investigation was needed to interpret<br />
it.<br />
Previous researches on antigenic uniqueness indicated<br />
that residues 20, 22 and 26 were critical for forming<br />
SECl- and SEC2-specific epitopes. SEC1 mutants with<br />
substitutions at all three positions reacted only with an<br />
SEC2-specific antibody (Turner et al., 1992). On the<br />
basis of the homology between SEC1 and SEC2, we<br />
hypothesized that Tyr26 was important for the serological<br />
characters in SEC2. The result from ELISA confirmed this<br />
hypothesis that SEC2(Y26V) and SEC2(Y26A) showed<br />
significantly decreased binding affinities to SEC2-specific<br />
IgG. The residue of Val26 in SEC2(Y26V) was homologous<br />
to Val26 in native SEC1, so Val26 could mediate<br />
the cross-reactivity of SEC2(Y26V) with rabbit anti-SEC2<br />
polyclonal IgG used in this study. It could be a possible<br />
explanation for that SEC2(Y26V) showed higher binding<br />
affinity to SEC2-specific IgG than SEC2(Y26A) did. For<br />
the lack of SEC1-specific IgG, we could not determine<br />
whether SEC2(Y26V) and SEC2(Y26A) were able to<br />
induce cross-reactivity with SEC1-specific IgG. However<br />
it was quite sure that the mutation introduced into position<br />
26 influenced the recognition of SEC2 by SEC2-specific<br />
antibodies, which suggested that Tyr 26 was critical for<br />
the antigenic uniqueness of SEC2.<br />
Concluded from our result, the roles of residue at<br />
position 26 in SEC2 are different from those of in SEC1,<br />
which may result from continuous evolution. This slight<br />
difference can display different serological specificity to<br />
avoid the cross-reactivity with antibodies from the host.<br />
In summary, we have investigated the potential roles of<br />
Tyr26 in SEC2 by site-directed mutagenesis. Our results<br />
indicated that Tyr26 is not important for the immune<br />
stimulating activities, but a critical site for the serological<br />
characters of SEC2. A low toxic mutant SEC2(Y26V)<br />
constructed in this study with potent superantigen<br />
activities and significantly decreased binding affinities to<br />
anti-SEC2 IgG has the potentiality to be a novel mutant to<br />
substitute native SEC2 in cancer immunotherapy.<br />
ACKNOWLEDGEMENT<br />
This work was supported by a grant from the National<br />
Science and Technology Major Specific Projects of China<br />
for "Significant Creation of New Drugs" (2009ZX09103-<br />
692).<br />
REFERENCES<br />
Andersen PS, Geisler C, Buus S, Mariuzza RA, Karjalainen K (2001).<br />
Role of the T Cell Receptor Ligand Affinity in T Cell Activation by<br />
Bacterial Superantigens. J. Biol. Chem., 276: 33452-33457.<br />
Balaban N, Rasooly A (2000). Staphylococcal enterotoxins. Int. J. Food<br />
Microbiol., 61: 1-10.<br />
Bohach GA, Schlievert PM (1989). Conservation of the biologically<br />
active portions of staphylococcal enterotoxins Cl and C2. Infect.<br />
Immun., 57: 2249-2252.<br />
Chen TZ (2005). The basis and criteria for the effective dose of SEC2<br />
oral liquid. Prog. in Microbiol. Immunol. China, 33: 51-58.<br />
Chen TZ (2007). The future development direction of HAS. Prog. in<br />
Microbiol. Immunol. China, 35: 49-50.<br />
Deringer JR, Ely RJ, Stauffacher CV, Bohach GA (1996). Subtypespecific<br />
interactions of type C stapholoccal enterotoxins with the Tcell<br />
receptor. Mol. Microbiol., 22: 523-534.<br />
Fields BA, Malchiodi EL, Li H, Ysern X, StauVacher CV, Schlievert PM,<br />
Karjalainen K, Mariuzza RA (1996). Crystal structure of a T-cell<br />
receptor beta-chain complexed with a superantigen. Nature, 384:<br />
188-192.<br />
Hovde CJ, Hackett SP, Bohach GA (1990). Nucleotide sequence of the<br />
staphylococcal enterotoxin C3 gene: sequence comparison of all<br />
three type C staphylococcal enterotoxins. Mol. Gen. Genet., 220:<br />
329-333.<br />
Hovde CJ, Marr JC, Hoffmann ML, Hackett SP, Chi YI, Crum KK,<br />
Stevens DL, Stauffacher CV, Bohach GA (1994). Investigation
of the role of the disulphide bond in the activity and structure of<br />
staphylococcal enterotoxin C1. Mol. Microbiol., 13: 897-909.<br />
Llewelyn M, Cohen J (2002). Superantigens: microbial agents that<br />
corrupt immunity. Lancet infect. Dis., 2: 156-162.<br />
Marr JC, Lyon JD, Roberson JR, Luphe MR, Davis WC, Bohach GA<br />
(1993). Characterization of novel type C staphylococcal enterotoxins:<br />
biological and evolutionary implications. Infect. Immun., 61: 4254-<br />
4262.<br />
Müller-Alouf H, Carnoy C, Simonet M, Alouf JE (2001). Superantigen<br />
bacterial toxins: state of the art. Toxicon, 39: 1691-1701.<br />
Papageorgiou AC, Acharya KR, Shapiro R, Passalacqua EF, Brehm<br />
RD, Tranter HS (1995). Crystal structure of the superantigen<br />
enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding<br />
site. Structure, 3:769-779.<br />
Pastacaldi C, Lewis P, Howarth P (2010). Staphylococci and<br />
staphylococcal superantigens in asthma and rhinitis: a systematic<br />
review and meta-analysis. Allergy, 66: 549-555.<br />
Roggiani M, Stoehr JA, Leonard BA, Schlievert PM (1997). Analysis of<br />
toxicity of streptococcal pyrogenic exotoxin A mutants. Infect.<br />
Immun., 65: 2868-2875.<br />
Schad EM, Papageorgiou AC, Svensson LA, Acharya KR (1997). A<br />
structural and functional comparison of staphylococcal enterotoxins A<br />
and C2 reveals remarkable similarity and dissimilarity. J. Mol. Biol.,<br />
269: 270-280.<br />
Shaw DM, Connolly NB, Patel PM, Kilany S, Hedlund G, Nordle O,<br />
Forsberg G, Zweit J, Stern PL, Hawkins RE (2007). A phase study of<br />
a 5T4 oncofoetal antigen tumor-targeted superantigen (ABR-214936)<br />
therapy in patients with advanced renal cell carcinoma. Br. J. Cancer,<br />
96: 567-574.<br />
Wang et al. 2337<br />
Strandberg KL, Rotschafer JH, Vetter SM, Buonpane RA, Kranz DM,<br />
Schlievert PM (2010). Staphylococcal superantigens cause lethal<br />
pulmonary disease in rabbits. J. Infect. Dis., 202: 1690-1697.<br />
Sundstedt A, Celander M, Ohman MW, Forsberg G, Hedlund G (2009).<br />
Immunotherapy with tumor-targeted superantigens (TTS) in<br />
combination with docetaxel results in synergistic anti-tumor effects.<br />
Int. Immunopharmacol., 9: 1063-1070.<br />
Turner TN, Smith CL, Bohach GA (1992). Residues 20, 22, and 26<br />
Determine the Subtype Specificities of Staphylococcal Enterotoxins<br />
Cl and C2. Infect. Immun., 60: 694-697.<br />
Wang XG, Xu MK, Cai YM, Yang HL, Zhang HW, Zhang CG (2009a).<br />
Functional analysis of the disulphide loop mutant of staphylococcal<br />
enterotoxin C2. Appl. Microbiol. Biotechnol., 82: 861-871.<br />
Wang XG, Xu MK, Zhang HW, Liu J, Li X, Zhang CG (2009b).<br />
Enhancement of superantigen activity and antitumor response of<br />
staphylococcal enterotoxin C2 by site-directed mutagenesis. Cancer<br />
Immunol. Immunother., 58: 677-686.<br />
Xu MK, Zhang CG (2006). Gene Expression and Function Study of<br />
Fusion Immunotoxin Anti-Her-2-scFv-SEC2 in E.coil. Appl. Microbiol.<br />
Biotechnol., 70: 78-84.
African Journal of Microbiology Research Vol. 5(16), pp. 2338-2348, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.136<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Prevalence study of cytomegalovirus (CMV) infection<br />
among foreign manpower in Jeddah Saudi Arabia<br />
N. A. Redwan 1 , M. M. M. Ahmed 1,2 * and M. S. H. AL Awfi 1<br />
1 Department of Biological Sciences, Faculty of Science, P. O. Box 80203, King Abdulaziz University, Jeddah, 21589,<br />
Saudi Arabia.<br />
2 Nucleic Acids Research Department, Genetic Engineering and Biotechnology Research Institute (GEBRI),<br />
Mubarak City for Scientific Research and Technology Applications, Alexandria, Egypt.<br />
Accepted 25 June, 2011<br />
Human cytomegalovirus (HCMV) is a species-specific DNA virus of the Herpetoviridae family.<br />
Cytomegalovirus (CMV) is more widespread in developing countries and in areas of low socioeconomic<br />
conditions. It causes high morbidity and mortality. After primary infection CMV is not<br />
eradicated but establishes life-long infection in its host. CMV dispersed and become dormant or latent<br />
in multiple end organs, and can later be reactivated by a number of different stimuli, including<br />
immunosuppresion and inflammation. To determine CMV prevalence in a sample of the foreign<br />
manpower population in Jeddah region, Saudi Arabia, we tested serum samples for CMV-specific<br />
immunoglobulin G from participants aged 20 to 60 years (n = 514) by enzyme linked immunosorbent<br />
assay (ELISA). The prevalence of CMV infection was 80.7% in studied population. CMV prevalence<br />
differed significantly by sex (p
through the epithelium of the upper alimentary,<br />
respiratory, or genitourinary tracts.<br />
However, the initial infection of epithelial cells is not<br />
essential, as demonstrated by infections from blood<br />
transfusions and organ transplantation. CMV is spread<br />
through the body with the aid of leukocytes and vascular<br />
endothelial cells (Halpern et al., 2004). Dissemination of<br />
CMV through the blood is typically followed by infection of<br />
the ductal epithelial cells. CMV spreads through the body<br />
quickly into many sites. Historical in-vitro studies<br />
characterize CMV as a slowly replicating virus, but in a<br />
recent study based on changes in viral load in humans,<br />
CMV has been shown to replicate quickly with a doubling<br />
time of approximately one day during active infection<br />
(Gerna et al., 2004). CMV infects a wide range of tissues<br />
and cell types: it has been found in salivary glands, lung,<br />
liver, pancreas, kidney, ear, eye, placenta, alimentary<br />
tract, heart, ovaries, pituitary, brain, skin, thyroid,<br />
esophagus, prostate, testes, and adrenals (Reddehase et<br />
al., 2002).<br />
In the vast majority of healthy individuals the immune<br />
system quickly reaches homeostasis with CMV. While the<br />
immune system of healthy individuals is usually able to<br />
prevent CMV from producing clinical manifestations, the<br />
immune system very rarely completely eliminates CMV<br />
from the body - the viral genome remains in a latent<br />
stage waiting for reactivation. While the latent stage of<br />
CMV infection has been researched extensively, the<br />
identity of cell types that harbor latent CMV, the ranges of<br />
genes expressed during latency, and the mechanisms of<br />
reactivation continue to be controversial (Jarvis and<br />
Nelson, 2002).<br />
A crucial part of the immune system defense against<br />
CMV is the development of CMV specific antibodies.<br />
Antibodies bind to CMV, thereby inhibiting its ability to<br />
infect new cells and marking it for removal from the body.<br />
The first type of antibody to develop in response to CMV<br />
is Immunoglobulin M (IgM), which develops within a few<br />
days following primary infection. While CMV IgM remains<br />
detectable for six to nine months, medium to high levels<br />
of CMV IgM can be detected during the first three months<br />
of a primary infection. IgM can also be detected during<br />
some secondary infections, both reactivation and<br />
reinfection, and is therefore not a valid marker of primary<br />
infection. The second antibody type to respond to CMV is<br />
IgG. This antibody develops within 1 to 2 weeks after<br />
infection and, once developed, can be detected throughout<br />
life. Consequently, IgG is commonly used and widely<br />
accepted measure of previous CMV infection (Drew,<br />
1988).<br />
CMV seropositivity rates are higher in females, older<br />
people, those of lower socioeconomic status (SES) and<br />
residents of developing countries. A recent study also<br />
shows a relationship between ethnicity and seroprevalence<br />
that is independent of factors such as SES.<br />
Worldwide, seroprevalence in adults in the general<br />
population varies from 40 to 90% (Dowd et al., 2009).<br />
Redwan et al. 2339<br />
Tests for antibodies in an individual's serum are called<br />
serologic tests. If antibodies are not detected in the<br />
serum, the individual is seronegative. For<br />
Immunoglobulin G (IgG), this is commonly interpreted to<br />
mean that the individual's immune system has never<br />
encountered the virus and they have never been infected<br />
with CMV. Individuals are called seropositive if antibody<br />
to the virus is detectable in their blood. This means that<br />
the individuals have been previously infected with CMV. If<br />
upon an individual's first CMV IgG test they are seronegative<br />
and on a later test are seropositive, the individual<br />
is said to have undergone seroconversion, indicating the<br />
occurrence of a primary infection.<br />
The aim of this study was a prevalence of infected<br />
CMV in worker population in Jeddah region, Saudi<br />
Arabia. In addition, find out the relationship of our result<br />
with age, gender and ethnicity.<br />
MATERIALS AND METHODS<br />
Serum samples collection<br />
A total of 514 serum samples were tested for CMV seroprevalence<br />
using enzyme linked immunosorbent assay (ELISA). Samples were<br />
collected from 4 diagnostic laboratories throughout Jeddah,<br />
including: the Medical Laboratory of Ghulail Dispensary, Medical<br />
Laboratory of Badr Adeen Dispensary, Medical laboratory of AL-<br />
Quds dispensary and Medical laboratory of University street<br />
hospital. These laboratories supplied remnant sera from samples<br />
that had been submitted for serological testing and would otherwise<br />
have been discarded. Sera from subjects who were known to be<br />
infected with human immunodeficiency virus, hepatitis B virus and<br />
hepatitis C virus were excluded. Sera were identified at the referring<br />
laboratory by the sex of the subject, age or date of birth, date of<br />
collection, and nationality. The samples were coded by date of<br />
collection, nationality/territory of origin, sample number and<br />
referring laboratory. All serum samples were stored at -20°C until<br />
use.<br />
Study population<br />
Serum samples were collected from foreign workers between 20<br />
and 60 years of age and stratified into the following age groups: 20<br />
to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49, 50 to 54 and.<br />
55 to 60, Serum samples were not available for less than 20 year of<br />
age. Approximately equal numbers of males and females were<br />
tested. Also, approximately equal numbers of seven nationalities<br />
including: Egyptian, Yemeni, Sudan, Pakistani, Indian, Bangladesh<br />
and Ethiopian were tested. Prevalence was calculated separately<br />
for each age group, for each nationality, for male and female<br />
separately, and for foreign workers as a whole. The CMV prevalence<br />
for the group aged 61 years and above was assumed to be<br />
the same as for the group aged 55 to 60 years. Sample sizes were<br />
calculated to achieve a 95% confidence interval (CI) of<br />
approximately ±5% for each age group.<br />
Serological testing<br />
Serum samples were tested for HCMV-specific immunoglobulin G<br />
(IgG) using a HCMV IgG enzyme-linked immunosorbent assay<br />
(ELISA) technique using DRG kit (DRG International, Inc., USA).
2340 Afr. J. Microbiol. Res.<br />
Principle of the test<br />
The antigen composed of partially purified and inactivated<br />
cytomegalovirus is bound to the solid phase (8-well strips). The<br />
specific immunoglobulin is bound to the antigen through incubation<br />
with diluted human serum. After washing to eliminate the proteins<br />
which have not reacted, incubation is performed with the conjugate,<br />
composed of human IgG monoclonal antibodies conjugated to<br />
horse radish peroxidase. The unbound conjugate is eliminated, and<br />
the peroxidase substrate added. The blue color which develops is<br />
proportional to the concentration of specific antibodies present in<br />
the serum sample. When the enzymatic reaction is interrupted by<br />
the addition of sulphuric acid solution, the yellow color, which<br />
develops, can be easily read by using a microplate reader (Wisdom,<br />
1976).<br />
Reagent preparation<br />
All reagents should be allowed to reach room temperature (18 to<br />
25°C) before use. Dilute 1 volume of wash buffer with 19 volume of<br />
distilled water. For example, dilute 50 ml of wash buffer into 950 ml<br />
distilled water to prepare 1000 ml of wash buffer which is stable for<br />
1 month at 2 to 8°C mixed well before use.<br />
Sample and controls dilution<br />
Prepare 1:40 dilution of test samples, negative control, positive<br />
control and calibrator by adding 5 l of the samples and controls to<br />
195 l of sample diluents and mixed well. Procedure is as in assay<br />
(ELISA) technique using DRG kit.<br />
RESULTS<br />
Calculation of the result<br />
Qualitative results<br />
The CMV IgG Index of each determination was<br />
calculated by dividing the absorbance value of each<br />
sample by absorbance value of cut-off. Samples with<br />
CMV index less than 0.90 was sero-negative for IgG<br />
antibody to CMV, those with CMV index between 0.91<br />
and 0.99 is equivocal and the samples should be<br />
repeated.<br />
Quantitative results<br />
For quantitative determination of anti-CMV IgG levels of<br />
positive specimens in IU/ml, the O.D of cut-off and<br />
positive calibrators are plotted on the Y-axis of a group<br />
against their corresponding anti-CMV IgG concentration<br />
of 0, 1, 2, 6, 18 IU/ml on the X-axis. The estimates of<br />
levels in patient sera are read off the graph using their<br />
individual O.D. values.<br />
Interpretation of the results<br />
Qualitative results<br />
The results were interpreted according to the<br />
manufacturer’s instructions. Samples with CMV index<br />
less than 0.90 was seronegative for IgG antibody to<br />
CMV, those with CMV index between 0.91 and 0.99 is<br />
equivocal and the samples should be repeated. Samples<br />
with CMV index of 1.00 or greater was seropositive for<br />
IgG antibody to CMV.<br />
Quantitative result<br />
The results were interpreted according to the<br />
manufacturer’s instructions. when the anti-CMV IgG<br />
concentration in the sample is less than 0.8 IU/ml, the<br />
sample was no immune, those with anti-CMV IgG<br />
concentration is more than 1.2 IU/ml, the sample was<br />
immune. If the result is between the two values, in this<br />
case it is advisable to repeat the test in duplicate.<br />
Statistical analysis<br />
The percentages of individuals with positive, negative,<br />
and equivocal results were determined for each age<br />
group and sex. SPSS program version 15 was used for<br />
the analysis and comparison of sero-statuses among age<br />
groups, male and female and each nationality. Ninetyfive-percent<br />
confidence intervals were calculated where<br />
appropriate, and P values of < 0.05 were considered<br />
statistically significant.<br />
Demographic characteristics of the studied<br />
population<br />
Serum samples according to sex divided to two groups'<br />
males (51.4%) and female (48.6%) with their ages varied<br />
from 20-60 years old. Serum samples were stratified<br />
according to age into the following groups: 20 to 24<br />
(12.6%), 25 to 29 (12.6%), 30 to 34 (12.8%), 35 to 39<br />
(12.8%), 40 to 44 (12.4%), 45 to 49 (12.3%), 50 to 54<br />
(12.3%) and 55 to 60 (12.1%) year. Serum samples<br />
were not available for less than 18 years of age. Serum<br />
samples according to nationality were divided to the<br />
following groups: Egyptian (14.6%), Yemen (14.2%),<br />
Sudan (14.4%), Pakistan (14.6%), Indian (14%),<br />
Bangladesh (14.2%) and Ethiopian (14%). According to<br />
race/ethnicity serum samples were divided to African<br />
(43%) and Asian (57%). Approximately equal numbers of<br />
males and females were tested. Also approximately<br />
equal numbers of each nationality and ages groups were<br />
tested. Prevalence of CMV- IgG in each group were<br />
tested using enzyme linked immunosorbent assay and
Table 1. Demographic characteristics of the studied population.<br />
Characteristic<br />
Age(years)<br />
No. of samples<br />
No.<br />
Positives<br />
No.<br />
P value<br />
20-24 12.6 65 53.8 35
2342 Afr. J. Microbiol. Res.<br />
Sex<br />
Figure 1. Prevalence of cytomegalovirus by sex (Males and females).<br />
Table 3. Prevalence of cytomegalovirus by age groups from 20 to 60 years old.<br />
Age group No. of samples<br />
Positive<br />
No. %<br />
Compared to age group 20 - 24<br />
2<br />
(p) (95%CI)<br />
20-24 65 35 50.8 Referent 41.0-61.8<br />
25-29 65 43 66.2 2.051(>0.05) 61.5-72.1<br />
30-34 66 46 69.7 3.486(>0.05) 62.2-77.8<br />
35-39 66 58 87.9 18.418(
Figure 2. Prevalence of cytomegalovirus by age groups from 20-60 years old.<br />
Table 4. Prevalence of cytomegalovirus in females by age groups from 20 to 60 years old.<br />
Age group No. of samples<br />
Positive<br />
No. %<br />
Redwan et al. 2343<br />
Compared to age group 20 - 24<br />
2<br />
(p) (95%CI)<br />
20-24 32 21 65.6 Referent 60.1-69.9<br />
25-29 33 26 78.8 1.406(>0.05) 74.8-83.6<br />
30-34 32 29 90.6 5.851(
2344 Afr. J. Microbiol. Res.<br />
Table 5. Prevalence of cytomegalovirus in males by age groups from 20 to 60 years old.<br />
Age group No. of samples<br />
Positive Compared to age group 20 - 24<br />
No. %<br />
2<br />
(p) (95%CI)<br />
20-24 33 14 42.4 Referent 34.3-50.1<br />
25-29 32 17 53.1 0.746(>0.05) 47.5-60.5<br />
30-34 34 17 50 0.387(
Redwan et al. 2345<br />
Table 6. Prevalence of cytomegalovirus by Nationality: (Egyptian; Yemeni; Sudan; Pakistan; Indian Bangladesh and Ethiopian).<br />
Nationality No. of samples<br />
Positive Compared to age group 20 - 24<br />
No. %<br />
2<br />
(p) (95%CI)<br />
Indian 72 48 66.7 Referent Referent<br />
Egyptian 75 59 78.7 2.671(>0.05) 72.9-85.1<br />
Yemen 73 56 76.7 1.804(>0.05) 73.5-79.5<br />
Sudan 74 65 87.8 9.350(
2346 Afr. J. Microbiol. Res.<br />
Table 7. Prevalence of cytomegalovirus by ethnicity (African and Asian).<br />
Ethnicity No. of sample<br />
No.<br />
Positive 2 (p) (95%CI)<br />
African 221 188 85.1 4.671(
toddlers. Infected infants and children, in particular those<br />
under 30 months old, actively excrete the virus in their<br />
saliva and urine. Thus, one hypothesis to explain the<br />
higher females CMV seroprevalence would be that<br />
women have more contact with children and have more<br />
opportunities for HCMV infection during pregnancy,<br />
delivery, and menstruation.<br />
In the study reported herein, the seroprevalence of<br />
CMV IgG among the studied population varied with<br />
nationality and/or ethnicity ranging from 66.7% in Indian,<br />
78.7% in Egyptian, 76.7% in Yemeni, 87.8% in Sudan,<br />
82.7% in Pakistan, 83.6% in Bangladesh, to 88.9% in<br />
Ethiopian. The prevalence varied significantly with<br />
nationality when all nationalities compared with Indian<br />
nationality as reference (p< 0.05) except for the Egyptian<br />
and Yemeni nationality (p>0.05). In general the seroprevalence<br />
of cytomegalovirus among the African population<br />
(85.1%) varied significantly from Asian population<br />
(77.5%). The differences in the prevalence rate in<br />
different nationalities perhaps could be related to socioeconomic<br />
factors, environmental, and climatic factors.<br />
The result of the present study is consistent to the<br />
results of other researches carried out in different parts of<br />
world. Badami et al. (2009) reported that the ethnicity<br />
appeared to be related to seroprevalence of cytomegalovirus<br />
(CMV) in New Zealand between 2003 and 2006<br />
and it ranging from 93.2% in Pacific Islanders, 54.8% in<br />
Caucasians, 80.4% in Maori, 77.6% in Asian, to 71.4% in<br />
Maori/Caucasian (Badami et al., 2009). The result of<br />
present study is also consistent to the result of another<br />
study carried out by Staras et al. (2006) between the year<br />
1988 and 1994 to determine CMV prevalence in the US<br />
population. CMV seroprevalence differed by race and/or<br />
ethnicity as follows: 51.2% in non-Hispanic white<br />
persons, 75.8% in non-Hispanic black persons, and<br />
81.7% in Mexican Americans. Racial and/or ethnic<br />
differences in CMV seroprevalence persisted when<br />
controlling for household income level, education, marital<br />
status, area of residence, census region, family size,<br />
country of birth, and type of medical insurance (Staras et<br />
al., 2006). Also similar results to our results shown in a<br />
study carried out by Gaytant et al. (2005) to investigate<br />
the incidence of congenital cytomegalovirus infections in<br />
the Netherlands. A significant difference (P
2348 Afr. J. Microbiol. Res.<br />
REFERENCES<br />
Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I<br />
(2008). Seroprevalence of HHV-8, CMV, and EBV among the general<br />
population in Ghana, West Africa. BMC Infect. Dis., 8:111.<br />
Ahmed SA, Al-Joudi FS, Zaidah AW, Roshan TM, Rapiaah M, Abdullah<br />
YMS, Rosline H (2006). The prevalence of human cytomegalovirus<br />
seroposoitivity among blood donors at the unit of blood transfusion<br />
medicine, hospital University Sains Malaysia. The Southeast Asian J.<br />
Trop. Med. Public Health., 37: 294-296.<br />
Badami KG, Mcquilkan-Bickerstaffe S, Ells JE, Parata M (2009).<br />
Cytomegalovirus seroprevalence and ‘cytomegalovirus-safe’<br />
seropositive blood donors. Epidemiol. Infect., 137: 1776-1780.<br />
Dowd JB, Aiello AE, Alley DE (2009). Socioeconomic disparities in the<br />
seroprevalence of cytomegalovirus infection in the US population:<br />
NHANES III. Epidemiol. Infect., 137: 58–65.<br />
Drew WL (1988). Diagnosis of Cytomegalovirus Infection. Review of<br />
Infect. Dis., 10: S468-S476.<br />
Fowler KB, Stagno S, Pass RF (2003). Maternal Immunity and<br />
Prevention of Congenital Cytomegalovirus Infection. JAMA., 289:<br />
1008-1011.<br />
Gaytant MA, Galama JMD, Semmekrot BA, Melchers WJG, Sporken<br />
JMM, Oosterbaan HP, van Dop PA, Huisman A, Merkus HM,<br />
Steegers EA (2005). The Incidence of Congenital Cytomegalovirus<br />
Infections in The Netherlands. J. Med. Virol., 76: 71–75.<br />
Gerna G, Baldanti F, Revello MG (2004). Pathogenesis of Human<br />
Cytomegalovirus Infection and Cellular Targets, Hum. Immunol., 65:<br />
381-386.<br />
Halpern CT, Hallfors D, Bauer DJ, Iritani B, Waller MW, Cho H (2004).<br />
Implications of Racial and Gender Differences in Patterns of<br />
Adolescent Risk Behavior for HIV and Other Sexually Transmitted<br />
Diseases. Perspectives Sexual Rep. Health, 36: 239-347.<br />
Jarvis MA, Nelson JA (2002). Human cytomegalovirus persistence and<br />
latency in endothelial cells and macrophages, Curr. Opin. Microbiol.,<br />
5: 403–407.<br />
Joseph SA, Beliveau C, Muecke CJ, Rahme E, Soto JC, Flowerdew G,<br />
Johnston L, Langille D, Gyorkos TW (2005). Risk factors for<br />
cytomegalovirus seropositivity in a population of day care educators<br />
in Montreal, Canada. Occupational Med., 55: 564–567.<br />
Kafi S, Eldouma E, Saeed S, Musa H (2009). Seroprevalence of<br />
Cytomegalovirus among blood donors and antenatal women<br />
attending two hospitals in Khartoum State, Sudan J. Med. Sci., 4: 1-5.<br />
Kanapeckien V, Kalibatas J, Redaitien E, eremnych J (2007). The<br />
association between cytomegalovirus infection and aging process,<br />
Medicina (Kaunas), 43: 419-423.<br />
Likitnukul S, Bhatarakosol P, poovorawan Y (2003). Seroprevalence of<br />
cytomegalovirus in children born to HIV 1 infected women. Asian<br />
Pacific journal of allergy and immunology / launched by the Allergy<br />
and Immunology Society of Thailand., 21: 127-130.<br />
Lübeck PR, Doerr HW, Rabenau HF (2009). Epidemiology of Human<br />
Cytomegalovirus (HCMV) in an urban region of Germany: what has<br />
changed?. Med. Microbiol. Immunol., 199: 53-60.<br />
Mussi-Pinhata MM, Yamamoto AY, Figueiredo LT, Cervi MC, Duarte G<br />
(1998). Congenital and perinatal cytomegalovirus infection in infants<br />
born to mothers infected with human immunodeficiency virus, J.<br />
Pediatr., 132: 285–290.<br />
O'Brien TP, Thompson JM, Black PN, Becroft DM, Clark PM, Robinson<br />
E, Wild C, Mitchell EA (2009). Prevalence and determinants of<br />
cytomegalovirus infection in pre-school children, J. Pediatr. Child<br />
Health, 45: 291 – 296.<br />
Ocak S, Duran N, Eskocak AF (2006). Seroprevalence of<br />
Cytomegalovirus Antibodies in Haemodialysis Patients. Turk. J. Med.<br />
Sci., 36: 155-158.<br />
Paschale MD, Agrappi C, TeresaManco M, Paganini A, Clerici P (2009).<br />
Incidence and Risk of Cytomegalovirus Infection during Pregnancy in<br />
an Urban Area of Northern Italy. Infect. Dis. Obstetr. Gynecol., pp. 1-<br />
5.<br />
Reddehase MJ, Podlech J, Grzimek NKA (2002). Mouse models of<br />
cytomegalovirus latenc, J. Clin. Virol., 25: S23-S36.<br />
Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert<br />
L (2006). National Serosurvey of Cytomegalovirus in Australia. Clin.<br />
Vaccine Immunol., 13: 1181–1184.<br />
Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon<br />
MJ (2006). Seroprevalence of Cytomegalovirus Infection in the<br />
United States, 1988–1994, Clin. Infect. Dis., 43: 1143–1151.<br />
Staras SAS, Flanders WD, Dollard SC, Pass RF, McGowan JE, Cannon<br />
MJ (2008). Cytomegalovirus seroprevalence and childhood sources<br />
of infection: A population-based study among pre-adolescents in the<br />
United States, J. Clin. Virol., 43: 266-271.<br />
Wisdom GB (1976). Enzyme – Immunoassay, Clin. Chem., 22: 1243.
African Journal of Microbiology Research Vol. 5(16), pp. 2349-2352, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
OI: 10.5897/AJMR11.169<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Antibacterial and cytotoxic activity of Eremurus<br />
persicus (Jaub and Spach) Boiss<br />
Mojdeh Hakemi Vala 1 , Jinous Asgarpanah 2 *, Mohammad Hossein Hedayati 3 , Jeilan Shirali 2<br />
and Fatemeh Bagheri Bejestani 4<br />
1 Microbiology Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br />
2 Pharmacognosy Department, Pharmaceutical Sciences Branch and Pharmaceutical Sciences Research Center,<br />
Islamic Azad University (IAU), Tehran, Iran.<br />
3 Pasteur Institute of Iran (Karaj branch), Iran.<br />
4 Microbiology Department, Pharmaceutical Sciences Branch, Islamic Azad University (IAU), Tehran, Iran.<br />
Accepted 30 May, 2011<br />
Traditional medicine has a key role in health care worldwide. Obtaining scientific information about the<br />
efficacy and safety of the plants is one of the researcher's goals. In this research, the flowering aerial<br />
parts of Eremurus persicus were collected from Golpayegan (Isfahan, Iran) in May 2010. The extract was<br />
tested for its antibacterial activity against 4 Gram-positive bacteria strains (Staphylococcus aureus,<br />
Staphylococcus epidermidis and Bacillus cereus, Streptococcus pyogenes) and 5 Gram-negative<br />
bacterial strains (Escherichia coli, Salmonella typhi, Shigella dysantriae, Klebsiella pneumoniae,<br />
Pseudomonas aeruginosa). Its cytotoxic activity was also investigated using MTT assay. Here we<br />
reported the antibacterial activity of E. persicus against S. aureus (MIC = 125 mg/ml), B. cereus (MIC =<br />
15.62 mg/ml), E. coli (MIC = 125 mg/ml), S. typhi (MIC = 31.25 mg/ml), S. dysantriae (MIC = 0.48 mg/ml)<br />
for the first time. Furthermore the cytotoxic potentials of E. persicus on two cell lines, HeLa and Caco-2,<br />
were studied.<br />
Key words: Eremurus persicus, antibacterial activity, cytotoxic activity.<br />
INTRODUCTION<br />
The genus Eremurus (Liliaceae) comprising nearly 50<br />
species, is mainly restricted to central and western Asia<br />
(Chong et al., 2000) and six species are known to exist in<br />
Iran. Eremurus persicus locally called "Serish” is widely<br />
distributed in south, east and west of Iran. The roots are<br />
used as natural glue. The leaves are traditionally used to<br />
relieve constipation and treatment of diabetes, liver and<br />
stomach disorders. Polysaccharides have been reported<br />
as chemical constituents of species in the genus<br />
Eremurus (Chong et al., 2000). Since the literature<br />
survey revealed that there is no any information on the<br />
biological activities of E. persicus, we prompted to investigate<br />
the antibacterial activity of methanolic extract of<br />
flowering aerial parts of this plant by using the cup plate<br />
*Corresponding author. E-mail: asgarpanah@iaups.ac.ir. Tel:<br />
+98 21 22640051. Fax: +98 21 22602059.<br />
method and determine its cytotoxic effect after infection<br />
by two cell lines (HeLa and Caco-2) and further by MTT<br />
assay.<br />
MATERIALS AND METHODS<br />
Plant material<br />
The flowering aerial part of E. persicus was collected from<br />
Golpayegan (Isfahan, Iran) in May 2010 and identified by Dr. Gh.R.<br />
Amin at the Pharmacognosy Department, Faculty of Pharmacy,<br />
Tehran University of Medical Sciences, Tehran, Iran. A voucher<br />
specimen (NO. 197) has been deposited in the herbarium of the<br />
Department of Pharmacognosy, Pharmaceutical Sciences Branch,<br />
Islamic Azad University (IAU), Tehran, Iran.<br />
Extraction and isolation<br />
The dried ground material was extracted by percolator apparatus
2350 Afr. J. Microbiol. Res.<br />
Table 1. IC50 of the methanolic extract of Eremurus persicus and DMSO in cell lines.<br />
Cell line<br />
HeLa<br />
Caco-2<br />
Eremurus persicus extract IC50 (mg/ml)<br />
4.74<br />
5<br />
using methanol (Merck). The extract was concentrated by rotary<br />
evaporator apparatus and the solvent removed to produce a dark<br />
brown gummy solid. The resulting extract was kept in a sterile vial<br />
in a dark and cool place for further tests.<br />
Bacterial strains<br />
Gram-positive bacteria including Staphylococcus aureus (PTCC<br />
1431), Staphylococcus epidermidis (PTCC 1435) and Bacillus<br />
cereus (PTCC 1247), Streptococcus pyogenes (PTCC 1447), and<br />
Gram-negative bacteria including Escherichia coli (PTCC1399),<br />
Salmonella typhi (PTCC 1639), Shigella dysantriae (PTCC 1188),<br />
Klebsiella pneumonia (PTCC 1053), Pseudomonas aeruginosa<br />
(PTCC 1430) were obtained from Persian Type Culture Collection,<br />
Iranian Research Organization for Science and Technology (PTCC,<br />
Iran).<br />
Antibacterial assay<br />
Antibacterial activity of the methanolic crude extract of E. persicus<br />
was investigated against 9 bacterial strains by the cup plate method<br />
(Fazyl Bazzaz et al., 2005). An overnight bacterial culture<br />
containing 1.5 x 10 8 CFU/ml was used to culture on surface of<br />
Muller-Hinton agar plates. The wells were made on agar plates.<br />
1000, 500 and 250 mg, respectively, of the extract were dissolved<br />
in 1 ml DMSO 10% and then filtered. 80 l of each test solution was<br />
added to each well. Following diffusion of solutions into agar, the<br />
plates were incubated at 37°C for 24 h. The diameter of inhibition<br />
zones around each well were determined in comparison with the<br />
well of ciprofloxacin (31.25 mg/ml) which was used as positive<br />
control. A well added by 80 l DMSO 10% instead of the extract<br />
solution, served as negative control too. The experiments carried<br />
out 3 times and the results were presented as mean ± SD.<br />
Minimum inhibitory concentration (MIC)<br />
After confirmation of the antibacterial activity in methanolic crude<br />
extract of E. persicus, MIC of the extract was determine by testing<br />
10 concentrations of the extract against sensitive Gram-positive<br />
and Gram-negative tested bacteria by the micro plate dilution<br />
method. The reconstituted extract was diluted to give concentrations<br />
of 250, 125, 62.5, 31.25, 15.62, 7.81, 3.90, 1.95, 0.97 and<br />
0.48 mg/ml, respectively. The lowest concentration of the extract<br />
that could inhibit the bacterial growth was considered as MIC<br />
(Mehregan et al., 2008). The data was subject to statistical analysis<br />
of SPSS software.<br />
Cytotoxic activity<br />
Cell culture<br />
HeLa (Human cervix carcinoma) and Caco-2 (Human colon<br />
carcinoma) cell lines were obtained from Iranian Cell Bank of<br />
Institute Pasteur of Iran. HeLa cells was grown in a flask and RPMI<br />
DMSO 10% IC50 (v/v)<br />
4.45 %<br />
4.73 %<br />
1640 media (Gibco, Germany) which was supplemented with 10%<br />
fetal bovine serum; FBS (Gibco, Germany) and 20mg/ml gentamicin<br />
(Sigma) was added. In addition, Caco-2 cell line was grown in<br />
DMEM media (Gibco, Germany) which was supplemented with 20%<br />
FBS and 20 mg/ml gentamicin. All plated were incubated in a CO2<br />
incubator at 37°C. 100 µl of 3 x 10 5 cells/ml suspension of HeLa cell<br />
line and 100 µl of 6 x 10 5 cells/ml suspension of Caco-2 cell line<br />
transferred to a 96- well microplate and incubated at the same<br />
condition.<br />
MTT assay<br />
Based on determined Ic50 (Table 1), 17 mg methanolic extract of E.<br />
persicus dissolved in DMSO 1%, separately for HeLa and Caco-2<br />
assay and 100 µl of each concentration was transferred in a row of<br />
separate microplate to make serial dilution. After 72 h incubation in<br />
a CO2 incubator at 37ºC, 20 µl of MTT (5 mg/ml in PBS) was added<br />
and incubated at the same condition for 3 to 5 h for MTT assay.<br />
After Formazan crystallization, 50 µl of isobutyl alcohol was added<br />
and OD (Optical density) was read at 570 nm wave length (Figures<br />
1 to 2).<br />
RESULTS<br />
The inhibitory effects of methanolic extract of E. persicus<br />
against different test organisms are shown in Table 2 (the<br />
p-value mentioned in Table 2 is only for the 1000 mg/ml<br />
concentration of extract). This extract indicated significant<br />
antibacterial activity (growth inhibition zone diameters<br />
ranging from (12.5 to 32 mm) against some Grampositive<br />
bacteria including S. aureus, B. cereus, S.<br />
epidermidis and Gram-negative bacteria including E. coli,<br />
S. typhi and specially S. dysantriae.<br />
Also, the MIC of the extract was determined by using<br />
the micro plate dilution method for Gram-positive<br />
bacteria, S. aureus and B. cereus. In addition, the<br />
methanolic extract could inhibit the growth of other Gramnegative<br />
bacteria at 125 and 15.62 mg/ml, respectively;<br />
the extract could effectively inhibit other test bacteria, E.<br />
coli, S. dysantriae and S. typhi, even at concentrations as<br />
low as 125, 0.48 and 31.25 mg/ml, respectively.<br />
The cytotoxicity effect of methanolic extract of E.<br />
persicus on HeLa cell and Caco-2 cell culture was<br />
evaluated by MTT assay. The result shows that the more<br />
concentration of extract in the cell culture the less OD<br />
was detected. It means, after increasing the concentration<br />
of methanolic extract the viability of cells were<br />
decreased. Similarly, both cell lines showed decrease in<br />
cell viability after the concentration of extract was<br />
increased and decrease in viability begins when 2.125<br />
and 4.25 mg/ml of methanolic extract was added to
Eremurus persicus<br />
Figure 1. Absorbance value versus concentration of E. persicus extract and DMSO in Caco-2 cell line.<br />
Eremurus persicus<br />
Figure 2. Absorbance value versus concentration of E. persicus extract and DMSO in HeLa cell line.<br />
Table 2. Antibacterial activity of E. persicus methanolic extract against various bacteria, as obtained by cup plate method (n=6).<br />
S/No.<br />
1<br />
2<br />
3<br />
4<br />
5<br />
6<br />
Organism<br />
S. aureus<br />
S. epidermidis<br />
B. cereus<br />
E-coli<br />
S. typhi<br />
S. dysantriae<br />
Mean zone of inhibition in mm and standard deviation (SD)<br />
A<br />
B<br />
C<br />
D<br />
Mean ± SD Mean ± SD Mean ± SD Mean ± SD<br />
0.0±0.0<br />
0.0±0.0<br />
0.0±0.0<br />
0.0 ±0.0<br />
0.0±0.0<br />
28.0±0.0<br />
11.0±1.1<br />
0.0±0.0<br />
0.0±0.0<br />
0.0 ±0.0<br />
0.0 ±0.0<br />
31.0±0.0<br />
17.5±0.5<br />
15.0±0.0<br />
13.5±1.6<br />
12.5± 0.5<br />
14.0±1.1<br />
32.0±0.0<br />
60.0±0.0<br />
57.0±3.3<br />
46.0±0.0<br />
50.0±0.0<br />
48.0±2.2<br />
60.0±0.0<br />
P- value*<br />
2352 Afr. J. Microbiol. Res.<br />
Eremurus persicus<br />
Figure 3. Effects of E. persicus extract and DMSO on cell viability in Caco-2 cell line.<br />
Eremurus persicus<br />
Figure 4. Effects of E. persicus extract and DMSO on cell viability in HeLa cell line.<br />
shows more sensitivity than Caco-2 cell line against both<br />
E. persicus extract and DMSO concentrations as positive<br />
control.<br />
DISCUSSION<br />
Since the presence of anthraquinones has been indicated<br />
in the aerial parts of other species of this genus (Chong<br />
et al., 2000), we suggest the strong antibacterial effect<br />
due to anthraquinones because they are more likely to<br />
possess antibacterial activity (Chukwujecwu et al., 2006).<br />
The cytotoxic activity is also related to the anthraxquinones<br />
because it is shown that they are able to induce<br />
opoptosis due to the fact that they are suitable substrate<br />
for one-electron-reducing enzymes and effective redox<br />
cycler which lead to the production of oxygen derived free<br />
radicals that eventually induce opoptotic cell death<br />
(Kagedal et al., 1999). Based on the results of this study,<br />
further in-vivo and ex-vivo confirmatory tests are<br />
recommended.<br />
ACKNOWLEDGMENT<br />
This work was supported by Pharmaceutical Sciences<br />
Branch, Islamic Azad University (IAU), Tehran, Iran and<br />
the authors are thankful for this support. We would like to<br />
thank Mr. M. Asoudeh for collecting the plant material.<br />
REFERENCES<br />
Chong L, Jian G, Peng Zhang Y, Zhong Z (2000). Constituents of<br />
Eremurus chinensis. J. Nat. Pro., 63: 653-656.<br />
Chukwujecwu JC, Coombes PH, Mulholland DA, Vanstaden J (2006).<br />
Emodin, an antibacterial anthraquinone from the roots of Cassia<br />
occidentalis. South Afr. J. Bot., 72(2): 295-297.<br />
Fazly Bazzaz BS, Khajehkaramadin M, Shokooheizadeh HR (2005).<br />
Antibacterial activity of Rheum ribes extract obtained from various<br />
plant parts against clinical isolates of Gram-negative pathogens. Iran.<br />
J. Pharm. Res., 2: 87-91.<br />
Kagedal K, Bironaite D, Ollinger K (1999). Anthraquinone cytotoxicity<br />
and opoptosis in primary cultures of rat hepatocytes. Free. Radic.<br />
Res., 31(5): 419-428.<br />
Mehregan H, Mojab F, Pakdaman SH, Poursaeed M (2008).<br />
Antibacterial activity of Thymus pubescence methanolic extract. Iran.<br />
J. Pharm. Res., 7(4): 291-295.
African Journal of Microbiology Research Vol. 5(16), pp. 2353-2358, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.174<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Optimization of ultrasound-assisted extraction<br />
conditions using orthogonal matrix design to enhance<br />
the antimicrobial activity of extracts from Cichorium<br />
intybus root<br />
Quanzhen Wang 1 *, Haitao Liu 1 , Jinhong Du 1 , Jian Cui 2 , Guo Chen 1 and Yuyan Liu 1<br />
1 Department of Grassland Science, College of Animal Science and Technology, Northwest Agriculture and Forestry<br />
University, 712100 Yangling, Shanxi Province, P. R. China.<br />
2 Department of Plant Science, College of Life Science, Northwest Agriculture and Forestry University, 712100,<br />
Yangling, Shanxi Province, P. R. China.<br />
Accepted 30 July, 2011<br />
Plant-derived compounds used as alternatives to chemical preservatives have been extensively<br />
researched for use as natural medical ingredients or food preservatives. Conditions for the ultrasoundassisted<br />
extraction (UAE) of chicory (Cichorium intybus) root (including type of solvent, impregnation<br />
time, number of sonication steps and ultrasonic power) were optimized to determine the best extract<br />
antibacterial activity by using orthogonal matrix design [L16 (4 5 )]. The combination of 70% ethanol v/v, a<br />
36 h impregnation time, three sonication rounds and 300 W ultrasonic power input provided the best<br />
antimicrobial activity results. Our results demonstrate that solvent composition has the largest effect<br />
on antimicrobial activity. Several extracts demonstrated antibacterial activity against Escherichia coli,<br />
Staphylococcus aureus, Bacillus thuringiensis and Salmonella typhi, and all extracts exhibited weak<br />
activity against Bacillus subtilis. To our knowledge, these results represent the first example of<br />
ultrasound-assisted chicory extracts aimed at increasing its potential for use in food industry.<br />
Key words: Cichorium intybus, antibacterial, ultrasound-assistant extract, optimal conditions, orthogonal matrix<br />
design.<br />
INTRODUCTION<br />
There are a variety of useful compounds from higher<br />
plants that have not yet been identified. Medical and food<br />
industries tend to use natural antimicrobials, such as<br />
plant-derived compounds, as an alternative to chemical<br />
preservatives (Bachir and Mohamed, 2010). These<br />
preferences have led to the search for plant products that<br />
have natural antimicrobial and antioxidant effects. Such<br />
products have been extensively researched and used as<br />
both natural medical ingredients and food additive<br />
agents (Issa-Zacharia et al., 2010; Kumaravel et al.,<br />
2010; Liu et al., 2010; Mini et al., 2010; Somchit et al.,<br />
2010).<br />
*Corresponding author. E-mail: wangquanzhen191@163.com.<br />
Tel: 0086-29-87091953 or 0086-13759942845. Fax: 0086-29-<br />
87092164.<br />
Chicory (Cichorium intybus) is a perennial plant of the<br />
Asteraceae family, which is a native of to the<br />
Mediterranean region and widely grown in Europe,<br />
Western Asia, Egypt and North America. In traditional<br />
Indian medicine, chicory has been used to treat fever,<br />
diarrhea, spleen and liver enlargement, jaundice, gout<br />
and rheumatism (Mulabagal et al., 2009). In Belgium,<br />
France and the United States, chicory root has been<br />
used as a coffee additive for its bitter taste, which is<br />
caused by sesquiterpene lactones (Peters and<br />
Amerongen, 1996; Poli et al., 2002).<br />
A number of studies report that chicory extracts<br />
possess antimicrobial activities. It was reported that<br />
water, ethanol and ethyl acetate extracts from chicory<br />
have antibacterial properties, and that root extracts have<br />
more intensive antibacterial activity than extracts from<br />
whole plants (Petrovic et al., 2004). Moreover, it was<br />
found that the sesquiterpene lactones extracted from
2354 Afr. J. Microbiol. Res.<br />
Table 1. Assignment of levels and condition factors using orthogonal matrix L16 (4 5 ).<br />
Levels<br />
Factors<br />
A (Solvent) B [Impregnation time (h)] C (Sonication repetitions) D [Ultrasonic input power (W)]<br />
I petroleum ether 12 1 200<br />
ii ethyl ether 24 2 300<br />
iii ethyl acetate 36 3 400<br />
iv 70% ethanol v/v 48 4 500<br />
chicory root can inhibit the growth of zoophilic and<br />
anthropophilic dermatophytes (Mares et al., 2005). Many<br />
gastrointestinal foodborne infections in humans, particularly<br />
those in developing countries, are often caused by<br />
enterobacteria (Ajayi and Akintola, 2010). Increasing<br />
concern over pathogenic and spoilage microorganisms in<br />
food is due to the growing prevalence of food borne<br />
disease outbreaks (Rahman and Kang, 2009). Considering<br />
the questionable safety of synthetic food<br />
preservatives, consumers are demanding more natural<br />
and fresh foods with fewer synthetic additives. However,<br />
to increase safety and maintain a long shelf life, food<br />
manufacturers are compelled to use natural or mild preservation<br />
techniques. Therefore, alternative sources of<br />
safe and effective natural preservatives must be explored<br />
(Abbasi et al., 2010; Negi et al., 2008; Hussain et al.,<br />
2009).<br />
Orthogonal matrix design has been used to evaluate<br />
the interaction of different production parameters and<br />
how they affect product recovery. Furthermore, this<br />
method has been used to optimize multiple production<br />
parameters to establish optimum conditions (Hedayat et<br />
al., 1999). At present, ultrasound-assisted extraction<br />
(UAE) is considered a desirable method for organic<br />
compound extraction from different matrices (Khan et al.,<br />
2010). This method can shorten extraction time because<br />
the increased pressure favors penetration and transport<br />
while the temperature decreased may improve solubility<br />
and diffusivity (Pena et al., 2006).<br />
In order to optimize conditions to achieve the best<br />
antibacterial activity for chicory extract use as a natural<br />
food preservative, the solvent, impregnation time, sonication<br />
repetitions and ultrasonic input power were evaluated<br />
by orthogonal matrix design. The L16 (4 5 ) experiment was<br />
adopted and sixteen different extraction groups were<br />
analyzed. The antibacterial activities of extracts derived<br />
using different extraction protocols were investigated.<br />
MATERIALS AND METHODS<br />
Plant materials<br />
Five-year-old Puna chicory roots were freshly harvested in<br />
September 2009 in an experimental field at the Grassland Science<br />
Department at Northwest Agriculture and Forestry University<br />
(Shaanxi Province, China). The plant was identified by associate<br />
professor Quanzhen Wang (Northwest Agriculture and Forestry<br />
University, China). A voucher specimen was deposited in the<br />
Herbarium of the Laboratory of Grassland Science at the Faculty of<br />
Animal Science and Technology (Northwest Agriculture and<br />
Forestry University, China).<br />
Preparation of plant extracts<br />
Four levels for each of four different extraction conditions resulting<br />
in sixteen extraction method combinations (Table 1) were studied<br />
by an L16 (4 5 ) orthogonal matrix design (Hedayat et al., 1999). For<br />
each sample, 100 g dried ground powder (40 meshes) was soaked<br />
in 800 ml of various solvents for different times at room temperature<br />
until extraction was exhausted. The extraction temperatures were<br />
30°C (ethyl ether), 50°C (petroleum ether and ethyl acetate) and<br />
65°C (70% ethanol v/v), respectively. An ultrasonic apparatus (KQ-<br />
500DE, Kunshan Ultrasound Instrument Co., Ltd., China) was used<br />
for accelerated extraction. A beaker was partially submerged in an<br />
isothermal water bath to maintain the extraction temperature for 30<br />
min. After extraction, the resulting mixture was passed through filter<br />
paper (Whatman No. 1.) by vacuum. The filtrate was concentrated<br />
on a rotary evaporator (SHB-III, Zhengzhou Science and Industrial<br />
Foreign Trade Co., Ltd., China) at 45°C and then stored at 4°C for<br />
further use. All samples were redissolved in dimethylsulfoxide<br />
(DMSO) at a concentration of 10 mg/mL and stored at 4°C.<br />
Bacteria<br />
The antibacterial activity of chicory extracts was determined using<br />
the following food-related bacteria obtained from the Department of<br />
Life Science, Northwest Agriculture and Forestry University: E. coli,<br />
Staphylococcus aureus, Bacillus thuringiensis, Bacillus subtilis,<br />
Salmonella typh. Cultures of each strain were maintained on beef<br />
cream-peptone culture media at 4°C (Monadi et al., 2010; Moussa<br />
and Hessan, 2010).<br />
Antibacterial assays of disc diffusion<br />
Antibacterial activity tests were conducted based on the disc<br />
diffusion method (Yan et al., 2009). A suspension of bacteria (2×10 8<br />
CFU/ml) was spread on solid media plates. Sterile paper discs (6<br />
mm diameter) were individually impregnated with solvent at 10<br />
mg/ml. Discs with the solvent used for dissolution were used as<br />
negative controls and the standard reference antibiotic streptomycin<br />
(10 g/disc) was used as a positive control for the bacteria in<br />
question. The plates were incubated at 37°C for 24 h after which<br />
the inhibition zone was measured in millimeters. Each assay in this<br />
experiment was performed in triplicate.<br />
Statistical analysis<br />
All experimental results are expressed the mean of four repeats.
Table 2. The L16 (4 5 ) matrix associated with analytical results.<br />
Group����<br />
Factors and levels<br />
A B C D<br />
Staphylococcus<br />
aureus b<br />
Bacillus<br />
subtilis b<br />
Zone of inhibition in mm a<br />
Bacillus<br />
thuringiensis b<br />
Wang et al. 2355<br />
Salmonella<br />
typhi c<br />
Escherichia<br />
coli c<br />
1 1 1 4 3 10.2 7.2 9.7 8.6 9.7<br />
2 2 1 1 1 11.6 6.5 9.4 8.2 8.1<br />
3 3 1 3 4 8.5 8.5 13.1 12.3 11.1<br />
4 4 1 2 2 12.2 8.9 10.8 7.5 9.5<br />
5 1 2 3 2 12.1 7.1 11.8 10.2 9.2<br />
6 2 2 2 4 11.7 8.1 8.9 10.1 11.5<br />
7 3 2 4 1 9.2 9.6 9.6 11.6 12.0<br />
8 4 2 1 3 9.8 8.2 12.7 8.6 11.7<br />
9 1 3 1 4 11.0 7.9 8.6 10.4 7.6<br />
10 2 3 4 2 9.4 9.8 10.7 14.2 11.2<br />
11 3 3 2 3 8.6 7.5 10.2 10.9 10.9<br />
12 4 3 3 1 11.1 6.7 10.3 12.2 13.6<br />
13 1 4 2 1 8.3 8.7 10.2 7.4 10.2<br />
14 2 4 3 3 8.4 7.1 9.7 9.7 6.9<br />
15 3 4 1 2 9.1 7.5 9.4 11.4 8.1<br />
16 4 4 4 4 11.5 9.1 11.5 7.1 10.1<br />
a Values are means (mm) of four separate treatments. b Gram positive bacteria. c Gram negative bacteria.<br />
Analysis of variance was performed by ANOVA. SAS software<br />
(version 8.2, USA) was used for statistical analysis. Results were<br />
considered statistically significant at p ultrasonic input power (D) > impregnation<br />
time (B) > sonication repetition number (C) (Table 3). The<br />
optimal extraction parameters were defined as the<br />
following: treatment with 70% ethanol v/v (A4), 300 W<br />
ultrasonic input power (D2), 12 h impregnation time (B1)<br />
and two rounds of sonication (C2). The impact of<br />
variables on the inhibition zone against Bacillus subtilis<br />
was measured in the following order: C > D > A > B. The<br />
optimal combination of parameters for this bacterium was<br />
to use four sonication rounds (C4), 300 W ultrasonic input<br />
power (D2), ethyl ether (A2) and a 36 h impregnation time<br />
(B3). The impact of variables on the inhibition zone of B.<br />
thuringiensis was in the following order: A > C > B > D.<br />
The optimal combination was to use ethyl acetate (A3),<br />
three sonication rounds (C3), a 12 h impregnation time<br />
(B1) and 500 W ultrasonic input power (D4). The impact of<br />
variables on the inhibition zone of Salmonella typh was in<br />
the following order: B > A > C > D. The optimal parameter<br />
combination was to use a 36 h impregnation time (B3),<br />
ethyl ether (A2), four sonication rounds (C4), and 300 W<br />
ultrasonic input power (D2). The impact of variables on<br />
the inhibition zone of against E. coli was in the following<br />
order: B > A > C > D. The optimal parameter combination<br />
was found using a 36 h impregnation time (B3), 70%<br />
ethanol v/v (A4), three sonication rounds (C3), and 200 W<br />
ultrasonic input power (D1). According to the results for<br />
antibacterial activities against all five types of bacteria,<br />
we found that extraction using 70% ethanol v/v, a 24 h<br />
impregnation time, three sonication rounds and 300 W<br />
ultrasonic input power is the optimal synthetic<br />
combination.<br />
Variance analyses of the models of all bacteria but B.<br />
thuringiensis were found to be significant (Table 4. Pr <<br />
0.001). Factors A, B and D were significantly effective for<br />
inhibiting S. aureus whereas factors C and D were significant<br />
against Bacillus subtilis (Table 4). Factors A, B and<br />
C consistently inhibited the Gram-negative bacteria S.<br />
typhi and E. coli; however, factor D (ultrasonic input<br />
power) was not significant (Table 4). Solvent type was<br />
found to be the most influential factor; increasing solvent<br />
polarity resulted in better antibacterial activities primarily<br />
because substances such as carbohydrates, proteins,
2356 Afr. J. Microbiol. Res.<br />
Table 3. Averages of levels with factors and ranges.<br />
Factors A B C D A B C D<br />
Staphylococcus aureus Bacillus subtilis<br />
Level i 10.4 10.63 10.38 10.05 7.73 7.78 7.53 7.88<br />
Level ii 10.35 10.70 10.20 10.70 7.88 8.25 8.30 8.33<br />
Level iii 8.85 10.03 10.03 9.25 8.28 7.98 7.35 7.50<br />
Level iv 11.15 9.33 10.08 10.68 8.23 8.1 8.93 8.40<br />
Range a 2.3 1.37 0.35 1.45 0.55 0.47 1.58 0.90<br />
Order 1 3 4 2 3 4 1 2<br />
Bacillus thuringiensis Salmonella typhi<br />
Level i 10.08 10.75 10.03 9.88 9.15 9.15 9.65 9.85<br />
Level ii 9.68 10.75 10.03 10.67 10.55 10.13 8.98 10.83<br />
Level iii 10.58 9.95 11.23 10.58 11.55 11.93 11.10 9.45<br />
Level iv 11.33 10.2 10.38 10.53 8.85 8.90 10.38 9.98<br />
Range a 1.65 0.8 1.2 0.79 2.7 3.03 2.12 1.38<br />
Order 1 3 2 4 2 1 3 4<br />
Escherichia coli<br />
Level i 9.18 9.6 8.87 10.98<br />
Level ii 9.43 11.1 10.53 9.5<br />
Level iii 10.53 10.83 10.2 9.8<br />
Level iv 11.23 8.83 10.75 10.08<br />
Range a 2.05 2.27 1.88 0.58<br />
Order b 2 1 3 4<br />
a R means the average range for four average responses in each level for the inhibition zone against Staphylococcus aureus, Bacillus<br />
subtilis, Bacillus thuringiensis, Salmonella typhi, Escherichia coli, respectively.<br />
b The ordinal numeral for the range sequence of the eight factors in decreasing order.<br />
Table 4. Variance analysis for the model and experimental factors.<br />
Factor<br />
Model<br />
A<br />
B<br />
C<br />
D<br />
Staphylococcus<br />
aureus b<br />
Bacillus subtilis b<br />
Bacillus<br />
thuringiensis b<br />
Salmonella<br />
typhi c<br />
Escherichia coli c<br />
F Value 3.85 3.72 1.87 4.93 4.33<br />
Pr > F 0.0003 0.0005 0.0608 F 0.0003 0.3348 0.0248 0.0007 0.0040<br />
F Value 3.49 0.88 1.14 8.11 6.19<br />
Pr > F 0.0221 0.4567 0.3415 0.0002 0.0011<br />
F Value 0.22 9.74 2.15 3.58 3.89<br />
Pr > F 0.8807 F 0.0113 0.0350 0.4933 0.2560 0.0956<br />
b Gram positive bacteria. c Gram negative bacteria.<br />
alkaloids, tannins, glycosides and amines increase in<br />
abundance with increased solvent polarity. Impregnation<br />
time, sonication repetition number and ultrasonic input<br />
power were found to be subordinate factors. Most
ioactive compounds such as polyphenolics (e.g., tannins<br />
and flavonoids) exist in higher polarity solvents.<br />
Additional compounds found in the extracts may either<br />
enhance or attenuate the effect of phenolic compounds.<br />
The 70% ethanol and acetic ether extracts exhibited<br />
significant antibacterial activity against many of the<br />
bacteria in this study. This antibacterial activity may be<br />
ascribed to polyphenols, tannins and coumarins found in<br />
crude extracts (Kilani et al., 2008). Phenolic compounds<br />
can attack cell walls and membranes by affecting their<br />
permeability, enabling the release of intracellular constituents<br />
and interfering with membrane functionality (Bajpai<br />
et al., 2009). There were differences in chicory extract<br />
antibacterial activity against Gram-positive and Gramnegative<br />
bacteria. Gram-positive bacteria were found to<br />
be more susceptible to chicory extracts than Gramnegative<br />
bacteria, possibly because the hydrophilic cell<br />
walls of Gram-negative bacteria are composed of<br />
lipopolysaccharide (LPS), which inhibits the accumulation<br />
of phenolic compounds in a target cell membrane (Bezic<br />
et al., 2003).<br />
Chicory contains several sesquiterpene lactones,<br />
particularly in the roots (Beek et al., 1990; Peters and<br />
Amerongen 1996; Poli et al., 2002). Poli et al. has<br />
reported the isolation of two guaianolides with different<br />
chemical structures, including 8-deoxylactucin and 11 ,<br />
13-dihydrolactucin, from the root extracts of C. intybus<br />
var. ‘Rosso di Chioggia’ (Picman, 1986). Two pure<br />
isolated lactones possess similar biological activity to<br />
chicory extracts against several phytopathogens, which<br />
cause morphological anomalies that have been observed<br />
using scanning electron microscopy (Mares et al., 2005).<br />
Conclusions<br />
The antibacterial activity of chicory extracts was found to<br />
be affected by the type of solvent used for extraction. The<br />
optimal UAE conditions were obtained to produce the<br />
best chicory root extract antimicrobial activity. It was<br />
concluded that combining 70% ethanol v/v, a 36 h<br />
impregnation time, three sonication rounds and 300 W<br />
ultrasonic input power could produce the highest<br />
antibacterial activity in the extracts. Extracts from chicory<br />
roots can be used as a natural food preservative as well<br />
as an antibacterial agent. To our knowledge, these<br />
results represent the first example of a practical application<br />
for UAE aimed at increasing the potential use of<br />
chicory extracts in food industry. Chicory root<br />
antibacterial activities against additional bacterial strains<br />
should also be studied.<br />
ACKNOWLEDGMENTS<br />
This work was supported by The Ministry of Science and<br />
Technology of the Peoples Republic of China,<br />
International Cooperation Research Project<br />
(2008DFA31650) and Shaanxi Province International<br />
Wang et al. 2357<br />
Cooperation Research Project (2008KW-29). We are<br />
grateful to Prof. Hu Tianming and postgraduate students<br />
Sun Luanzhi and Wu Chunhui.<br />
REFERENCES<br />
Abbasi FM, Ahmad H, Perveen F, Inamullah, Sajid M, Brar DS (2010).<br />
Assesment of genomic relationship between Oryza sativa and Oryza<br />
australiensis. Afr. J. Biotechnol., 9(12): 1312-1316.<br />
Ajayi AO, Akintola TA (2010). Evaluation of antibacterial activity of some<br />
medicinal plants on common enteric food-borne pathogens. Afr. J.<br />
Microbiol. Res., 4: 314-316.<br />
Bachir RG, Mohamed B (2010). Antimicrobial activity determination of<br />
the gum of Pistacia atlantica Desf. Oil. Afr. J. Microbiol. Res., 4:<br />
2457-2460.<br />
Bajpai VK, Al-Reza SM, Choi UK, Lee JH, Kang SC (2009). Chemical<br />
composition, antibacterial and antioxidant activities of leaf essential<br />
oil and extracts of Metasequioa glyptostroboides Miki ex Hu. Food<br />
Chemic. Toxicol., 47: 1876-1883.<br />
Beek TV, Maas P, King B, Leclercq E, Voragen A, Groot AD (1990).<br />
Bitter sesquiterpene lactones from chicory roots. J. Agric. Food<br />
Chem., 38: 1035-1038.<br />
Bezic N, Skocibusic M, Dunkic V, Radonic A (2003). Composition and<br />
antimicrobial activity of Achillea clavennae L. essential oil. Phytother.<br />
Res., 17: 1037-1040.<br />
Hedayat A, Sloane N, Stufken J (1999). Orthogonal arrays: theory and<br />
applications: Springer Verlag.<br />
Issa-Zacharia A, Kamitani Y, Muhimbula H, Iwasaki K (2010).<br />
Antimicrobial effect of slightly acidic electrolyzed water for inactivation<br />
of Salmonella spp. and Escherichia coli on fresh strawberries<br />
(Fragaria L.). Afr. J. Microbiol. Res., 4: 2174-2180.<br />
Khan MK, Abert-Vian M, Fabiano-Tixier AS, Dangles O, Chemat F<br />
(2010). Ultrasound- assisted extraction of polyphenols (flavanone<br />
glycosides) from orange (Citrus sinensis L.) peel. Food Chem., 119:<br />
851-858.<br />
Kilani S, Sghaier MB, Limem I, Bouhlel I, Boubaker J, Bhouri W (2008).<br />
In vitro evaluation of antibacterial, antioxidant, cytotoxic and apoptotic<br />
activities of the tubers infusion and extracts of Cyperus rotundus.<br />
Bioresource Technol., 99: 9004-9008.<br />
Kumaravel K, Ravichandran S, Sritama bose S (2010). In vitro<br />
antimicrobial activity of shrimps haemolymph on clinical pathogens.<br />
Afr. J. Microbiol. Res., 4: 2592-2596.<br />
Liu GQ, Lin QL, Guo-Pu Ren GP, Han WJ, Wang XL, Zhang HY (2010).<br />
Use of response surface methodology to optimize critical medium<br />
components for biomass and extracellular polysaccharide production<br />
by Ganoderma sinense. Afr. J. Microbiol. Res., 4: 2735-2741.<br />
Mares D, Romagnoli C, Tosi B, Andreotti E, Chillemi G, Poli F (2005).<br />
Chicory extracts from Cichorium intybus L. as potential antifungals.<br />
Mycopathologia, 160: 85-92.<br />
Mini NV, Ida B, Seema D, Shital D, Riva DS, Astrida R (2010).<br />
Antimicrobial activity of ten common herbs, commonly known as<br />
‘Dashapushpam’ from Kerala, India. Afr. J. Microbiol. Res., 4: 2357-<br />
2362.<br />
Monadi AR, Mirzaei H, Javadi A, Hosseinzade N, Amjadi Y (2010).<br />
Effect of some probiotics on Salmonella typhi during associated<br />
growth in milk. Afr. J. Microbiol. Res., 4: 2708-2711.<br />
Moussa IM, Hessan AM (2010). Rapid detection of community<br />
acquired- methicillin resistance Staphylococcus aureus recovered<br />
from King Saudi Arabia. Afr. J. Microbiol. Res., 4: 2804-2810.<br />
Mulabagal V, Wang H, Ngouajio M, Nair MG (2009). Characterization<br />
and quantification of health beneficial anthocyanins in leaf chicory<br />
(Cichorium intybus) varieties. European Food Res. Technol., 230: 47-<br />
53.<br />
Negi PS, Jayaprakasha GK, Jena BS (2008). Antibacterial activity of the<br />
extracts from the fruit rinds of Garcinia cowa and Garcinia<br />
pedunculata against food borne pathogens and spoilage bacteria.<br />
Lwt-Food Sci. Technol., 41: 1857-1861.<br />
Pena A, Ruano F, Mingorance MD (2006). Ultrasound-assisted<br />
extraction of pesticides from olive branches: a multifactorial approach<br />
to method development. Analytic. Bioanalytic. Chem., 385: 918-925.
2358 Afr. J. Microbiol. Res.<br />
Peters AM, Amerongen AV (1996). Sesquiterpene lactones in chicory<br />
(Cichorium intybus L) - Distribution in chicons and effect of storage,<br />
Food Res. Int., 29: 439-444.<br />
Petrovic J, Stanojkovic A, Comic L, Curcic S (2004). Antibacterial<br />
activity of Cichorium intybus. Fitoterapia, 75: 737-739.<br />
Picman A (1986). Biological activities of sesquiterpene lactones.<br />
Biochem. Syst. Ecol., 14: 255-281.<br />
Poli F, Sacchetti G, Tosi B, Fogagnolo M, Chillemi G, Lazzarin R<br />
(2002). Variation in the content of the main guaianolides and sugars<br />
in Cichorium intybus var. "Rosso di Chioggia" selections during<br />
cultivation. Food Chem., 76: 139-147.<br />
Rahman A, Kang S (2009). In vitro control of food-borne and food<br />
spoilage bacteria by essential oil and ethanol extracts of Lonicera<br />
japonica Thunb. Food Chem., 116: 670-675.<br />
Somchit MN, Abdul RR, Abdullah A, Zuraini A, Zakaria ZA, Sulaiman<br />
MR, Arifah AK, Mutalib AR (2010). In vitro antimicrobial activity of<br />
leaves of Acalypha indica Linn. (Euphorbiaceae). Afr. J. Microbiol.<br />
Res., 4: 2133-2136.<br />
Yan RW, Yang Y, Zeng Y, Zou G (2009). Cytotoxicity and antibacterial<br />
activity of Lindera strychnifolia essential oils and extracts. J.<br />
Ethnopharmacol., 121: 451-455.
African Journal of Microbiology Research Vol. 5(16), pp. 2359-2366, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.273<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
Optimization of the production of exopolysaccharides<br />
by Bacillus thuringiensis 27 in sand biological soil<br />
crusts and its bioflocculant activity<br />
Z. R. Wang 1.2 , J. P. Sheng 1 , X. L. Tian 1 , T. T. Wu 1 , W. Z. Liu 1 and L. Shen 1 *<br />
1 College of Food Science and Nutritional Engineering, China Agricultural University, Beijing100083, China.<br />
2 School of Food Science, Henan Institute of Science and Technology, Xinxiang 453003, China.<br />
Accepted 30 June, 2011<br />
To improve the yield of exopolysaccharides (EPS) by Bacillus thuringiensis 27 from sand biological soil<br />
crusts in Gurban Tonggut Desert, Xinjiang, China and to analyze its bioflocculant activity, orthogonal<br />
matrix method was used and this method enabled us to obtain maximum EPS production. By studying<br />
the optimal medium condition of beef extract 3 g/l, peptone 10 g/l, maltose 40 g/l, and NaCl 4g/l we<br />
observed that the optimal medium condition was pH 6.0, incolum size 8%, liquid volume 40 ml in 200 ml<br />
flak and temperature 28°C. The maximum EPS production was 20.19 g/l which is about five times more<br />
than that at the basal condition. Furthermore, results obtained indicated that the flocculation activity of<br />
the extracellular polymer can be achieved at over 80.4% in kaolin suspension and this occurred at a<br />
concentration of 0.4 mg/l. This paper describes the optimum condition of exopolysaccharides<br />
production by Bacillus thuringiensis 27 and showed that exopolysaccharides had high bioflocculant<br />
activity. This work provides a scientific foundation to explore new exopolysaccharides and<br />
bioflocculation in sand biological soil crusts. Maximum production of exopolysacchaides under the<br />
optimal medium and condition can be achieved and exopolysaccharides have high bioflocculating<br />
activity in kaolin system.<br />
Key words: Biological soil crusts, exopolysaccharides, flocculation, optimization, Bacillus.<br />
INTRODUCTION<br />
Extreme environments, once thought to be too hostile to<br />
permit survival of living organisms, are the natural habitat<br />
of certain microorganisms. It is now recognized that the<br />
microorganisms living in extreme environments have<br />
different genetic background and metabolic pathway<br />
when compare to general microbiology and their seconddary<br />
metabolites have special function (Kennedy et al.,<br />
2001). Among the secondary metabolites from extreme<br />
environments, polysaccharide for biotechnological applications<br />
has been reported in Literature (Nicolaus et al.,<br />
2004). Therefore a wide search for bacteria that are able<br />
*Corresponding author. E-mail: pingshen@cau.edu.cn. Tel:<br />
8610-62738456. Fax: 8610-62737604.<br />
Abbreviation: EPS, Exopolysaccharide.<br />
to produce new polysaccharides with potentially useful<br />
properties has been undertaken. Sand biological soil<br />
crusts (BSCs) as extreme environment are a unique mininature<br />
landscape in desert district as well as the obvious<br />
sign of fixing mobile dune. They are composed of living<br />
microorganisms, their product of metabolism (mainly<br />
extracellular polysaccharides) and sand granule<br />
(Gundlapally and Garcia-Pichel, 2006).<br />
Exopolysaccharides (EPS) produced by microorganisms<br />
in BSCs are barely reported in the recent research.<br />
Medium condition and other bacteria growth conditions<br />
are important factors for EPS production. There are large<br />
numbers of reports on optimization of EPS production by<br />
statistical optimization techniques (Xu et al., 2003; 2010;<br />
Kaditzky and Vogel, 2008; Hao et al., 2010) Orthogonal<br />
design as one of the important statistical methods has<br />
been successfully applied to improvement of the
2360 Afr. J. Microbiol. Res.<br />
Table 1. Orthogonal matrix table of the L9 (3 4 ).<br />
Factor 1 2 3<br />
Beef extract (g/100ml) 0.2 0.3 0.4<br />
Peptone (g/100ml) 0.5 1.0 1.5<br />
Maltose (g/100ml) 2 3 4<br />
NaCl (g/100ml) 0.4 0.5 0.6<br />
production of primary and secondary metabolites in<br />
cultivation process (Xu et al., 2003).<br />
This work is an attempt to isolated strain producing<br />
EPS from sand BSCs, analysize suitable media and<br />
culture condition for the production of EPS from B.<br />
thuringiensis 27 and examines the bioflocculaton activity<br />
of EPS. To the best of our knowledge, the nutritional<br />
requirements and culture condition of EPS production<br />
form B. thuringiensis 27 isolated from sand BSCs and its<br />
bioflocculation activity has not been demonstrated.<br />
MATERIALS AND METHODS<br />
Bacterial strain<br />
Bacillus thuringiensis 27 was originally isolated from BSCs collected<br />
in the Gurban Tonggut Desert. It was maintained on agar slants<br />
containing (g/l): beef extract 3; peptone 10; NaCl 5 and agar 20 (pH<br />
7.0-7.4). The slants were incubated at 35°C for 24 h and the fully<br />
grown slants were stored at 4°C.<br />
Culture medium<br />
Basal medium, beef extract 3 g, peptone 10 g, NaCl 5 g, water<br />
1000 g, pH 7.0-7.4. Fermentation medium, beef extract 3 g,<br />
peptone 10 g, NaCl 5 g, water 1000 g, pH 7.0-7.4, temperature<br />
35°C.<br />
Single factor experiments of culture requirement<br />
To find the optimal culture requirements, the following factors were<br />
investigated using the one-factor-at-a-time method, including<br />
carbon sources nitrogen sources inorganic ions, initial pH value,<br />
cultivation temperature, inoculum size, liquid volume triangle flask.<br />
All experiments were performed in triplicates (n = 3).<br />
Orthogonal matrix method<br />
The orthogonal L9 (3 4 ) was used to obtain the optimal medium after<br />
the test by the one-factor-at-a-time method. This enables us to<br />
determine which process variables affect the response. A logical<br />
next step is to determine the point in the important factors that<br />
leads to the best possible response (Di et al., 2003; Li et al., 2001).<br />
The levels of components of the culture medium are listed in Table<br />
1. All experiments were performed in triplicate (n = 3). The software<br />
SPSS was used for experimental design, data analysis and model<br />
building. The optimal fermentation conditions for enhanced yield of<br />
EPS and cell growth were obtained by solving the regression<br />
equation using the software Origin 8.0.<br />
Determination of flocculating activity<br />
A kaolin suspension was used to measure the flocculating activity<br />
of the EPS crude extracts. One milliliter of 90 mmol/l CaCl2 and one<br />
milliliter were added into 50 ml 4.0 g/l kaolin suspension. The<br />
mixture was vigorously stirred for 0.5 min, and stand for 4 min. The<br />
optical density (OD) of the clarifying solution was measured with a<br />
spectrophotometer at 550 nm. A control experiment was conducted<br />
in the same manner by replacing distilled water. The flocculating<br />
activity was calculated according to the following equation (Kurane<br />
et al., 1986):<br />
η= (A-B) ×100/A<br />
where; A is the optical density of the control experiment at 550 nm<br />
and B is the optical density of the sample experiment at 550 nm. All<br />
experiments were performed in triplicates (n = 3).<br />
Analytical methods<br />
Samples collected at various culture conditions from shake flasks<br />
were centrifuged at 7000 g for 15 min. The 2 ml resulting<br />
supernatant was precipitated with threefold times 95% ethanol,<br />
stirred vigorously, and left overnight at 4°C. The precipitated<br />
polysaccharides were collected by centrifugation at 7000 g for 15<br />
min, discarding the supernatants, and dissolved with distilled water,<br />
dialyzing for 24 h, adding distilled water to 20 ml. Phenol-Sulfuric<br />
Acid Method was used for determining EPS yield (Pazur et al.,<br />
1994), using glucose solution as a standard reference. The EPS<br />
yield was expressed as gram per liter.<br />
RESULTS<br />
Effect of carbon and nitrogen source on EPS yield<br />
To find out the optimal carbon and nitrogen source for the<br />
EPS production of B. thuringiensis 27 five 2% carbon<br />
sources (glucose, maltose, sucrose, lactose and glycerol)<br />
were separately provided in the basal medium and five<br />
1% nitrogen sources (ammonium chloride, ammonium<br />
sulfate, peptone, beef extract and yeast extract) were<br />
separately instead of peptone employed in the basal<br />
medium. A high level of EPS was obtained when maltose<br />
and glycerol were used as the carbon source. Among the<br />
carbon sources tested, maximum EPS (10.45 g/l) was<br />
obtained in the maltose medium. Based on this study<br />
maltose is a good candidate. The maximum EPS
EPS prduction (g/l)<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
0<br />
Basal medium<br />
Glucose<br />
Frucose<br />
Maltose<br />
Carbon sources<br />
Lactose<br />
Glycole<br />
Figure 1. Effect of carbon and nitrogen sources on EPS production.<br />
production (10.53 g/l) was obtained in the peptone<br />
(Figure 1). So we selected maltose peptone as our<br />
optimal nitrogen source.<br />
Effect of concentration of carbon and nitrogen<br />
source on EPS yield<br />
To find out the suitable concentration of maltose for the<br />
EPS yield B. thuringiensis 27 five different concentration<br />
(1, 2, 3, 4 and 5%) maltose were separately instead of<br />
2% maltose above. The maximum EPS production (10.25<br />
g/l) was obtained when the concentration is 3% (Figure<br />
2). To find out the suitable concentration of nitrogen<br />
source for the EPS yield five different concentration (0.1,<br />
0.2, 0.5, 1.0 and 1.5%) peptone were separately instead<br />
of 1% peptone above. The maximum EPS production<br />
(10.74 g/l) was obtained when the concentration is 1%<br />
(Figure 2).<br />
Effect of inorganic ions and its concentration on EPS<br />
yield<br />
To find out the suitable mineral elements for the EPS<br />
yield of B. thuringiensis 27 six different 0.5% mineral<br />
elements (sodium chloride, magnesium chloride, copper<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
0<br />
NaNO3<br />
NH4Cl<br />
NH4SO4<br />
Nitrogen sources<br />
peptone<br />
Wang et al. 2361<br />
Yeast extracts<br />
sulfate, zinc chloride, ferric chloride and manganese<br />
chloride) were separately in basal medium. The maximum<br />
EPS production (15.36 g/l) was obtained in sodium<br />
chloride (Figure 3). Besides magnesium chloride, others<br />
depress the EPS production. Based on the result we<br />
selected sodium chloride as our selection.<br />
Further, to find out the suitable concentration of NaCl<br />
for the EPS yield five different concentration (0.3, 0.4,<br />
0.5, 0.6 and 0.7%) sodium chloride were separately<br />
instead of 0.5% sodium chloride above.<br />
The maximum EPS production (15.36 g/l) was obtained<br />
when the concentration is 0.5% (Figure 3). The difference<br />
in EPS yield between the peptone concentrations of 0.5%<br />
and 0.6% was not significant because the cell could not<br />
absorb more mineral element. But considering the<br />
economic factor, we use the 0.5% NaCl as our optimal<br />
option.<br />
Effect of initial pH and temperature on EPS yield<br />
To find out the optimal temperature for and EPS<br />
production, B. thuringiensis 27 was cultivated at various<br />
temperatures ranging from 23 to 45°C. The EPS (12.12<br />
g/l) were observed at 28°C (Figure 4). B. thuringiensis 27<br />
was grown at initial pH 7.0 for polysaccharide production<br />
and optimum EPS production is 14.96 g/l) (Figure 4).
2362 Afr. J. Microbiol. Res.<br />
EPS Production (g/l)<br />
EPS Production (g/l)<br />
Figure 2. Effect of maltose and peptone concentration on EPS production.<br />
16<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
(g/l)<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
FeCl 3<br />
10 20 30 40 50<br />
ZnCl 2<br />
Maltose Concentration (g/l)<br />
MnCl 2<br />
MgCl 2<br />
Inorganic ions<br />
CuSO 4<br />
Figure 3. Effect of inorganic ions and NaCl concentration on EPS production.<br />
Effect of inoculum size and liquid volume on EPS<br />
yield<br />
To examine the effect of inoculum size, B. thuringiensis<br />
27 was varying the inoculum size (2, 5, 8 and 11%) in<br />
basal medium. The results indicated 8% inoculums size<br />
NaCl<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
16<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
1 2<br />
5<br />
10<br />
Pepton Concentration (g/l)<br />
15<br />
3 4 5 6 7<br />
NaCl (g/l)<br />
was fit for EPS production (Figure 5).<br />
To find out the optimal oxygen rate four different culture<br />
medium volumes (25, 40, 55 and 70 ml) added in 200 ml<br />
flask were separately instead of 60 ml basal medium. The<br />
maximum EPS production (14.38 g/l) was obtained when<br />
the culture medium volume is 25 ml in 200 ml flask
(Figure 5).<br />
EPS Production (g/l)<br />
EPS Yield (g/L)<br />
Figure 4. Effect of initial pH value and temperature on EPS production.<br />
16<br />
14<br />
12<br />
10<br />
8<br />
6<br />
16<br />
14<br />
12<br />
(g/L)<br />
10<br />
8<br />
6<br />
4<br />
5 6 7 8 9<br />
Initial pH value<br />
25 40 55 70<br />
Liquid Volume (ml/200ml flask)<br />
Figure 5. Effect of liquid volume and inoculum size on EPS production.<br />
Optimization by orthogonal matrix method<br />
According to the orthogonal method, the effect of those<br />
medium on EPS production was analyzed and the results<br />
are shown in Table 2. Based on the magnitude order of R<br />
value (maximum difference), the order of effects of all<br />
factors on EPS production was maltose > peptone ><br />
NaCl > beef extract. In terms of the maximum K-value of<br />
16<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
16<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
23°C 28°C 33°C 38°C 43°C<br />
Temperature<br />
2 5 8 11<br />
Inoculum Size (%)<br />
Wang et al. 2363<br />
each column in Table 3, optimal level of each medium<br />
ingredient for EPS yield was 3 g/l beef extract glucose,<br />
10 g/l peptone, 40 g/l maltose, 4 g/l NaCl.<br />
Based on the magnitude order of R value (maximum<br />
difference), the order of effects of all factors on EPS yield<br />
was maltose >peptone >NaCl >beef extracts. According<br />
to ANOVA (Table 4), the factors, peptone and maltose<br />
had significant effect on EPS yield (P
2364 Afr. J. Microbiol. Res.<br />
Table 2. Results of L9 (34) orthogonal test of exopolysaccharide production of Bacillus strain 27 strain in shake flask culture.<br />
Run 1 2 3 4<br />
Factor Beef extract (g/L) Peptone (g/L) Maltose (g/L) NaCl (g/L) Results (g/L)<br />
1 2 5 20 4 5.63±0.2<br />
2 2 10 30 5 15.98±1.07<br />
3 2 15 40 6 13.24±0.73<br />
4 3 5 30 6 5.83±0.31<br />
5 3 10 40 4 18.08±2.26<br />
6 3 15 20 5 5.59±0.52<br />
7 4 05 40 5 10.54±2.21<br />
8 4 10 20 6 8.57±0.22<br />
9 4 15 30 4 13.48±0.2<br />
Values are means ± SD of triple determinations.<br />
Table 3. Analysis of media on exopolysaccharide production of Bacillus strain. 27 in shake flask culture with<br />
L9 (34) orthogonal test.<br />
Beef extract (g/l) Peptone (g/l) Maltose (g/l) NaCl (g/l)<br />
k1 11.61 7.33 6.59 12.39<br />
k2 9.83 14.21 11.76 10.70<br />
k3 10.86 10.77 13.953 9.21<br />
R 1.78 6.87 7.356 3.18<br />
Ki =Σ exopolysaccharide in thrice experiment at Xi. Values are means ±SD of triple determinations<br />
R = maximum Kix -minimum Kix. Values are means ± SD of triple determinations.<br />
Table 4. Variance analysis of L9 (34) orthogonal experiment on EPS yield.<br />
Sum of squares Degree of freedom Mean square Significance<br />
Beef extract 4.809 2 1.000<br />
Peptone 70.933 2 14.750 *<br />
Maltose 85.611 2 17.802 *<br />
NaCl 15.221 2 3.165<br />
Error 4.81 2<br />
inoculum size 8%, liquid volume 40 ml in 200 ml flask)<br />
was carried on. Consequently, the maximal EPS<br />
production was 20.17 g/l. The EPS yield on optimal<br />
condition was about five times than that at the basal<br />
culture condition.<br />
Bio-flocculating activity<br />
The flocculating activity of the EPS was measure by<br />
using a kaolin suspension. In order to neutralize the<br />
charge, one milliliter of 90 mmol/L CaCl2 were added into<br />
50 ml 4.0 g/l kaolin suspension. The optical density (OD)<br />
of the clarifying solution was measured with a<br />
spectrophotometer at 550 nm. After calculation the<br />
flocculating activity of B. thuringiensis 27 is 80.4%.<br />
DISCUSSION<br />
Carbon source plays a very important role in growth<br />
especially in polysaccharide production. A substantial<br />
change in the polysaccharide production was observed<br />
with different carbon sources. Maltose supported<br />
maximum EPS production which was difference with<br />
other bacillus (Lee et al., 1997a). The difference in EPS<br />
production among the maltose concentration of 3, 4 and<br />
5% was not significant because the cell maybe not<br />
absorb more maltose. It also is report that see that the<br />
EPS production increased as the initial carbon resource<br />
concentration increased from 20 to 100 g/l (Lee et al.,<br />
1997b). Nitrogen sources in the form of proteins and<br />
nucleic acid play an important role in the cell mass.<br />
Peptone as organic nitrogen source is the best nitrogen
source in our work. Additionally, it was found in the study<br />
that organic nitrogen source are more suitable for the<br />
EPS production. It was reported that organic nitrogen<br />
sources were absorbed by the cells easier than the<br />
inorganic ones (Hwang et al., 2003; Gandhi et al., 1998).<br />
Inorganic ions affected EPS production by combined with<br />
enzyme. The result showed NaCl could provide the<br />
maximum EPS production, which did not match those of<br />
other researcher (Lung and Huang, 2010).<br />
Optimum pH for polysaccharide production for bacteria<br />
ranges from 6.0 to 7.5 (Kumar et al., 2007), which exactly<br />
accorded with those of B. thuringiensis 27. Optimum EPS<br />
production (14.96 g/l) was obtained in the neutral pH<br />
range. The maximum EPS production by B. thuringiensis<br />
27 were observed at 28°C, which is comparable to many<br />
kinds of bacillus that have relatively low temperature<br />
optimal (example 20 to 25°C) in their submerged<br />
cultures(Cerning et al., 1992). Among several bacteria<br />
physiological properties inoculum size may play an<br />
important role in biological development (Gancel and<br />
Novel, 1994). Inoculum size and liquid volume may play<br />
an important role in cell reproduction and EPS production<br />
(Chen et al., 2008). Result showed 8% inoculum size and<br />
25 ml in 200 ml flasks was fit for EPS production.<br />
From the single factors experiments the three critical<br />
factors affect the EPS yield were identified. Considered<br />
beef extract as an important nitrogen source it is selected<br />
to further optimize. To investigate the relationship among<br />
various factors the orthogonal experimental design<br />
technique as a mathematical method were used the<br />
orthogonal matrix method was obviously a serviceable<br />
experimental design to simultaneously investigate the<br />
relationship between the effect of medium components<br />
and their optimal concentrations (Gundlapally and<br />
Garcia-Pichel, 2006). In addition, the orthogonal matrix<br />
can comprehensively investigate central composite<br />
design, and thus facilitates economical benefit, experimental<br />
convenience. In our work by orthogonal method<br />
the EPS production arrived to 20.17 g/l, which is not only<br />
about five times than those of the basal medium but more<br />
than those of the maximum result of orthogonal design.<br />
That is means the orthogonal matrix method can be used<br />
for optimizing the EPS production in a submerged<br />
fermentation process. Furthermore it is applied to<br />
optimization of culture media for the production of primary<br />
and secondary metabolites in fermentation processes<br />
(Chen et al., 2008).<br />
Flocculation technology as a kind of effective and quick<br />
method is used for wastewater treatment. And bioflocculation<br />
is a dynamic process resulting from the synthesis<br />
of extracellular polymers by living cells. In recent years,<br />
the use of microbial flocculants has been promoted as a<br />
solution to environmental problems because their<br />
intermediates are harmless and biodegradable. Thus<br />
searching and usage bioflocculation arouse the<br />
interesting of researcher in the world. The flocculating<br />
activity of 27 is 80.4% which is below the bioflocculant p-<br />
KG03 (Yim et al., 2007). To obtain new and better<br />
Wang et al. 2365<br />
bioflocculant, we need screen more strain to obtain<br />
functional EPS in BSCs. Otherwise new usage for<br />
microbiology in the desert and desert biological soil<br />
crusts is proved a scientific basis.<br />
Conclusion<br />
The traditional separation, screening and purification<br />
methods were used, 27 strains of producing EPS were<br />
isolated. Under optimal condition the strain could produce<br />
a large amount of EPS. And the EPS possess a certain<br />
degree of flocculation, the flocculation rate was 80.4%,<br />
which is lower than the previously reported strain isolated<br />
from the soil (flocculation rate can reach 97%). Further<br />
screening and optimization to increase the flocculation<br />
rate still carry on. It is well known that microbial<br />
flocculants as a kind of sewage treatment agent are nontoxic,<br />
harmless, no secondary pollution. In this subject,<br />
the discovery of new sources of microbial flocculant has<br />
brought new interest in dealing with the pollution of water<br />
resource. And new usage for the desert biological soil<br />
crusts is provided a scientific basis.<br />
ACKNOWLEDGEMENT<br />
This work was supported by the Commonweal Industry<br />
Scientific Researcher Project from the Ministry of<br />
Agriculture (No. 200803033).<br />
REFERENCES<br />
Cerning J, Bouillanne C, Landon M, Desmazeaud M (1992). Isolation<br />
and characterization of exopolysaccharides from slime-forming<br />
mesophilic lactic acid bacteria. J. Dairy Sci., 75:692.<br />
Chen W, Zhao Z, Chen SF, Li YQ (2008). Optimization for the<br />
production of exopolysaccharide from Fomes fomentarius in<br />
submerged culture and its antitumor effect in vitro. Bioresour.<br />
Technol., 99: 3187-3194.<br />
Di X, Chan K, Leung HW, Huie CW (2003). Fingerprint profiling of acid<br />
hydrolyzates of polysaccharides extracted from the fruiting bodies<br />
and spores of Lingzhi by high-performance thin-layer<br />
chromatography. J. Chromatogr. A., 1018: 85-95.<br />
Gancel F, Novel G (1994). Exopolysaccharide production by<br />
Streptococcus salivarius ssp. thermophilus cultures. 1. Conditions of<br />
production. J. Dairy Sci., 77: 685-688.<br />
Gandhi HP, Ray RM, Patel RM (1998). Exopolymer production by<br />
Bacillus species. Carbohydr. Polym., 34:323-327.<br />
Gundlapally SR, Garcia-Pichel F (2006). The community and<br />
phylogenetic diversity of biological soil crusts in the Colorado Plateau<br />
studied by molecular fingerprinting and intensive cultivation. Microb.<br />
Ecol., 52: 345-357.<br />
Hao LM, Xing XH, Li Z, Zhang JC, Sun JX, Jia SR, Qiao CS, Wu T<br />
(2010). Optimization of effect factors for mycelial growth and<br />
exopolysaccharide production by Schizophyllum commune. Appl.<br />
Biochem. Biotechnol., 160: 621-631.<br />
Hwang HJ, Kim SW, Choi JW, Yun JW (2003). Production and<br />
characterization of exopolysaccharides from submerged culture of<br />
Phellinus linteus KCTC 6190. Enzyme Microb. Technol., 33: 309-319.<br />
Kaditzky S, Vogel RF (2008). Optimization of exopolysaccharide yields<br />
in sourdoughs fermented by lactobacilli. Eur. Food Res. Technol.,<br />
228: 291-299.
2366 Afr. J. Microbiol. Res.<br />
Kennedy SP, Ng WV, Salzberg SL, Hood L, Dassarma S (2001).<br />
Understanding the adaptation of Halobacterium species NRC-1 to its<br />
extreme environment through computational analysis of its genome<br />
sequence. Genome Res., 11: 1641.<br />
Kumar AS, Mody K, Jha B (2007). Bacterial exopolysaccharides - A<br />
perception. J. Basic Microbiol., 47: 103-117.<br />
Kurane R, Takeda K, Suzuki T (1986). Screening for and characteristics<br />
of microbial flocculants. Agric. Biol. Chem., 50: 2301-2307.<br />
Lee IY, Seo WT, Kim GJ, Kim MK, Ahn SG, Kwon GS, Park YH (1997a).<br />
Optimization of fermentation conditions for production of<br />
exopolysaccharide by Bacillus polymyxa. Bioprocess Eng., 16: 71-75.<br />
Lee IY, Seo WT, Kim GJ, Kim MK, Ahn SG, Kwon GS, Park YH (1997b).<br />
Optimization of fermentation conditions for production of<br />
exopolysaccharide by Bacillus polymyxa. Bioprocess Eng., 16: 71-75.<br />
Li Y, Chen J, Lun SY, Rui XS (2001). Efficient pyruvate production by a<br />
multi-vitamin auxotroph of Torulopsis glabrata: key role and<br />
optimization of vitamin levels. Appl. Microbiol. Biotechnol., 55: 680-<br />
685.<br />
Lung MY, Huang PC (2010). Optimization of exopolysaccharide<br />
production from Armillaria mellea in submerged cultures. Lett. Appl.<br />
Microbiol., 50: 198-204.<br />
Nicolaus B, Moriello VS, Lama L, Poli A, Gambacorta A (2004).<br />
Polysaccharides from extremophilic microorganisms. Orig. Life Evol.<br />
Biosph., 34: 159-169.<br />
Pazur JH, Chaplin MF, Kennedy JF (1994). Em Carbohydrate Analysis:<br />
A Practical Approach. New York: IRL, pp. 93-100.<br />
Xu CP, Kim SW, Hwang HJ, Choi JW, Yun JW (2003). Optimization of<br />
submerged culture conditions for mycelial growth and exo-biopolymer<br />
production by Paecilomyces tenuipes C240. Process Biochem., 38:<br />
1025-1030.<br />
Xu R, Ma S, Wang Y, Liu L, Li P (2010). Screening, identification and<br />
statistic optimization of a novel exopolysaccharide producing<br />
Lactobacillus paracasei HCT. Afr. J. Microbiol. Res., 4: 783-795.<br />
Yim JH, Kim SJ, Ahn SH, Lee HK (2007). Characterization of a novel<br />
bioflocculant, p-KG03, from a marine dinoflagellate, Gyrodinium<br />
impudicum KG03. Bioresour. Technol., 98: 361-367.
African Journal of Microbiology Research Vol. 5(16), pp. 2367-2373, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.893<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
A simple and efficient method that uses low<br />
concentration fetal bovine serum to culture and purify<br />
Schwann cells<br />
Han Feng, Qu Wei*, Jiang Huajun, Fu Chongyang, Lu Ming, Zhang Weiguo and Lv Decheng<br />
Department of Orthopaedic Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, China.<br />
Accepted 18 April, 2011<br />
To develop a simple and efficient method for the isolation of highly purified Schwann cells (SCs) from<br />
the sciatic nerves of newborn rats, cells were initially cultured in 10% FBS for 6 days, and then cultured<br />
in 2% FBS for 6 days. And we used the immunocytochemical characterization, flow cytometry, RT-PCR,<br />
to observe the condition of SCs. After the 12-day treatment protocol, we obtained a high yield of SCs<br />
with an average purity of 96.9%. Furthermore, the condition of SCs had no change. In our purification<br />
protocol, we had shown that our procedures did not alter the cell cycle and neurokines’ secretion. Our<br />
simple and efficient method yielded pure and healthy SCs and did not require treatment with antimitotic<br />
agents or any special equipment.<br />
Key words: Schwann cells, cell culture, low fetal bovine serum concentration, tissue engineering, fibroblast.<br />
INTRODUCTION<br />
Tissue engineering, the use of cells and engineering<br />
methods to modify biological functions, has already been<br />
applied to diverse clinical fields. In neurology, tissue<br />
engineering appears to have certain advantages over<br />
nerve cell transplantation. There are three critical<br />
meterials of tissue engineering: (i) biodegradable<br />
materials; (ii) trophic factors; and (iii) cells, typically<br />
autologous cells that do not cause antigenic reactions<br />
(Mackinnon and Dellon, 1990; Vacanti et al., 2001). In<br />
peripheral nerve tissue engineering, it is critical to rapidly<br />
obtain large numbers of pure Schwann cells (SCs)<br />
(Fansa and Keilhoff, 2004). SCs are the principal<br />
supporting cells of the peripheral nervous system, and<br />
are crucially involved in the functional recovery of injured<br />
peripheral nerves (Bunge, 1993). SCs play an important<br />
role in nerve regeneration and are at the core of<br />
peripheral nerve tissue engineering, a procedure that<br />
requires a large number of cells. Diverse methods have<br />
been proposed for the purification of SCs: antimitotic<br />
agent and antibody-mediated cytolysis methods (Brockes<br />
*Corresponding author. E-mail: fhtg001@sina.com.<br />
et al., 1979); repeated explantation methods (Oda et al.,<br />
1989); the cold jet technique (Jirsová et al., 1997);<br />
immunoselective methods (Calderon-Martinez et al.,<br />
2002); in vivo or in vitro predegeneration methods<br />
(Komiyama et al., 2003; Mauritz et al., 2004); differential<br />
adhesion methods (Pannuzio et al., 2005); differential<br />
detachment methods (Jin et al., 2008); and a combination<br />
of the in vitro predegeneration and cold jet technique<br />
(Haastert et al., 2007; 2009). These methods can yield<br />
highly purified SCs with various efficiencies, but all<br />
require special equipments, complicated procedures<br />
and/or high costs.<br />
Preparation of SCs for tissue engineering requires a<br />
safe, rapid, easy and high yield methodology for<br />
purification. We aimed to develop an economical method<br />
besides those requirements from 7 days old Sprague<br />
Dawley (SD) rats by use of low concentration FBS.<br />
MATERIALS AND METHODS<br />
Animals<br />
Postnatal SD rats (7 days old, 11.3±0.5 g) were obtained from the<br />
Dalian Medical University Animal Center (Dalian, China). All animal
2368 Afr. J. Microbiol. Res.<br />
protocols were approved by the Animal Experiment and Care<br />
Committee of Dalian Medical University.<br />
Primary culture<br />
Rats were sacrificed by decapitation, and sciatic nerve segments<br />
(10 to 15 mm in length) were harvested aseptically under a<br />
dissecting microscope and were temporarily maintained in 60 mm<br />
culture plates (Corning, USA). Then, 2 ml of ice-cold D-Hanks<br />
solution (Sigma USA) was added, and the sciatic nerve segments<br />
were removed from the epineurium and cut into pieces (1 mm 3 )<br />
under a dissecting microscope. Finally, nerve fragments were<br />
placed in 15 mL conical centrifuge tubes (Corning, USA) and<br />
centrifuged (140 g × 5 mins). The supernatant was discarded. 1 mL<br />
each of 0.25% trypsogen (Gibco, USA) and collagen 0.2% type- II<br />
(Gibco, USA) were added, then incubated in a cell incubator<br />
(Thermo, USA) with 5% carbon dioxide at 37°C for 30 min and heat<br />
shocked once every 5 mins. Addition of 2 mL of Dulbecco’s<br />
Minimum Eagle’s Medium (DMEM) (Hyclone, USA) that contained<br />
10% FBS (Gibco, USA). The mixture was centrifuged again (140 g<br />
× 5 min), and the supernatant was again discarded. Removed<br />
nerve fragments to 60 mm culture plates. Then, 1.5 mL<br />
DME/10%FBS containing 50 U/ml penicillin and 50 µg/ml<br />
streptomycin (Gibco, USA) was added, and all plates were<br />
maintained in a cell incubator within a humidified atmosphere with<br />
5% CO2 at 37°C. The growth medium was changed every 48 h.<br />
Purification of SCs<br />
Cells isolated from nerve segments after the first 6 days were<br />
divided into three groups: Group A (control) were fed every 2 days<br />
using DMEM with 10% FBS; Group B were fed every 2 days using<br />
DMEM with 2% FBS and cells were collected on day 6; Group C<br />
were fed every 2 days using serum-free DMEM, and cells were<br />
collected on day 6.<br />
Immunocytochemical characterization of SCs and SC purity<br />
Immunohistochemical staining was accomplished in the culture dish<br />
after 12 days. Cells were marked with the Strept Avidin-Biotin<br />
Complex (SABC) kit and rabbit anti-S100 protein antibody (Boster,<br />
China) according to the manufacturer’s instructions. Then, cells<br />
were washed two times with PBS (pH 7.2) (Gibco, USA), fixed for<br />
90 mins in 4% paraformaldehyde, and then immersed in a mixture<br />
of 30% H2O2 and pure methanol (1:50) for 30 mins. After that, 5%<br />
BSA (confining liquid) was added drop-wise at room temperature in<br />
20 mins. BSA was shaken out of the dish. Then anti-S100 protein<br />
antibody was added drop-wise at 37°C for 1 h, washed 3 times with<br />
PBS, incubated with secondary antibodies at 37°C for 20 mins,<br />
washed 2 times with PBS. Then, SABC was added drop-wise at<br />
37°C for 20 mins, washed 4 times with PBS. Finally, cells were<br />
stained by DBA (Hsu and Ree, 1980; Klosen, 1989) using a kit<br />
(Boster, China), at room temperature for 8 min, then post-stained<br />
with hematoxylin and examined under a microscope. Cells with a<br />
bipolar or tripolar shapes were identified as SCs, whereas flat or<br />
polygonal cells were identified as fibroblasts (Pannuzio et al.,<br />
2005).<br />
SC purity was expressed as the percentage of SCs (SC purity =<br />
[number of SCs]/[number of SCs + number of fibroblasts]) from<br />
samples of ten visual fields at 200 × magnification.<br />
Flow cytometry<br />
Cells from Groups A and B were digested with 0.25% trypsogen and<br />
0.02% EDTA, treated into the single cell suspension, centrifuged<br />
(314 g × 5 min) and washed with PBS. Then, centrifuged again, and<br />
the precipitate were resuspended and fixed in 2 mL of cold 80%<br />
reagent grade ethanol and left overnight at 4°C. Then, centrifuged<br />
and used 0.01% RNAase (Sigma, USA) to resuspend the<br />
precipitate and heat shocked at 37°C for 10 min. The cells were<br />
centrifuged and0.5%PI (propidium iodide) (Sigma, USA) was added<br />
to the precipitate and cell concentration was adjusted to 1 × 10 6 per<br />
mL.<br />
Finally, the cells were stained in darkness for 30 min and<br />
detected by flow cytometry.<br />
Reverse transcriptase polymerase chain reaction (RT-PCR)<br />
Total RNA was extracted separately from Groups A and B after 12<br />
days and cDNA was synthesized from the total RNA using a RNA<br />
PCR Kit (AMV) Ver.3.0 (Takara, China) according to the<br />
instructions. The sequences of the primers for NGFb (Yan et al.,<br />
2007), BDNF (Yan et al., 2007), β-actin are depicted in Table 1. The<br />
PCR conditions were 94°C for 30s (denaturation), 56°C for 30 s<br />
(annealing) and 72°C for 1 min (extension) for a total of 30 cycles<br />
(NGFb, BDNF), or 55°C for 30 s (annealing) for β-actin. And a<br />
DL2000 DNA-ladder (TaKaRa, Japan) was run in parallel to the<br />
samples. Amplification products were separated by 2.0% agarose<br />
gel electrophoresis. After the gels were scanned, the relative<br />
intensity of NGFb and BDNF bands was determined by using Gelpro<br />
Analyzer software (Media Cybernetics, USA).<br />
Statistics<br />
SC purity and cell yields are presented as means ± SDs. Values<br />
were subjected to a Student’s t-test, with a P value less than 0.05<br />
considered to be statistically significant.<br />
RESULTS<br />
Primary culture and purification of SCs<br />
During the first 48 h of the primary culture, two distinct<br />
types of cells split off from the nerve fragments (Figure<br />
1a). Phase-contrast microscopy (× 200) indicated that<br />
most of the cells attached to the bottom of the culture<br />
dishes could be classified as SCs (spindle-shaped,<br />
bipolar, and sometimes tripolar, with a small cytoplasmto-nucleus<br />
ratio) or as fibroblasts (flat polygonal shaped,<br />
with a prominent ovoid nucleus and abundant cytoplasm).<br />
Most of the fibroblasts appeared to be scattered among<br />
the SCs, but some were beneath the SCs. During the first<br />
48 h, SCs proliferated faster than fibroblasts. However,<br />
96 h later, fibroblasts gradually became the dominant cell<br />
type, and SCs stopped growing and migrated onto<br />
fibroblasts. SCs and fibroblasts were both growing rapidly<br />
after 4 days.<br />
After 6 days of primary culture of Group A cells (DMEM<br />
with 10% FBS), most of the fibroblasts growing among<br />
the SCs were easily detached from the culture plates,<br />
whereas those growing under or interacting with SCs<br />
could not be removed (Figure 1b). For group B cells<br />
(DMEM with 2% FBS), the fibroblasts started to die after<br />
48 h, quite a number of cell were gone after 96 h of
Table 1. The sequences of the primers for NGFb, BDNF, β-actin.<br />
Feng et al. 2369<br />
Forward primer Reverse primer Ta (°C) Amplicon length (bp)<br />
NGFb 5'-GGCCACTCTGAGGTGCATAG-3' 5'-CATGGGCCTGGAAGTCTAAA-3' 56 349<br />
BDNF 5'-AAACCATAAGGACGCGGACT-3’ 5'-GATTGGGTAGTTCGGCATTG-3' 56 393<br />
β-actin 5’-TCTACGAGGGCTATGCTCTCC-3’ 5-GGATGCCACAGGATTCCATAC-3’ 55 320<br />
Figure 1. Observe the results of the growing cells with inverted microscope. A as SC, B as fibroblast, C as nerve<br />
segment and D as dead cells. During the 2nd day of the primary culture, two distinct types of cells emerged from<br />
the nerve fragments (a). And, at the 6th day of the primary culture, SCs and fibroblasts were growing fast (b).<br />
However, used DMEM with 2% FBS, numerous fibroblasts died within 96 h; (c) and almost all of the fibroblasts<br />
were cleared away by the 6th day and SCs morphology was not changed with 2% FBS (d). But after 6 days<br />
barely any cells survived at the culture plate in Group C. scale bar: 100 um).<br />
culturing (Figure 1c), and almost all fibroblasts were gone<br />
after 6 days of culturing. The morphology of SCs did not<br />
change during this time (Figure 1d). For group C cells<br />
(serum-free DMEM), a few cells died after 48 h, but after<br />
96 h, both types of cells had died in significant numbers.<br />
The death rate continued to increase, and after 6 days<br />
of culturing, almost all cells had died (Figure 1e).<br />
Immunocytochemical characterization of SC and SC<br />
purity<br />
S-100 is a well-established sensitive and specific marker<br />
for SCs (Raff et al., 1979). We observed S-100 staining in<br />
the SCs body and along the processes (Figure 2). Our<br />
purified SCs had typical bi- or tri-polar morphology and<br />
oval nuclei. In contrast, the contaminating fibroblasts<br />
were negative for S-100 staining. Because our<br />
immunological staining was performed in culture dishes,<br />
we had acquired very high yield and high-quality cells.<br />
Since so many of the Group C cells died, we could not<br />
collect enough cells for immunocytochemical staining.<br />
Table 2 shows the percentage of cells positive for S-100.<br />
SC purity in Group B was significantly better than in<br />
Group A (P < 0.01). However, the total numbers of SCs<br />
were too little to discriminate Group A from B (p > 0.05).<br />
Flow cytometry<br />
To further provide qualitative evidences of the characters<br />
of our SCs, we compare the SC cycle of Groups A and B<br />
cells (Figure 3). As shown in Table 3, there was no<br />
significant difference in the cells cycles between Groups
2370 Afr. J. Microbiol. Res.<br />
A and B cells (p > 0.05).<br />
Figure 2. Immunocytochemical characterization of SCs with<br />
S100 showed that the purified SCs had typical bi- or tri-polar<br />
morphology and oval nuclei. (a) In contrast, the contaminating<br />
fibroblasts were negative for S-100 staining (b). Used DMEM with<br />
10% FBS, numerous fibroblasts are shown at (A). Used DMEM<br />
with 2% FBS (B), by contrast, cells were very purified (scale bar:<br />
100 um).<br />
Table 2. Summary of results in the present method for SCs preparation.<br />
View Number of S100 protein positive cells/total number of counted cells<br />
Group A Group B<br />
1 646*/753 (0.857902)** 779*/824 (0.945388)**<br />
2 988*/1173 (0.842285)** 1045*/1094(0.955210)**<br />
3 1111*(/12340.900324)** 1368*/1415(0.966784)**<br />
4 845*/978 (0.864008)** 722*/746 (0.967828)**<br />
5 750*/849 (0.883392)** 901*/936 (0.962607)**<br />
6 731*/862 (0.848028)** 1711*/1752(0.976598)**<br />
7 1130*/1270(0.889764)** 749*/762 (0.982940)**<br />
8 1083*/1210(0.895041)** 939*/956 (0.982218)**<br />
9 1092*/1206(0.905473)** 839*/860 (0.975581)**<br />
10 592*/738 (0.802168)** 836*/856 (0.976636)**<br />
* There was an insignificant difference between SCs total at Groups A and B (p>0.05); **There was a<br />
significant difference between SC purity at Groups A and B (p
DISCUSSION<br />
Main findings<br />
Feng et al. 2371<br />
Figure 3. The cell cycle of SCs detected by flow cytometer showed that used DMEM with 10%FBS(A). DIP<br />
G2:0.53%, S:47.37%, and used DMEM with 2%FBS(B) DIP G2:0.10%, S:44.92%.<br />
Table 3. Summary of results in the present method for SCs cycle.<br />
Cell cycle<br />
Group A<br />
Group B<br />
G2 a (%) S b (%) G2 a (%) S b (%)<br />
0.53 47.37 0.10 44.92<br />
0.37 45.44 0.68 48.23<br />
0.13 44.80 0.42 46.04<br />
a There was a insignificant difference between G2 percentage at Groups A and B (p>0.05); b There was a<br />
insignificant difference between S percentage at Groups A and B (p>0.05).<br />
Our method of culturing the sciatic nerves of newborn SD<br />
rats in DMEM with 10% FBS allowed SCs and fibroblasts<br />
to split off from intact nerve fragments. Once SCs have<br />
migrated in high densities, they proliferate actively due to<br />
the production of autocrine growth factors, IGF-2, NT-3<br />
and PDGF-BB (Jessen and Mirsky, 1999), regardless of<br />
being cultured in a medium with low FBS concentration.<br />
However, cells in serum-free DMEM (Group C) did not<br />
have adequate nutrition for growth and proliferation.<br />
Thus, although there were few fibroblasts in Group C, the<br />
growth of SCs was also greatly affected. There was no<br />
significant difference in the number of SCs in Groups A<br />
and B, but the SC purity was significantly greater in<br />
Group B. Our results indicate that culturing of nerve cells<br />
in DMEM with 2% FBS can gradually reduce the<br />
percentage of fibroblasts, while having no effect on SC<br />
differentiation, morphology or character.<br />
The immuno staining results indicated that staining was<br />
evident in both SC cell body and processes during the<br />
culture period. The flow cytometry results indicated that<br />
the number of cells in S period and G2 period were similar<br />
in Groups A and B. NGFb and BDNF are the main growth<br />
factors secreted by SCs, which are known to have<br />
neurotrophic effects on nerve regeneration (Schicho et<br />
al., 1999; Serpe et al., 2005).<br />
Semi-quantitative analysis of NGF mRNA and BDNF<br />
mRNA by RT–PCR showed that SCs of Group B had<br />
similar productive function of secretion the normal<br />
cultured SCs. Thus, we conclude that our culturing<br />
protocol is a simple and efficient method to purify SCs<br />
that also preserves the function and morphology of SCs.<br />
Comparison with the existing literature<br />
Gross dissection of nerve cells may lead to contamination<br />
of the desired cells (Jessen and Mirsky, 1999) and<br />
peripheral nerve regeneration with tissue-engineered<br />
cells requires highly purified SCs for the construction of<br />
artificial nerve grafts. Many previous studies have
2372 Afr. J. Microbiol. Res.<br />
500bp<br />
250bp<br />
500bp<br />
250bp<br />
M<br />
5<br />
6<br />
M 1 2<br />
3 4<br />
Figure 4. Total RNA was analyzed for the expression of NGFb and BDNF by RT–PCR at 12 days.1: BDNF<br />
(Group A); 2 BDNF (Group B); 3: NGFb (Group A); 4::NGFb (Group B); 5: β-actin(Group A);6: β-actin(Group B);<br />
M: Marker.<br />
attempted to reduce the fibroblast contamination and<br />
increase SC purity by use of: (i) antimitotic treatment<br />
(Schicho et al., 1999); (ii) a combination of antimitotic<br />
treatment and antibody-mediated cytolysis with complements<br />
(Brockes et al., 1979); (iii) repeated explantation<br />
methods 6 (Serpe et al., 2005; Smith and Greenfield,<br />
2003); (iv) differential adhesion methods (Pannuzio et al.,<br />
2005; Wood, 1976); and (v) immunoselective methods<br />
(Manent et al., 2003; Askanas et al., 1980; Wrathall et<br />
al., 1981). Those previously proposed methods have<br />
been shown to enrich SCs with various efficiencies, but<br />
all have certain limitations. In particular, antimitotic agents<br />
are harmful to SC function (Serpe et al., 2005; Assouline<br />
et al., 1983) and can reduce SC yield because of their<br />
non-specific antimitotic effects. Antibodies and<br />
complements are expensive for large-scale SC<br />
preparations, so do not provide an economical approach<br />
to SC purification. Repeated explantation and<br />
differential adhesion can be comparatively complicated<br />
and time-consuming procedures, and may lead to a loss<br />
of SCs and delay of therapy. Immunoselection is a good<br />
method for achieving high purity, but requires expensive<br />
antibodies and special facilities.<br />
In a previous study, Needham et al. (1987), described<br />
the use of serum-free medium (S4) that allowed for<br />
optimal SC proliferation (up to 90% purity after 10 days),<br />
and suppressed fibroblast overgrowth in primary cultures<br />
of neonatal rat sciatic nerves (Assouline et al., 1983). But<br />
this serum-free media, though suitable for selective SC<br />
migration, was not as conducive for SC proliferation.<br />
However, use of a growth medium with 10% FBS<br />
supported not SC proliferation but an explosive fibroblast<br />
overgrowth. Komiyama et al. (2003) described the use of<br />
low FBS concentration for the purification of SCs, and<br />
obtained an average purity of 98% after 8 days by using<br />
DMEM for the first 6 days and changing to DMEM with<br />
2.5% FBS on day 6. However, this method yielded low<br />
cell counts, and the resulting SC purity was only 88.0%.
Another method described by Komiyama et al. (2003)<br />
cultured cells in DMEM with 10% FBS for the first 3 days,<br />
then in serum-free DMEM for 3 days, then, on day 6 in<br />
DMEM with 2.5% FBS. The SC purity was 93.6% at 14<br />
days, but was reduced to 89.5% at 21 days. Thus,<br />
regardless of method, the total cell counts were<br />
increasing, but the percentage of SCs decreased over<br />
time.<br />
This phenomenon was also noted in our study.<br />
IMPLICATIONS FOR FUTURE RESEARCH<br />
The protocol described here is a simple, economical,<br />
rapid and efficient method for the purification of SCs. Our<br />
method has a high yields and results in highly pure cells.<br />
We suggest that our method might be useful for the<br />
development of tissue-engineered nerves and for other<br />
studies related to peripheral nerve injuries.<br />
ACKNOWLEDGEMENT<br />
This research was supported by National Natural Science<br />
Foundation of China (30973066).<br />
REFERENCES<br />
Askanas V, EngelWK, Dalakas MC, Lawrence JV, Carter LS (1980).<br />
Human Schwann cells in tissue culture: histochemical and<br />
ultrastructural studies. Arch Neurol., 6: 329–337.<br />
Assouline JG, Bosch EP, Lim R (1983). Purification of rat Schwann cells<br />
from cultures of peripheral nerve: an immunoselective method using<br />
surfaces coated with anti-immunoglobulin antibodies. Brain Res., 2:<br />
389–9.<br />
Brockes JP, Fields KL, Raff MC (1979). Studies on cultured rat Schwann<br />
cells. I. Establishment of purified populations from cultures of<br />
peripheral nerve. Brain Res., 1: 105–118.<br />
Bunge RP (1993). Expanding roles for the Schwann cell: ensheathment,<br />
myelination, trophism and regeneration. Curr. Opin. Neurobiol., 3:<br />
805–809.<br />
Calderon-Martinez D, Garavito Z, Spinel C, Hurtado H (2002). Schwann<br />
cell-enriched cultures from adult human peripheral nerve: a technique<br />
combining short enzymatic dissociation and treatment with cytosine<br />
arabinoside (Ara-C). J. Neurosci. Methods, 114: 1–8.<br />
Fansa H, Keilhoff G (2004). Comparison of different biogenic matrices<br />
seeded with cultured Schwann cells for bridging peripheral nerve<br />
defects. Neurol. Res., 26(2): 167-173.<br />
Haastert K, Mauritz C, Chaturvedi S, Grothe C (2007). Human and rat<br />
adult Schwann cell cultures: fast and efficient enrichment and highly<br />
effective non-viral transfection protocol. Nat. Protoc., 2: 99–104<br />
Haastert K, Seef P, Stein VM, Tipold A, Grothe C (2009). A new cell<br />
culture protocol for enrichment and genetic modification of adult<br />
canine Schwann cells suitable for peripheral nerve tissue<br />
engineering. Res. Vet. Sci., 87: 140–142.<br />
Feng et al. 2373<br />
Hsu S, Ree H (1980). Self-sandwich method: an improved<br />
immunoperoxidase technique for the detection of small amounts of<br />
antigens. Am. J. Clin. Pathol., 74: 32–40.<br />
Jessen KR, Mirsky R (1999). Why do Schwann cells survive in the<br />
absence of axons. Ann New York Acad. Sci., 883: 109-115.<br />
Jin YQ, Liu W, Hong TH, Cao YL (2008). Efficient Schwann cell<br />
purification by differential cell detachment using multiplex collagenase<br />
treatment. J. Neurosci. Methods, 170: 140–148.<br />
Jirsová K, Sodaar P, Mandys V, Bär PR (1997). Cold jet: a method to<br />
obtain pure Schwann cell cultures without the need for cytotoxic,<br />
apoptosis-inducing drug treatment. J. Neurosci. Methods, 78: 133–<br />
137.<br />
Klosen P (1989). Techniques Immunocytochimiques. Louvain:<br />
Universite ´Catholique de Louvain, pp. 24–44.<br />
Komiyama T, Nakao Y, Toyam Y, Asou H, Vacanti CA, Vacanti MP<br />
(2003). Anovel technique to isolate adult Schwann cells for an<br />
artificial nerve conduit. J. Neurosci. Methods, 122: 195-200.<br />
Mackinnon SE, Dellon AL (1990). Clinical nerve reconstruction with a<br />
bioabsorbable polyglycolic acid tube. Plast Reconstr. Surg., 85(3):<br />
419-24.<br />
Manent J, Oguievetskaia K, Bayer J, Ratner N, Giovannini M (2003).<br />
Magnetic cell sorting for enriching Schwann cells from adult mouse<br />
peripheral nerves. J. Neurosci. Methods, 2: 167–173.<br />
Mauritz C, Grothe C, Haaster K (2004). Comparative study of cell<br />
culture and purification methods to obtain highly enriched cultures of<br />
proliferating adult rat Schwann cells. J. Neurosci. Res., 77: 453–461<br />
Needham LK, Tennekoon GI, McKhann GM (1987). Selective growth of<br />
rat Schwann cells in neuron- and serum-free primary culture. J.<br />
Neurosci., 7(1): 1-9.Oda Y, Okada Y, Katsuda S, Ikeda K, Nakanishi I<br />
(1989). A simple method for the Schwann cell preparation from<br />
newborn rat sciatic nerves. J. Neurosci. Methods, 3: 163–169.<br />
Pannuzio ME, Jou IM, Long A, Wind TC, Beck G, Balian G (2005). A<br />
new method of selecting Schwann cells from adult mouse sciatic<br />
nerve. J. Neurosci. Method, 1: 74–81.<br />
Raff MC, Fields KL, Hakamori S, Mirski R, Pruss RM, Winter J (1979).<br />
Cell-type-specific markers for distinguishing and studying neurons<br />
and the major classes of glial cells in culture. Brain Res., 174: 283–<br />
308.<br />
Schicho R, Skofitsch G, Donnerer J (1999). Regenerative effect of<br />
human recombinant NGF on capsaicin-lesioned sensory neurons in<br />
the adult rat. Brain Res., 815: 60–69.<br />
Serpe CJ, Byram SC, Sanders VM, Jones KJ (2005). Brain-derived<br />
neurotrophic factor supports facial motoneuron survival after facial<br />
nerve transection in immunodeficient mice. Brain Behav. Immun., 19:<br />
173–180.<br />
Smith L, Greenfield A (2003). DNA microarrays and development. Hum<br />
Mol. Genet ., 12: R1–R8.<br />
Vacanti CA, Bonassar LJ, Vacanti MP, Burger JS (2001) . Replacement<br />
of an avulsed phalanx with tissue-engineered bone. New Engl. J.<br />
Med., 344(20): 1511-1514.<br />
Wood PM (1976). Separation of functional Schwann cells and neurons<br />
from normal peripheral nerve tissue. Brain Res., 3: 361–75.<br />
Wrathall JR, Rigamonti DD, Braford MR, Kao CC (1981). Non-neuronal<br />
cell cultures from dorsal root ganglia of the adult cat: production of<br />
Schwann-like cell lines. Brain Res., 1: 163–81.<br />
Yan S, BingFang Z, ChangQing Z, Kai-Gang Z, XueTao X (2007). Study<br />
of biocompatibility of small intestinal submucosa (SIS) with Schwann<br />
cells in vitro. Brain Res., 1145: 41-47.
African Journal of Microbiology Research Vol. 5(16), pp. 2374-2379, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR09.455<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
First report on Enterobacter sakazakii from Sudanese<br />
patients<br />
Humodi A. Saeed¹* and Rania M. Musallam²<br />
Department of Microbiology, College of Medical laboratory Science, Sudan University of Science and Technology,<br />
Arbab El Agaid Street, P. O. Box 407 Khartoum, Sudan.<br />
Accepted 12 March, 2010<br />
Enterobacter sakazakii (E. sakazakii) has been identified as emerging opportunistic pathogens that can<br />
cause enterocolitis, bacteraemia, meningitis, brain abscess, and urinary tract infection. They have been<br />
particularly associated with meningitis in neonates where infant milk formulae have been<br />
epidemiologically linked to the disease. This study was carried out during the period of November 2008<br />
to March 2009; to determine the occurrence of E. sakazakii in clinical specimens and its resistance to<br />
traditionally used antimicrobial agents in the Sudan. A total of 389 (311 urine specimens, 11 wound<br />
specimens, and 67 stool specimens) were collected from outpatients of three leading hospitals in<br />
Khartoum State. The urine specimens and wound swabs were cultured on blood and MacConkey's<br />
agars for primary isolation of pathogen, while stool specimens were cultured on selenite F broth and<br />
incubated overnight then subcultured on xylose lysine deoxycholate agar. Identification of the E.<br />
sakazakii was done by colonial morphology, Grams stain and biochemical tests using API 20E. Modified<br />
Kirby-Bauer disc diffusion method was adopted to determine the resistance rate of E. sakazakii to<br />
fifteen antimicrobial agents. Minimum inhibitory concentration (MIC) of antimicrobial agents was<br />
determined by E-test. The result showed that out of 389 specimens examined, 6 (1.5%) E. sakazakii were<br />
recovered, 4 (1.03%) from urine, 1(0.3%) from wound and 1(0.3%) from stool. The results more over<br />
revealed that the antimicrobial resistance of E. sakazakii was as follows; ceftazidime, amoxicillin,<br />
amoxyclav (100% each), co-trimoxazole, ticarcyline (83.3% each), chloramphenicol, tetracycline,<br />
ceftriaxone, nitrofuratoin, cephotaxime, tobramycin (66.7% each), ciprofloxacin, amikacin and nalidixic<br />
acid (16.7% each). None of the isolates were found to be resistant to gentamicin. In addition to that, the<br />
result indicated that the MIC, MIC50 and MIC90 of different antimicrobial agents range from 0.001 to > 240,<br />
0.1 to > 240 and 0.5 to > 240 µg/ml respectively. The results indicated for the first time the presence of E.<br />
sakazakii in the examined clinical specimens in Sudan. The occurrence was high and the antimicrobial<br />
resistance of the isolated E. sakazakii was also high.<br />
Key words: Enterobacter sakazakii, API 20E, E-Test, Khartoum, Sudan.<br />
INTRODUCTION<br />
Enterobacter sakazakii (E. sakazakii) is a Gram-negative<br />
rod belonging to the family Enterobacteriaceae (Fiore et<br />
al., 2008). The organisms have been identified as<br />
emerging opportunistic pathogens that can cause<br />
enterocolitis, bacteraemia, meningitis, brain abscess and<br />
urinary tract infection. They have been particularly
associated with meningitis in neonates (Ongrádi, 2002;<br />
MacLean et al., 2009). Neonatal pathologies also include<br />
wound exudates, appendicitis, and conjunctivitis (Conte<br />
and Passantino, 2008). The organism can be found in<br />
broad range of foods including powdered infant formula,<br />
cheese, meat, vegetables, grain, herbs, spices, tomato,<br />
and in water, in a variety of areas, including hospitals and<br />
houses (Fiore et al., 2008; Kim et al., 2008; Beuchat et<br />
al., 2009).<br />
Although most documented cases involve infant<br />
reports, infections in adult have been also described<br />
(Bhat et al., 2009). Adults with E. sakazakii infection<br />
usually have serious underlying disease or malignancies.<br />
The wound infection with E. sakazakii wound infection in<br />
an adult patient has been reported. The organism was<br />
resistant to multiple antibiotics and required prolonged<br />
treatment with broad spectrum antibiotics (Hamilton et al.,<br />
2003). It is thus necessary to introduce various control<br />
measures to reduce the risk of contamination at various<br />
levels (Fiore et al., 2008).<br />
Antimicrobial agents from natural sources (muscadine<br />
seed extracts, rich sources of phenolic compounds and<br />
organic acids) demonstrated a strong antimicrobial effect<br />
against E. sakazakii (Kim et al., 2009). Control can be<br />
done using accurate antimicrobial agents. The later have<br />
been recovered from natural sources like, muscadine<br />
seed extracts, rich sources of phenolic compounds and<br />
organic acids to demonstrate a strong antimicrobial effect<br />
against E. sakazakii (Kim et al., 2009).<br />
Cited publications have demonstrated that E. sakazakii<br />
can be isolated in hospitals from clinical specimens taken<br />
from patients. Revising literature, we found that this<br />
organism has never been isolated in the Sudan. This<br />
study was designed to determine possible occurrence<br />
and antimicrobial resistance of E. sakazakii in clinical<br />
specimens.<br />
MATERIALS AND METHODS<br />
Study design<br />
This work is a descriptive and cross-sectional study that included<br />
389 patients, complaining from symptoms of UTI, enterocolitis, and<br />
wound infection in Khartoum state. Urine, stool, and wound swab<br />
*Corresponding author. E-mail: biotechsust@hotmail.com. Tel:<br />
+249 83773074. Fax: +249 83 771512.<br />
Humodi and Rania 2375<br />
collection and patient’s data were done in Kartoum Teaching<br />
Hospital (KTH), Gaffer Iben Auff Specialized Hospital for Children<br />
(GIASH) and Omdurman Teaching Hospital. Laboratory investigation<br />
was done in Research Laboratory, College of Medical Laboratories<br />
Science, Sudan University of Science and Technology. Data were<br />
collected in accordance with structured interview questionnaire.<br />
Collection of specimens<br />
Urine<br />
Mid-stream urine (MSU) was collected. Patients were asked to<br />
clean the pre-urethra area with soap and water. Adult females were<br />
asked to make swabbing of the urethra with sterile swab avoiding<br />
any antiseptic then were asked to pass the first drops of urine and<br />
collect 10-20 ml of mid stream urine in sterile, wide mouth<br />
containers.<br />
Wound swabs<br />
Sterile cotton wool swab was used to collect specimens of<br />
discharge from the infected wound. Where there was no discharge,<br />
swab was moistened with sterile normal saline, prior to collection of<br />
specimen and subsequently inserted in sterile tube. In case of<br />
deeply ulcerated wound, a syringe was employed to aspirate the<br />
sample from the side wall of the ulcer. Specimens were delivered to<br />
the laboratory as soon as possible.<br />
Stool<br />
Freshly passed stool specimens were collected in sterile wide<br />
mouth containers and cultures were performed immediately after<br />
collection. In case of delay, specimens were stored at 4°C.<br />
Cultivation of specimens<br />
Under aseptic conditions, urine and wound specimens were<br />
streaked on MacConkey's agar and blood agar (Oxoid Ltd., UK).<br />
Stool specimens were cultured in selenite F broth (Oxoid Ltd., UK),<br />
incubated overnight at 37°C then subcultured on xylose lysine<br />
deoxycholate agar (XLD), (Oxoid Ltd., UK) and incubated<br />
aerobically overnight at 37°C.<br />
Examination of growth<br />
Abundant growth was examined for lactose fermentation on<br />
MacConkey's agar, XLD agar and haemolysis on blood agar. The<br />
various morphological characters of the targeted organism were<br />
also observed and recorded. The isolates were then streaked on<br />
nutrient agar and incubated overnight at 37°C. The growth was<br />
checked for purity and stored in Bijou Bottles for further<br />
investigations.
2376 Afr. J. Microbiol. Res.<br />
Criteria of isolation of E. sakazakii<br />
Gram-negative rods were considered significant (Guptta et al.,<br />
2003) and were investigated.<br />
Identification of E. sakazakii<br />
Bacterial colonies were examined for round, irregular, crenated or<br />
branching appearance, transparency or opacity, smoothness or<br />
roughness, dullness or shiny appearance. The color of the colonies<br />
was also examined (Murray et al., 2007).<br />
Gram's stain<br />
The method was carried out according to Murray et al. (2007).<br />
Oxidase test<br />
The test was carried out according to Barrow and Filtham (2003).<br />
Briefly, oxidase reagent discs were placed on sterile Petri dish and<br />
rubbed with colony of the test organism removed by using a<br />
wooden stick. Formation of a red-purple color within 20 s indicated<br />
positive oxidase test.<br />
Analytical profile index (API 20E)<br />
The API 20E (20 biochemical tests) was performed according to<br />
manufacturer instructions. These were ONPG, ADH, LDC, ODC,<br />
CIT, H2S, URE, TDA, IND, VP, GEL, GLU, MAN, INO, SOR, RHA,<br />
SAC, MEL, AMY and ARA. Identification was obtained with the<br />
numerical profile and performed using the database with the<br />
analytical profile index by looking up to the numerical profile in the<br />
list of profile.<br />
Antimicrobial sensitivity test<br />
Modified Kirby-Bauer disc diffusion method was performed (WHO,<br />
1996; NCCLS. 1997; Murray et al., 2007). Briefly, plates of Mueller-<br />
Hinton agar (Oxoid Ltd, UK) were prepared according to the<br />
manufacturer instructions; the sterilized molten medium was cooled<br />
to 45 to 50°C and poured in sterile, dry Petri plates on a leveled<br />
surface, to a depth of 4 mm. The inoculum was prepared and<br />
turbidity was adjusted to 0.5 McFarland standard. A sterile non-toxic<br />
cotton swab on a wooden applicator was dipped into the<br />
standardized inoculum and the soaked swab was rotated firmly<br />
against the upper inside wall of the tube to express excess fluid.<br />
The entire agar surface of the plate was streaked with the swab<br />
three times with turning the plate at an angle of 60 degrees<br />
between each streaking; the inoculum was allowed to dry for 5-15<br />
min with lid in place. Using sterile forceps the antimicrobial discs<br />
were placed and evenly distributed on the inoculated plate. The<br />
plate was then inverted and incubated aerobically at 35-37°C for<br />
18-24 h. After overnight incubation, the control and test plates were<br />
examined to ensure the growth is confluent or near confluent. Using<br />
a ruler on the under side of the plate, the diameter of each inhibition<br />
zone was measured in (mm).<br />
Interpretation of the zone size<br />
Using the interpretive chart, the inhibition zone around each<br />
antibiotic disc was measured and reported as sensitive, resistant or<br />
intermediate according to WHO (1996), NCCLS (1997) and Murray<br />
et al. (2007).<br />
Minimum inhibitory concentration (MIC) test<br />
The MIC test was performed to each isolate by the E-test technique<br />
as recommended by the manufacturer (HiMedia Laboratories Pvt.<br />
Limited). Briefly, each isolate was tested against the fifteen<br />
antimicrobial agents. A 200 mm Petri plate containing 90 ml of<br />
Mueller-Hinton agar (M173) was used. The inoculum was prepared<br />
as suspension in 0.85% NaCl. The suspension was adjusted to a<br />
0.5 McFarland standard. Plates were seeded with a cotton swab as<br />
described by manufacturer. The E-test strips were applied after the<br />
excess moisture had been absorbed into the agar. The plates were<br />
then incubated at 35-37�C and examined after 18-24 h.<br />
RESULTS<br />
During the course of this study (November 2008 to March<br />
2009) a total of 389 patients were recruited. 311 of these,<br />
presented with UTI, 11 with wound infection and 67 with<br />
enterocolitis. Out of the total number of urine samples<br />
collected, 163 (52.4%) showed significant bacterial<br />
growth (127 lactose fermeters (LF) and 36 non-lactose<br />
fermeters (NLF)). 10 (90.9%) of wound swabs and 61<br />
(91%) of stool specimens revealed significant growth, 4<br />
LF; 6 NLF and 61 LF 6 NLF respectively.<br />
Identification of E. sakazakii<br />
Colonial morphology<br />
Colonial morphology was observed on blood and<br />
MacConkey’s agars after overnight incubation for urine<br />
and wound specimens, and on XLD for stool. Suggestive<br />
E. sakazakii isolates produced large (3-4 mm), dull-gray,<br />
and dry or mucoid colonies on blood agar, large and pink<br />
or colorless, mucoid colonies on MacConkey ’ s agar and
Table 1. Criteria for identification E. sakazakii on API 20 E.<br />
Biochemical tests Reaction Result<br />
ONPG Yellow-pale yellow Positive<br />
ADH Red / orange Positive<br />
LDC Yellow color Negative<br />
ODC Red / orange Positive<br />
CIT Blue-green blue Positive<br />
H2S Colorless Negative<br />
URE Yellow color Negative<br />
TDA Yellow color Negative<br />
IND Colorless Negative<br />
VP Pink/ red Positive<br />
GEL Diffusion of black pigment Positive<br />
GLU Yellow color Positive<br />
MAN Yellow color Positive<br />
INO Blue/ blue-green Negative<br />
SOR Blue/ blue-green Negative<br />
RHA Yellow color Positive<br />
SAC Yellow color Positive<br />
MEL Yellow color Positive<br />
AMY Blue/ blue-green Negative<br />
ARA Yellow color Positive<br />
Table 2. Antimicrobial resistance of E.<br />
sakazakii isolates (n=6).<br />
Antibiotic Resistance (%)<br />
Chloramphenicol 66.7<br />
Ciprofloxacin 16.7<br />
Tetracycline 66.7<br />
Gentamicin 00.0<br />
Ceftazidime 100.0<br />
Amikacin 16.7<br />
Ceftriaxone 66.7<br />
Ticarcyline 83.3<br />
Nitrofuratoin 66.7<br />
Co-trimoxazole 83.3<br />
Amoxicillin 100.0<br />
Amoxyclav 100.0<br />
Nalidixic acid 16.7<br />
Cefotaxime 66.7<br />
Tobramycin 66.7<br />
pink color on XLD.<br />
API 20 E<br />
Humodi and Rania 2377<br />
The results of API 20E revealed that ONPG, ADH, ODC<br />
and CIT were positive, H2S, LDC, URE, TDA and IND<br />
were negative. VP and GEL were also positive and all<br />
sugars GLU, MAN, RHA, SAC MEL, AMY and ARA were<br />
positive except INO, SOR, AMY which were negative<br />
(Table 1).<br />
The total number of E. sakazakii isolates were 6 (1.5%)<br />
including 4 (1.03%) from urine, 1 (0.3%) from wound and<br />
1(0.3%) from stool. The results revealed that the<br />
resistance rate of E. sakazakii was (100%) to amoxicillin<br />
and amoxyclav, ceftazidime, (0%) to gentamicin, (83.3 %)<br />
to co-trimoxazole and ticarcyline, (16.7%) to<br />
ciprofloxacin, amikacin, and nalidixic acid, (66.7%) to<br />
chloramphenicol, tetracycline, nitrofuratoin, cefotaxime,<br />
ceftriaxone, and tobramycin (Table 2). The Minimum<br />
Inhibitory Concentration (MIC), MIC50 and MIC90 values<br />
respectively were (3->240, 60 and >240 µg/ml) for<br />
nitrofurantoin, (0.5->240, 4 and 4 µg/ml ) for nalidixic<br />
acid, (0.1->240, >240 and >240 µg/ml) for cotrimoxazole,<br />
(0.01->240, 4 and 4 µg/ml) for<br />
chloramphenicol, (0.1-64, 0.1 and 0.5 µg/ml) for<br />
amikacin, (0.1-30, 5 and 30 µg/ml) for gentamicin, (1-16,<br />
4 and 8 µg/ml) for tobramicin, (0.001-0.5, 0.25 and 0.5<br />
µg/ml) for ciprofloxacin, (0.1-60, 30 and 30 µg/ml) to<br />
ceftriaxone, (0.1->240, 15 and 15 µg/ml) for ceftazidime,<br />
(0.01-3, 2 and 3 µg/ml) for tetracycline, (10->240, >240<br />
and >240 µg/ml) for ticarcycline, (0.1->240, >240 and<br />
>240 µg/ml) for amoxicillin, (0.1->240, 60 and 60 µg/ml )<br />
for cefotaxime, (2->240, >240 and >240 µg/ml) for<br />
amoxyclav (Table 3).<br />
DISCUSSION<br />
This study was conducted to determine the frequency<br />
and antimicrobial resistance of E. Sakazakii. Three<br />
hundred and eleven urine specimens, eleven wound<br />
specimens, and sixty seven stool specimens were<br />
investigated. Of these, 163 (52.4 %) from urine<br />
specimens, 10 (90.9%) from wound specimens, and<br />
61(91%) from stool specimens showed significant various<br />
bacterial growth.<br />
E. sakazakii was isolated from 6(1.5%) out of 389
2378 Afr. J. Microbiol. Res.<br />
Table 3. MIC range, MIC50 and MIC90 of antimicrobial agents to E. sakazakii.<br />
Antibiotics MIC µg/ml No tested<br />
MIC range<br />
MIC µg/ml<br />
MIC50 MIC90<br />
Nitrofuratoin 6 3 to >240 60 >240<br />
Nalidixic Acid 6 0.5 to> 240 4 4<br />
Co-trimoxazole 6 0.1 to > 240 >240 >240<br />
Chloramphenicol 6 0.01 to > 240 4 4<br />
Amikacin 6 0.1 to 64 0.1 0.5<br />
Gentamicin 6 0.1 to 30 5 30<br />
Tobramicin 6 1 to >16 4 8<br />
Ciprofloxacin 6 0.001 to >0.5 0.25 0. 5<br />
Ceftriaxone 6 0.1 to > 60 30 30<br />
Ceftazidime 6 0.1 to > 240 15 15<br />
Tetracycline 6 0.01 to 3 2 3<br />
Ticarcyline 6 10 to > 240 >240 >240<br />
Amoxycillin 6 0.1 to > 240 >240 >240<br />
Cefotazime 6 0.1 to > 240 60 60<br />
Amoxyclav 6 2 to > 240 >240 >240<br />
MIC; Minimum inhibitory concentration.<br />
patients (urine, wound and stool). The isolates showed<br />
large, dull-gray, and dry or mucoid colonies on blood agar<br />
and large, pink, mucoid colonies on MacConkey's agar.<br />
These results were comparable to those described by<br />
Erickson and Kornacki (2002) and Engelkirk and Duben-<br />
Engelkirk (2007). The frequency 6 (1.5%) of E. sakazakii<br />
in three types of infections (UTI, Enterocolitis, Wound<br />
infection) is similar to the results obtained by Paterso et<br />
al. (2005), who reported that E. sakazakii was responsible<br />
for (0.4%) of the three types of infection in five<br />
international regions including Asia, Europe, Latin<br />
America, North America, and Middle East.<br />
In vitro activities of antimicrobial agents indicated that<br />
the resistance rate of E. sakazakii to amoxicillin and<br />
ceftazidime were (100%). This result is consistent with<br />
Farajnia et al. (2009) who found that the resistance rate<br />
of E. sakazakii to amoxicillin was (100%) in Iran but<br />
different from those of Sader et al. (2005) who found the<br />
resistance rate to ceftazidime was (17.5%) in United<br />
States. The resistance rate of E. sakazakii to nitrofuratoin<br />
(66.7%), however is widely different from those of<br />
Farajnia et al. (2009) who reported a 37.5% resistance<br />
rate to nitrofuratoin in Iran.<br />
The efficacy of cefotaxime, tobramycin, gentamicin and<br />
ciprofloxacin were evaluated and the result showed the<br />
resistance rates of E. Sakazakii to these antibiotics was<br />
(66.7%), (66.7%), (0%) and (16.7%) respectively. This<br />
differs from results obtained by Pfaller and Jones (2002),<br />
who reported that the resistance rate to cefotaxime,<br />
tobramycin and gentamicin is (23%), (16%) and (11%)<br />
respectively but similar to ciprofloxacin (16%) in<br />
European countries. However, the results indicated that<br />
resistance to nalidixic acid (16.7%) was different<br />
compared to that of Farajnia et al. (2009) who reported a<br />
resistance rate of 0.0 % to this antibiotic. Similarly the<br />
resistance rate to amikacin in this investigation is quite<br />
different from (0.0%) resistance rate reported by Farajnia<br />
et al. (2009).<br />
On the other hand, this study showed that the MIC50<br />
and MIC90 of amikacin, ciprofloxacin, tobramycin, and<br />
gentamicin were in agreement with Pfaller and Jones<br />
(2002).<br />
It is concluded that resistance rate of E. sakazakii is<br />
high to commonly used antimicrobial agents. It is also<br />
concluded that gentamicin is the first choice for treatment<br />
of E. sakazakii infections. Ciprofloxacin, amikacin, and<br />
nalidixic acid are the second choice of antimicrobial<br />
therapy with resistance rate of (16.7%). Nitrofurantoin,
tetracycline, ceftriaxone, cephotaxime, chloramphenicol,<br />
and tobramycin on the other hand are less effective<br />
antimicrobial agents due to their high resistance rate<br />
(66.7 %). Amoxicillin, amoxyclav, and ceftazidime are not<br />
effective, having a resistance rate of 100 %. However;<br />
further future studies including larger sample sizes are<br />
recommended, and to our knowledge this report<br />
represents the first record of E. sakazakii in the Sudan.<br />
ACKNOWLEDGEMENT<br />
The authors are grateful to Prof. A. Rahim M. El Husien<br />
for manuscript review.<br />
REFERENCES<br />
Barrow GI, Feltham RKA (2003). Cowan and Steel's Manual for the<br />
Identification of Medical Bacteria: 3 rd edition; Cambridge University<br />
Press, p. 352. ISBN: 0521543282.<br />
Beuchat LR, Kim H, Gurtler JB, Lin L, Ryu J, Richards GM (2009).<br />
Cronobacter sakazakii in foods and factors affecting its survival,<br />
growth, and inactivation, Int. J. Food. Microbiol., 2: 570-749.<br />
Bhat G, Anandhi RS, Dhanya VC, Shenot MS (2009). Urinary tract<br />
infection due to Enterobacter sakazakii. India J. Pathol. Microbiol.<br />
52(3): 430-431. DOI: 10.4103/0377-4929.55017.<br />
Conte F, Passantino A (2008). Isolation of E. sakazakii from ass’ milk in<br />
Sicily: Case report, safety and legal issues, 2 nd Int Conference. J.<br />
Travel Med. Infect. Dis., 6(4): 250-252.<br />
Engelkirk PG, Duben-Engelkirk J (2007). Laboratory Diagnosis of<br />
Infectious Disease: Essentials of Diagnostic Microbiology, Edition<br />
illustrated, Lippincott Williams and Wilkins, Philadelphia, USA. Ch,<br />
12: 307-308.<br />
Erickson MC, Kornacki JL (2002). Enterobacter sakazakii: an emerging<br />
food pathogen, J. Center. Food Safety, pp. 2-8.<br />
Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhband A (2009).<br />
Causitive agents and antimicrobial susceptibilities of urinary tract<br />
infections in the northwest of Iran, Int. J. Infect. Dis., 13(2): 140-144.<br />
Fiore A, Casale M, Aureli P (2008). Enterobacter sakazakii:<br />
epidemiology, clinical presentation, prevention and control. Ann Ist<br />
Super Sanità, 44(3): 275-280.<br />
Humodi and Rania 2379<br />
Guptta V, Yadav A, Joshi RM (2003). Antibiotics Resistance Pattern in<br />
uropathogen Indian. J. Med. Microbial., 20: 96-98.<br />
Hamilton JV, Lehane J, Braig HR (2003). Isolation of Enterobacter<br />
sakazakii from midgut of stomoxys calcitrans, J. Emerg. Infect. Dis.,<br />
9(10): 1355-1356.<br />
Kim JB, Cho Seund-Hak JC, Park YB, lee JB, lec Kim JC, Lee BK<br />
(2008). Surveillance of stool samples for the presence of E. sakazakii<br />
among Korean people, Yonsei Med. J., 49(6): 1017-1022.<br />
Kim TJ, Silva JL, Weng WL, Chen WW, Corbitt M, Jung YS, Chen YS<br />
(2009). Inactivation of E. sakazakii by water-soluble muscadine seed<br />
extracts, Int. J. Food. Microbiol., 129(3): 295-299.<br />
MacLean LL, Pagotto F, Farber JM, Perry MB (2009). The structure of<br />
the O-antigen in the endotoxin of the emerging food pathogen<br />
Cronobacter (Enterobacter) muytjensii strain 3270, J. Carbohydrate<br />
Res., 344(5): 667-671.<br />
Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (2007).<br />
Manual of Clinical Microbiology. 9th ed. Washington DC: ASM Press,<br />
2007.<br />
NCCLS (1997). Performance standards for Antimicrobial disk<br />
Susceptibility tests. Six edition. ISBN 1 56238 306 6. Available from<br />
NCCLS. 940 West Valley Road. Suit 1400. Wayne. PA 19087-1898,<br />
USA.<br />
Ongrádi J (2002). Vaginal infection by Enterobacter sakazakii. Sex<br />
Transm Infect., 78: 467.<br />
Paterso DL, Rsossi F, Baquero F, Hsueh P, Woods GL, Satishchandran<br />
V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW (2005).<br />
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli<br />
isolate from patients with intra-abdominal infection world wide with<br />
2003 Study for Monitoring Antimicrobial Resistance Trends (SMART),<br />
J. Antimicrob. Chemother., 33(6): 965-973.<br />
Pfaller MA, Jones RN (2002). MYSTIC Study Group (Europe)<br />
Antimicrobial susceptibility of inducible Ampc B-lactamase-producing<br />
Enterobacteriaceae from the Meropenem Yearly Susceptibility Test<br />
Information Collection (MYSTIC) Programme Europe 1997-2000, Int .<br />
J. Antimicrob. Agents, 19(5): 383-388.<br />
Sader HS, Fritsche TR, Jones RN (2005). Potency and spectrum trends<br />
for cefepime tested against 65746 clinical bacterial Isolates Collected<br />
in North American Medical Centers: Results from the SENTRY<br />
Antimicrobial Surveillance Program (1998-2003), J. Diagnostic<br />
Microbiol. Infect. Dis., 52(3): 265-273.<br />
WHO (1996). Guideline for antimicrobial resistance Surveillance, ISBN<br />
92 9021 2136. Available from WHO Regional Office for the Eastern<br />
Mediterranean. PO Box 151. Alexandria 21511. Egypt.
African Journal of Microbiology Research Vol. 5(16), pp. 2380-2384, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR09.462<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Full Length Research Paper<br />
In search of enteroviruses in water media in Marrakech<br />
Amina Hssaine 1 , Jawhar Gharbi 2 , Rafik Harrath 2 , Rajae Harrak 3 , Abderrahman Chait 4 ,<br />
Mahjoub Aouni 2 and Jamal Hafid 1 *<br />
1 Equipe Immuno-Parasitologie et Physiologie, Laboratoire Aliments, Environnement et Santé,<br />
Faculté des Sciences et Techniques, Gueliz, Marrakech, Morocco.<br />
2 Laboratoire des maladies transmissibles et substances biologiquement actives (MDT-01), Faculté de Pharmacie,<br />
5000 Monastir, Tunisie.<br />
3 Laboratoire régional du diagnostic épidémiologique et de l’hygiène du Milieu, Marrakech Morocco.<br />
4 Laboratoire d’Ecophysiologie, Faculté des Sciences Semlalia, Marrakech, Morocco.<br />
Accepted 7 April, 2010<br />
Enteroviruses are among the most common viruses infecting the human intestine; they are very<br />
widespread in nature and resistant to external agents. They are eliminated in the faeces and<br />
contaminate water and food. These viruses cause various clinical syndromes and constitute a big<br />
public health problem. The aim of our study was to search for enteroviruses in the water samples. For<br />
this, a total of 225 L of tap water coming from the national network office for drinking water (ONEP) and<br />
18 samples of waste water originating from Marrakech city were studied. These samples were<br />
concentrated, treated with polyethylene glycol 6000 and then analyzed by RT-PCR. Only two samples<br />
were found to be positive for enteroviruses by RT-PCR among the 18 waste water samples analyzed,<br />
which gave a rate of 11.11%. On the other hand, no positive samples were found in the tap water. This<br />
study made it possible on the one hand to apply for the first time RT-PCR for the detection of<br />
enteroviruses in water samples originating from Marrakech city, and on the other hand to show that tap<br />
water of this city does not present any risk of contamination by this type of germ.<br />
Key words: Drinking water, waste water, enterovirus, RT-PCR, Marrakech.<br />
INTRODUCTION<br />
Water is essential to life, its availability in quantity and<br />
quality sufficient to meet basic needs is essential both for<br />
improving health and for sustainable development.<br />
Combating and reducing diseases linked to water is one<br />
of the important and urgent tasks which can be achieved<br />
only through enhanced cooperation at all levels.<br />
Enteric viruses can be present naturally in aquatic<br />
environments. These viruses can be transported into the<br />
environment through groundwater, estuaries, sea water,<br />
rivers, aerosols, sewage, inadequately treated water,<br />
drinking water, wells etc. (Fong and Lipp, 2005). The risk<br />
of infection by enteroviruses in water is 10 to 10,000<br />
times greater than bacterial infections (Bosch, 1998).<br />
Enteroviruses were isolated from environmental<br />
samples for more than 60 years (Paul and Trask, 1941)<br />
and have subsequently been widely studied and qualified<br />
*Corresponding author. E-mail: hfjamal@yahoo.fr.<br />
as a real threat to the quality of drinking water. The<br />
contamination rate allowed was set by the World Health<br />
Organization to be 3.2 x 10 -5 particles per litre (WHO,<br />
2006).<br />
Viruses excreted in faeces are found in sewage, the<br />
viral concentration of waste water is variable depending<br />
on many factors, geographic, socio-economic, seasonal<br />
and especially health. Thus, the higher the proportion of<br />
children in a community, the lower the level of hygiene<br />
and the higher the quantity of virus found in waste water.<br />
Enteroviruses are transmitted by the faecal-oral route,<br />
their effects may exceed gastroenteritis, because they<br />
pass from the intestinal tract to other organs. The enteric<br />
virus infections are primarily associated with diarrhoea in<br />
humans (Kocwa-Haluch, 2001). Thus, in the United<br />
States, cases of acute gastroenteritis recorded exceeded<br />
50% of all waterborne diseases from 1946 until 1980<br />
(Lippy and Waltrip, 1984) and, viruses were identified as<br />
the cause of 12% of the cases registered during this<br />
period.
In Morocco, few studies have been devoted to sources of<br />
contamination of people by enteroviruses, which is why in<br />
the present work we focused on assessing the virological<br />
quality of water intended for public consumption as well<br />
as surface waste in the region of Marrakech. The aim of<br />
this study was to search for enteroviruses, by RT-PCR, in<br />
225 L of tap water coming from the national network<br />
office for drinking water (ONEP) and in 18 samples of<br />
waste water originating from Marrakech city.<br />
MATERIALS AND METHODS<br />
Samples<br />
Water faucet<br />
Samples were taken directly from the tap (Régie autonome de<br />
distribution d'eau et d'électricité de Marrakech: RADEEMA). 15<br />
samples were taken during the months of July, September and<br />
August 2007 and October 2008 making a total volume of 225 L.<br />
Wastewater<br />
Samples were taken from the waste water treatment plant of<br />
Marrakech. Eighteen samples of 250 ml were taken, in June, July<br />
and October 2008, in clean glass containers. Eleven were taken<br />
from the raw water at the entrance to the station and seven from<br />
the treated waste water as it exited. These samples were taken to<br />
the Environment, Food and Health Laboratory of Marrakech for<br />
extraction and concentration of the virus. The last pellets after<br />
concentration were kept at -20°C for analysis by RT-PCR in the<br />
Diseases and Biologically Active Substances Laboratory of<br />
Monastir, Tunisia.<br />
Water wells<br />
During the months of June and July 2007, eight samples of one litre<br />
each were collected in eight wells located within a 2 km radius<br />
around the Oued Tensift located 6.3 km north of the city of<br />
Marrakech at 410 m altitude. The wells were located in clusters of<br />
habitats near Oued Tensift. This water is used by the people both<br />
for drinking and for the preparation of food without any treatment.<br />
These villages are not served by the national drinking water<br />
system.<br />
Sample processing<br />
Concentration of enteroviruses<br />
The concentration of virus in samples of tap water and wells has<br />
been done by filtration through membranes of sterile cellulose<br />
nitrate with porosity of 0.22 microns. The filtration device was<br />
connected to a vacuum pump. Each filter is then placed in a moist<br />
chamber and stored at 4°C (Wallis et al., 1972).<br />
Elution<br />
Each filter was cut into very fine pieces separately and put in 20 ml<br />
of a solution of meat extract pH 9.5 and centrifuged at 10, 000<br />
rounds/min for 35 min. The float was recovered and its pH adjusted<br />
to 7.2 with 5M HCl. One milliliter of the mixture of antibiotics and<br />
Hssaine et al. 2381<br />
antifungal (penicillin, streptomycin and fungizone) was added and<br />
the final mixture was placed at 4°C overnight and stored at -20°C.<br />
Extraction and concentration from waste water<br />
We adapted the protocol described by Gerba et al. (1979), based<br />
on the adsorption of virus to acidic pH and elution at basic pH.<br />
Thus, 100 ml of sample were homogenized by magnetic stirring. A<br />
solution of AlCl3 was added until a final concentration of 0.0005 M<br />
and the pH was adjusted to 3.5 with 5N HCl. The mixture was<br />
stirred vigorously for 30 min then centrifuged at 2500 g for 15 min at<br />
4°C and the pellet was taken in 100 ml of 10% beef extract of at pH<br />
9. The mixture was stirred for 30 min and centrifuged at 10 000 g<br />
for 30 min at 4°C and the supernatant was collected in a sterile<br />
container. PEG 6000 was added until a final concentration of 10%<br />
and the mixture was homogenized and incubated overnight at 4°C.<br />
The next day, after a centrifugation step at 10 000 g for 45 min at<br />
4°C, the pellet was resuspended in 10 ml phosphate buffer pH 7.2<br />
and kept at -20°C.<br />
Extraction of viral RNA<br />
A volume of 120 µl of each sample was put in 500 l of Tri-reagent<br />
(Sigma) and vortexed for 15 s and left in contact 5 min at room<br />
temperature. Then, 200 l of chloroform were added to the mixture<br />
to separate the nucleic acids of proteins to which they are<br />
associated. The mixture was vortexed, left to react at room<br />
temperature for 15 min and then centrifuged at 13 500 rpm for 15<br />
min at 4°C. The aqueous phase was transferred to a new tube, and<br />
mixed with 500 l of isopropanol. The mixture was allowed to react<br />
for 15 min at -20°C and then centrifuged at 13500 rounds/min for 10<br />
min at 4°C to remove the cell debris. The pellet underwent two<br />
successive washes with 75% ethanol followed by centrifugation at<br />
7500 rounds/min at 4°C for 15 min for the first wash and 5 min for<br />
the second. The pellet was left to dry at room temperature for 15<br />
min. To standardize the RNA in the solution, the pellet was put in<br />
30 l of Diethylpyrocarbonate treated water.<br />
Detection of the viral genome<br />
We used RT-PCR, a method considered sensitive in the detection<br />
of enteroviruses in both environmental and clinical samples (Zoll et<br />
al., 1992; Rutjeset al., 2005; Soule et al., 2000) using reverse<br />
transcriptase (Moloney-Murine Leukemia Virus) and two primers<br />
from the conserved non-coding region of the viral genome. The<br />
product of amplification gives a 154 bp band.<br />
Choice of primers: In the case of enteroviruses, a sequence which<br />
is stable and common to all serotypes must be identified. Thus,<br />
several sequences have been described by Zoll et al. (1992). The<br />
primers used in this work are positioned at 445 - 464 and 599 - 580<br />
on the genome of Coxackievirus B3 and their nucleotide sequences<br />
are 5 'TCCTCCGGCCCCTGAATGCG 3' and 3<br />
'ATTGTCACCATAAGCAGCCA 5' (Invitrogen), respectively.<br />
Preparation of complementary DNA (cDNA): For the preparation<br />
of cDNA, we mixed 2.5 l of of reverse transcriptase buffer<br />
(Promega), 1 l of dithiothreitol (Promega), 0.5 l of NTPS<br />
(Boehring Mannheim), 0.5 l of antisense primer (25 pmole) and<br />
0.5 l of the enzyme reverse transcriptase (Promega). To this<br />
mixture, we added 5 l of extracted RNA and incubated for 30 min<br />
at 42°C and then amplified.
2382 Afr. J. Microbiol. Res.<br />
Table 1. Presence of enteroviruses in waste water<br />
samples of Marrakech.<br />
Samples Date Results<br />
RW1<br />
-<br />
02/06/2008<br />
TW1 -<br />
RW 2<br />
-<br />
18/06/2008<br />
TW2 -<br />
RW 3<br />
-<br />
20/06/2008<br />
TW3 -<br />
RW 4<br />
-<br />
25/06/2008<br />
TW4 -<br />
RW 5<br />
-<br />
27/06/2008<br />
TW5 -<br />
RW 6<br />
01/07/2008<br />
RW 7<br />
-<br />
02/07/2008<br />
TW7 -<br />
RW 8<br />
07/07/2008<br />
RW 9<br />
+<br />
08/07/2008<br />
TW9 -<br />
RW 10<br />
RW 11<br />
25/10/2008<br />
26/10/2008<br />
RW: Raw water; TW: Treated water.<br />
Amplification: The amplification mixture consisted of 2.5 l Taq<br />
polymerase buffer, 0.5 l of NTPs: dATP, dCTP, dGTP and dTTP,<br />
0.5 l antisense primer (25pmole), 0.5 l of sense primer 25 pmole:<br />
oligo (dt) 12 - 18 (pharmacia Biotech), 0.15 l of Taq polymerase<br />
1.25 l (Invitrogen), 0.75 l of MgCl2 and 18 l of sterile doubledistilled<br />
water.<br />
The positive control (RNA Coxackievirus Nancy B) and negative<br />
control (sterile distilled water) were treated in the same conditions<br />
as the samples studied. The amplification was performed in an<br />
Eppendorf thermal cycler with a denaturing RNA-cDNA for 5 min at<br />
94°C and a series of thirty cycles of the following: 30 s at 94°C,<br />
hybridization of primers for a minute at 42°C, elongation 2 min at<br />
72°C and an extension of 10 min at 72°C, the final stretch.<br />
Revelation: After amplification, electrophoretic migration of the<br />
PCR product was performed on 2% agarose gel. Ten milliliters of<br />
each sample of PCR product mixed with 5 l of migration blue were<br />
deposited on the gel. Migration was done in TBE buffer (1x) at 90 V<br />
and lasted for approximately 45 min. The gel was then soaked in<br />
a solution of ethidium bromide (Sigma) at 10 mg/ml. Visualization of<br />
the specific band was conducted by transillumination under<br />
ultraviolet light (UV) against a size marker of 100 bp (Pharmacia<br />
Biotech).<br />
-<br />
+<br />
-<br />
-<br />
RESULTS AND DISCUSSION<br />
During the study, a total of 41 samples were collected<br />
including 18 samples of waste water during the months of<br />
May, June, July and October 2008, 15 samples of tap<br />
water during the months of July, September and August<br />
2007 and October 2008 and 8 samples of water wells<br />
during the months of June and July 2007.<br />
Using RT-PCR enabled the detection of enterovirus<br />
RNA in 2 samples of waste water; this gives a rate of<br />
11.1% (2/18). These two positive samples were collected<br />
in July, known as the driest month of the year 2008 in the<br />
city of Marrakech. However, no positive result was<br />
obtained in the treated waste water, tap water or water<br />
wells (Table 1 and Figure 1).<br />
We have little data on the detection of enteroviruses in<br />
the environment in Morocco because there are few<br />
studies that have been done. This allows us to emphasize<br />
that our present work is original. Our results are<br />
compared to those recorded by researchers in other<br />
countries.<br />
Several studies have shown that the increase in<br />
enteroviruses is seasonal Summer-Fall (Troudi et al.,<br />
1997), while other studies claim that the rainy season is<br />
the perfect time when the frequency of enterovirus<br />
reaches its peak (Bini et al., 2006). A more prolonged<br />
follow-up of our study throughout the year can confirm<br />
either study. We also noted that no positive sample of<br />
treated waste water coming out of the treatment plant has<br />
been detected. This can be explained by the fact that<br />
much of the suspended matter is removed during the<br />
treatment; where the viruses are adsorbed on this<br />
material under the influence of physical surface<br />
properties. Some authors argue that the setting of virus<br />
particles suspended in the water environment is linked<br />
not only to the species and serotype but also to the strain<br />
itself (Nestor and Brisou, 1986). For more sensitivity, it<br />
will be interesting to use nested-PCR for low levels of<br />
enteroviruses (Lee and Lee, 2008; Zhang et al., 2008).<br />
Indeed, RT-PCR is a sensitive technique but is influenced<br />
by the presence of inhibitors which are rich environmental<br />
samples (Sdiri et al., 2006), a factor that limits its<br />
effectiveness. However, many precautions must be taken<br />
both in the implementation of the RT-PCR (including<br />
choosing the method of virus concentration and<br />
extraction technique of RNA). Thus the large amount of<br />
genetic material from environmental samples makes<br />
possible a non-specific amplification of sequences unrelated<br />
to the virus searched.<br />
Regarding the tap water, 225 L of water were analyzed<br />
without any positive result. This could be explained bythe<br />
efficiency of the water decontaminating treatment<br />
process by the treatment plant. Our results are consistent<br />
with those found in Korea (Kyung and Jeong, 2004) where<br />
no enterovirus was detected in treated water for<br />
consumption. However they are different from the study<br />
of Coin (1966) which was the first to have isolated viruses<br />
in water intended for consumption in Paris, and those of
(-) PM 1 2 3 4 (+) PM<br />
Hssaine et al. 2383<br />
154bp<br />
Figure 1. Results of electrophoresis of amplification products by RT-PCR of gene 5'NC<br />
enteroviruses from samples of waste water.<br />
(-): negative control; (+): positive control (Coxackievirus B Nancy); 1, 4: positive samples; 2,<br />
3: negative samples; PM: Size Marker 100 bp.<br />
other studies that were conducted in Romagne (France)<br />
(Nestor and Costin, 1976) and Russia (Rabshko, 1974).<br />
The authors had explained the presence of the virus by<br />
inadequate treatment which did not allow effective<br />
disinfection. In addition, other studies have shown high<br />
contamination of drinking water by enteroviruses in Korea<br />
(Lee and Kim, 2002), South Africa (Ehlers et al., 2005)<br />
and Egypt (Ali et al., 2004) with positivity rates of 47.8,<br />
18.7% and 17.5 PFU/L respectively. These high rates<br />
have been explained by the insufficiency of the treatment<br />
used and the possible contamination of water pipes.<br />
As the methods used in environmental virology are<br />
limited by the low concentration of virus in drinking water,<br />
the techniques of adsorption/elution using electropositive<br />
filters or electronegative methods are most recommended<br />
by APHA (1985) and Karim et al. (2009). Nevertheless,<br />
our study has demonstrated the effectiveness of<br />
the treatment technologies for water consumption, the<br />
technique used and the volume of samples analyzed to<br />
meet international quality standards (EPA, 1999b).<br />
Regarding groundwater, we have made samples in 8<br />
wells and none was found to be positive. These wells<br />
which are not deep (between 6 and 10 m) are located<br />
near agricultural fields irrigated with waste water. Study<br />
should be conducted using wider areas and larger<br />
volumes of water. In other studies, conducted between<br />
1971 and 1982, groundwater accounted for 51% of<br />
waterborne diseases (Craun, 1986). Hepatitis viruses and<br />
rotaviruses are considered the main causes of these<br />
diseases (Gerba et al., 1985). These infections are<br />
mainly due to infiltration of waste water through the pits<br />
as well as due to the spread of waste water and sewage<br />
sludge, domestic discharge, oxidation ponds etc<br />
(Borchardt et al., 2007). With their small size, viruses are<br />
able to travel hundreds of meters through soil to reach<br />
groundwater (Gerba and Bitton, 1984) this movement<br />
depends mainly on the type of virus, the type of soil and<br />
climate.<br />
The present work allowed us to detect for the first time,<br />
enteroviruses in waste water of the region of Marrakech.<br />
This encourages us to continue the search for these<br />
viruses in a larger number of water and human biological<br />
samples.<br />
REFERENCES<br />
Ali MA, Al-Herrawy AZ, El-Hawaary SE (2004). Detection of enteric<br />
viruses, Giardia and Cryptosporidium in two different types of drinking<br />
water treatment facilities. Water Res., 38: 3931-3939.<br />
American Public Health Association (APHA) (1985). Standard Methods<br />
for the examination of water and wastewater, 16 th ed. Washington,<br />
D.C.<br />
Bini JC, Ekaza E, Gnagne T, Borget AMY, Veh KA, Akran AV, Coulibaly<br />
ND, Faye-Kette H, Sess ED, Dosso M (2006). Apport de la RT-PCR<br />
pour la détection des entérovirus dans les eaux usées à Abidjan<br />
(Côte d’ivoire). Cah. Santé Publique, 5: 55-65.<br />
Borchardt MA, Bradbury KR, Gotkowitz MB, Cherry JA, Parker BL<br />
(2007). Human enteric viruses in groundwater from a confined<br />
bedrock aquifer. Environ. Sci. Technol., 15: 6606-6612.<br />
Bosch A (1998). Human enteric viruses in the water environment: a<br />
minireview. Microbiol., 1: 191-196.<br />
Coin L (1966). Modern microbioligical and virological aspects of water<br />
pollution. In Jaag, O (eds) Advances in water Pollution Research,<br />
Pergamon Pres, London, pp. 1-10.<br />
Craun GF (1986). ed. Waterborne diseases in the United States. Boca<br />
Raton: CRC Press, p.13.<br />
Ehlers MM, Grabow WOK, Pavlov DN (2005). Detection of<br />
enteroviruses in untreated and treated drinking water supplies in<br />
South Africa. Water Res., 39: 2253-2258.<br />
EPA (1999b). Drinking water criteria document for enteroviruses and<br />
hepatitis a: an addendum, p. 173.<br />
Fong TT, Lipp EK (2005). Enteric Viruses of Humans and Animals in<br />
Aquatic Environments: Health Risks, Detection, and Potential Water<br />
Quality Assessment Tools. Microbiol. Mol. Biol. R, 69: 357-371.<br />
Gerba CP, Bitton G (1984). Microbial pollutants: their survival and
2384 Afr. J. Microbiol. Res.<br />
transport pattern to groundwater. In Bitton G, Gerba CP (eds)<br />
Groundwater pollution microbiology. Wiley, New York, pp. 39-54.<br />
Gerba CP, Goyal SM, Labelle RL, Cech I, Bodgan GF (1979). Failure of<br />
indicatorbacteria to reflect the occurrence of enteroviruses in marine<br />
water. A. J. Pub. Health, 69: 1116-1119.<br />
Gerba CP, Sing SN, Rose JB (1985). Waterborne viral gastroenteritis<br />
and hepatitis. CRC Crit. Rev. Environ. Contr., 15: 213-216.<br />
Karim M, Rhodes E, Brinkman N, Wymer L, Fout GA (2009). New<br />
Electropositive Filter for Concentrating Enterovirus and Norovirus<br />
from Large Volumes of Water. Appl. Environ. Microbiol., 75: 2393-<br />
2399.<br />
Kocwa-Haluch R (2001). Waterborne Enteroviruses as a Hazard for<br />
Human. Pol. J. Environ. Stud., 10: 485-487.<br />
Kyung Lee H, Jeong YS (2004). Comparison of Total Culturable Virus<br />
Assay and Multiplex Integrated Cell Culture-PCR for Reliability of<br />
Waterborne Virus Detection. Appl. Environ. Microbiol., 70: 3632-<br />
3636.<br />
Lee G, Lee C (2008). Molecular detection and characterization of<br />
human enteroviruses in Korean surface water. J. Microbiol., 46: 319-<br />
324.<br />
Lee S, Kim S (2002). Detection of infectious enteroviruses and<br />
adenoviruses in tap water in urban areas in Korea. Water Res., 36:<br />
248-256.<br />
Lippy EC, Waltrip SC (1984). Waterborne disease outbreaks-1946-<br />
1980: a thirty-five –year perspective. J. Am. Water Works Assn, 76:<br />
60-67.<br />
Nestor I, Costin L (1976). Presence of certain enteroviruses (coxsakie )<br />
in sewage effluents and river waters of Romania. J. Hyg. Epidemiol.<br />
Microbiol. Immunol., 21: 137-149.<br />
Nestor J, Brisou J (1986). Incidence sanitaires de l’adsorption sur les<br />
sédiments marins et fluviaux. Rev. Epidemiol. Sante Publique, 34:<br />
181-190.<br />
Paul JR, Trask JD (1941). The virus of poliomyelitis in stools and<br />
sewage. J. Am. Med. Ass., 116: 493-498.<br />
Rabshko EV (1974). Certain problems of circulation of enteroviruses in<br />
the environemental objects. Gig. Sanit. 39: 105-106.<br />
Rutjes SA, Italiaander R, van den Berg HHJL, Lodder WJ, de Roda<br />
Husman AM (2005). Isolation and Detection of Enterovirus RNA from<br />
Large-Volume Water Samples by Using the NucliSens miniMAG<br />
System and Real-Time Nucleic Acid Sequence-Based Amplification.<br />
Appl. Environ. Microbiol., 71: 3734-3740.<br />
Sdiri K, Khelifi H, Belghith K, Aouni M (2006). Comparaison de la<br />
culture cellulaire et de la RT–PCR pour la détection des entérovirus<br />
dans les eaux usées et les coquillages en Tunisie. Pathol. Biol.,<br />
54: 280-284.<br />
Soule H, Genoulaz O, Gratacap-Cavallier B, Chevallier P, Liu J,<br />
Seigneurin J (2000). Ultrafiltration and reverse transcriptionpolymerase<br />
chain reaction: an efficient process for poliovirus,<br />
rotavirus and hepatitis A virus detection in water. Water. Res., 34:<br />
1063-1067.<br />
Troudi M, Aouni M, Poozzetto B, Dhidah M (1997). Surveillance de la<br />
circulation des entérovirus dans la région du Sahel. Tunis Med., 75:<br />
23-26.<br />
Wallis C, Henderson M, Melnick J (1972). Enterovirus concentration on<br />
cellulose membranes. Appl. Environ. Microbiol., 19: 476-480.<br />
World Health Organization (2006). Guidelines for Drinking-water<br />
Quality. First Addendum To Third Edition Recommendations. – 3rd<br />
ed. 1: 121-144c.<br />
Zhang CM, Wang XC, Liu YJ, Xue XP (2008). Characteristics of<br />
bacterial and viral contamination of urban waters: a case study in<br />
Xi'an, China. Water Sci. Technol., 58: 653-560.<br />
Zoll GJ, Melchers WJG, Kopecka H, Jambroes G, van der Poel HJ,<br />
Galama JM (1992). General primer-mediated polymerase chain<br />
reaction for detection of enteroviruses: application for diagnostic<br />
routine and persistant infections. J. Clin. Microbiol., 30: 160-165.
African Journal of Microbiology Research Vol. 5(16), pp. 2385-2387, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR09.389<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Short Communication<br />
Laboratory analysis of a fatal meningococcal case due<br />
to serogroup B Neisseria meningitidis belonging to ST-<br />
4821 complex<br />
Zengguo Wang*, Tiejun Hou, Zhijun Chen, Jinsong Li, Shouzhi Wu, Xiaoguang Wei,<br />
Yahui Sun and Quanli Du<br />
Xi’an Center for Disease Control and Prevention, 599 Xi Ying Road, Xi’an, 710054, PR China.<br />
Accepted 12 November, 2009<br />
We describle a suspicious Meningococcal death case, confirmating by the laboratory PCR methods.<br />
The infection developed rapidly within only 24 h until the patient died. Analyzing the close contact strain<br />
and the DNA template extracted from the serum of this patient, we characterized a serogroup B<br />
Neisseria meningitidis as the pathogen of this case, which, in terms of sequence typing, belonged to<br />
ST-4821 complex which first characterized in serogroup C Neisseria meningitidis as a new unique<br />
hypervirulent meningococcal lineages.<br />
Key words: Neisseria meningitidis, multilocus sequence typing, serogroup.<br />
INTRODUCTION<br />
As a major bacterial meningititis pathogen, Neisseria<br />
meningitidis could cause a rapidly progressive and often<br />
fatal illness mainly in children and young adults all over<br />
the world. 13 serogroups were known of this organism<br />
based on the chemical and serological properties of the<br />
capsular polysaccharide. Serogroup A meningococci<br />
were the main cause of meningitis and responsibled for<br />
several nationwide epidemics during the last century in<br />
China (Hu, 1991). After the mass vaccination campaign<br />
with mainly the MenA vaccine initiated in 1982, the<br />
incidence of meningococcal disease rapidly declined and<br />
only some sporadic case reported. However, several<br />
outbreaks caused by serogroup C, ST -4821 meningococci<br />
occurred in Anhui province in 2003 and then spread<br />
to other provinces (Shao et al., 2006). To control this<br />
disease, a mass vaccination using polysaccharide<br />
vaccine for serogroup A plus C were undertaken in<br />
several provinces and the A plus C vaccine was used<br />
more prevalent than before in China.<br />
An etiologic diagnosis of N. meningitidis is confirmed by<br />
the isolation of strain from cerebrospinal fluid, blood or<br />
other body fluids. However, this diagnosis was hindered<br />
*Corresponding author. E-mail: upwilly@gmail.com. Tel: 86-10-<br />
8551-2367.<br />
by the failure to isolate bacteria because of the early<br />
treatment of the patient (Cartwright et al., 1992). So the<br />
PCR-based methods have been extensively used for the<br />
diagnosis and also the serotying based on several genes<br />
special for Neisseria meningitidis or the serotype. In this<br />
study, we confirmed a suspicious death case of meningococci<br />
infection with laboratory methods such as PCR<br />
(multiplex-PCR) (Jordens et al., 2002), MLST (Maiden et<br />
al., 1998). We also found the etiologic serogroup B<br />
meningococci belonging to the ST-4821 complex which<br />
was a newly identified lineage that most prevalent in<br />
serogroup C meningococci in China (Zhang et al., 2007).<br />
CASE REPORT<br />
A 16 years old female student was characterized by a<br />
high fever and headache without other symptoms like<br />
cough, diarrhea, vomit, which began on March 11, 2009.<br />
The body temperature was 39.4°C. The symptom was<br />
exacerbated when the patient was checked in LanTian<br />
Hosiptal next day at 7:30 am. Several petechiate rashes<br />
emerged on the whole body with the blood pressure was<br />
118/68 mmHg and pulse rate of 132 per minute. The<br />
numbers of white cell in the blood were 1.6 × 1010/L. The<br />
patient receiving azithromycin, and within drug administration,<br />
the patient had nausea several times. After the
2386 Afr. J. Microbiol. Res.<br />
drug administration, the body temperature was normal<br />
but also with the headache. Then the patient was<br />
transferred to Tang Du Hospital at 10:50 am, the body<br />
temperature was 36°C and the blood pressure was 84/65<br />
mm Hg with pulse rate of 116 per minute. Neck stiffness<br />
and purpura fulminans were noted during clinical examination.<br />
The blood and CSF samples were obtained and<br />
submitted for laboratory examination. Laboratory investigations<br />
revealed thrombocytopenia, the TP, ALB and<br />
GLO were all decreased, the blood culture was negative<br />
for any bacterial. The patient was initially sta-bilized with<br />
volume resuscitation, dopamine infusion, until 13:30, the<br />
patient was shortness of breath and dysphoria again, and<br />
died of acidemia at 14:35. In accordance with the<br />
observed clinical symptoms, this case was diagnosed as<br />
suspicious meningococcal meningitis. The serum of the<br />
patient was transferred to Xi’an CDC laboratory for<br />
detection via PCR and MLST.<br />
The close contact in this case was defined as 5<br />
roomates with the patient. Within the 5 roommates’<br />
oropharyngeal swabs, the ctrA gene was positive in two<br />
samples and 1 strain was isolated. The ctrA gene was<br />
also positive in the patient’s serum. To check the serotype<br />
we use the molecular serogroup methods to predict the<br />
possible serotype described elsewhere (Taha, 2000),<br />
(Bennett et al., 2004). A 450 bp fragment predicted<br />
serogroup B Neisseria meningitidis was positive in the<br />
two ctrA gene positive oropharyngeal swabs sample and<br />
also the patient’s serum. MLST analyses were verified<br />
here with the close contact strain. The sequence type of<br />
this close contact strain was ST -7623 which was a new<br />
ST type found in our study belonging to ST-4821 complex.<br />
MLST was also conducted using the DNA template<br />
extracted from the serum of this patient. Only three<br />
fragments (adk, aroE and gdh) were obtained and<br />
sequenced. To search the type in the PubMLST net, the<br />
allelic profile was identical to 12 sequence types that all<br />
belonging to ST-4821 complexs. Also, the sequence of<br />
these three fragments identical to the close contact strain.<br />
According to the above-listed, we conclude that the<br />
pathogen of this fatal case was serogroup B N.<br />
meningitidis which belonging to ST-4821 complexs.<br />
DISCCUSSION<br />
Currently, rapid laboratory diagnosis of meningococcal<br />
disease has been widely used as routine methods<br />
(Bryant et al., 2004; Hoang et al., 2005). Especially, when<br />
the bacterial could not been isolated, PCR based<br />
methods will be very important in confirming the<br />
meningococci infection. With the only sample like serum<br />
of patient, MLST could be used in epidemiology research<br />
(Zhang et al., 2006). In this case, PCR and MLST method<br />
was used in laboratory confirmation and epidemiology<br />
research as only the serum sample was obtained. To our<br />
knowledge, this is the first death case causing by<br />
serogroup B meningococci belonging to ST- 4821<br />
complexs in China.<br />
Serogroup C meningococci have been associated with<br />
the outbreaks in 2003. Then a unique ST-4821 clone has<br />
been characterized (Shao et al., 2006). ST-4821 complex<br />
isolates were observed as early as 1980 in China and<br />
existed in several serogroups like C, B, H, I and K (Yang<br />
et al., 2007; 2008; Zhang et al., 2007). In addition to ST-<br />
4821 complex has been seen in serogrop B<br />
meningococcal isolated from healthy carriers on the<br />
Chinese mainland, it also have been seen from invasive<br />
cases in Taiwan (Chiou et al., 2006). Here we also found<br />
the serogroup B meningococcal belonging to ST- 4821<br />
complex in a fatal case. Because the pathogen strain of<br />
the patient was not able to isolate and we can only get 3<br />
gene fragments from the patient’s serum. Moreover we<br />
isolated two N. meningitidis strains from the oropharyngeal<br />
swabs of patient’s other 10 classmates. This two<br />
strains also belongs to B serogroup and the sequence<br />
type was ST-4821 and ST-5586 each. The 3 gene<br />
fragments from the patient’s serum also indentical to the<br />
ST-4821 strain. We also got ctrA gene positive result from<br />
2 of 5 close contacts, one close contact strain with the<br />
exact sequence type is unsatisfactory. So we presumed<br />
there was not sufficient evidence to confirm the exact<br />
sequence type of this etiological strain. After all it seems<br />
belonging to ST-4821 complex.<br />
Multivalence vaccines A plus C have used widely in<br />
China after the serogroup C meningococci outbreaks.<br />
Thus, the B serogroup has been observed in healthy<br />
carrier is relative higher than before and even maybe the<br />
capsule switch between B and C (Beddek et al., 2009).<br />
The case presented here indicate the need for better<br />
surveillance of the epidemiology of meningococcal meningitis<br />
in China, especially the new unique hypervirulent<br />
meningococcal lineage ST- 4821 complexs.<br />
ACKNOWLEDGEMENTS<br />
We thank all the researchers in hospitals and Wang Qian<br />
in the Baqiao district CDC. We also thank Dr Julia<br />
Bennett at the University of Oxford for the registration of<br />
the close contact strain as new ST in the MLST database.<br />
REFERENCES<br />
Beddek AJ, Li MS, Kroll JS, Jordan TW, Martin DR (2009). Evidence for<br />
capsule switching between carried and disease-causing Neisseria<br />
meningitidis strains. Infect. Immun., 77: 2989-2994.<br />
Bennett DE, Mulhall RM, Cafferkey MT (2004). PCR-based assay for<br />
detection of Neisseria meningitidis capsular serogroups 29E, X, and<br />
Z. J. Clin. Microbiol., 42: 1764-1765.<br />
Bryant PA, Li HY, Zaia A, Griffith J, Hogg G, Curtis N, Carapetis JR<br />
(2004). Prospective study of a real-time PCR that is highly sensitive,<br />
specific, and clinically useful for diagnosis of meningococcal disease<br />
in children. J. Clin. Microbiol., 42: 2919-2925.<br />
Cartwright K, Reilly S, White D, Stuart J (1992). Early treatment with<br />
parenteral penicillin in meningococcal disease. Bmj, 305: 143-147.<br />
Chiou CS, Liao JC, Liao TL, Li CC, Chou CY, Chang HL, Yao SM, Lee<br />
YS (2006). Molecular epidemiology and emergence of worldwide
epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect. Dis.,<br />
6: 25.<br />
Hoang LM, Thomas E, Tyler S (2005). Rapid and fatal meningococcal<br />
disease due to a strain of Neisseria meningitidis containing the<br />
capsule null locus. Clin. Infect. Dis., 40: 38-42.<br />
Hu X (1991). Study on periodically prevalent feature for epidemic<br />
cerebrospinal meningitis in China. J. Chin. Epidemiol., 12: 136-139.<br />
Jordens JZ, Williams JN, Jones GR, Heckels JE (2002). Detection of<br />
meningococcal carriage by culture and PCR of throat swabs and<br />
mouth gargles. J. Clin. Microbiol., 40: 75-79.<br />
Maiden MC, Bygraves JA, Feil E (1998). Multilocus sequence typing: a<br />
portable approach to the identification of clones within populations of<br />
pathogenic microorganisms. Proc. Natl. Acad. Sci. USA., 95: 3140-<br />
3145.<br />
Shao Z, Li W, Ren J (2006). Identification of a new Neisseria<br />
meningitidis serogroup C clones from Anhui province, China. Lancet,<br />
367: 419-423.<br />
Wang et al. 2387<br />
Taha MK (2000). Simultaneous approach for non-culture PCR-based<br />
identification and serogroup prediction of Neisseria meningitidis. J.<br />
Clin. Microbiol., 38: 855-857.<br />
Yang J, Zhang X, Xu X (2007). Genotypic analysis of serogroups other<br />
than A, B or C of Neisseria meningitidis in China. Scand. J. Infect.<br />
Dis., 39: 819-821.<br />
Yang L, Shao Z, Zhang X, Xu L, Peng J, Xu X, Liang X, Qi Y, Jin Q<br />
(2008). Genotypic characterization of Neisseria meningitidis<br />
serogroup B strains circulating in China. J. Infect., 56: 211-218.<br />
Zhang TG, He X, Chen LJ, He JG, Luo M, Yang J, Shao ZJ, Sun MP<br />
(2006). Laboratory confirmation of a suspicious meningococcal<br />
meningitis death case. J. Microbiol., 44: 457-460.<br />
Zhang X, Shao Z, Yang E (2007). Molecular characterization of serogroup<br />
C Neisseria meningitidis isolated in China. J. Med. Microbiol.,<br />
56: 1224-1229.
African Journal of Microbiology Research Vol. 5(16), pp. 2388-2390, 18 August, 2011<br />
Available online http://www.academicjournals.org/ajmr<br />
DOI: 10.5897/AJMR11.536<br />
ISSN 1996-0808 ©2011 <strong>Academic</strong> <strong>Journals</strong><br />
Short Communication<br />
Genotyping of Hepatitis C virus (HCV) in infected<br />
patients from Saudi Arabia<br />
Mohammed Ali M. Marie<br />
Clinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University,<br />
P. O. Box 10219 Riyadh 11433, Kingdom of Saudi Arabia. E-mail: mmarie@ksu.edu.sa. Tel: +96614696022.<br />
Accepted 30 June, 2011<br />
A molecular study was carried to investigate the prevalence of Hepatitis C virus (HCV) genotypes in<br />
HCV infected population of Saudi Arabia. A total of HCV-positive clinical specimens (serum, EDTA<br />
plasma) with viral loads above 2,000 IU/ml were collected for genotyping. Genotyping of 358 samples<br />
revealed four different genotypes including 1 (1a and 1b), 2a, 3 (3a) and 4. The most prevalent genotype<br />
was 4 with rate of 74.2% followed by genotype 3 (11.7%) and 1a (3.9%). The predominance of HCV<br />
genotype 4 in our population confirms the predominance of HCV genotype 4 in Saudi Arabia and most<br />
of the Arab countries in the Middle East.<br />
Key words: Hepatitis C virus (HCV), genotypes, Saudi Arabia, Riyadh.<br />
INTRODUCTION<br />
Hepatitis C virus (HCV) infection is a global public health<br />
problem. World Health Organization (WHO) estimates up<br />
to 3% of the world's population to be infected with HCV<br />
and there are approximately 180 million individuals are<br />
thought to be infected. On average, 80% of acutely infected<br />
individuals develop a chronic infection (Lavanchy,<br />
2009; Ghany, 2009). HCV has a positive-sense singlestranded<br />
RNA genome of flavivirus and about 9.6 kb<br />
containing one long open reading frame (ORF) with<br />
untranslated regions at both ends (Choo et al., 1989). So<br />
far, six major genotypes (HCV-1 to HCV-6) have been<br />
described, each containing multiple subtypes (for<br />
example, 1a, 1b, etc.) (Tokita et al., 1995). The genotype<br />
of the HCV strain appears to be an important determinant<br />
of the severity and aggressiveness of liver infection, as<br />
well as patient response to antiviral therapy (Zein, 2000).<br />
HCV genotypes display significant differences in their<br />
global distribution and prevalence, making genotyping a<br />
useful method for determining the source of HCV transmission<br />
in an infected localized population (Hnatyszyn,<br />
2005).<br />
Abbreviations: HCV, Hepatitis c virus; WHO, world health<br />
organization; ORF, open reading frame; RNA, ribonucleic acid;<br />
PCR, polymerase chain reaction; EDTA,<br />
ethylenediaminetetraacetic acid; HCC, hepatocellular<br />
carcinoma.<br />
HCV genotype 1, 2 and 3 are distributed worldwide and<br />
their relative prevalence varies from one geographic area<br />
to another, whereas genotype 4 is predominantly prevalent<br />
in the Middle East and Africa, genotype 5 in South<br />
Africa and genotype 6 in Southeast Asia (Zein, 2000;<br />
Gish and Lua, 1997). According to the recent studies,<br />
genotype 4 is predominant in Egypt, 4 and 1 in Kuwait<br />
and Syria, and genotype 1 in Lebanon, Iraq and Iran<br />
(Osaba, 2002; Pacsa et al., 2001; Zali et al., 2000). Saudi<br />
Arabia shows an intermediate endemicity for HCV.<br />
Seroprevalence rates ranging from 0.9 to 5% have been<br />
reported among children and adults, respectively<br />
(Shobokshi et al., 1999). Some studies have indicated<br />
the predominance of genotype 4 in this region (Mellor et<br />
al., 1995; Al-Faleh et al., 1995). Hence HCV subtype<br />
distribution is needed to provide clues for studying<br />
epidemiology, the mode of transmission, and response to<br />
treatment. The objective of this study was to determine<br />
the distribution of HCV genotypes among the patients<br />
attending different hospitals and polyclinics in Riyadh,<br />
Saudi Arabia.<br />
MATERIALS AND METHODS<br />
This was a descriptive study conducted from January 2008 to<br />
December 2010 from different hospitals as well as polyclinics at<br />
Advanced Cell laboratory, Riyadh, Saudi Arabia. The latter is a<br />
reference laboratory serving a number of hospitals and polyclinics<br />
in Riyadh. Patients positive for anti-HCV antibodies were referred
Table 1. Genotype distribution of 358 HCV positive patients.<br />
Nationality Total<br />
HCV genotype<br />
Mohammed 2389<br />
1 1a 1b 2a 3 3a 4<br />
Saudi 208 - 6 7 5 8 - 182<br />
Egyption 98 13 - - - 8 - 79<br />
Pakistan 33 - - - - 26 7 -<br />
Others 17 - 8 5 - - - 4<br />
Total (%) 358 (100) 13 (3.6) 14 (3.9) 12 (3.3) 5 (1.4) 42 (11.7) 7 (1.9) 265 (74.2)<br />
Table 2. HCV Genotype among male and female.<br />
Gender<br />
1 1a 1b<br />
HCV genotype<br />
2a 3 3a 4<br />
Total (%)<br />
Male 13 3 2 1 36 7 178 240 (67)<br />
Female 0 11 10 4 6 0 87 118 (33)<br />
to the reference laboratory for detection of HCV RNA level and for<br />
genotyping. The study was designed to include patient's demographics<br />
(age, sex and nationality) as well. Detection of HCV<br />
ribonucleic acid (RNA) was carried out on a 500 ul sample of each<br />
serum sample positive for anti-HCV antibodies, using a commercial<br />
polymerase chain reaction (PCR) -based test (Taqman amplicor,<br />
Roche, USA) and following manufacturer’s instructions. Internal<br />
control supplied by the manufacturer was added to each specimen,<br />
as an extraction and amplification control. HCV positive clinical<br />
specimens (serum, ethylenediaminetetraacetic acid) (EDTA) plasma<br />
with viral loads >2,000 IU/ml were selected for genotyping using<br />
Versant HCV genotype assay (LiPA) 2.0 (Innogenetics, Siemens<br />
Healthcare Diagnostics, USA). This kit allows an improved and<br />
more accurate distinction between HCV genotype 1 and subtypes c<br />
to l of genotype 6 as well as between subtypes a and b of genotype<br />
1. Data was analyzed using SPSS-14 version. A p Value of < 0.5<br />
was considered significant for statistical analysis.<br />
RESULTS<br />
Genotype distribution in 358 HCV-positive patients is<br />
shown in Table 1. Overall, HCV genotype 4 was the most<br />
predominant genotype (74.2%) followed by genotype 3<br />
(11.7%) and 1a (3.9%). Differences in genotype distribution<br />
were statistically significant (p
2390 Afr. J. Microbiol. Res.<br />
Saudi Arabian patients can be attributed to many factors.<br />
These include the expatriates from different nationalities<br />
resided in Saudi Arabia for quite some time and participated<br />
in blood donation.<br />
According to the World Health Organization, 180 million<br />
individuals in the world are infected with HCV and this is<br />
a growing global problem. The development of an<br />
effective vaccine remains the ideal way to combat HCV<br />
infection. In addition to the implications for clinical outcome<br />
of infection, and for treatment, genotyping of HCV<br />
also has major implications for HCV vaccine development.<br />
Recent data suggest that for a vaccine to be fully<br />
protective it should contain a range of deferent envelope<br />
proteins corresponding to the common genotypes in<br />
particular geographic regions. Vaccines for use in the<br />
Middle East should, therefore, not be based only on<br />
genotype 4 sequences; other genotypes such as 1a and<br />
1b are also equally important. Finally, genotyping of HCV<br />
may be a useful epidemiological marker particularly in<br />
establishing suspected unconventional routes of HCV<br />
transmission such as vertical, intraspousal or interfamilial<br />
transmission (Alfaresi, 2011).<br />
ACKNOWLEDGMENT<br />
The author would like to thank all the staff at Research<br />
center, college of applied medical sciences, King Saud<br />
University for their valuable support.<br />
REFERENCES<br />
Al-Faleh FZ, Ramia S, Arif M, Ayoola EA, Al-Rashed RS, Al-Jeffry M,<br />
Hossain A, El-Hazmi M (1995). Profile of hepatitis C virus (HCV) and<br />
the possible modes of transmission of the virus in Gizan, area of<br />
Saudi Arabia: a community-based study. Ann. Trop. Med. Parasitol.,<br />
89(4): 431-437.<br />
Alfaresi MS (2011). Prevalence of hepatitis C virus (HCV) genotypes<br />
among positive UAE patients. Mol. Biol. Rep., 38(4): 2719-2722.<br />
Bdour S (2002). Hepatitis C virus infection in Jordanian haemodialysis<br />
units, serological diagnosis and genotyping. J. Med. Microbiol., 51(8):<br />
700-704.<br />
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M<br />
(1989). Isolation of a cDNA clone derived from a bloodborne non-A,<br />
non-B hepatitis genome. Science, 244(4902): 359-362.<br />
Ghany MG (2009). Diagnosis, management, and treatment of hepatitis<br />
C: An update. Hepatology, 49(4): 1335-1374.<br />
Gish RG, Lua JYN (1997). Hepatitis C virus: eight years old. Viral Hep.<br />
Rev., 3: 17-37.<br />
Hnatyszyn HJ (2005). Chronic hepatitis C and genotyping: the clinical<br />
significance of determining HCV genotypes. Antivir. Ther., 10(1): 1-<br />
11.<br />
Idrees M, Riazuddin S (2008). Frequency distribution of hepatitis C virus<br />
genotypes in different geographical regions of Pakistan and their<br />
possible routes of transmission. BMC Infect. Dis., 23(8): 69-78.<br />
Lavanchy D (2009). The global burden of hepatitis C. Liver Int., 29(1):<br />
74-81.<br />
McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi<br />
VK (1998). Interferon alfa-2b alone or in combination with ribavirin as<br />
initial treatment for chronic hepatitis C. Hepatitis Interventional<br />
Therapy Group. N. Eng. J. Med., 339(21): 1485-1492.<br />
Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P (1995).<br />
Investigation of the pattern of hepatitis C virus sequence diversity in<br />
different geographical regions: implications for virus classification.<br />
The international HCV collaborative study group. J. Gen. Virol., 76(Pt<br />
10): 2493-2507<br />
Mujeeb SA (2002). HCV 3 in Pakistan: does it offer more hope for cure<br />
or control. J. Pak. Med. Assoc., 52: 191-192.<br />
Osaba AO (2002). Hepatitis C virus genotypes in Saudi Arabia. Saudi<br />
Med. J., 23(1): 7-12.<br />
Pacsa AS, Al-Mufti S, Chugh TD, Said-Adi G (2001). Genotypes of<br />
Hepatitis C virus in Kuwait. Med. Principles Pract., 10: 55-57.<br />
Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000). Genetic<br />
Epidemiology of hepatitis C throughout Egypt. J. Infect. Dis., 182(3):<br />
239-244.<br />
Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN (1999).<br />
Hepatitis C genotypes and subtypes in Saudi Arabia. J. Med. Virol.,<br />
58(1): 44-48.<br />
Tokita H, Okamoto H, Luengrojanakul P, Vareesangthip K, Chainuvati<br />
T, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M (1995). Hepatitis C<br />
virus variants from Thailand classifiable into five novel genotypes in<br />
the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic<br />
groups. J. Gen. Virol., 76(Pt 9): 2329-2335.<br />
Zali MR, Mayumi M, Rouf M, Noowroozi A (2000). Hepatitis C virus<br />
genotypes in the Islamic Republic of Iran: a preliminary study.<br />
Eastern Mediterr. Health J., 6: 372-377.<br />
Zein NN (2000). Clinical significance of hepatitis C virus genotypes.<br />
Clin. Microbiol. Rev., 13(2): 223-235.<br />
Zekri AR, Bahnassy AA, Shaarawy SM, Mansour OA, Maduar MA,<br />
Khaled HM, El-Ahmadi O (2000). Hepatitis C virus genotyping in<br />
relation to neu-oncoprotein overexpression and the development of<br />
hepatocellular carcinoma. J. Med. Microbiol., 49(1): 89-95.
UPCOMING CONFERENCES<br />
7th Conference of the World Mycotoxin Forum and<br />
XIIIth IUPAC International Symposium on Mycotoxins and Phycotoxins,<br />
Rotterdam, Netherlands, 5 Nov 2012<br />
13th International Congress on Yeasts, Madison, USA,<br />
26-30 Aug 2012
Conferences and Advert<br />
August 2012<br />
13th International Congress on Yeasts, Madison, USA, 26 Aug 2012<br />
September 2012<br />
6th International Congress on Biocatalysis, Hamburg, Germany, 2 Sep 2012<br />
9th International Congress on Extremophiles, Sevilla, Spain, 10 Sep 2012<br />
October 2012<br />
Actinobacteria within Soils: Capacities for Mutualsim, Symbiosis and Pathogenesis,<br />
Muenster, Germany, 25 Oct 2012<br />
November 2012<br />
7th Conference of the World Mycotoxin Forum and XIIIth IUPAC International<br />
Symposium on Mycotoxins and Phycotoxins, Rotterdam, Netherlands, 5 Nov 2012<br />
December 2012<br />
Marine Microbiology and Biotechnology: Biodiscovery, Biodiversity and<br />
Bioremediation, Cork, Ireland, 19 Dec 2012<br />
International Conference on Pathology and Microbiology, Bangkok, Thailand, 26 Dec<br />
2012
African Journal of<br />
Microbiology Research<br />
Related <strong>Journals</strong> Published by <strong>Academic</strong> <strong>Journals</strong><br />
■ Journal of Cell and Animal Biology<br />
■ African Journal of Biotechnology<br />
■ Biotechnology and Molecular Biology Reviews<br />
■ African Journal of Microbiology Research<br />
■ African Journal of Biochemistry Research<br />
■ Journal of Bacteriology Research